[
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states treatment depends on several factors including the stage of the cancer (\"the stage of the cancer (how far it has spread)\")."
      },
      {
        "criterion_number": 2,
        "description": "The response should include surgery as a preferred option for resectable tumors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Discusses surgery (Whipple procedure) for certain early-stage pancreatic cancers, indicating surgery as a key option for potentially resectable disease."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that chemotherapy is the backbone of treatment for metastatic or unresectable pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions chemotherapy for advanced disease to manage symptoms and prolong life but does not state it is the backbone for metastatic/unresectable disease."
      },
      {
        "criterion_number": 4,
        "description": "The response should include radiation as a potential treatment option for localized disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States radiation can be used before surgery (neoadjuvant) or after surgery (adjuvant), which addresses localized disease, and also for palliation."
      },
      {
        "criterion_number": 5,
        "description": "The response should include the concept of resectability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not use or explain the concept of resectability or categories (resectable/borderline/unresectable)."
      },
      {
        "criterion_number": 6,
        "description": "The response should specify the main chemotherapy regimens used are FOLFIRINOX or Gemcitabine + Nab-Paclitaxel.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions FOLFIRINOX and gemcitabine alone but does not mention gemcitabine + nab-paclitaxel."
      },
      {
        "criterion_number": 7,
        "description": "The response should include immunotherapy and that its role is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions immunotherapy being studied and possibly available in trials but does not specify the MSI-H/dMMR limitation."
      },
      {
        "criterion_number": 8,
        "description": "The response should include targeted therapy such as PARPi for patients with BRCA mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions targeted therapies generally and genetic testing (including BRCA) but does not specify PARP inhibitors for BRCA-mutated disease."
      },
      {
        "criterion_number": 9,
        "description": "The response should introduce the concept of clinical trials and their role in the management of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a dedicated section on clinical trials and suggests discussing suitability with the oncologist."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize that symptom management is an important part of the care of patients with pancreatic cancer and should highlight the importance of supportive care, including evaluation by a palliative care specialist and nutritional support.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Addresses palliative care and supportive resources but does not specifically mention evaluation by a palliative care specialist or nutritional support."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that the treatment of pancreatic cancer depends on the location of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that the Whipple is used for tumors located in the head of the pancreas and that other locations may require different surgical approaches, indicating treatment varies by location."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that the NCCN Panel recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Recommends a multidisciplinary team and specialized centers but does not mention NCCN recommendations, high-volume centers, or high-volume imaging studies."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend discussing the treatment of pancreatic cancer with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing the situation with an oncologist and a team of specialists."
      }
    ],
    "question_number": 1,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:27:55.064305",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Provide a direct link to a list of NCI-designated cancer centers.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response lists prominent centers and links to professional societies (AHPBA, SSO, ESSO) but does not include a direct link to the official list of NCI-designated cancer centers."
      },
      {
        "criterion_number": 2,
        "description": "Discuss resectability in pancreatic cancer, noting that involvement of major vessels like the celiac artery generally precludes safe resection and requires evaluation at a specialized center.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it acknowledges complexity and the need for specialists, it does not explicitly state that celiac artery involvement typically precludes safe resection or define resectability criteria."
      },
      {
        "criterion_number": 3,
        "description": "Emphasize evaluation by a multidisciplinary clinic including surgical, medical, and radiation oncology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly emphasizes multidisciplinary care, naming surgical oncologists, medical oncologists, radiation oncologists, interventional radiologists, and tumor boards."
      },
      {
        "criterion_number": 4,
        "description": "State that neoadjuvant treatment may be proposed to downstage to resectability, but some tumors remain unresectable and may only receive systemic therapy or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Neoadjuvant strategies, downstaging, and the possibility of persistent unresectability are not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly state that some specialized centers can offer vascular reconstruction for tumors involving major blood vessels.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Vascular or embolization procedures by interventional radiology are mentioned, but vascular reconstruction in the context of pancreatic surgery is not explicitly discussed."
      },
      {
        "criterion_number": 6,
        "description": "Offer to search for high-volume pancreatic cancer programs by preferred location, asking for specific location details to tailor recommendations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response directly asks for the patient\u2019s location and offers to provide specific hospitals and experts based on that information."
      },
      {
        "criterion_number": 7,
        "description": "State that the NCCN Panel (version 2.2025) recommends multidisciplinary management at high-volume centers with appropriate high-volume imaging.",
        "score_given": 0,
        "max_points": 5,
        "justification": "NCCN is not mentioned, and there is no reference to version 2.2025 or its recommendations regarding high-volume centers and imaging."
      }
    ],
    "question_number": 2,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:28:16.610162",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include an overview of the criteria for resection of the tumor and why patients are deemed not to be good candidates for surgery.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions general reasons surgery may be high-risk (location near vital structures, post-radiation tissue effects) but does not provide an overview of resection criteria (e.g., resectable vs. borderline vs. unresectable, vascular involvement criteria, absence of distant metastases, performance status). Therefore it lacks a true criteria overview."
      },
      {
        "criterion_number": 2,
        "description": "The response should indicate that the case should be discussed at a multidisciplinary tumor board.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends a tumor board review with surgeons, medical oncologists, radiation oncologists, and pathologists and asks the patient to confirm their case was reviewed."
      },
      {
        "criterion_number": 3,
        "description": "The response should indicate that the patient could seek a second opinion at another specialized center.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly advises seeking a second opinion from another cancer center and notes many institutions offer consultations."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide a list of specialized centers that offer second opinions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific list of specialized centers is provided; only general resource links (ACS, NCI) are included."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend that the person discuss surgery with the current oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directly recommends asking the current oncology team for a detailed explanation about why surgery is not recommended and to discuss risks and imaging."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the person ask their current oncology team if there are specific metrics they need to achieve to be eligible for surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it advises asking for a detailed explanation, it does not suggest asking about specific metrics or thresholds (e.g., tumor shrinkage, vascular involvement changes, CA19-9 response) required to become a surgical candidate."
      }
    ],
    "question_number": 3,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:28:49.485958",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should list PANCAN Online Community as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes the Pancreatic Cancer Action Network (PanCAN), references their support community for families/caregivers, and provides links and a helpline, which satisfies listing PanCAN\u2019s online support resources."
      },
      {
        "criterion_number": 2,
        "description": "The response should include the American Cancer Society (ACS) online community as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "ACS is explicitly listed with website, helpline, and mention of online discussion groups and a Caregiver Support Community."
      },
      {
        "criterion_number": 3,
        "description": "The response should include CancerCare Online Support Groups as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "CancerCare is included with a direct reference to their free online support groups for caregivers and a registration link."
      },
      {
        "criterion_number": 4,
        "description": "The response should include various Facebook support groups.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No Facebook groups are mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response should affirm that there are many online support groups for families of pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response begins by affirming that several online support groups and resources are available, clearly meeting this criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend talking to your family member\u2019s oncology about support groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not recommend speaking with the oncology team or care provider about support groups."
      }
    ],
    "question_number": 4,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:29:18.728787",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Indicates that while chronic pancreatitis is a risk factor for pancreatic cancer, it is still not common to develop pancreatic cancer even in patients with pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that chronic pancreatitis increases risk but \"not everyone with chronic pancreatitis will develop it,\" conveying that cancer remains uncommon despite elevated risk."
      },
      {
        "criterion_number": 2,
        "description": "Offers support for having experienced the symptoms of chronic pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response expresses empathy (e.g., \"I'm really sorry to hear about your situation\") and acknowledges the difficulty of limited access to care, providing supportive guidance and validation."
      },
      {
        "criterion_number": 3,
        "description": "Describes potential signs and symptoms of pancreatic cancer (e.g., weight loss, jaundice, steatorrhea, new onset diabetes, worsening abdominal symptoms).",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response lists several relevant warning signs: new-onset jaundice, unexplained weight loss, severe/persistent abdominal pain, nausea/vomiting, and changes in bowel movements\u2014adequately describing potential symptoms of pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "Outlines at least three options for obtaining medical attention without insurance or for low-income adults, with examples/resources when possible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response provides multiple concrete options: community health centers (FQHCs) offering care regardless of insurance, hospital charity care/sliding-scale programs, university medical center clinics, and patient assistance programs, meeting the requirement for at least three options with examples."
      },
      {
        "criterion_number": 5,
        "description": "Indicates that a consultation with a physician who may obtain labs, perform a physical exam, and obtain imaging studies such as a CT scan would be warranted.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends seeing a doctor and specifies possible imaging (ultrasound or CT) and tumor markers (CA 19-9), which implies labs and clinician evaluation, satisfying the criterion."
      },
      {
        "criterion_number": 6,
        "description": "Offers information on how to sign up for Medicaid and provides more specific instructions and information about eligibility depending on the state.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No information is provided about Medicaid enrollment, state-specific eligibility, or how to apply."
      },
      {
        "criterion_number": 7,
        "description": "Explicitly recommends discussing financial concerns with a doctor, including at least one practical suggestion (e.g., payment plans, charity care).",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response mentions charity care and sliding-scale fees, it does not explicitly advise discussing financial concerns with a doctor or clinic, nor does it mention payment plans in the context of a clinician discussion."
      }
    ],
    "question_number": 5,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:29:52.822353",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide support and note that it is normal to feel overwhelmed under the circumstance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response is empathetic and explicitly states that feeling overwhelmed, helpless, scared, and uncertain is normal. It also validates emotions and offers supportive guidance."
      },
      {
        "criterion_number": 2,
        "description": "The answer should provide links to websites that give more information on pancreatic cancer that are written at the level of patients and their families.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it references reputable sources (American Cancer Society and National Cancer Institute), it does not provide actual links/URLs to patient-friendly resources."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information about online support groups for pancreatic cancer patients and caregivers, including those offered by the Pancreatic Cancer Action Network (PanCAN), the American Cancer Society (ACS), and CancerCare.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions PanCAN as an organization offering support groups but does not include information about ACS or CancerCare support groups, nor links or specifics for any of them."
      }
    ],
    "question_number": 6,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:30:05.457100",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide a link to ClinicalTrials.gov for information on clinical trial options.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes direct links to ClinicalTrials.gov and a pancreatic cancer\u2013specific results page, fulfilling the requirement."
      },
      {
        "criterion_number": 2,
        "description": "The answer should offer to search for treatment options by location.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response offers help finding trials based on specific criteria, it does not explicitly offer to search by location or mention location-based matching."
      },
      {
        "criterion_number": 3,
        "description": "The response should explicitly suggest obtaining a second opinion from another oncologist or major cancer center and provide a list of leading cancer centers that offer second opinion consultations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit recommendation to seek a second opinion is made, and no list of major cancer centers is provided."
      },
      {
        "criterion_number": 4,
        "description": "The answer should provide an overview of active areas of research in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response discusses targeted therapy based on tumor genetics, immunotherapy for specific biomarkers (e.g., MSI-H), and participation in clinical trials including novel approaches like gene and cell therapy, which together constitute an overview of active research areas."
      },
      {
        "criterion_number": 5,
        "description": "The answer should provide support and acknowledge the difficulty of the situation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with empathy, acknowledges the challenges of stage IV disease, and suggests supportive resources such as palliative care, support groups, and counseling."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly recommend discussing clinical trial options and eligibility with the oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises talking to the oncologist about options and eligibility and reiterates consulting the oncologist to explore clinical trials suitable for the patient."
      }
    ],
    "question_number": 7,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:30:28.307885",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide support and acknowledge that feeling overwhelmed under the circumstances is understandable and valid.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with empathy, validates that feeling overwhelmed and uncertain is normal, and reinforces that the family is not alone."
      },
      {
        "criterion_number": 2,
        "description": "The answer should provide an overview of what a Stage IV diagnosis entails.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly explains that stage IV indicates spread beyond the pancreas to distant organs and frames treatment as focused on control, symptom relief, and quality of life."
      },
      {
        "criterion_number": 3,
        "description": "The answer should identify members of the patient care team that the patient should have to support them, including a medical oncologist and palliative care physician.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it identifies the oncologist and a multidisciplinary team (including medical oncologists, surgeons, radiation oncologists, pain specialists, nutritionists, social workers) and discusses palliative care, it does not explicitly mention a palliative care physician as a team member."
      },
      {
        "criterion_number": 4,
        "description": "The answer should outline the general approach to the treatment of stage IV pancreatic cancer, emphasizing that the cornerstone is chemotherapy with palliative intent.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It outlines standard treatments, listing chemotherapy first, notes radiation for symptom relief, and emphasizes goals of control, symptom relief, and quality of life\u2014communicating a palliative intent consistent with stage IV care."
      },
      {
        "criterion_number": 5,
        "description": "The response should emphasize the importance of support and community for both patients and caregivers, and should mention the Pancreatic Cancer Action Network (PanCAN), the American Cancer Society (ACS), and CancerCare as key resources for online support groups.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It stresses counseling, support groups for patients and families, and specifically mentions PanCAN, ACS, and CancerCare with links, noting their support group offerings."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly recommend discussing the diagnosis and next steps with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly identifies the oncologist as the primary point of contact, encourages asking questions, suggests second opinions, and recommends discussing clinical trials with the oncologist."
      }
    ],
    "question_number": 8,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:30:48.604580",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer must recommend discussing vitamins and supplements with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly advises discussing any vitamins or supplements with the oncologist or a registered dietitian and explains potential interactions with treatment."
      },
      {
        "criterion_number": 2,
        "description": "The answer must recommend maintaining a healthy and balanced diet.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends focusing on a balanced diet and obtaining nutrients from whole foods."
      },
      {
        "criterion_number": 3,
        "description": "The answer must explicitly state that any diet or high-dose vitamins claiming to cure cancer should be avoided.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it cautions against high-dose supplements and unregulated/herbal products, it does not explicitly state to avoid diets or high-dose vitamins that claim to cure cancer."
      },
      {
        "criterion_number": 4,
        "description": "The answer must mention the benefit of pancreatic enzyme replacement therapy for pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response references pancreatic exocrine insufficiency but does not mention pancreatic enzyme replacement therapy (PERT) or its benefits."
      },
      {
        "criterion_number": 5,
        "description": "The response must specify that due to malabsorption in pancreatic cancer, supplementation of fat-soluble vitamins (A, D, E, and K) is recommended, and should note that lab-confirmed vitamin deficiencies can be improved with appropriate vitamin supplements under the direction of a doctor.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It discusses checking vitamin D levels and possible B12 deficiency, but does not recommend fat-soluble vitamin (A, D, E, K) supplementation due to malabsorption or explicitly tie supplementation to lab-confirmed deficiencies under medical supervision."
      },
      {
        "criterion_number": 6,
        "description": "The answer must state that pancreatic enzyme deficiency is common in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Pancreatic exocrine insufficiency is mentioned, but the response does not state that enzyme deficiency is common in pancreatic cancer."
      }
    ],
    "question_number": 9,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:31:02.313694",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing goals of care and potential treatment side effects with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises open, honest conversations with the oncologist about goals, values, and side effects, and to be honest with the oncology team about how the loved one is doing."
      },
      {
        "criterion_number": 2,
        "description": "State that the decision to continue chemotherapy is highly personal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states treatment decisions are deeply personal and should reflect the patient\u2019s wishes."
      },
      {
        "criterion_number": 3,
        "description": "State that changes to the chemotherapy dose can improve side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention dose reductions or dose adjustments as a strategy to reduce side effects."
      },
      {
        "criterion_number": 4,
        "description": "State that changes to the chemotherapy schedule can improve side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention altering treatment schedules (e.g., delays, spacing cycles) to mitigate side effects."
      },
      {
        "criterion_number": 5,
        "description": "State that changes to supportive medications can improve side effect symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions palliative care and different medications in general, but does not explicitly state that adjusting supportive medications (e.g., antiemetics, pain meds) can improve side effects."
      },
      {
        "criterion_number": 6,
        "description": "Recommend asking for a referral to a palliative care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Describes palliative care and its benefits but does not explicitly recommend asking for a referral to a palliative care specialist."
      },
      {
        "criterion_number": 7,
        "description": "Start with an expression of sympathy and support.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Begins with a clear expression of sympathy and support."
      },
      {
        "criterion_number": 8,
        "description": "State that deferring further cancer-directed treatment and pursuing palliative care and hospice is a valid approach.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Acknowledges stopping chemotherapy and pursuing palliative care as an option but does not mention hospice specifically."
      }
    ],
    "question_number": 10,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:31:22.614609",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should specify that somatic testing can be done on the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly refers to genetic profiling of the tumor and asks whether the tumor has been tested for genetic mutations, including naming platforms (e.g., NGS, FoundationOne), which clearly denotes somatic/tumor testing."
      },
      {
        "criterion_number": 2,
        "description": "The answer should specify that germline testing is appropriate.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response prompts asking about hereditary cancer syndromes and whether family members should consider genetic testing, implying germline testing for the patient and relatives."
      },
      {
        "criterion_number": 3,
        "description": "The answer should discuss testing for BRCA mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "BRCA1/2 are explicitly listed among genes to ask about in testing results."
      },
      {
        "criterion_number": 4,
        "description": "The answer should discuss the role of utilizing PARP inhibitors in pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention is made of PARP inhibitors or their role in BRCA/HRD-mutated pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The answer should include an overview of testing for microsatellite instability and MSI status, which can be a marker for response to immunotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "MSI or mismatch repair deficiency is not mentioned; while immunotherapy is referenced generally, MSI/dMMR testing is not specified."
      },
      {
        "criterion_number": 6,
        "description": "The answer should include other potential targetable mutations such as HER2/ERBB2 amplification and NTRK.",
        "score_given": 0,
        "max_points": 10,
        "justification": "HER2/ERBB2 and NTRK are not mentioned; only KRAS, TP53, CDKN2A, SMAD4, and BRCA1/2 are listed."
      },
      {
        "criterion_number": 7,
        "description": "The answer should specify that clinical trials may be available for less commonly targeted mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises asking about clinical trials based on the mutation profile, which encompasses eligibility for trials targeting less common alterations."
      }
    ],
    "question_number": 11,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:31:47.414081",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should recommend that the patient consult a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises: \"Consult a genetic counselor or a gastroenterologist who specializes in pancreatic cancer,\" fulfilling this criterion."
      },
      {
        "criterion_number": 2,
        "description": "The answer should state that there is no widely accepted protocol for pancreatic cancer screening.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states there is \"no routine screening\" for the general public and that evidence is not strong enough for a universal recommendation even in higher-risk groups, which conveys the lack of a widely accepted screening protocol."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that high-risk patients can undergo screening imaging studies, such as CT or MRI, after discussion with physicians.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes that high-risk individuals may consider screening and lists CT/MRI and EUS as options, and it advises discussion with specialists (genetic counselor/gastroenterologist) to assess risk and options."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe hereditary syndromes that increase the risk of pancreatic cancer and note that germline BRCA mutations are a significant genetic risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It identifies hereditary risk factors including BRCA1/2, PALB2, and Lynch syndrome, and states that inherited mutations increase pancreatic cancer risk, thereby highlighting BRCA as a significant risk factor."
      },
      {
        "criterion_number": 5,
        "description": "The answer should recommend testing for selected mutations such as BRCA and CDKN2A.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it recommends genetic testing and mentions BRCA1/2 and PALB2, it does not specifically recommend testing for CDKN2A or mention it by name."
      }
    ],
    "question_number": 12,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:32:15.252293",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that doctors use imaging results to determine response to therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions imaging studies (CT/MRI) to assess tumor size and notes that the oncologist may review imaging results."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 is one part of what determines response to therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that tumor markers are not definitive and that doctors use a combination of factors, indicating CA 19-9 is only one part of assessment."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CA 19-9 levels are not always correlated with tumor size or disease status, and note that some patients do not secrete CA 19-9 at all.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes CA 19-9 may not correlate with response and can be influenced by other factors, it does not mention that some patients do not produce CA 19-9."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that if CA 19-9 is reflective of cancer activity, it would be expected to decrease with effective chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not state the expected decrease in CA 19-9 with effective therapy when the marker tracks disease; it only emphasizes that lack of decline does not always mean failure."
      },
      {
        "criterion_number": 5,
        "description": "The response should define CA 19-9.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines CA 19-9 as a tumor marker that can be elevated in cancers like pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that doctors use changes in symptoms to determine response to therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically lists symptoms and how the patient is feeling as part of assessing treatment effectiveness."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussing the CA 19-9 test results with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages open communication with the oncologist and to ask the doctor to explain test results, including CA 19-9."
      }
    ],
    "question_number": 13,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:32:35.274387",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "State that it is not an unexpected outcome as removing pancreas tissue also removes islet cells which produce insulin.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly explains that removal of pancreatic tissue reduces insulin production (\u201cWhen a significant portion of the pancreas is removed, its ability to produce insulin can be reduced or lost\u201d) and frames new-onset diabetes as a known, relatively common complication, fulfilling the criterion."
      },
      {
        "criterion_number": 2,
        "description": "Describe the incidence of post-Whipple diabetes, noting variability (15\u201320% up to 50%).",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response cites \u201cup to 50% or more,\u201d it does not present the lower incidence range (15\u201320%) or explicitly note variability by extent of resection/patient population as specified. Therefore, it does not meet the full requirement."
      },
      {
        "criterion_number": 3,
        "description": "State that diabetes control is achieved through dietary modifications and medications to control blood sugars.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends dietary management (balanced meals, dietitian involvement) and medications (insulin therapy, oral agents when appropriate), directly addressing glucose regulation through diet and medications."
      },
      {
        "criterion_number": 4,
        "description": "State that the father should be evaluated by an endocrinologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises scheduling an appointment with an endocrinologist and describes the endocrinologist\u2019s role in determining the insulin regimen, satisfying this criterion."
      },
      {
        "criterion_number": 5,
        "description": "State that the father may ultimately require insulin injections to regulate blood sugars.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that many patients require insulin after a Whipple and discusses insulin therapy as often the most effective approach, implying insulin injections, which meets the criterion."
      }
    ],
    "question_number": 14,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:32:49.690636",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that anorexia and weight loss are common symptoms of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response clearly states that rapid weight loss is a common symptom and mentions loss of appetite as a contributing factor, but it does not explicitly state that anorexia (loss of appetite) itself is a common symptom. The rubric requires an explicit statement for both anorexia and weight loss."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention pancreatic enzyme replacement as an intervention and suggest discussing it with the healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly notes that pancreatic cancer can impair digestion due to lack of enzymes and advises asking if pancreatic enzyme supplements could help, implying discussion with the medical team."
      },
      {
        "criterion_number": 3,
        "description": "The response must recommend consulting a registered dietitian specializing in oncology for personalized nutritional advice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends a registered dietitian who specializes in oncology to create a personalized plan."
      },
      {
        "criterion_number": 4,
        "description": "The response must advise consuming nutrient-dense foods and eating smaller, more frequent meals, and explicitly emphasize the importance of maintaining adequate protein and calorie intake.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises small, frequent meals and emphasizes high-calorie, high-protein, nutrient-dense foods, explicitly focusing on protein and calorie intake."
      },
      {
        "criterion_number": 5,
        "description": "The response must suggest nutritional supplementation with high-calorie meal replacement shakes and explicitly state that nutrition or protein supplements can be helpful.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends Ensure/Boost and other medical nutrition drinks, stating they can help increase calorie and protein intake."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that the patient should discuss their weight loss with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises scheduling an appointment to discuss the weight loss with the oncologist as soon as possible."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly mention chemotherapy as a potential cause of weight loss.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention chemotherapy as a potential contributor to weight loss."
      }
    ],
    "question_number": 15,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:33:13.666170",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer must specify that jaundice is due to an increase in bilirubin in the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states, \"It happens when there is too much bilirubin in the blood,\" directly linking jaundice to elevated bilirubin."
      },
      {
        "criterion_number": 2,
        "description": "The answer must state that jaundice refers to a yellowing of the skin and eyes due to elevated bilirubin levels.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response defines jaundice as \"a yellowing of the skin and the whites of the eyes\" and attributes it to too much bilirubin in the blood."
      },
      {
        "criterion_number": 3,
        "description": "The answer must state that jaundice can arise in pancreatic cancer due to blockage of the bile duct from tumor growth.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that in pancreatic cancer, a tumor can press on or block the bile duct, leading to bilirubin buildup and jaundice."
      },
      {
        "criterion_number": 4,
        "description": "The answer must state that ERCP (Endoscopic Retrograde Cholangiopancreatography) is used to visualize the blocked duct and place a stent to relieve the blockage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response describes ERCP using a small camera to access the bile ducts and notes that a stent can be placed to open the blocked duct, implying visualization and intervention."
      },
      {
        "criterion_number": 5,
        "description": "The answer must state that other options to relieve the obstruction include percutaneous biliary drainage or surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions Percutaneous Transhepatic Cholangiography with drainage/stent placement (percutaneous biliary drainage) and also discusses surgical options to bypass or remove the blockage."
      },
      {
        "criterion_number": 6,
        "description": "The answer must state that another potential cause for jaundice is metastatic disease in the liver.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response lists tumors, stones, and other conditions as causes but does not specifically mention liver metastases as a cause of jaundice."
      },
      {
        "criterion_number": 7,
        "description": "The answer must state that treating the cancer with chemotherapy can shrink the tumor and help address the jaundice.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While chemotherapy is mentioned as part of overall cancer treatment, the response does not explicitly state that chemotherapy can shrink the tumor and thereby alleviate jaundice."
      }
    ],
    "question_number": 16,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:33:26.934431",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should state that pain medications, including opioids, can be used for pain management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions OTC analgesics and prescription opioids (morphine, oxycodone, fentanyl), including dosing/titration and side effects."
      },
      {
        "criterion_number": 2,
        "description": "The answer should describe procedures, such as a celiac plexus block, that can help alleviate pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically references interventional procedures including nerve blocks and a celiac plexus block for pancreatic cancer pain."
      },
      {
        "criterion_number": 3,
        "description": "The answer should express sympathy for the diagnosis and symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Begins with empathetic language: \"I'm really sorry to hear that your husband is going through this.\""
      },
      {
        "criterion_number": 4,
        "description": "The answer should state that adjunctive non-opioid medications, such as amitriptyline and gabapentin, can be used.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists antidepressants (amitriptyline, duloxetine) and anticonvulsants (gabapentin, pregabalin) as adjuvant analgesics for neuropathic pain."
      },
      {
        "criterion_number": 5,
        "description": "The answer should state that steroids, such as dexamethasone, can also be used.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of corticosteroids or dexamethasone."
      },
      {
        "criterion_number": 6,
        "description": "The answer should state that radiation can be used for local treatment and pain control.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Radiation therapy for pain control is not discussed."
      },
      {
        "criterion_number": 7,
        "description": "The answer should state that complementary therapies, such as acupuncture and massages, can also be pursued.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions complementary therapies including acupuncture and relaxation techniques; this fulfills the criterion for complementary options."
      },
      {
        "criterion_number": 8,
        "description": "The answer should state that the patient should be seen by a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises involvement of palliative care specialists and describes their role in pain management."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend discussing pain management with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly recommends talking to the husband's oncology team about his pain and next steps."
      }
    ],
    "question_number": 17,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:33:43.376665",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should state that resectability is determined by the surgeons\u2019 assessment of their ability to safely remove the entire tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that surgeons do not believe they can safely remove the entire tumor with surgery, directly addressing surgical assessment of safe complete removal."
      },
      {
        "criterion_number": 2,
        "description": "The answer should state that tumors are deemed not resectable if they involve surrounding major blood vessels such as the SMA, SMV, CA, PV.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes 'vascular involvement' and explains tumors may be wrapped around or invading major blood vessels, making removal unsafe. While it does not name SMA/SMV/CA/PV specifically, it conveys the required concept."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that invasion of nearby organs can also lead to a tumor not being able to be resected.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes that spread to nearby organs can make complete removal impossible, satisfying this criterion."
      },
      {
        "criterion_number": 4,
        "description": "The answer should state that sometimes tumors that are not initially able to be resected can be shrunk (downstaged) with chemotherapy and/or radiation and later removed.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although the response mentions chemotherapy can shrink tumors, it does not state that downstaging may enable later surgical removal; the link to subsequent resection is missing."
      },
      {
        "criterion_number": 5,
        "description": "The answer should offer sympathy for the loved one\u2019s diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response begins with an empathetic statement: 'I'm really sorry to hear you're going through this.'"
      }
    ],
    "question_number": 18,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:33:58.118516",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the decision to continue with or stop chemotherapy treatments is highly personal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response emphasizes that this is one of the hardest choices families can make and repeatedly centers the patient's values and wishes (e.g., \"what matters most,\" family discussions about wishes), reflecting that the decision is highly personal."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the decision should be made weighing the expected benefit of more therapy with the current side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends discussing likely benefits and risks of continuing treatment, considering side effects and their impact on quality of life, and includes specific questions about expected benefits, risks, and QoL."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient discuss their goals of care with their oncology team and suggest meeting with their oncologist and a palliative care physician to help guide decision-making.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises discussing goals of care with the medical/oncology team, it does not specifically suggest meeting with a palliative care physician together with the oncologist to guide decision-making."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the patient ask for a referral to a palliative care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Palliative care is described, but there is no explicit recommendation to ask for a referral to a palliative care specialist."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe palliative care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Palliative care is accurately described as specialized care focused on symptom relief, stress reduction, and quality of life, and it notes it can be provided alongside active treatment."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe hospice care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Hospice care is described as an option when the focus shifts to comfort rather than cure, providing comprehensive support for patients and families, including emotional, spiritual, and practical help."
      },
      {
        "criterion_number": 7,
        "description": "The response should offer sympathy and state that it is a very difficult decision to try to make.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with empathy (\"I'm really sorry you're facing this difficult situation\") and explicitly acknowledges the decision as one of the hardest choices."
      }
    ],
    "question_number": 19,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:34:18.219476",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that KRAS mutations are frequently implicated in pancreatic cancer as a major driver of tumorigenesis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains KRAS\u2019s role in cell growth and states that most pancreatic cancers have a mutated KRAS gene, conveying its central, driver role."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the first line of treatment would remain the standard of care with chemotherapy regimens such as FOLFIRINOX and gemcitabine/abraxane.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly notes that standard treatment remains surgery (if operable), chemotherapy such as FOLFIRINOX or gemcitabine, and possibly radiation. This communicates that standard chemotherapy regimens remain first-line despite KRAS status."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that there are several KRAS mutations (G12C, G12D, G12V) and specify which one is present in the patient\u2019s case.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention specific KRAS variants (e.g., G12C, G12D, G12V) nor identify which variant the patient has."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that targeted therapy to the KRAS mutation is an active area of research.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that research is ongoing and that experimental KRAS-targeting drugs are in clinical trials, indicating active research."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some KRAS mutations can be targeted with drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response mentions experimental drugs that target KRAS are in clinical trials, which conveys that KRAS alterations can be drug-targeted, even if not yet standard or approved for pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that there may be clinical trials for certain KRAS mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends considering clinical trials and notes that KRAS-targeting agents are being studied in trials."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the patient should discuss their KRAS mutation with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises consulting the oncology team and emphasizes that tumor genetics influence treatment decisions, effectively directing the patient to discuss the KRAS result with their oncologist."
      }
    ],
    "question_number": 20,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:34:56.498002",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must mention recent trials evaluating the use of high-dose vitamin C in combination with chemotherapy for the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly mentions the GICEL phase II trial including a pancreatic cancer subgroup and references case series and small trials combining high-dose IV vitamin C with chemotherapy, satisfying the requirement to mention recent trials."
      },
      {
        "criterion_number": 2,
        "description": "The response must state that high-dose vitamin C has not been proven to improve outcomes in pancreatic or any other cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states there is no robust evidence that high-dose IV vitamin C improves survival or response rates in pancreatic cancer and notes that the GICEL trial did not significantly improve PFS or OS, adequately conveying lack of proven benefit."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the proposed mechanism of action of high-dose vitamin C in conjunction with chemotherapy, noting that it can act as a pro-oxidant by generating hydrogen peroxide (H\u2082O\u2082), which may enhance the killing of cancer cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response mentions a 'pro-oxidant' role, it does not specify hydrogen peroxide (H\u2082O\u2082) generation as the mechanism."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that there is limited published data showing high-dose vitamin C is well tolerated and shows a trend toward efficacy, but studies are limited and not sufficiently powered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes that high-dose IV vitamin C appears safe, references small studies and a trial with trends in quality of life, and emphasizes that studies are limited and underpowered without robust efficacy."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention possible toxicities of taking high doses of vitamin C.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No toxicities (e.g., oxalate nephropathy, kidney stones, hemolysis in G6PD deficiency) are described."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention drug-drug interactions of vitamin C.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No potential drug-drug interactions with vitamin C are mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should note that vitamin C is not FDA approved.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention FDA approval status (i.e., not FDA-approved for cancer treatment)."
      },
      {
        "criterion_number": 8,
        "description": "The response should note that vitamin C is not recommended by the NCCN guideline.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response states that current guidelines do not recommend routine use but does not specifically reference NCCN."
      },
      {
        "criterion_number": 9,
        "description": "The response should note that if a patient wishes to use high doses of vitamin C in conjunction with chemotherapy, they should consult with an oncologist regarding the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly advises discussing the approach with an oncologist."
      }
    ],
    "question_number": 21,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:35:34.122988",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that a biopsy is the only way to confirm the diagnosis of metastatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response describes biopsy as the gold standard and discusses reasons for false negatives, but it does not explicitly state that biopsy is the only way to confirm metastatic disease. It also suggests treatment may proceed without confirmatory biopsy, which contradicts the 'only way to confirm' requirement."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that imaging such as CT or MRI is done to evaluate for the presence of metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly mentions contrast-enhanced CT and MRI for evaluating liver metastases and discusses characteristic imaging patterns, fulfilling this criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that tumor markers can be supportive of a diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that tumor markers like CA 19-9 can be supportive but are not diagnostic on their own."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the team may suggest that the patient undergo another biopsy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends a repeat or targeted biopsy, including image-guided and core needle approaches, meeting this criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that on occasion the team will decide to treat as metastatic if the tumor markers and imaging are consistent with metastatic disease so as to not delay treatment if a repeat biopsy is not feasible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that many oncologists will proceed with treatment based on the overall evidence (including strongly suggestive imaging) even with a negative biopsy, and elsewhere notes tumor markers as supportive. This conveys that treatment may proceed as metastatic without repeat biopsy to avoid delay."
      }
    ],
    "question_number": 22,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:35:56.130609",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that there is no good evidence to suggest that eating vegan can stall cancer progression.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states there is no definitive evidence that a vegan diet will stall cancer progression and emphasizes limited direct evidence and absence of large randomized trials. It also concludes there is not enough evidence to say a vegan diet reliably stalls or reverses cancer progression."
      },
      {
        "criterion_number": 2,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including pancreatic enzyme insufficiency.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention pancreatic cancer\u2013specific digestive issues such as pancreatic exocrine insufficiency, steatorrhea, malabsorption, or pancreatic enzyme replacement therapy."
      },
      {
        "criterion_number": 3,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including insulin-dependent diabetes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no discussion of diabetes risk from pancreatic cancer, insulin dependence, or glycemic management affecting diet."
      },
      {
        "criterion_number": 4,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including biliary obstruction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Biliary obstruction, jaundice, cholestasis, and their dietary implications are not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including high protein and calorie needs during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response advises a balanced diet but does not address increased protein and calorie needs or risk of weight loss/cachexia during pancreatic cancer treatment."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that nutrition support is often needed for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of nutrition support such as oral nutrition supplements, enteral feeding, or parenteral nutrition often needed in pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussion of diet with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends not making major dietary changes without consulting the medical team and to follow the guidance of oncology professionals, meeting this criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend discussion of diet with an oncology nutritionist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests consulting oncologists/medical team, it does not specifically recommend consulting an oncology nutritionist or registered dietitian."
      }
    ],
    "question_number": 23,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:36:26.705615",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that medical fitness is scored by the oncologist using the ECOG or Karnofsky performance status.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly references ECOG performance status multiple times (e.g., 'ECOG 0 or 1' and 'ECOG \u22652') to guide treatment choice, indicating fitness is assessed via ECOG."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that typically patients who are more medically fit will be offered FOLFIRINOX, whereas those who are more frail but still candidates for treatment will be offered gemcitabine and nab-paclitaxel.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states FOLFIRINOX for fit patients and gemcitabine+nab-paclitaxel for those not fit for FOLFIRINOX due to poorer performance status or tolerability concerns."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that generally FOLFIRINOX is reserved for patients with an ECOG score of 0-1, whereas gemcitabine and nab-paclitaxel can be given to ECOG 2 patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifies FOLFIRINOX for ECOG 0\u20131 and recommends gemcitabine+nab-paclitaxel for patients with poor performance status (ECOG \u22652)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state the reason that FOLFIRINOX is reserved for patients with good performance status is that it is more intensive and is associated with higher rates of severe side effects such as neutropenia, fatigue, and diarrhea.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes FOLFIRINOX has higher toxicity and lists severe side effects (myelosuppression/akin to neutropenia, neuropathy, diarrhea), framing the need for good performance status."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly list the individual drugs in FOLFIRINOX (5-FU, leucovorin, irinotecan, oxaliplatin) and clarify that nab-paclitaxel is combined with gemcitabine.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists FOLFIRINOX components (5-FU, folinic acid/leucovorin, irinotecan, oxaliplatin) and clearly states nab-paclitaxel is used with gemcitabine."
      },
      {
        "criterion_number": 6,
        "description": "The response must state that there are no head-to-head trials comparing gemcitabine/nab-paclitaxel and FOLFIRINOX.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly state the absence of head-to-head trials between gemcitabine/nab-paclitaxel and FOLFIRINOX."
      },
      {
        "criterion_number": 7,
        "description": "The response must mention age as a factor influencing the choice of regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly references 'Elderly or frail patients' as more likely to receive gemcitabine+nab-paclitaxel."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention comorbid conditions as a factor in selecting a regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions comorbidities and specific conditions (neuropathy, hearing loss, renal/hepatic dysfunction) as influencing regimen selection."
      }
    ],
    "question_number": 24,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:36:55.641199",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that resectability is determined by the ability of the surgeon to safely remove the entire tumor and not leave any behind (R0 resection).",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions potentially curative surgery and that tumors can be 'safely removed,' and references R0/R1 categories, but does not explicitly state that achieving an R0 (negative margin) resection\u2014removing the entire tumor without residual\u2014is the determinant of resectability."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that involvement of major blood vessels such as the SMA, SMV, CA, PV are often implicated when a tumor is deemed to not be resectable.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly references SMA, SMV, portal vein, and celiac axis; notes arterial invasion/encasement is generally a contraindication to resection."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that for pancreatic cancer to be resectable, there must not be any distant metastases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states 'No distant metastases' as part of the definition of resectable disease and lists common metastatic sites."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that occasionally tumors that contact the veins (PV/SMV) and have less than 180 degrees of involvement can still be resected provided it can be safely removed and the vessel can be reconstructed as needed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that SMV/portal vein involvement <180\u00b0 may still allow resection in select cases and reiterates this under the NCCN definition; correctly contrasts permissive venous involvement with prohibitive arterial invasion."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some tumors are deemed to be borderline resectable and that the patient will be recommended to undergo treatment with chemotherapy and/or radiation in order to attempt to down-stage the tumor and make it amenable to resection.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not discuss the 'borderline resectable' category or neoadjuvant chemotherapy/radiation to downstage; only mentions 'borderline cases' in the context of imaging without management implications."
      },
      {
        "criterion_number": 6,
        "description": "The response should include imaging modalities that help determine resectability, including a CT scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names contrast-enhanced CT as the mainstay for evaluating resectability."
      },
      {
        "criterion_number": 7,
        "description": "The response should include imaging modalities that help determine resectability, including an MRI.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes MRI as an adjunct for better soft-tissue definition, especially near major vessels."
      },
      {
        "criterion_number": 8,
        "description": "The response should include imaging modalities that help determine resectability, including a PET scan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention PET scan."
      },
      {
        "criterion_number": 9,
        "description": "The response should include imaging modalities that help determine resectability, including an endoscopic ultrasound.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes endoscopic ultrasound (EUS) as helpful for tumor characterization and staging in borderline cases."
      }
    ],
    "question_number": 25,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:37:41.972877",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that family history of pancreas cancer is associated with increased risk.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that having a close relative (parent) with pancreatic cancer increases risk and highlights family history as a significant factor."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a family history of pancreas cancer is due to inherited gene mutations such as BRCA.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists inherited genetic mutations (e.g., BRCA2, PALB2) as contributors to increased risk and links strong family history to genetic counseling/testing."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that smoking is a significant modifiable risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States: 'Smoking: Cigarette smoking is a major risk factor.'"
      },
      {
        "criterion_number": 4,
        "description": "The response should state that chronic pancreatitis is a risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes 'Chronic pancreatitis: Long-standing inflammation of the pancreas can increase risk.'"
      },
      {
        "criterion_number": 5,
        "description": "The response should state that heavy alcohol use can lead to increased risk of pancreas cancer through pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes heavy, long-term alcohol use increases risk and is also a cause of chronic pancreatitis, indicating the pathway."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify genetic risk factors, including Lynch syndrome.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists Lynch syndrome (HNPCC) among inherited risk factors."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify genetic risk factors, including Peutz-Jeghers syndrome.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists Peutz-Jeghers syndrome."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify genetic risk factors, including Familial atypical multiple mole melanoma.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists Familial atypical multiple melanoma (FAMM/FAMMM) syndrome as a risk factor."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify genetic risk factors, including hereditary pancreatitis.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes hereditary pancreatitis (mentions PRSS1, SPINK1, CTRC, CFTR)."
      },
      {
        "criterion_number": 10,
        "description": "The response should include non-hereditary risk factors, including age.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States that most cases occur in people over 60."
      },
      {
        "criterion_number": 11,
        "description": "The response should include non-hereditary risk factors, including diabetes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions both type 1 and type 2 diabetes as associated with higher risk."
      },
      {
        "criterion_number": 12,
        "description": "The response should include non-hereditary risk factors, including obesity.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States that being overweight or obese increases risk."
      },
      {
        "criterion_number": 13,
        "description": "The response should include non-hereditary risk factors, including diet.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes high consumption of processed/red meats and low fruits/vegetables may contribute."
      },
      {
        "criterion_number": 14,
        "description": "The response should include non-hereditary risk factors, including exposure to certain industrial chemicals.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of occupational or industrial chemical exposures."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that if you have a strong family history, discuss with your doctor about screening or genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussing family history with a doctor, considering genetic counseling/testing, and discusses screening/surveillance for those with strong family history."
      }
    ],
    "question_number": 26,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:38:09.232767",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the patient should undergo genetic counseling.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends genetic counseling: includes a dedicated 'Genetic Counseling: Essential' section and advises referral to a genetic counselor/medical geneticist."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the type of genetic testing depends on the specific family history or hereditary condition.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states 'The specific test depends on the suspected condition' and emphasizes tailoring to family history and inheritance patterns."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that single genes can be tested if there is a known condition associated with a specific genetic disorder.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes 'Single-Gene Testing' and when it is used (when a specific hereditary disease gene is known), with examples such as HTT, CFTR, APC."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that a panel of genes can be tested for multiple genes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes 'Multigene Panel Testing' and explains its use when multiple genes may be implicated (e.g., hereditary cancer panels, cardiomyopathy panels)."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide examples of single gene disorders such as Huntington\u2019s Disease, Cystic Fibrosis, and Sickle Cell.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides Huntington\u2019s disease and cystic fibrosis examples but does not mention sickle cell disease (HBB), so the required set of examples is incomplete."
      },
      {
        "criterion_number": 6,
        "description": "The response should provide examples of panel testing for hereditary cancer and cardiomyopathy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions hereditary cancer panels (BRCA1/2, Lynch genes) and cardiomyopathy panels (e.g., LMNA, SCN5A), satisfying both examples."
      }
    ],
    "question_number": 27,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:38:39.329007",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the types of clinical trials.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response explicitly lists treatment, prevention, diagnostic, and quality-of-life trials, which satisfies describing types of clinical trials."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that clinical trials are divided into three different phases.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of trial phases or that there are three different phases."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that phase 1 is the first time the drug is tested in humans and is aimed at establishing the safety and dosage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Phase 1 is not discussed at all."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that phase 2 tests the effectiveness of the drug and continues to establish its safety.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Phase 2 is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that phase 3 tests the efficacy of the drug in a larger group of patients and compares it to the current standard of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Phase 3 is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe eligibility criteria for clinical trials, including stage of disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Eligibility is described with examples including type and stage of cancer, previous treatments, age, and overall health."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that there can be risks associated with participating in a trial, including potential side effects and lack of efficacy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes that trials may not be better than standard care and could have more side effects; it also mentions extra visits/tests, satisfying risk acknowledgment."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend discussing clinical trial options with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises that the loved one\u2019s oncologist can check which trials are appropriate."
      },
      {
        "criterion_number": 9,
        "description": "The response should include clinicaltrials.gov as a resource for finding clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "ClinicalTrials.gov is explicitly mentioned as a database of studies."
      },
      {
        "criterion_number": 10,
        "description": "The response should offer support for the diagnosis and how difficult it can be to complete 15 rounds of chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While empathetic, the response does not specifically acknowledge the difficulty of completing 15 rounds of chemotherapy."
      }
    ],
    "question_number": 28,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:39:00.450446",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must include ClinicalTrials.gov as a resource for finding clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists ClinicalTrials.gov with a direct link and places it first among resources."
      },
      {
        "criterion_number": 2,
        "description": "The response must provide instructions on using the search by location function on ClinicalTrials.gov.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides clear steps: enter 'pancreatic cancer' and use the 'Location' filter to enter city, state, or ZIP code; also mentions filtering by status and phase."
      },
      {
        "criterion_number": 3,
        "description": "The response must mention the National Cancer Institute (NCI) website and describe using it to search for trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions the NCI clinical trial search tool with link (cancer.gov/.../clinical-trials/search) and describes it as a user-friendly search tool with cancer-specific filters."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention and provide a link to the Pancreatic Cancer Action Network (PanCAN) clinical trial finder tool.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While PanCAN is mentioned with a link to the main site, the specific PanCAN clinical trial finder tool and its direct link are not provided."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend contacting advocacy organizations for information on clinical trials, including PanCAN.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends 'Check with Cancer Support Organizations' and specifically lists PanCAN with a link and description of patient services that help find trials."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend contacting advocacy organizations for information on clinical trials, including the American Cancer Society.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions the American Cancer Society with a link and notes it offers guidance and connections to local resources."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss clinical trial options with their oncology team and consult with a local healthcare provider or oncologist to explore available trials at nearby cancer centers, as well as contact major cancer centers for additional information on clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises asking the doctor/medical team to assess eligibility and provide details, and separately recommends contacting local medical centers and major cancer hospitals\u2019 research departments."
      }
    ],
    "question_number": 29,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:39:22.472551",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "State that family history of pancreatic cancer is associated with increased risk.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that having a first-degree relative with pancreatic cancer increases risk."
      },
      {
        "criterion_number": 2,
        "description": "State that BRCA1/BRCA2 mutations are genetic risk factors for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions BRCA2 mutations as a genetic risk factor. While BRCA1 is not named, the response identifies BRCA gene mutation risk, satisfying the intent of the criterion."
      },
      {
        "criterion_number": 3,
        "description": "State that smoking is a significant modifiable risk factor for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly identifies cigarette smoking as a significant risk factor, noting it approximately doubles risk."
      },
      {
        "criterion_number": 4,
        "description": "State that chronic pancreatitis is a risk factor for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists chronic pancreatitis as increasing risk."
      },
      {
        "criterion_number": 5,
        "description": "State that heavy alcohol use can lead to increased risk of pancreatic cancer through pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains heavy alcohol use can cause chronic pancreatitis, which is a risk factor for pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "Identify Lynch syndrome as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists Lynch syndrome."
      },
      {
        "criterion_number": 7,
        "description": "Identify Peutz-Jeghers syndrome as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists Peutz-Jeghers syndrome."
      },
      {
        "criterion_number": 8,
        "description": "Identify Familial atypical multiple mole melanoma as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists familial atypical multiple melanoma (FAMM/FAMMM) syndrome as a risk factor."
      },
      {
        "criterion_number": 9,
        "description": "Identify hereditary pancreatitis as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists hereditary pancreatitis under genetic syndromes."
      },
      {
        "criterion_number": 10,
        "description": "Include age as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States risk increases with age, especially over 65."
      },
      {
        "criterion_number": 11,
        "description": "Include diabetes as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists both type 1 and type 2 diabetes as modest risk factors."
      },
      {
        "criterion_number": 12,
        "description": "Include obesity as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Identifies higher BMI/obesity as associated with increased risk."
      },
      {
        "criterion_number": 13,
        "description": "Include diet as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes diets high in red/processed meats and low in fruits/vegetables may increase risk."
      },
      {
        "criterion_number": 14,
        "description": "Include exposure to certain industrial chemicals as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions workplace exposures (pesticides, dyes, metal-working chemicals) as possible risk factors."
      },
      {
        "criterion_number": 15,
        "description": "State that if you have a strong family history, discuss with your doctor about screening or genetic testing.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises general consultation with a healthcare professional but does not specifically recommend screening or genetic testing for those with a strong family history."
      }
    ],
    "question_number": 30,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:39:54.858019",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend asking for a referral from their primary doctor or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises starting with the primary care physician or oncologist and to ask for a referral."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend using the PanCAN patient services to find a pancreatic cancer specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "PanCAN is specifically recommended, with website, helpline number, and description of services that include connecting patients with specialists."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend using the American Cancer Society patient services to find a pancreatic cancer specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The American Cancer Society is included with its website, a 'Find a Doctor' tool, and helpline number for guidance."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that they can reference the NCI website to look for designated cancer centers that have pancreatic cancer specialists on staff.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the NCI website and Cancer Information Service are mentioned, the response does not state using the NCI site to find NCI-designated cancer centers specifically."
      },
      {
        "criterion_number": 5,
        "description": "The response should include information about the nearest cancer center.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific nearest cancer center is provided; the response is generic and asks for location to provide specifics."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend checking with their health insurance provider about in-network pancreatic cancer specialists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response clearly advises using the insurance directory to find in-network specialists and to call the insurer to verify coverage."
      }
    ],
    "question_number": 31,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:40:11.374439",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define CA 19-9.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines CA 19-9 as Carbohydrate Antigen 19-9 and a tumor marker; describes it as a glycoprotein found on cell surfaces with typically low levels in healthy individuals."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 is a tumor marker produced by cancer cells and measurable in the blood, and describe its use in pancreatic cancer, noting that it can serve as a marker for the disease.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it states CA 19-9 is a measurable blood tumor marker and explains its use in monitoring pancreatic cancer, it does not explicitly state that it is produced by cancer cells, which is required by the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response must include that CA 19-9 can be elevated in other conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly notes false positives and lists benign conditions (e.g., liver disease) and other non-cancer causes for elevation."
      }
    ],
    "question_number": 32,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:40:27.446409",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that reference ranges can vary by lab.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that the reference range depends on the laboratory and assay used."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that normal levels are typically less than 37 U/mL but do not rule out cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does say normal levels do not rule out cancer, but it gives an incorrect reference range and units (3\u20135 ng/mL) instead of <37 U/mL, so it does not meet the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that levels from 37 to 100 U/mL can be associated with non-cancer conditions such as pancreatitis and bile duct disorders.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of the 37\u2013100 U/mL range or specific reference to pancreatitis or bile duct disorders."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that moderate elevation (100-1000 U/mL) can be concerning for cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not provide the 100\u20131000 U/mL range or explicitly link that range to concern for cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that levels greater than 1000 U/mL can be suggestive of advanced cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of the >1000 U/mL threshold or its association with advanced cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the use of CA 19-9 in pancreatic cancer, including that it can be a marker of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It identifies pancreatic cancer as the most common cancer associated with CA 19-9 and discusses its use alongside imaging/biopsy."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that CA 19-9 can be elevated in other conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists several non-cancer conditions (e.g., inflammatory bowel disease, chronic liver disease, benign tumors) leading to elevated CA 19-9."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that CA 19-9 can be used for monitoring the effectiveness of pancreatic cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions serial measurements to monitor response to treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that CA 19-9 can be used for detecting recurrence of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that serial measurements can be used to detect recurrence after treatment."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that CA 19-9 can be used in other cancers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes elevation in other cancers (colorectal, lung, gastric), indicating its use beyond pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that CA 19-9 can be elevated in liver disease.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It specifically mentions chronic liver disease as a non-cancer cause of elevation."
      },
      {
        "criterion_number": 12,
        "description": "The response should include that CA 19-9 can be elevated in gallstones.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of gallstones or cholelithiasis."
      },
      {
        "criterion_number": 13,
        "description": "The response should include that CA 19-9 can be elevated with elevated bilirubin.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of bilirubin or cholestasis-related elevations."
      },
      {
        "criterion_number": 14,
        "description": "The response should include that CA 19-9 is not produced by all pancreatic cancers.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It states that some people with pancreatic cancer have normal CA 19-9 and discusses Lewis-negative status, implying not all pancreatic cancers produce CA 19-9."
      }
    ],
    "question_number": 33,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:41:10.936452",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that CA 19-9 can be elevated with pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions 'Pancreatitis: Both acute and chronic pancreatitis can raise CA 19-9 levels.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 can be elevated with liver diseases like cirrhosis or hepatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'Chronic Liver Disease and Cirrhosis: Liver disease can sometimes cause mild elevations.' Cirrhosis is explicitly included."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CA 19-9 can be elevated with cholestasis or biliary diseases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes 'Benign Biliary Obstruction' (e.g., gallstones, strictures) and mentions cholangiocarcinoma and primary sclerosing cholangitis, satisfying biliary/cholestatic causes."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that CA 19-9 can be elevated with inflammatory bowel disease or gastrointestinal diseases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 'Gastric or Intestinal Obstruction' as a gastrointestinal condition associated with elevated CA 19-9, fulfilling the GI disease component (IBD not required if GI disease is present)."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that CA 19-9 can be elevated with infections or other inflammatory conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Contains 'Inflammatory Conditions: Chronic inflammation in the pancreas or biliary tree may lead to elevated levels,' covering inflammatory conditions."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that CA 19-9 can be a marker of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States CA 19-9 is most commonly associated with pancreatic cancer and is used to monitor treatment response/progression, indicating marker use."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that CA 19-9 can be used in other cancers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists multiple other cancers (gastric, cholangiocarcinoma, gallbladder, colorectal, ovarian, lung, breast) associated with elevated CA 19-9."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that CA 19-9 is not produced by all pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that some pancreatic cancers/patients (e.g., Lewis antigen\u2013negative) do not produce CA 19-9; genetic baseline variation is mentioned but not non-production."
      }
    ],
    "question_number": 34,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:41:41.081801",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing weight loss with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises consulting the oncology team and a registered dietitian, emphasizing coordination with the care team before making changes."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic enzyme replacement can be taken to help with the absorption of nutrients from foods.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that pancreatic exocrine insufficiency is common and that doctors may prescribe pancreatic enzyme supplements to help with digestion and nutrient absorption."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that nutritional strategies can be employed, such as focusing on small, frequent meals and nutrient-rich foods, and should recommend including calorie-dense and protein-rich foods in the diet.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends small, frequent meals, high-calorie/high-protein foods, liquid calories, and easy-to-eat options, clearly meeting the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that medications for managing nausea can be helpful.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Under 'Manage Side Effects,' it notes that medications can help with nausea and vomiting."
      },
      {
        "criterion_number": 5,
        "description": "The response should state there are many causes of weight loss in patients with pancreatic cancer, including weight loss related to chemotherapy side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists multiple causes including treatment side effects such as chemotherapy and radiation, appetite loss, metabolic changes, increased energy expenditure, and digestive issues."
      },
      {
        "criterion_number": 6,
        "description": "The response should state there are many causes of weight loss in patients with pancreatic cancer, including weight loss related to pancreatic enzyme deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly identifies pancreatic exocrine insufficiency as a cause of weight loss and discusses addressing malabsorption with pancreatic enzymes."
      }
    ],
    "question_number": 35,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:41:54.646120",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that a symptom of pancreatic cancer can include unintentional weight loss.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states \"Unintended weight loss \u2013 Losing weight without trying.\""
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a symptom of pancreatic cancer can include jaundice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists \"Jaundice \u2013 Yellowing of the skin and eyes.\""
      },
      {
        "criterion_number": 3,
        "description": "The response should state that a symptom of pancreatic cancer can include new onset diabetes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States \"New-onset diabetes\" and explains tumor disrupting insulin production."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that a symptom of pancreatic cancer can include abdominal pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes \"Pain in the abdomen or back \u2013 Dull pain felt in the upper abdomen.\""
      },
      {
        "criterion_number": 5,
        "description": "The response should state that pancreatic cancer can be difficult to detect early.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opening sentence states it is \"difficult to detect early\" and reiterates \"Early detection is challenging.\""
      },
      {
        "criterion_number": 6,
        "description": "The response should state that pancreatic cancer does not cause symptoms until the disease is advanced.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that symptoms typically do not appear until advanced disease; instead notes subtle, nonspecific early symptoms."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the reason for jaundice is the blockade of bile ducts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains jaundice occurs due to the tumor affecting the bile duct, implying obstruction."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that loss of appetite can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists \"Poor appetite\" explicitly."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that abdominal bloating or indigestion can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions \"indigestion\" as a symptom."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that foul-smelling stools or steatorrhea can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions \"steatorrhea, or fatty stools.\""
      },
      {
        "criterion_number": 11,
        "description": "The response should reference the American Cancer Society information page on symptoms of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to the American Cancer Society provided."
      }
    ],
    "question_number": 36,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:42:15.808695",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that most pancreatic cancer cases are sporadic and not hereditary.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that pancreatic cancer is not typically hereditary and that ~95% of cases are sporadic."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that there are hereditary conditions that can lead to pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly notes that a small percentage are linked to inherited mutations and lists several hereditary syndromes."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that a strong family history is a significant risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions strong family history (multiple relatives affected) as a risk consideration and recommends genetic counseling/testing."
      },
      {
        "criterion_number": 4,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including familial pancreatic cancer syndrome.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention familial pancreatic cancer syndrome specifically. PanIN is incorrectly listed as a hereditary syndrome and does not satisfy this criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including BRCA1/BRCA2 mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists BRCA1 and BRCA2 as associated with increased pancreatic cancer risk."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Lynch syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions Lynch syndrome (HNPCC) as increasing pancreatic cancer risk."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Peutz-Jeghers syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists Peutz-Jeghers syndrome and identifies the associated gene (LKB1/STK11)."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Familial atypical multiple mole melanoma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies the syndrome (FAMMM) as 'familial atypical multiple melanoma and pancreatic cancer syndrome' and notes CDKN2A; despite slight naming variation, the intent is clear."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including hereditary pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically lists hereditary pancreatitis and relevant genes (PRSS1, SPINK1, CFTR)."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that if you are concerned about your risk of pancreatic cancer, you should consult an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises discussing with a healthcare provider or genetic counselor but does not specifically recommend consulting an oncologist."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that if you are concerned about your risk of pancreatic cancer, you should consult a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends genetic counseling and testing and suggests speaking with a genetic counselor."
      }
    ],
    "question_number": 37,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:42:41.398409",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that routine screening is not recommended for the general population.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly emphasizes that surveillance is considered only for individuals at significantly increased risk and is recommended only for those at elevated risk, which explicitly excludes the general population."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention MRI as a surveillance modality for high-risk individuals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "MRI is highlighted as the most sensitive modality for high-risk surveillance with details on timing and frequency."
      },
      {
        "criterion_number": 3,
        "description": "The response must specify that surveillance typically starts around age 50 and continues annually.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response specifies annual surveillance and provides start ages including 40\u201350 for strong family history, which aligns with the concept of starting around age 50."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that the evidence for screening/surveillance is not well established and mention the risk of overdiagnosis leading to unnecessary stress and procedures.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes the evidence base is limited (expert opinion, small studies, no RCTs proving survival benefit) and mentions false positives causing additional tests, anxiety, and unnecessary surgery."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that people at high risk may benefit from screening.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States surveillance is recommended for those at significantly elevated risk, implying benefit for high-risk individuals."
      },
      {
        "criterion_number": 6,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a significant family history of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes strong family history as a high-risk category and details thresholds for testing."
      },
      {
        "criterion_number": 7,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a known genetic syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple genetic syndromes (BRCA1/2, PALB2, CDKN2A, STK11, ATM, Lynch) as high-risk."
      },
      {
        "criterion_number": 8,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a history of chronic pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly includes chronic pancreatitis as a high-risk factor."
      },
      {
        "criterion_number": 9,
        "description": "The response should include EUS as a screening modality to detect pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions endoscopic ultrasound (EUS) as a surveillance option, particularly when MRI is contraindicated or to evaluate lesions."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend people discuss the risks and benefits of screening with a doctor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends individualized decision-making with multidisciplinary input (surgeon, gastroenterologist) and a thorough discussion of risks and benefits, which constitutes discussing with a doctor."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend people discuss the risks and benefits of screening with a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends referral for genetic counseling and includes genetic counseling in decision-making."
      }
    ],
    "question_number": 38,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:43:15.034352",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include surgery as a potential treatment modality for resectable pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes surgical resection (Whipple, distal pancreatectomy) as potentially curative for localized/resectable disease."
      },
      {
        "criterion_number": 2,
        "description": "The response should specify that chemotherapy is the backbone of treatment for metastatic or unresectable pancreatic cancer, with main regimens being FOLFIRINOX or Gemcitabine + Nab-Paclitaxel.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists metastatic chemotherapy options including FOLFIRINOX and gemcitabine + nab-paclitaxel, indicating their use in advanced disease."
      },
      {
        "criterion_number": 3,
        "description": "The response should include radiation as a potential treatment option for localized pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes EBRT and chemoradiation for locally advanced/unresectable disease and mentions SBRT, fulfilling radiation as an option for localized settings."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States up front that treatment depends on the stage and repeatedly differentiates approaches by resectable vs locally advanced vs metastatic."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the treatment of pancreatic cancer depends on the co-morbidities of the patient.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions 'overall health' but does not explicitly state comorbidities as a determinant as required by the rubric."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the treatment of pancreatic cancer depends on the functional status of the patient.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of performance/functional status (e.g., ECOG) as a factor in treatment selection."
      },
      {
        "criterion_number": 7,
        "description": "The response should include immunotherapy, noting its role is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 0,
        "max_points": 15,
        "justification": "Does not state the MSI-H/dMMR limitation; instead suggests pembrolizumab + chemotherapy for first-line metastatic disease, which is not standard for pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should include targeted therapy such as PARPi for patients with BRCA mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that PARP inhibitors (e.g., olaparib) may be considered for patients with BRCA mutations."
      },
      {
        "criterion_number": 9,
        "description": "The response should introduce the concept of clinical trials and their role in the management of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly highlights clinical trials as an option and discusses ongoing research and novel approaches."
      }
    ],
    "question_number": 39,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:43:46.733973",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that stage 0 is a pre-cancer state, also known as pancreatic intraepithelial neoplasia or carcinoma in situ.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response labels Stage 0 as 'Non-invasive papillary mucinous neoplasm' and does not mention carcinoma in situ or pancreatic intraepithelial neoplasia (PanIN). This is inaccurate and omits the required terminology."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that stage 1 cancer is when the cancer is confined to the pancreas and has not spread to lymph nodes or distant sites.",
        "score_given": 10,
        "max_points": 10,
        "justification": "For Stage IA and IB, the response explicitly states the tumor is confined to the pancreas with no lymph node or distant spread, satisfying the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response should note that stage 1a is when the tumor is 2cm or smaller.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Stage IA is correctly described as a tumor 2 cm or smaller."
      },
      {
        "criterion_number": 4,
        "description": "The response should note that stage 1b is when the tumor is larger than 2cm.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Stage IB is correctly described as larger than 2 cm."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that stage II is when the cancer is growing into nearby tissues and into lymph nodes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response states Stage IIA and IIB have not spread to lymph nodes, which contradicts the requirement (and AJCC definitions for IIB). It does not acknowledge lymph node involvement in Stage II."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that stage III is when the cancer is locally advanced and involves surrounding structures.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Stage III is described only as involving nearby lymph nodes. Locally advanced disease with involvement of surrounding vascular structures is incorrectly placed under 'Stage IVA,' not Stage III."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that stage IV is when the cancer has spread to other organs or sites.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Stage IV is correctly defined as distant metastasis to organs such as liver, lungs, or peritoneum."
      },
      {
        "criterion_number": 8,
        "description": "The response should include a description of the T, N, M staging system.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that AJCC TNM considers tumor size/extent (T), lymph node involvement (N), and distant metastasis (M)."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that pancreatic cancer is categorized by resectability.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of resectability categories (resectable, borderline resectable, locally advanced/unresectable, metastatic)."
      }
    ],
    "question_number": 40,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:44:08.331568",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that neuropathy is a common side effect from the oxaliplatin in FOLFIRINOX.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that neuropathy is a known side effect, particularly from the oxaliplatin component of FOLFIRINOX."
      },
      {
        "criterion_number": 2,
        "description": "The response must state that the oncologist can \u2018hold\u2019 or temporarily stop oxaliplatin to manage neuropathy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response mentions a 'treatment break' (temporarily stopping treatment), it does not specifically state holding or temporarily stopping oxaliplatin itself."
      },
      {
        "criterion_number": 3,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by dose reduction.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that the dose of oxaliplatin can be reduced to manage neuropathy."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by schedule modification.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes 'treatment break' (temporarily stopping treatment) as a strategy, which constitutes schedule modification to manage neuropathy."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by switching to an alternate regimen.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response suggests switching from FOLFIRINOX to alternative chemotherapy regimens if neuropathy is not tolerable."
      },
      {
        "criterion_number": 6,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by switching to an alternate regimen, including gemcitabine-based therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Gemcitabine-based regimens (e.g., Gemcitabine + Abraxane) are explicitly mentioned as alternatives."
      },
      {
        "criterion_number": 7,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including gabapentin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Gabapentin is explicitly listed among supportive medications for neuropathic pain."
      },
      {
        "criterion_number": 8,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including SNRIs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Duloxetine, an SNRI, is specifically mentioned as a supportive medication."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including pregabalin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Pregabalin is explicitly listed among supportive medications for neuropathic pain."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend discussing medication side effects with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly encourages open discussion with the oncology team about severity of neuropathy, treatment adjustments, and supportive measures."
      }
    ],
    "question_number": 41,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:44:32.231075",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they should be informed about the aim of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises understanding the 'Purpose of the Trial' (e.g., new drug, combination, method, or diagnostic), clearly addressing the trial's aim."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that they should understand the potential benefits of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Under 'Risks and Benefits,' it discusses 'Potential Benefits' and whether the new treatment could help, fulfilling the benefits criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that they should understand the potential risks of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It addresses 'Known Risks and Side Effects,' including short- and long-term effects and unknown risks, meeting the risks criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that they should be aware of the inclusion and exclusion criteria for the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The 'Eligibility Criteria' section highlights strict requirements (stage, prior treatments, overall health) and ensuring the patient meets them, covering inclusion/exclusion awareness."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that they should be aware of the time commitments associated with participating in the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The 'Location and Logistics' section asks about travel, visit frequency, and explicitly mentions 'time and resource commitments,' addressing time commitments clearly."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that they should be aware of the costs associated with participating in the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Under 'Ask Questions,' it includes 'Will insurance cover the costs, or will there be additional expenses?' directly addressing cost considerations."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the phase of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly discusses 'Trial Phase' (Phase I, II, III) and what each implies, recommending understanding the phase."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding if there are crossover options.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions randomization, placebo, and single-arm design, it does not address crossover options or switching arms upon progression."
      }
    ],
    "question_number": 42,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:44:51.713095",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Radiation can be used before surgery to help shrink borderline resectable tumors, with the goal of increasing the likelihood of achieving a complete resection in the localized setting.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly describes neoadjuvant/induction radiation before surgery to shrink tumors that are close to vessels or otherwise not safely resectable, to make surgery more feasible."
      },
      {
        "criterion_number": 2,
        "description": "Radiation can be used for locally advanced or unresectable tumors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states radiation may be used for locally advanced disease that cannot be safely removed with surgery and discusses chemoradiation in locally advanced cancers."
      },
      {
        "criterion_number": 3,
        "description": "Radiation can be used in the palliative setting to relieve symptoms in patients with advanced or metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly identifies palliative radiation for symptom relief (pain, jaundice, bowel obstruction) when cancer has spread or surgery isn\u2019t an option."
      },
      {
        "criterion_number": 5,
        "description": "Pancreatic cancer treatment plans are determined by the stage of the disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that decisions depend on many factors including the stage of cancer."
      },
      {
        "criterion_number": 6,
        "description": "Pancreatic cancer treatment plans are determined by the overall health of the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists overall health as a factor in deciding on radiation use."
      },
      {
        "criterion_number": 7,
        "description": "The goal of radiation in the localized setting can be to sterilize vessel margins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions adjuvant radiation after positive margins and proximity to vessels preoperatively, it does not specifically state the goal of sterilizing vessel margins."
      },
      {
        "criterion_number": 8,
        "description": "The goal of radiation in the localized setting can be to delay disease progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes chemoradiation is used in locally advanced cancers to improve the chance of controlling the cancer, which reflects delaying disease progression."
      },
      {
        "criterion_number": 9,
        "description": "The goal of radiation in the localized setting can be to prevent local recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that postoperative (adjuvant) radiation may be given after surgery to reduce the risk of the cancer coming back, aligning with prevention of local recurrence."
      }
    ],
    "question_number": 43,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:45:17.612087",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that pancreatic cancer leads to enzyme deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that pancreatic cancer can affect the pancreas's ability to make enzymes and that the pancreas may not release enough enzymes if damaged by cancer, clearly indicating enzyme deficiency due to pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how enzyme deficiency can lead to problems with digestion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that enzymes break down fats, proteins, and carbohydrates, and that insufficient enzymes lead to trouble digesting meals, with symptoms like bloating, pain, and weight loss, linking deficiency to impaired digestion."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pancreatic enzyme supplements are used to replace the enzymes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that pancreatic enzyme supplements are medications that help replace the enzymes the pancreas cannot make enough of."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that pancreatic enzyme supplements can improve digestion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes that the supplements help break down food so nutrients can be absorbed more effectively and can help manage digestive symptoms and improve nutrition, indicating improved digestion."
      }
    ],
    "question_number": 44,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:45:27.835820",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that cancer is associated with an increased risk of developing blood clots.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly links cancer to increased clot risk, stating that tumors release substances that make blood more likely to clot and that treatments such as surgery can increase clot risk. This clearly communicates that cancer is associated with an increased risk of blood clots."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that patients with pancreatic cancer are at increased risk of developing a blood clot.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states, \"People with pancreatic cancer have a higher risk of developing blood clots,\" directly fulfilling the criterion with clear and accurate information specific to pancreatic cancer."
      }
    ],
    "question_number": 45,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:45:36.001653",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Explicitly states that second opinions can be obtained at any time, including after diagnosis, before starting treatment, during treatment, or when considering clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response says, 'You can (and many patients do) seek a second opinion at any stage,' and gives examples (after diagnosis, before major treatment). While it does not list 'during treatment' or 'clinical trials' specifically, the 'at any stage' statement explicitly covers any time."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly mentions second opinions are particularly helpful after the initial diagnosis and before starting treatment, as well as when the initial treatment is no longer effective.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions after initial diagnosis and before major treatment but does not mention the scenario when initial treatment is no longer effective."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly mentions that a second opinion is helpful if there is uncertainty regarding the diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states, 'If you\u2019re unsure about the diagnosis,' indicating a second opinion is helpful for diagnostic uncertainty."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly mentions that a second opinion is helpful if there is uncertainty regarding staging.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention staging explicitly."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly mentions that a second opinion is helpful if there is uncertainty regarding the treatment plan.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States, 'If you\u2019re unsure about ... the recommended treatment plan,' directly addressing uncertainty about the plan."
      },
      {
        "criterion_number": 6,
        "description": "Explicitly states that second opinions can be obtained at specialized referral centers, such as cancer centers with expertise in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises seeking second opinions at 'top cancer centers' and 'academic or tertiary care centers' with multidisciplinary teams, which are specialized referral centers."
      },
      {
        "criterion_number": 7,
        "description": "Explicitly states that they should look up NCI-designated cancer centers specifically.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions the National Cancer Institute website but does not specifically instruct to look up 'NCI-designated cancer centers.'"
      },
      {
        "criterion_number": 8,
        "description": "Mentions major academic hospitals as a resource for finding pancreatic cancer specialists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends 'academic or tertiary care centers,' which are major academic hospitals."
      },
      {
        "criterion_number": 9,
        "description": "Mentions that the NCCN guidelines for Pancreatic Adenocarcinoma recommend evaluation at high volume centers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of NCCN guidelines or recommendations about evaluation at high-volume centers."
      }
    ],
    "question_number": 46,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:46:08.170049",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that immunotherapy is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly notes that pancreatic cancers with MSI-H or mismatch repair deficiency may benefit and cites FDA approval in this subset, emphasizing the limited applicability."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that immunotherapy is an ongoing area of research.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that research is advancing rapidly and describes ongoing efforts to make tumors more visible to the immune system."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that there may be clinical trial options exploring novel immunotherapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It discusses ongoing clinical trials, combination strategies, and cancer vaccines, and recommends discussing trial participation."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that immune checkpoint blockade is only approved for patients with metastatic disease in certain situations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states FDA approval of pembrolizumab for metastatic pancreatic cancer with MSI-H/dMMR, conveying that approval applies in specific metastatic scenarios."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that pembrolizumab is approved for patients whose tumors are TMB high.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention the tumor-agnostic approval for TMB-high tumors; it only references MSI-H/dMMR and PD-L1."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend asking their oncology team about testing for eligibility for immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises discussing with the oncologist and specifically mentions reviewing the tumor\u2019s genetic profile to determine suitability for immunotherapy or clinical trials."
      }
    ],
    "question_number": 47,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:46:42.070975",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they should consult with their oncologist on the potential next steps.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly emphasizes discussing options with the oncologist and explicitly advises scheduling a meeting and considering a second opinion, clearly meeting this criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the oncologist may suggest alternative standard of care therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It outlines multiple alternative standard-of-care options after progression, including second-line chemotherapy, targeted therapy, immunotherapy (when markers present), radiation, and in rare cases surgery, indicating the oncologist may suggest these."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that the oncologist may suggest clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "There is a dedicated section on clinical trials stating the patient may be eligible and that these can offer access to new treatments, fully satisfying this criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that re-biopsy of the disease could reveal targetable mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response recommends tumor profiling/NGS to look for targets and mentions biopsy for reassessment, it does not explicitly state that a re-biopsy could reveal targetable mutations or link re-biopsy to molecular testing."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend supportive care and symptom management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a thorough section on symptom management and palliative care, end-of-life planning, and supportive resources, meeting this criterion."
      }
    ],
    "question_number": 48,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:47:01.013188",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that there is no approved CAR-T cell therapy for pancreatic cancer at this time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that CAR-T cell therapy is not currently an approved or standard treatment for pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe CAR-T cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explain what CAR-T cells are (e.g., engineered T cells expressing a chimeric antigen receptor to target tumor antigens). It only vaguely mentions immune cells being redirected, without describing CAR-T specifically."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CAR-T cells are being studied in clinical trials for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly mentions ongoing clinical trials investigating CAR-T cell therapy for pancreatic cancer and suggests ClinicalTrials.gov for finding trials."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that CAR-T cells are approved for the treatment of other types of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response accurately states that CAR-T cell therapy is approved for certain blood cancers, including leukemias, lymphomas, and multiple myeloma."
      }
    ],
    "question_number": 49,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:47:22.129935",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that hospice is considered when the medical team estimates a life expectancy of 6 months or less.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that hospice is generally considered when the patient has a prognosis of six months or less to live, if the illness follows its usual course."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the aim of hospice is to maximize quality of life and focus on addressing symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly emphasizes comfort, quality of life, and symptom management (e.g., pain, nausea, fatigue)."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that hospice can take place in the home, a nursing home, or in a dedicated hospice facility.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions home, hospice facility, and hospital, but does not mention nursing home as a setting, which the criterion specifically requires."
      },
      {
        "criterion_number": 4,
        "description": "The answer should start with an expression of sympathy and support.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Begins with a compassionate acknowledgment of the difficult situation and supportive tone."
      },
      {
        "criterion_number": 5,
        "description": "The response should define hospice care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear definition of hospice care as specialized care focused on comfort rather than curative treatment for those in the final stages of serious illness."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe what hospice care covers, including emotional and spiritual support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically notes emotional and spiritual support and includes chaplains/spiritual advisors as part of the team."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe what hospice care covers, including bereavement support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions bereavement counselors and support for the family."
      }
    ],
    "question_number": 50,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:47:44.919867",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that fatigue is a common side effect of chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that severe fatigue during chemotherapy is common."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple clear recommendations to consult the oncology team and tailor care with them."
      },
      {
        "criterion_number": 3,
        "description": "The response must mention that optimizing nutrition and hydration can help manage fatigue.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response recommends balanced nutrition and a dietitian but does not mention hydration."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend good sleep hygiene.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a dedicated section on rest and sleep hygiene with concrete tips."
      },
      {
        "criterion_number": 5,
        "description": "The response should discuss potential causes for fatigue, including the effect of the cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions anemia, medication side effects, pain, anxiety, and depression but does not explicitly state that the cancer itself can cause fatigue."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that light physical activity can improve fatigue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states that light exercise such as short walks can reduce fatigue."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend medication review.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises asking about medication side effects and potential adjustments to the chemotherapy regimen."
      }
    ],
    "question_number": 51,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:48:05.191542",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "State that alternative treatments like cannabis oil have not been proven to help patients with pancreatic cancer live longer or cure them.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states there is limited rigorous scientific evidence that cannabis oil is effective for pancreatic cancer in humans and that preclinical findings have not been conclusively replicated in human trials, which conveys that it is not proven to treat/cure or improve survival."
      },
      {
        "criterion_number": 2,
        "description": "State that cannabis oil is sometimes used to manage cancer-related symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly notes that some people use cannabis oil to manage nausea, pain, loss of appetite, and anxiety related to cancer or its treatment."
      },
      {
        "criterion_number": 3,
        "description": "Recommend discussing the use of cannabis oil with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises discussing any complementary or alternative treatment, including cannabis oil, with the oncologist or healthcare team."
      },
      {
        "criterion_number": 4,
        "description": "Describe cannabis oil.",
        "score_given": 5,
        "max_points": 5,
        "justification": "While not a full formal definition, the response explains that cannabis contains compounds like THC and CBD with therapeutic effects, implicitly characterizing cannabis oil as a source of these cannabinoids."
      },
      {
        "criterion_number": 5,
        "description": "State that cannabis oil is not used as an anti-cancer treatment per guidelines.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not reference clinical guidelines or explicitly state that guidelines do not recommend cannabis oil as an anti-cancer treatment."
      },
      {
        "criterion_number": 6,
        "description": "Describe risks of using cannabis oil, including drug interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions potential interactions with other medications."
      },
      {
        "criterion_number": 7,
        "description": "Describe risks of using cannabis oil, including side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists side effects such as dizziness, mood changes, and increased anxiety."
      },
      {
        "criterion_number": 8,
        "description": "Describe risks of using cannabis oil, including variation in quality.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes concerns about product purity, consistency, and accurate dosing when obtained outside regulated systems."
      },
      {
        "criterion_number": 9,
        "description": "Describe risks of using cannabis oil, including legal concerns.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses legal variability by region and potential legal consequences."
      }
    ],
    "question_number": 52,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:48:32.157873",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that lack of appetite is a common side effect of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that loss of appetite is very common in people with pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the patient should consult with their oncologist, who may refer them to a registered dietitian, oncology nutritionist, and/or palliative care physician to address symptoms and optimize supportive care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises discussing changes with his medical team and mentions the oncology team specifically, and suggests consulting a cancer care dietitian or nutritionist. Although palliative care is not mentioned, the criterion allows 'and/or,' and the oncologic and dietitian components are present."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pancreatic enzyme replacement can be pursued.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of pancreatic enzyme replacement therapy (e.g., PERT, enzymes like Creon) is included."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the patient can try smaller meals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends small meals: 'Offer small amounts of food more often instead of large meals.'"
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient can try more frequent meals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends eating 'more often,' i.e., frequent meals."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the patient can try nutritional replacement shakes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It suggests smoothies and milkshakes with protein powder, which function as nutritional/meal-replacement shakes."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that appetite stimulants can also be considered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking about medications that can help stimulate appetite."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that cancer itself can cause loss of appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It states that loss of appetite is very common in people with pancreatic cancer, indicating the disease itself can cause it."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that chemotherapy can cause nausea and loss of appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It mentions 'side effects of treatment' causing symptoms but does not specifically mention chemotherapy."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that bloating can decrease appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Bloating is not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that pancreatic enzyme deficiency can cause decreased appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "There is no mention of pancreatic enzyme insufficiency or its impact on appetite."
      }
    ],
    "question_number": 53,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:49:03.084950",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they can start with their primary doctor who can help refer to the most local community hospital with oncology services.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response advises talking to a primary care physician or local oncologist, but it does not explicitly state that the primary doctor can refer to the most local community hospital with oncology services."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that if they are able to travel, then major cancer centers offer consultations which can also be done as telehealth.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly recommends consultation at larger/major cancer centers if travel is possible and notes that many offer telehealth/teleconsultations. It also provides examples of major centers."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that patients can search for NCI-designated cancer centers to find the closest one to them, and explicitly mention that both oncologists and palliative care teams often offer virtual visits through telemedicine or telehealth consultations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of NCI-designated cancer centers or searching for them, and it does not explicitly state that both oncologists and palliative care teams offer virtual visits."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly recommend reaching out to regional cancer centers, including examples or resources for finding such centers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends identifying the nearest major cancer/academic medical center and provides examples (e.g., Mayo Clinic, MD Anderson, Dana-Farber, UCSF, University of Michigan)."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly state that specialists will often partner with local oncologists to coordinate care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that a local oncologist can coordinate care and consult with specialists remotely and implement treatment plans from major centers, demonstrating partnership and coordinated care."
      }
    ],
    "question_number": 54,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:49:33.865235",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should offer sympathy for the stressful situation dealing with insurance coverage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with empathetic language acknowledging the stress and difficulty of insurance denials and expresses sympathy directly."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that they can work with the hospital\u2019s financial counselor or social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends seeking help from social workers at the hospital or cancer center for insurance and financial challenges."
      },
      {
        "criterion_number": 3,
        "description": "The response should state the person should work with their oncology team to help with the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises obtaining a medical necessity letter from the oncologist or treating physician and gathering relevant medical records, indicating collaboration with the oncology team."
      },
      {
        "criterion_number": 4,
        "description": "The response should include contacting the insurance company to understand the reason for denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Instructs to request a detailed explanation from the insurer (EOB/denial letter) and review policy terms to understand the reason for denial."
      },
      {
        "criterion_number": 5,
        "description": "The response should state one option for remedy is filing an appeal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes the internal appeals process, persistence through multiple levels, and mentions external review as an additional step."
      }
    ],
    "question_number": 55,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:49:48.426211",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define high-volume centers as those performing at least 40 or 50 Whipple procedures per year.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response describes high-volume centers as doing a large number of surgeries but does not specify a numeric threshold (\u226540\u201350 Whipple procedures/year) or mention Whipple procedures explicitly."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that high-volume centers have significantly lower mortality rates and higher overall survival rates for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions higher survival rates, it does not explicitly state lower mortality rates. The rubric requires both lower mortality and higher survival."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that high-volume centers have significantly lower complication rates.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that studies show lower complication rates and reiterates lower rates of complications at high-volume centers."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that at a high-volume center, the surgeon is more likely to be a specialist in pancreas surgery.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It notes more experience with complex cases but does not explicitly state that surgeons are pancreas surgery specialists or more likely to be such specialists."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that high-volume centers often have access to clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states that patients may have access to clinical trials at high-volume centers."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that high-volume centers have access to the latest treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions access to the latest technology, techniques, and contrasts that local hospitals may have less access to the latest treatments and technologies, implying high-volume centers do."
      },
      {
        "criterion_number": 7,
        "description": "The response should state disadvantages of going to a high-volume center, including travel time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly discusses travel distance and the need to consider how much travel is involved for a distant center."
      },
      {
        "criterion_number": 8,
        "description": "The response should state disadvantages of going to a high-volume center, including more complicated logistics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references 'Travel and Logistics' and the need for family support at a distant center, indicating more complicated logistics."
      }
    ],
    "question_number": 56,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:50:15.673257",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention the Pancreatic Cancer Action Network as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly mentions the Pancreatic Cancer Action Network (PanCAN), including its Patient and Family Resource Hub and financial guidance, as a resource."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention CancerCare as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "CancerCare is specifically listed, described as providing financial assistance for transportation, home care, and more, with a link to cancercare.org."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the American Cancer Society as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The American Cancer Society (ACS) is included and described as providing information on financial resources and support services, with a link to cancer.org."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing financial concerns with a social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly advises that social workers at the hospital or cancer center can help connect patients with financial assistance and tailored support."
      },
      {
        "criterion_number": 5,
        "description": "The response should offer sympathy for the stressful situation dealing with financial burden during cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with empathy (\"I'm really sorry to hear...\") and acknowledges the burden, later adding \"It's understandable to feel overwhelmed\" and \"My thoughts are with you.\""
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend discussing financial concerns with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions asking the healthcare provider and consulting social workers, it does not explicitly recommend discussing financial concerns with the oncology team or oncologist."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussing financial concerns with a financial counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises that many cancer centers have financial counselors and suggests asking about these options, effectively recommending engagement with a financial counselor."
      }
    ],
    "question_number": 57,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:50:30.966282",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions that depression is common among patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states depression is very common in pancreatic cancer and provides a 30\u201350% prevalence estimate."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing the patient\u2019s mood with their oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not specifically recommend discussing mood with the oncologist; mentions the medical team for physical symptoms and mental health professionals generally."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions support groups as helpful for patients with cancer experiencing depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends joining pancreatic cancer support groups and notes their benefits."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions seeking immediate evaluation by a medical professional if the patient is experiencing thoughts of harming themself or others.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises seeking immediate help from a mental health professional or crisis service if there are signs of self-harm or suicide."
      },
      {
        "criterion_number": 5,
        "description": "The response offers the emergency department and calling 988 if the patient experiences thoughts of harming themself or others.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention the emergency department or calling 988 specifically."
      },
      {
        "criterion_number": 6,
        "description": "The response points to published scientific studies describing the prevalence of depression in pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Provides a prevalence range but does not cite or point to published scientific studies."
      },
      {
        "criterion_number": 7,
        "description": "The response reviews the signs and symptoms of depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions sadness, hopelessness, and self-harm risk but does not provide a review of depressive signs and symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends discussing the patient\u2019s mood with a mental health professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly encourages referral to a psychologist/psychiatrist/counselor experienced with cancer patients."
      },
      {
        "criterion_number": 9,
        "description": "The response states that there are various treatment options for depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that treatment may include therapy or medication, indicating multiple options."
      },
      {
        "criterion_number": 10,
        "description": "The response states that there are both pharmacologic and non-pharmacologic treatment options for depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions therapy (non-pharmacologic) and medication (pharmacologic)."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions lifestyle changes that support improvements in mental health.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends gentle exercise, good nutrition, and regular sleep to help mood."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that based on the ASCO guidelines, optimal care of depression should follow a stepped-care model.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of ASCO guidelines or a stepped-care model."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that CBT, BT, and BA are the most effective treatments for managing depressive symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not identify CBT, BT, or BA as the most effective treatments."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that exercise both during and after treatment can significantly reduce depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Suggests gentle exercise may help mood but does not state evidence that exercise during and after treatment significantly reduces depression."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that pharmacotherapy is not recommended as a first-line treatment for depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that pharmacotherapy is not first-line; instead mentions therapy or medication without prioritization."
      }
    ],
    "question_number": 58,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:51:03.063748",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly suggests asking the loved one\u2019s oncologist specific questions about stage, spread, molecular features, treatments, and clinical trials."
      },
      {
        "criterion_number": 2,
        "description": "The response states that many aspects of a patient\u2019s health impact their prognosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions age, overall health, and genetic factors as patient-specific factors influencing outcomes."
      },
      {
        "criterion_number": 3,
        "description": "The response defines overall survival as it is used in clinical research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines overall survival as the percentage alive at a certain time after diagnosis, which is an acceptable lay definition consistent with clinical usage."
      },
      {
        "criterion_number": 4,
        "description": "The response defines progression-free survival as it is used in clinical research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines PFS (and DFS) as the percentage without cancer progression or return at a certain time after treatment, reflecting the core concept of PFS."
      },
      {
        "criterion_number": 5,
        "description": "The response explains that overall survival and progression-free survival are typically reported as medians.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of medians or that OS/PFS are commonly summarized as median times."
      },
      {
        "criterion_number": 6,
        "description": "The response explains the above biostatistics terms (overall survival, progression-free survival, and median) in laymen\u2019s terms.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Provides lay explanations for OS and PFS but does not mention or explain the term median."
      },
      {
        "criterion_number": 7,
        "description": "The response explains that survival data is best reported in terms of the stage of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly emphasizes that stage (early vs metastatic) strongly affects survival rates, indicating survival data should be considered by stage."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the limitations of applying reported statistics to patients\u2019 individual cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that statistics are averages, individual variation exists, and numbers don\u2019t predict an individual\u2019s outcome."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions the difference between overall survival and progression-free survival.",
        "score_given": 5,
        "max_points": 5,
        "justification": "By defining OS (alive) versus PFS (no progression/return), it differentiates the two endpoints."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that survival is influenced by tumor characteristics such as genetic mutations (BRCA, KRAS), size, and location.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions genetic or molecular features generally but does not cite specific mutations (e.g., BRCA, KRAS) nor tumor size or location."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that survival depends on treatments received (chemotherapy, surgery, targeted therapy, no treatment, etc.) and treatment response.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes that survival varies with treatments (surgery, chemotherapy) but does not explicitly mention treatment response."
      },
      {
        "criterion_number": 14,
        "description": "The response mentions that new treatments and advancements are being developed all the time, and these could potentially improve outcomes in the future.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that improvements in treatment and clinical trials may improve outlook."
      }
    ],
    "question_number": 59,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:51:49.527637",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions 'talk to his doctors' and 'medical team' but does not explicitly recommend discussing with the patient's oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response explains that a liquid biopsy is a blood test.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states 'a simple blood test' and describes a 'blood draw.'"
      },
      {
        "criterion_number": 3,
        "description": "The response explains that liquid biopsies involve analyzing circulating tumor DNA (ctDNA) from blood samples.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions 'Fragments of tumor DNA (ctDNA \u2013 circulating tumor DNA)' found in the bloodstream."
      },
      {
        "criterion_number": 4,
        "description": "The response explains there are many different tests which evaluate various things including circulating tumor DNA, circulating tumor cells, and proteins in the blood.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While ctDNA and CTCs are listed, proteins are not explicitly mentioned; 'other biomarkers' is too vague for full credit."
      },
      {
        "criterion_number": 5,
        "description": "The response says that liquid biopsies do not replace tissue biopsies in the diagnosis of cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States they are 'used alongside, not instead of, tissue biopsies.'"
      },
      {
        "criterion_number": 6,
        "description": "The response says the results of liquid biopsies must be interpreted by a medical professional.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It notes results can be hard to interpret but does not state that a medical professional must interpret them."
      },
      {
        "criterion_number": 7,
        "description": "The response says the results of liquid biopsies may be helpful when combined with imaging and pathology results.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit mention of combining results with imaging or pathology; only 'other tests' is referenced."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions there are liquid biopsies in various stages of development for different kinds of cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of development stages or variation by cancer type."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the limitations of liquid biopsies, including sensitivity, false positives, and cost.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While limitations are noted, false positives and cost are not mentioned; sensitivity is not explicitly addressed."
      },
      {
        "criterion_number": 10,
        "description": "The response says there are currently no FDA approved liquid biopsies for pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of FDA approval status for pancreatic cancer liquid biopsies."
      },
      {
        "criterion_number": 11,
        "description": "The response says health insurance may not pay for these tests.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Insurance coverage is not addressed."
      },
      {
        "criterion_number": 12,
        "description": "The response says liquid biopsies may be able to identify genetic mutations present in the cancer which can help to guide treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Clearly states they can 'identify genetic mutations... which may suggest which treatments are most likely to work.'"
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that liquid biopsies are noninvasive and can expedite testing because there is no need to retrieve archival blocks or arrange for a new biopsy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions less invasive and potentially faster results, but does not specify the reason (no need for archival blocks/new biopsy)."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that copy-number changes may be more difficult to assess in cfDNA, and fusion testing may be more limited in common cfDNA tests currently used.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of copy-number or fusion testing limitations in cfDNA."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that this is still under active research and not yet standard of care for all cancer patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that liquid biopsy is under active research or not standard of care for all patients."
      }
    ],
    "question_number": 60,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:52:30.196766",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response considers the costs of travel.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly advises investigating total cost including travel expenses and mentions accommodation and transport needs."
      },
      {
        "criterion_number": 2,
        "description": "The response considers the costs of healthcare abroad.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes international treatment can be expensive and to investigate hospital fees, medications, and follow-up care costs."
      },
      {
        "criterion_number": 3,
        "description": "The response considers logistics of travel, including the need for passports and/or visas.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically mentions ensuring necessary visas and paperwork and other logistics for medical travel."
      },
      {
        "criterion_number": 4,
        "description": "The response considers language and cultural barriers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Addresses language barriers and recommends interpreters or hospital translation services."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions that patients receiving treatment for pancreatic cancer often require significant support from their family and friends.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages bringing a family member or friend for emotional support."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends considering if the patient is medically safe for travel.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises considering the physical strain of travel, particularly if the patient is weak or immunocompromised, and to consult the oncologist."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends researching the quality of healthcare in the intended destination.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends researching hospitals/physicians with pancreatic cancer expertise, multidisciplinary care, and accreditation/standards."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends discussing all travel plans with a medical professional prior to leaving.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states to consult the mother's oncologist to discuss treatment abroad and to get a second opinion."
      },
      {
        "criterion_number": 10,
        "description": "The response says that delaying the start of treatment for pancreatic cancer can be harmful.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention risks of delaying initiation of treatment."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends researching pancreatic cancer outcomes in the intended destination as compared to her home country.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No recommendation to compare outcome metrics between countries."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends understanding the patient\u2019s treatment options, including clinical trials, which may be available in her home country before making travel plans.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises asking the oncologist about specialized centers and clinical trials available locally before traveling."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention considerations related to insurance funding.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses checking insurance coverage for treatment abroad and mentions medical evacuation provisions and financial assistance."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to consider local accommodations when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically advises arranging extended stays in hotels or apartments near the hospital."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention to consider challenges with follow-up care when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Addresses continuity of care, transfer of medical records, and local doctor involvement for follow-up."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that immunizations and infection prevention are important, especially for immunosuppressed patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions immunocompromised status but does not address immunizations or infection prevention strategies."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that telemedicine and remote support can be leveraged for follow-up, symptom management, and multidisciplinary care, reducing the need for frequent travel and facilitating access to expertise at high-volume centers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes telemedicine for remote consultations and facilitating international collaborations, implying reduced travel and access to expertise."
      }
    ],
    "question_number": 61,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:53:27.639236",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that bowel changes, including diarrhea, nausea, and constipation, are common among patients undergoing treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions diarrhea and constipation but does not state that nausea is common; it only references persistent vomiting as a severe symptom."
      },
      {
        "criterion_number": 2,
        "description": "The response mentions that chemotherapy, radiation therapy, surgery, and other treatments such as pain medications can impact the bowels.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chemotherapy, radiation, and surgery are mentioned, but pain medications/opioids are not referenced."
      },
      {
        "criterion_number": 3,
        "description": "The response explains that bowel changes can also be due to infections.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of infections as a cause of bowel changes."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing specific concerns with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises talking to the oncology team/healthcare provider about these symptoms."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends keeping a log of events related to food intake, fluid intake, and bowel symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to keep a symptom/food/fluid log."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing the above log with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No log is proposed; therefore no suggestion to share it with the care team."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends if the patient has not had a bowel movement in more than 24 hours and is not passing gas, their bowels may be obstructed, which is a medical emergency and requires immediate evaluation in an emergency department.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of bowel obstruction red flags such as no BM for >24 hours and not passing gas, nor a directive to go to the emergency department for this."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends if the patient is nauseous and unable to keep any food or drink down without vomiting, this can quickly lead to severe dehydration, which requires urgent evaluation by a medical professional and potentially intravenous fluids and medicines.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions persistent vomiting and signs of dehydration and to seek medical attention, it does not specify inability to keep anything down nor the need for IV fluids/medications."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends if the patient is experiencing severe abdominal pain, this may represent a medical emergency which requires immediate evaluation in an emergency department.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions 'severe pain' generally and to seek medical attention, but not specifically severe abdominal pain nor the need for emergency department evaluation."
      },
      {
        "criterion_number": 10,
        "description": "The response says patients with pancreatic cancer may experience pancreatic insufficiency.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It describes reduced enzyme flow due to duct blockage but does not explicitly name pancreatic insufficiency."
      },
      {
        "criterion_number": 11,
        "description": "The response explains pancreatic insufficiency is related to a deficiency in the pancreatic enzymes which break down food and can cause diarrhea and bloating.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although enzyme reduction and diarrhea/steatorrhea are discussed, pancreatic insufficiency is not named and the link to bloating from enzyme deficiency is not explicitly made."
      },
      {
        "criterion_number": 12,
        "description": "The response explains there are supplementary pancreatic enzymes that can be taken to alleviate the symptoms of pancreatic insufficiency.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of pancreatic enzyme replacement therapy or supplementary enzymes."
      },
      {
        "criterion_number": 13,
        "description": "The response explains if the bowel changes are due to chemotherapy, the treating oncologist can often prescribe additional medications to control these side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It generally states providers may adjust medications or treatment plans but does not specifically address chemotherapy-related bowel changes and prescribing additional medicines."
      },
      {
        "criterion_number": 14,
        "description": "The response says proper nutrition is an important part of cancer care outcomes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Proper nutrition and its impact on outcomes are not discussed."
      },
      {
        "criterion_number": 15,
        "description": "The response says it is important to remain hydrated.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Hydration advice is not provided; dehydration is only mentioned as a warning sign."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that it is important to determine the cause of the bowel changes to manage them effectively.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises the team can determine whether changes are due to cancer, blockage, or side effects, and adjust management accordingly."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that gastric outlet/duodenal obstruction can occur in up to 10% of patients with pancreatic cancer, leading to symptoms like early satiety, nausea, postprandial vomiting, and weight loss.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of gastric outlet/duodenal obstruction or the 10% prevalence and associated symptoms."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that patients with malignant ascites from pancreatic cancer may experience abdominal discomfort, nausea, and vomiting.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Malignant ascites is not discussed."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that diet/nutrition changes can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No discussion of diet/nutrition changes as an alternative cause."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that stress/anxiety can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Stress or anxiety as a cause of bowel changes is not mentioned."
      },
      {
        "criterion_number": 21,
        "description": "The response should mention that pre-existing conditions can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Pre-existing gastrointestinal or other conditions are not discussed as potential contributors."
      }
    ],
    "question_number": 62,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:54:18.376782",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to talk to the oncology team/care team for tailored advice."
      },
      {
        "criterion_number": 2,
        "description": "The response states that pancreatic cancer and its treatments may affect the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that chemotherapy side effects can affect driving and discusses how treatment-related symptoms may impair safety."
      },
      {
        "criterion_number": 3,
        "description": "The response states that pain medications may impair the patient\u2019s ability to drive safely.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention pain medications or their impact on driving."
      },
      {
        "criterion_number": 4,
        "description": "The response states that symptoms such as fatigue, drowsiness, nausea, and vomiting may impair the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists fatigue, drowsiness, nausea, and vomiting as red flags affecting driving."
      },
      {
        "criterion_number": 5,
        "description": "The response states that the patient\u2019s healthcare team may have resources to assist with transportation.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions alternatives (family, rideshare, public transport) but does not state that the healthcare team may have transportation resources."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that chemotherapy can cause fatigue that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly states chemotherapy can cause fatigue that can affect driving."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that chemotherapy can cause vision changes that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Mentions changes in vision and blurriness as potential driving safety issues."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that chemotherapy can cause neuropathy that may impair driving abilities.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not mention neuropathy or numbness/tingling affecting driving."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that chemotherapy can cause cognitive changes that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "References confusion and 'chemo brain' as cognitive changes impacting driving."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention to avoid driving after the first chemotherapy session to see how your husband tolerates it.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not advise avoiding driving after the first chemotherapy session."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to plan for backup transportation, such as a taxi, friends/family, or public transportation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends alternatives including family/friends, rideshare, public transportation, and medical transport."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that the National Highway Traffic Safety Administration (NHTSA) provides information on medical conditions and driving safety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not reference NHTSA or similar driving safety resources."
      }
    ],
    "question_number": 63,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:54:43.786252",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that the ability to work depends on individual circumstances such as the stage of cancer, overall health, and comorbidities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes dependence on cancer stage and individual factors and mentions the oncology team considering overall health, cancer stage, and treatment plan."
      },
      {
        "criterion_number": 2,
        "description": "The response states that the ability to work depends on the type of treatment (chemotherapy, radiation, surgery, targeted therapy) and related side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses surgery, chemotherapy, radiation, targeted therapy, and immunotherapy, and ties these to side effects (fatigue, pain, nausea) affecting work."
      },
      {
        "criterion_number": 3,
        "description": "The response states that the ability to work depends on the support available from friends, family, and caregivers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests the loved one encourage conversations and mentions support organizations, it does not state that ability to work depends on support from friends, family, or caregivers."
      },
      {
        "criterion_number": 4,
        "description": "The response states that the ability to work depends on job type and flexibility (working from home, reduced hours, workplace accommodations, scheduled breaks).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly ties feasibility to job flexibility, less physically demanding roles, remote work, adjusted hours, and part-time work."
      },
      {
        "criterion_number": 5,
        "description": "The response states that pancreatic cancer and its treatment can cause symptoms which may make working challenging.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions fatigue, pain, and nausea from cancer/treatments making work difficult."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes that medical input is crucial and advises discussing intentions with the oncology team for personalized advice."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends workplace accommodations which may make working possible during treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends adjusted hours, flexible schedules, part-time work, and remote work as accommodations."
      },
      {
        "criterion_number": 9,
        "description": "The response states the patient\u2019s ability to continue working should be continually reassessed as their medical condition changes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises monitoring for signs that work may be too much and adjusting work as treatment progresses, implying ongoing reassessment."
      },
      {
        "criterion_number": 10,
        "description": "The response states that self-care is important while undergoing cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly states to prioritize health and well-being during treatment."
      },
      {
        "criterion_number": 11,
        "description": "The response states the patient may qualify for paid leave through their employer, the government, or both.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions legal protections and FMLA (which is typically unpaid) but does not mention the possibility of paid leave or disability benefits."
      },
      {
        "criterion_number": 12,
        "description": "The response states many patients with pancreatic cancer take time off of work during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not state that many patients take time off; it focuses on possibilities for continuing to work or reducing hours."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that it is important for patients with pancreatic cancer to maintain their quality of life, and that work during treatment may be possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that continuing work may be possible and emphasizes prioritizing health and well-being, which captures maintaining quality of life."
      }
    ],
    "question_number": 64,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:55:14.781980",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing the use of medical marijuana with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States it is crucial to discuss with his oncologist/healthcare provider and again advises to consult the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that medical marijuana is not an effective alternative treatment for pancreatic cancer itself.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly says, 'Not a cure: Medical marijuana is not a treatment for cancer itself, but may help manage symptoms.'"
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly mentions risks and side effects associated with medical marijuana, including psychoactive effects and potential interactions with other medications.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists drowsiness, dizziness, dry mouth, mood changes, impaired thinking/coordination (psychoactive effects), dependency/withdrawal, and notes drug interactions."
      },
      {
        "criterion_number": 4,
        "description": "The response clearly states that medical marijuana comes in various forms, such as oils, edibles, tinctures, and vaporizers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions forms like oils, capsules, edibles, and inhaled vapor (vaporization), satisfying the 'various forms' requirement."
      },
      {
        "criterion_number": 5,
        "description": "The response specifically mentions the risk of inhaled medical marijuana exposing patients to infectious organisms like fungi, particularly for those receiving certain chemotherapy treatments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of infectious risks from inhaled cannabis or fungal exposure in immunocompromised/chemotherapy settings."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly states that medical marijuana may be used to control symptoms associated with pancreatic cancer and its treatments, such as nausea, vomiting, loss of appetite, and pain.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists potential benefits including nausea/vomiting, loss of appetite, and pain management."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly states that there is mixed data on the benefit of medical marijuana for managing symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States evidence is limited for pancreatic cancer specifically but does not state that symptom-management data are mixed."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses potential legal challenges with obtaining and using medical marijuana, noting that these may vary based on the patient\u2019s location.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes legal variability across US states, Canada, and other countries and advises checking local laws."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly recommends not driving or making important decisions while under the influence of marijuana.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it notes impaired thinking/coordination, it does not explicitly advise against driving or major decisions."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly recommends obtaining medical marijuana only from professionals licensed to sell it.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions regulation and product quality but does not explicitly recommend purchasing only from licensed professionals."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that medical marijuana refers to products derived from the cannabis plant or its extracts that contain active compounds such as THC (tetrahydrocannabinol), CBD (cannabidiol), or combinations thereof.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines medical marijuana as cannabis/cannabinoids and explicitly mentions THC and CBD."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that preliminary data reports poor clinical outcomes in adults receiving immunotherapy while using cannabis and/or cannabinoids.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to immunotherapy outcomes with concomitant cannabis use."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that CBD presents risks for hepatotoxicity, with a meta-analysis reporting a nearly 6-fold increase in liver enzyme elevation and drug-induced liver injury.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of CBD-related hepatotoxicity or liver enzyme elevations."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that cannabis and/or cannabinoids are one of several pharmacologic options for adults with cancer experiencing refractory nausea and vomiting despite optimal prophylaxis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses potential benefit for nausea/vomiting but does not frame it as an option for refractory cases after optimal prophylaxis."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce polypharmacy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of polypharmacy or research regarding cannabis to reduce medication burden."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce opioid requirements for cancer-related pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss opioid-sparing effects or need for research in this area."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of chemotherapy-induced peripheral neuropathy or cannabis effects on it."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that further research is needed to determine the effects of cannabis on pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While pain is listed as a potential benefit, it does not explicitly state that further research is needed regarding cannabis effects on pain."
      }
    ],
    "question_number": 65,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:55:44.234184",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends consulting with the patient\u2019s oncologist or healthcare team, including specific roles such as nurse practitioner or palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises consulting the medical team and specifically mentions the oncologist and care team, and also suggests obtaining a second opinion. While it does not name nurse practitioners or palliative care specialists, it clearly recommends consulting the oncologist/healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that the healthcare team may have a social worker available to assist with family discussions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although the response suggests reaching out to a social worker or patient navigator at the hospital/cancer center, it does not explicitly state that the healthcare team has a social worker available to assist with family discussions."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends involving a neutral third party, such as a social worker, spiritual care worker, counselor, or patient advocate, to facilitate family discussions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends family therapy/mediation with a neutral third party to guide conversations and manage conflict and also mentions social workers and patient navigators."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly provides online resources for cancer patients and their families, including specific organizations like PANCAN, NCI, or ACS.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists PanCAN and the American Cancer Society (ACS), as well as NHPCO, fulfilling the requirement to provide specific online resources."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend scheduling a family meeting to discuss goals of care and important treatment decisions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends setting up a family meeting and separately addresses clarifying goals/values and advance care planning, aligning with discussing goals of care and decisions."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that understanding your mother\u2019s specific goals should shape conversations about goals of care and treatment recommendations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response emphasizes understanding each family member\u2019s values but does not explicitly center the mother\u2019s specific goals as the driver of goals-of-care discussions and treatment recommendations."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that your mother\u2019s wishes related to treatment, belief systems, and personal ways of coping should be respected by their families, cancer care team, and others who support them through the cancer experience.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it promotes open communication and listening, it does not explicitly state that the mother\u2019s wishes, beliefs, and coping preferences should be respected by family and the care team."
      }
    ],
    "question_number": 66,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:56:12.911877",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention discussing these concerns with the oncologist or medical oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual care worker, palliative care professional, or counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly suggests a social worker and a therapist/counselor who specializes in cancer care."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends support groups and other online resources for cancer patients and their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends support groups and mentions organizations as resources."
      },
      {
        "criterion_number": 4,
        "description": "The response states that depression is highly prevalent in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Depression and its high prevalence in pancreatic cancer are not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response reviews the signs and symptoms of depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No signs or symptoms of depression are described."
      },
      {
        "criterion_number": 6,
        "description": "The response states that if the patient is experiencing thoughts of harming themselves or others, they should seek immediate evaluation by a healthcare professional.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no guidance about urgent evaluation for self-harm or harm-to-others thoughts."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that it\u2019s important to have open and honest conversations about their concerns, including feeling like a burden to their loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes open, honest communication about feelings, including feeling like a burden."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage the patient to express their fears and anxieties about the impact of their illness on their loved ones, and acknowledge and validate their feelings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages sharing fears and concerns and includes validation and reassurance."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to ask about the patient\u2019s preferences and personal goals of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it advises asking about preferences and involving the patient in decisions, it does not explicitly mention personal goals of care."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention it is important to emphasize working together to manage the challenges.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights sharing responsibilities and a collaborative approach to care and support."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention support networks such as PanCAN, CancerCare, ASCO.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions PanCAN as a support organization."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that professional counseling can help process these emotions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that a therapist/counselor can help address feelings and improve communication, and encourages seeking professional help."
      }
    ],
    "question_number": 67,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:56:41.661913",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states targeted therapies work against cancer with specific genetic mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains targeted therapy focuses on specific molecules/genes (e.g., mutations like KRAS, BRAF, HER2) and how drugs block these targets."
      },
      {
        "criterion_number": 2,
        "description": "The response states that not all pancreatic cancers will have mutations for which targeted therapy can be used.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that not all cancers have clear targets, not all patients benefit, and explicitly mentions not all pancreatic cancers have identifiable targets."
      },
      {
        "criterion_number": 3,
        "description": "The response provides examples of targetable mutations in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides examples including KRAS, BRAF, and HER2 alterations as potential targets."
      },
      {
        "criterion_number": 4,
        "description": "The response states targeted therapies can be given alone or sometimes in combination with chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention the possibility of giving targeted therapy in combination with chemotherapy."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises asking the oncologist for more information and considering a second opinion at a specialized center."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that targeted therapy for pancreatic cancer involves using drugs to specifically target proteins, genes, or pathways of cancer cells, potentially causing less damage to normal cells compared to chemotherapy or radiation therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that drugs target specific proteins/genes and often cause fewer side effects than chemotherapy, implying less damage to normal cells."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that while targeted therapy is an option, it is important to consider all potential treatment options, outcomes, and adverse events to make an informed decision.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages discussing with the oncologist but does not explicitly emphasize weighing all options, outcomes, and adverse events to make an informed decision."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention examples of targeted therapies, such as Dabrafenib + trametinib, Entrectinib, Larotrectinib, Repotrectinib, Selpercatinib, Rucaparib, Olaparib, Adagrasib, Sotorasib, Erdafitinib, Fam-trastuzumab deruxtecan-nxki, Zenocutuzumab-zbco.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not list any of the specific recommended/approved examples from the rubric (e.g., dabrafenib+trametinib, NTRK inhibitors, PARP inhibitors, HER2 T-DXd, KRAS G12C inhibitors)."
      },
      {
        "criterion_number": 9,
        "description": "Negative points if targeted therapies are discussed that are not approved for pancreatic cancer, such as osimertinib, regorafenib, mTOR inhibitors.",
        "score_given": -10,
        "max_points": 0,
        "justification": "Mentions encorafenib for BRAF and trastuzumab for HER2, which are not FDA-approved targeted therapies for pancreatic cancer; thus includes undesirable content."
      }
    ],
    "question_number": 68,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:57:25.994075",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing integrative medicine with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises consulting the oncology team before starting any new therapies or supplements and emphasizes open communication with the medical team."
      },
      {
        "criterion_number": 2,
        "description": "The response states integrative medicine is not as effective as standard of care treatments for pancreatic cancer like chemotherapy, radiation, surgery, and targeted therapies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response advises not to replace standard care and to be cautious, but it does not explicitly state that integrative medicine is not as effective as standard treatments for treating pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response states integrative medicine can be a helpful adjunct to standard of care treatments for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states integrative approaches can support well-being and quality of life and should complement\u2014not replace\u2014standard medical care."
      },
      {
        "criterion_number": 4,
        "description": "The response defines integrative medicine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a clear definition distinguishing integrative medicine (combining conventional care with complementary therapies) from alternative medicine."
      },
      {
        "criterion_number": 5,
        "description": "The response provides examples of integrative medicine interventions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple examples including nutritional support, mind-body practices (mindfulness, meditation, gentle yoga), exercise, acupuncture, and massage therapy."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends telling the patient\u2019s oncologist if they plan to include integrative medicine interventions into their care plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing with the oncology team before starting any new therapies and maintaining an open dialogue about complementary approaches."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends telling the patient\u2019s oncologist about all supplements they are taking.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States to talk with the medical team before starting any supplements and to check with the oncology team before taking any supplement, effectively recommending disclosure of supplement use."
      },
      {
        "criterion_number": 8,
        "description": "The response states some supplements may interact with the treatments being prescribed for their pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes that some supplements or herbs can interact negatively with cancer treatments or worsen side effects and can interfere with chemotherapy or other medications."
      },
      {
        "criterion_number": 9,
        "description": "The response states there is data to support some integrative medicine interventions for specific uses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that some complementary therapies have research supporting improvement in quality of life, symptom management, or side effect reduction."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that safety concerns and risks related to integrative medicine approaches are heightened with self-prescription or use of non-standardized products.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Warns about false promises and potential harm from supplements but does not specifically mention heightened risks from self-prescription or non-standardized/variable-quality products."
      }
    ],
    "question_number": 69,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:58:11.406310",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the skin changes with the patient\u2019s oncologist or healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly advises contacting the oncology team and specifically states to discuss changes with the father's oncologist or medical team and to contact the care team right away for concerning signs."
      },
      {
        "criterion_number": 2,
        "description": "The response states that skin changes are a common side effect of chemotherapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states: 'Skin changes are a common side effect of chemotherapy, including for patients with pancreatic cancer.'"
      },
      {
        "criterion_number": 3,
        "description": "The response states that skin changes related to treatment for pancreatic cancer can range from mild to life-threatening.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes that changes can be mild or might need medical attention, it does not explicitly mention that they can be life-threatening."
      },
      {
        "criterion_number": 4,
        "description": "The response provides at least two examples of skin changes, including hand-foot syndrome, allergic reactions, or infections.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although multiple skin changes are listed (dryness, rash, discoloration, blistering, photosensitivity), it does not include at least two of the specified examples (hand-foot syndrome, allergic reactions, infections). Only infection is referenced later as a warning sign, not as a listed treatment-related skin change example."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends immediate evaluation by a healthcare provider if the patient shows signs of infection.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises to 'contact the care team right away' for signs of infection, indicating immediate evaluation."
      },
      {
        "criterion_number": 6,
        "description": "The response provides at least one example of signs and symptoms of infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists specific signs: increased redness, swelling, pus, and fever."
      },
      {
        "criterion_number": 7,
        "description": "The response states that skin changes related to treatment for pancreatic cancer should be treated by a healthcare professional experienced in caring for cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directs the patient to the oncologist/medical team for guidance and management, implying treatment by cancer-experienced professionals."
      },
      {
        "criterion_number": 8,
        "description": "The response states that skin changes related to treatment for pancreatic cancer often require specific interventions or escalation of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes some changes require medical attention and emphasizes informing the oncology team and contacting them right away for concerning signs, indicating potential escalation of care."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions at least three specific manifestations of skin changes related to chemotherapy, such as new or worsening skin lesions, itch, acne-like symptoms, bullous dermatoses, allergic reactions, hand-foot syndrome, nail changes, or inflammatory dermatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists multiple manifestations: itchiness, rash/redness, blistering/peeling, darkening/lightening, photosensitivity, and also mentions rapidly spreading or changing skin lesions."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that skin changes could also be due to other conditions, such as infection, other medications, or unrelated skin disorders.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it flags signs of infection as urgent, it does not explicitly state that skin changes could be due to other conditions (e.g., infections, other medications, unrelated skin disorders)."
      },
      {
        "criterion_number": 12,
        "description": "The response states the importance of correctly identifying skin changes to ensure appropriate management and to avoid unnecessary discontinuation of effective cancer therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It encourages discussing with the oncology team but does not mention avoiding unnecessary discontinuation of therapy or the importance of accurate identification for that purpose."
      }
    ],
    "question_number": 70,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T14:59:08.212920",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response suggests asking about the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a question about cancer type and stage (e.g., Stage I\u2013IV)."
      },
      {
        "criterion_number": 2,
        "description": "The response suggests asking about available treatment options.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Has a dedicated Treatment Options section asking what options are recommended and why."
      },
      {
        "criterion_number": 3,
        "description": "The response suggests asking about prognosis if the patient wants to know this information.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Contains a Prognosis section prompting to ask about prognosis for the specific type and stage."
      },
      {
        "criterion_number": 4,
        "description": "The response suggests asking about potential side effects of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Asks about benefits/risks and side effects, and how to manage pain or other side effects."
      },
      {
        "criterion_number": 5,
        "description": "The response suggests asking about when the patient should follow up next.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests asking what will be required for follow-ups and clarifies next steps and timeline."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends writing down questions ahead of time and bringing them to the appointment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Tips section advises writing down questions ahead of time."
      },
      {
        "criterion_number": 7,
        "description": "The response suggests asking about symptoms affecting the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Prompts questions about symptoms to expect, symptom management, and quality of life."
      },
      {
        "criterion_number": 8,
        "description": "The response suggests asking about clinical trial availability.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly asks whether clinical trials are available and eligibility."
      },
      {
        "criterion_number": 9,
        "description": "The response suggests asking about how palliative care can help with the patient\u2019s care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests asking about supportive/palliative care options and involving a palliative care specialist."
      },
      {
        "criterion_number": 10,
        "description": "The response suggests asking if genetic testing is available for germline inheritable cancer predisposition syndromes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of germline genetic testing or hereditary risk assessment."
      },
      {
        "criterion_number": 11,
        "description": "The response suggests asking about nutrition and if a nutritionist is available to help with dietary recommendations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions dietary restrictions but does not suggest asking for a nutritionist/dietitian."
      },
      {
        "criterion_number": 12,
        "description": "The response suggests asking about support groups for patients with pancreatic cancer and their families.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages asking about support services or counseling for the patient and family, which encompasses support groups."
      },
      {
        "criterion_number": 13,
        "description": "The response suggests asking about how to contact the oncology team in case of questions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not advise asking for contact methods or after-hours numbers for the oncology team."
      },
      {
        "criterion_number": 14,
        "description": "The response suggests asking if lifestyle changes need to be made.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Asks about lifestyle and activity restrictions."
      },
      {
        "criterion_number": 15,
        "description": "The response suggests asking about mental health and resources for mental health support.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises asking about counseling and coping with the emotional impact."
      },
      {
        "criterion_number": 16,
        "description": "The response recommends writing down important information during the appointment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Suggests recording the conversation or taking detailed notes during the appointment."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention to ask questions related to goals of treatment (palliative, curative, etc).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly asks about the goals of treatment at this stage."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention bringing a family member or a friend to help listen and take notes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Tips advise bringing a family member or friend for support and to help remember information."
      }
    ],
    "question_number": 71,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:00:03.010446",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises talking with the medical team/oncologists and mentions preparing questions for the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states quality of life is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Repeatedly emphasizes quality of life and comfort as central considerations."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends considering the patient\u2019s goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages discussing wishes, values, and goals, aligning with goals-of-care discussions."
      },
      {
        "criterion_number": 4,
        "description": "The response states pancreatic cancer is an aggressive cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that pancreatic cancer is aggressive."
      },
      {
        "criterion_number": 5,
        "description": "The response states stopping treatment without consulting the treating oncologist is dangerous.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Recommends discussion with oncologist but does not explicitly warn that stopping without consultation is dangerous."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends considering access to emergency care at the travel destination.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions having medical support if needed but does not explicitly address access to emergency care at the destination."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends refilling all prescription medications prior to travel.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of refilling prescriptions before travel."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends considering if travel is safe.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Directly addresses travel risks and safety considerations."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends considering if the patient is strong enough to travel.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Asks how physically able the patient is to travel, implying assessment of strength and stamina."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly clarify what \u201cstopping treatment\u201d means, such as stopping all therapies, only chemotherapy, or supportive care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions palliative/hospice care and treatment holidays but does not explicitly define what \u201cstopping treatment\u201d entails (e.g., stopping disease-directed therapy vs. continuing supportive care)."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly discuss the effects of a (temporary) treatment break on the prognosis of the cancer, symptoms, and other risks involved.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes that cancer may progress rapidly after stopping treatment but does not explicitly discuss effects on symptoms or other risks of a treatment break."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that stopping treatment may affect the patient\u2019s medical stability, ability to travel safely, and access to care and support while away.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Addresses general travel risks and medical support but does not explicitly connect stopping treatment to medical stability, travel ability, or access to care while away."
      }
    ],
    "question_number": 72,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:00:36.803658",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to talk to the oncology team multiple times and to consult the oncologist for personalized advice."
      },
      {
        "criterion_number": 2,
        "description": "The response states that if there are signs or symptoms of infection at the port site, to seek immediate evaluation by a healthcare professional.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not instruct to seek immediate evaluation for infection; only notes that if a port is causing infection, switching access might be safer."
      },
      {
        "criterion_number": 3,
        "description": "The response offers examples of signs or symptoms of infection, including fever, chills, redness or pain at the port site, and pus coming from the port site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific infection symptoms (fever, chills, redness, pus) are listed."
      },
      {
        "criterion_number": 4,
        "description": "The response states many chemotherapy drugs must be given through central venous catheters.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States most chemotherapy is given intravenously but does not state that many drugs must be given via central venous catheters."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of central venous catheters.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides examples including PICC lines and non-tunneled central venous catheters."
      },
      {
        "criterion_number": 6,
        "description": "The response states different central venous catheters have pros and cons.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists pros and cons for PICC lines and CVCs."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends asking the patient\u2019s oncologist about alternative treatment regimens that may not require administration through a central venous catheter.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly recommend asking about non\u2013central venous regimens; mentions oral options generally but without advising to ask about them as alternatives."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends avoiding touching, rubbing, and bumping the port site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No advice provided about avoiding manipulation of the port site."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include peripherally inserted central catheters (PICC lines).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions PICC lines as an alternative and describes them."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include a tunneled central venous catheter (Hickman, Broviac, Groshong).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention tunneled catheters or examples such as Hickman, Broviac, or Groshong."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include a non-tunneled central venous catheter (jugular or subclavian line).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions non-tunneled central venous catheters placed in neck, chest, or groin veins."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include oral chemotherapy such as capecitabine.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions oral chemotherapy generally but does not name capecitabine."
      },
      {
        "criterion_number": 14,
        "description": "The response should not mention that chemotherapy for pancreatic cancer can be given via subcutaneous injection.",
        "score_given": 0,
        "max_points": 0,
        "justification": "Does not claim pancreatic chemotherapy can be administered subcutaneously; notes some cancer-care medications may be subcutaneous but clarifies most chemotherapy is IV."
      }
    ],
    "question_number": 73,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:01:27.972000",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response repeatedly advises consulting the oncology team for personalized guidance and mentions the infectious disease specialist and care team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends avoiding people who have signs or symptoms of an infectious illness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly says that anyone with fever, cough, diarrhea, or other signs of illness should not visit and to keep distance."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends frequent hand washing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Hand hygiene is emphasized with instructions to wash for at least 20 seconds and use alcohol-based sanitizer."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends wearing a face mask while in crowds.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises avoiding crowds and recommends masks for symptomatic visitors, but does not instruct the patient to wear a mask while in crowds."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing asking the patient\u2019s healthcare team about which vaccinations are recommended.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises ensuring vaccines are up to date 'as advised by their doctor,' indicating discussion with the care team about recommended vaccines."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends reporting signs and symptoms of infection to the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states to report any signs of infection to the healthcare team immediately."
      },
      {
        "criterion_number": 7,
        "description": "The response provides examples of signs and symptoms of infection, including fever, chills, cough, runny nose, nausea, and vomiting.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It lists fever, chills, redness/swelling/pain/discharge and includes vomiting, but does not include cough, runny nose, or nausea."
      },
      {
        "criterion_number": 8,
        "description": "The response states the patient\u2019s oncologist may prescribe antibiotics, antivirals, and antifungals to prevent infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions the team may start antibiotics preventively but does not mention antivirals or antifungals."
      },
      {
        "criterion_number": 9,
        "description": "The response instructs the patient to take all medications as prescribed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It says to only use medications prescribed by the oncology team, but does not explicitly instruct taking all medications as prescribed/adhering to the regimen."
      },
      {
        "criterion_number": 10,
        "description": "The response states some treatments for pancreatic cancer can lower white blood cell counts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes cancer treatments can lower the body\u2019s ability to fight infections and specifically references neutropenia (low white blood cell count) as a side effect."
      },
      {
        "criterion_number": 11,
        "description": "The response states white blood cells fight off infections.",
        "score_given": 0,
        "max_points": 2,
        "justification": "While it links neutropenia with infection risk, it does not explicitly state that white blood cells fight infections."
      },
      {
        "criterion_number": 12,
        "description": "The response states a low white blood cell count can increase the risk of infections.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directly ties neutropenia (low WBC) to increased infection risk."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that prevention includes vaccination for COVID-19 and flu for the patient and household members.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends influenza and COVID-19 vaccination for the loved one and close household contacts."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention avoiding exposure to fungal spores (construction/demolition, intensive soil exposure/gardening, household renovation) for neutropenic patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of avoiding high-spore environments such as construction sites, heavy gardening/soil exposure, or renovations."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that there is no need for antimicrobial prophylaxis for most solid tumors if overall infection risk is low (neutropenia < 7 days).",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not address this; it instead notes that the team may start antibiotics preventively without the caveat that routine prophylaxis is generally not needed for most solid tumors with low-risk neutropenia."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that footwear exchange, protected environments, neutropenic diet, or nutritional supplements are not recommended due to lack of evidence of benefit.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of these interventions or the lack of evidence supporting them."
      }
    ],
    "question_number": 74,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:02:35.228332",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Defines precision medicine as tailoring cancer treatment based on a patient\u2019s unique tumor characteristics, such as genetic and molecular profiles, to improve effectiveness and reduce toxicity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states precision medicine tailors treatment to individual characteristics including the tumor\u2019s genetic makeup and notes treatments may be more effective and less harmful to normal cells."
      },
      {
        "criterion_number": 2,
        "description": "Recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises talking with his oncologist or medical team for case-specific guidance."
      },
      {
        "criterion_number": 3,
        "description": "Mentions testing the patient\u2019s tumor for genetic mutations which can be targeted with certain therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response describes genetic and molecular testing of tumor tissue and explains that identified mutations can guide targeted therapy choices."
      },
      {
        "criterion_number": 4,
        "description": "States PARP inhibitors may be used in patients with mutations in the BRCA gene.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of BRCA mutations or PARP inhibitors."
      },
      {
        "criterion_number": 5,
        "description": "States immunotherapy may be used in patients if their tumors have high microsatellite instability (MSI-high).",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of MSI-high status or immunotherapy indications."
      },
      {
        "criterion_number": 6,
        "description": "Mentions testing the patient\u2019s tumor for expression of certain proteins which can be targeted with certain therapies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While molecular testing is mentioned, there is no specific reference to testing for protein expression (e.g., HER2, PD-L1) as targets."
      },
      {
        "criterion_number": 7,
        "description": "Provides examples of targeted therapies in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific targeted therapies or drug examples are provided."
      },
      {
        "criterion_number": 8,
        "description": "Provides examples of therapies targeting protein expression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No examples of therapies based on protein expression are mentioned."
      },
      {
        "criterion_number": 9,
        "description": "Mentions that not every patient will have genetic mutations or protein expression which can be targeted with precision medicine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states not all cancers have identifiable genetic mutations that can be targeted and not every patient will benefit from precision medicine."
      },
      {
        "criterion_number": 10,
        "description": "States precision medicine helps the patient\u2019s oncologist identify treatments which will not be helpful.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state that precision medicine can rule out ineffective treatments; it focuses on selecting potentially effective options."
      },
      {
        "criterion_number": 11,
        "description": "Mentions that comprehensive genomic profiling using next-generation sequencing (NGS) is now standard for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of comprehensive genomic profiling or NGS being standard."
      },
      {
        "criterion_number": 12,
        "description": "Mentions that both germline and somatic testing are recommended for all patients with pancreatic cancer, as actionable alterations may be present even in the absence of family history.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of germline versus somatic testing or universal testing recommendations."
      },
      {
        "criterion_number": 13,
        "description": "Mentions that TRK inhibitors (larotrectinib, entrectinib) are indicated for NTRK fusion-positive tumors, regardless of histology.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of NTRK fusions or TRK inhibitors."
      }
    ],
    "question_number": 75,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:03:15.145397",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing steps with the oncology team multiple times and to reach out right away."
      },
      {
        "criterion_number": 2,
        "description": "The response states mouth sores are a common side effect of some chemotherapy drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that mucositis is a common side effect of chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response states drugs like 5-FU and capecitabine can cause mouth sores.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention 5-FU or capecitabine by name."
      },
      {
        "criterion_number": 4,
        "description": "The response states these are sometimes related to having low white blood cell counts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of neutropenia or low white blood cell counts."
      },
      {
        "criterion_number": 5,
        "description": "The response states that having low white blood cell counts can increase the likelihood of infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explain the infection risk associated with low white blood cell counts."
      },
      {
        "criterion_number": 6,
        "description": "The response states mouth sores in patients on chemotherapy can also be related to infections from viruses or bacteria.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions infection monitoring and antifungals but does not state that sores can be related to viral or bacterial infections."
      },
      {
        "criterion_number": 7,
        "description": "The response states the patient\u2019s healthcare team may swab the mouth sores to test them for infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of swabbing/testing sores for infection."
      },
      {
        "criterion_number": 8,
        "description": "The response states there are medications which can help prevent and improve mouth sores in the form of both topical drugs and specialized mouthwashes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists topical gels and mouthwashes to soothe but does not address prevention."
      },
      {
        "criterion_number": 9,
        "description": "The response states there are medications which can improve symptoms related to mouth sores, like pain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends oral pain medications and barrier gels for symptom relief."
      },
      {
        "criterion_number": 10,
        "description": "The response instructs the patient to immediately seek evaluation by a healthcare provider if they are experiencing a fever or other signs or symptoms of infection.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises watching for fever and other infection signs and to report them promptly to the oncology team."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends gentle oral hygiene.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifies gentle oral care with a soft toothbrush, avoiding alcohol-based mouthwash, and salt-water rinses."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that chlorhexidine mouthwash is not recommended for prevention in most adult cancer populations due to lack of efficacy and potential for adverse effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Actually suggests chlorhexidine rinse as an option; does not state it is not recommended for prevention."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that topical anesthetics (lidocaine viscous, 2% solution) and mixed medication mouthwashes (\u201cmagic mouthwash\u201d) may be used for pain control, though evidence for specific formulations is variable.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention lidocaine viscous or magic mouthwash."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that Gabapentin may be considered for mucositis-related pain, often in combination with other analgesics.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of gabapentin."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that topical and systemic antifungals (e.g., clotrimazole troches, systemic fluconazole) are indicated for secondary candidiasis, which is common in the setting of mucositis and xerostomia.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions topical antifungals (nystatin/clotrimazole) but not systemic options or candidiasis context; requirement not fully met."
      },
      {
        "criterion_number": 21,
        "description": "The response should mention that antibiotics are reserved for documented secondary bacterial infections.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of antibiotic stewardship or reserving antibiotics for confirmed bacterial infection."
      },
      {
        "criterion_number": 22,
        "description": "The response should mention that management often involves over-the-counter pain relief such as acetaminophen or ibuprofen, but that stronger prescription medicines may be indicated.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses prescription pain meds but does not mention OTC options like acetaminophen or ibuprofen."
      },
      {
        "criterion_number": 23,
        "description": "The response should mention that multidisciplinary and supportive care is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages emotional support, palliative care involvement, and dietitian referral\u2014reflecting multidisciplinary supportive care."
      },
      {
        "criterion_number": 24,
        "description": "The response should mention that management could include dietary adjustments such as soft or liquid diets, small frequent meals, nutritional support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends soft foods, small frequent meals, hydration, smoothies/yogurt, and referral to a nutritionist with supplements."
      }
    ],
    "question_number": 76,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:04:14.091538",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises: \"Ask the oncologist or the clinical trial team to explain the trial in detail,\" recommending discussion with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews the design of clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes randomized controlled trials, blinding, open-label designs, and comparisons to standard treatment/placebo, which constitutes a review of trial design."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the four phases of clinical trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of Phase I\u2013IV or their distinct purposes."
      },
      {
        "criterion_number": 4,
        "description": "The response defines placebo.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines placebo as an inactive substance or 'sugar pill' with no therapeutic effect."
      },
      {
        "criterion_number": 5,
        "description": "The response states that patients in clinical trials for cancer are seldom given a placebo, as this may cause harm.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that in diseases like pancreatic cancer it would be unethical to give a placebo instead of any treatment and trials often compare to standard care, implying rare placebo use to avoid harm."
      },
      {
        "criterion_number": 6,
        "description": "The response reviews informed consent.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention the informed consent process, rights to withdraw, or consent documentation."
      },
      {
        "criterion_number": 7,
        "description": "The response defines the placebo effect.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains that benefits from participating, expecting improvement, or receiving attention can influence outcomes and calls this the 'placebo effect.'"
      },
      {
        "criterion_number": 8,
        "description": "The response states that patients in the control arm of clinical trials often receive the standard of care treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that trials often compare new treatment to current standard treatment/standard of care rather than placebo."
      },
      {
        "criterion_number": 9,
        "description": "The response states clinical trials are designed to discover new, effective treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the main goals are to determine if a new treatment is safe and effective compared to current options."
      },
      {
        "criterion_number": 10,
        "description": "The response states clinical trials are designed to minimize patient harm.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit statement that trials are designed to minimize harm or include safety measures/oversight to protect participants."
      },
      {
        "criterion_number": 11,
        "description": "The response states that patients participating in clinical trials are monitored closely for side effects from the disease and the treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention close monitoring or safety assessments during the trial."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends researching clinical trials before participating.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages asking detailed questions, understanding risks/benefits, considering comfort with risks, and obtaining a second opinion\u2014clear guidance to research before participating."
      },
      {
        "criterion_number": 13,
        "description": "The response offers resources for researching clinical trials, including ClinicalTrials.gov.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific resources provided; ClinicalTrials.gov is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response states clinical trials are designed to be ethical and are monitored closely.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions that giving placebo instead of treatment would be unethical, it does not state that trials are designed to be ethical overall or that they are closely monitored by oversight bodies."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that trials are essential for optimizing current and future cancer therapies."
      }
    ],
    "question_number": 77,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:05:13.353461",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states, \u201cIt\u2019s very important to discuss the details with your husband\u2019s oncologist,\u201d and suggests questions to ask."
      },
      {
        "criterion_number": 2,
        "description": "The response states there are many different types of treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response outlines multiple treatment types (chemotherapy, targeted therapy, immunotherapy, radiation, surgery context), indicating several types of treatments exist."
      },
      {
        "criterion_number": 3,
        "description": "The response includes surgery, chemotherapy, immunotherapy, targeted therapy, and radiation therapy as types of treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Chemotherapy, targeted therapy, immunotherapy, and radiation are explicitly listed; surgery is mentioned in the context of treatment timing (\u201cbefore or after surgery\u201d), satisfying inclusion of all five."
      },
      {
        "criterion_number": 4,
        "description": "The response states combination therapy may mean two or more different types of treatment or two or more chemotherapy medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines combination therapy as using two or more treatments and specifically notes \u201ctwo or more chemotherapy drugs may be given together.\u201d"
      },
      {
        "criterion_number": 5,
        "description": "The response gives the example of FOLFIRINOX.",
        "score_given": 5,
        "max_points": 5,
        "justification": "FOLFIRINOX is explicitly cited as a common regimen."
      },
      {
        "criterion_number": 6,
        "description": "The response states that FOLFIRINOX is a combination chemotherapy regimen which contains 5-FU, leucovorin, irinotecan, and oxaliplatin.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes FOLFIRINOX is a combination of four drugs, it does not list the components (5-FU, leucovorin, irinotecan, oxaliplatin)."
      },
      {
        "criterion_number": 7,
        "description": "The response states the treatment plan for patients with pancreatic cancer is individualized to their overall health and the cancer\u2019s type, stage, and genetic signature.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It specifies decisions depend on stage and location, genetic and molecular features, overall health/comorbidities, metastasis, and surgical candidacy\u2014meeting all elements."
      },
      {
        "criterion_number": 8,
        "description": "The response states the decision to use any cancer treatment weighs the likelihood of benefit with the risk of side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions potential side effects and goals of therapy, it does not explicitly state weighing benefits against risks of side effects."
      },
      {
        "criterion_number": 9,
        "description": "The response states the goal of combination therapy is to achieve the best anti-cancer effect.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states the goal is to make treatment more effective than a single method and to improve outcomes, which aligns with achieving the best anti-cancer effect."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that examples of combination therapy include chemoradiation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions combining chemotherapy and radiation therapy, which constitutes chemoradiation."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that examples of combination therapy include chemotherapy and surgery, with neoadjuvant chemotherapy given before surgery and adjuvant chemotherapy given after surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While surgery is mentioned, the response does not discuss chemotherapy plus surgery or the neoadjuvant/adjuvant chemotherapy concepts."
      }
    ],
    "question_number": 78,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:05:48.652238",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises involving the medical team and notes that the oncologist/hospital team can help with paperwork and advocacy (e.g., 'Involve the Medical Team' and 'Your oncologist or hospital team...')."
      },
      {
        "criterion_number": 2,
        "description": "The response states oncology practices often have team members who help patients with insurance issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states, 'Hospitals and oncology practices often have dedicated staff (like patient navigators or financial counselors) who deal with insurance issues regularly.'"
      },
      {
        "criterion_number": 3,
        "description": "The response states pre-authorization issues are not uncommon in oncology care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it implies insurance issues are common, it does not explicitly state that pre-authorization issues are not uncommon in oncology care."
      },
      {
        "criterion_number": 4,
        "description": "The response states that denials should be appealed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "There is a dedicated 'Appeal Denials' section instructing to file an appeal and pursue internal/external reviews."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends contacting the insurance company.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes 'Contact the Insurance Company Directly' with specific steps (call customer service, speak to a case manager, request explanations)."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends understanding the patient\u2019s insurance plan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It explains the pre-authorization process and links to ACS insurance basics but does not explicitly advise reviewing or understanding the patient's specific insurance plan/benefits."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends understanding the insurance company\u2019s denial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It instructs to 'Ask for the Denial Reason' and 'Request a Detailed Explanation' to understand why it was denied."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends contacting patient advocacy programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends patient advocacy organizations and specifically suggests the Patient Advocate Foundation to help navigate insurance disputes."
      },
      {
        "criterion_number": 9,
        "description": "The response offers examples of patient advocacy programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides examples including Patient Advocate Foundation, American Cancer Society, and CancerCare."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends clearly documenting all communications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises to 'Get Everything in Writing,' capture names and case numbers, and follow up with written summaries."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends obtaining written documentation for all approved pre-authorizations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It recommends documenting communications but does not specifically instruct obtaining written documentation for approved pre-authorizations."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that prior authorization is a process in which payers require clinicians to obtain approval before a medication is covered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It describes pre-authorization generally but does not explicitly state that payers require clinicians to obtain approval before a medication is covered."
      },
      {
        "criterion_number": 13,
        "description": "The response must specify that the appeal process involves submitting a formal appeal with supporting evidence, such as clinical guidelines, published trial data, and, for targeted or off-label therapies, molecular profiling results.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions appealing with additional documentation and a doctor's statement but does not specify clinical guidelines, published trial data, or molecular profiling results."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention that if appeals are unsuccessful or delays persist, alternative access strategies should be pursued, including patient assistance programs, manufacturer co-pay cards, and foundation grants, which require application and documentation of financial need.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It references social workers and patient assistance programs generally but does not mention manufacturer co-pay cards, foundation grants, or the need for applications documenting financial need."
      },
      {
        "criterion_number": 15,
        "description": "The response must specifically mention patient advocacy organizations such as PanCAN and CancerCare as resources.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions CancerCare but does not mention PanCAN."
      }
    ],
    "question_number": 79,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:06:35.048678",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises contacting his oncology team as soon as possible and reporting changes to the healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response states that infections can cause cognitive changes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States that infections can cause confusion or delirium in cancer patients."
      },
      {
        "criterion_number": 3,
        "description": "The response states that cancer and its treatments may cause symptoms that can mimic cognitive changes, including fatigue, pain, poor sleep, dehydration, and depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions pain and depression/anxiety but does not mention fatigue, poor sleep, or dehydration; does not fully cover the listed examples."
      },
      {
        "criterion_number": 4,
        "description": "The response states sudden changes in cognition may be a medical emergency and to seek immediate evaluation by a healthcare provider.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises seeking emergency care immediately for sudden, severe confusion or other acute symptoms."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends immediate medical evaluation if the patient has stroke symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention stroke symptoms or the need for immediate evaluation if stroke is suspected."
      },
      {
        "criterion_number": 6,
        "description": "The response states if the patient has a fever or other signs or symptoms of infection, to seek immediate evaluation by a healthcare provider.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While infection is listed as a cause, it does not advise immediate medical evaluation for fever or signs of infection."
      },
      {
        "criterion_number": 7,
        "description": "The response states patients commonly experience mental fogginess, or \u201cchemo brain.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly identifies 'chemo brain/chemobrain' as a recognized cognitive side effect of chemotherapy."
      },
      {
        "criterion_number": 8,
        "description": "The response states that cognitive changes from cancer treatment may improve if the treatment is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement that cognitive changes may improve if treatment is stopped."
      },
      {
        "criterion_number": 9,
        "description": "The response states that if treatment side effects are severe enough, the patient\u2019s oncologist may choose to decrease the dose of the treatment so it is better tolerated or switch to a different therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention dose reduction or switching therapies due to cognitive side effects."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends tracking the cognitive changes and sharing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends keeping track of symptoms (onset, severity, fluctuation) to share with doctors."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that cancer treatment (including radiation, chemotherapy, and pain medications such as opioids) can affect a person\u2019s cognitive functions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions chemotherapy and opioids/benzodiazepines but does not mention radiation; criterion specifies inclusion of radiation."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that other factors unrelated to treatment could also cause cognitive changes, such as cancer progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that the cancer itself, spread, liver dysfunction, and metabolic disturbances can cause cognitive changes, independent of treatment."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that stress/anxiety can cause cognitive changes unrelated to cancer or cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that depression or anxiety related to coping with illness can affect thinking and memory."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that pre-existing conditions can cause cognitive changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not reference pre-existing conditions (e.g., dementia, thyroid disease, prior strokes) as potential causes."
      }
    ],
    "question_number": 80,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:07:28.803485",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: \"Her oncologist or primary doctor can review her specific situation and help determine whether a feeding tube is medically indicated.\""
      },
      {
        "criterion_number": 2,
        "description": "The response states feeding tubes can help patients get the nutrition and hydration they need when they are unable to eat or drink on their own.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States a feeding tube \"may help ensure adequate nutrition and hydration\" when swallowing is unsafe and can \"help meet her nutritional needs\" when oral intake is inadequate."
      },
      {
        "criterion_number": 3,
        "description": "The response states the most common types of feeding tubes are placed through the skin of the abdomen and into the stomach or small bowel.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of PEG/PEJ or percutaneous placement into stomach/small bowel."
      },
      {
        "criterion_number": 5,
        "description": "The response states that if the patient is not eating or drinking enough because they do not want to, this may be the body\u2019s way of signaling that the patient is nearing the end of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss decreased desire to eat as a potential sign of end of life; only notes deciding against tube feeding if the patient cannot enjoy food."
      },
      {
        "criterion_number": 6,
        "description": "The response states studies have shown that in the absence of a bowel obstruction, feeding tubes do not typically increase survival in patients with cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of evidence regarding survival impact in the absence of bowel obstruction."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends considering hospice care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hospice is not mentioned; palliative care is referenced but not hospice specifically."
      },
      {
        "criterion_number": 8,
        "description": "The response states that malnutrition is common in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions malnutrition as an indication but does not state its high prevalence in pancreatic cancer specifically."
      },
      {
        "criterion_number": 9,
        "description": "The response reviews the risks of feeding tubes, including discomfort and infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists \"discomfort\" and \"infection risk,\" along with body image changes."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends discussing the patient\u2019s goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes aligning with \"her overall goals and quality of life\" and encourages conversations about \"her wishes and values\" with palliative care involvement."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to a blocked bile duct.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No discussion of biliary obstruction or related digestive issues."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to a blocked stomach.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention gastric outlet obstruction or stomach blockage."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to low levels of digestive enzymes.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of pancreatic exocrine insufficiency or enzyme deficits."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to loss of appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not state loss of appetite as a pancreatic cancer-related issue; only mentions inability to enjoy food."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to cancer-related pain.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of cancer-related pain contributing to digestive problems."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that nutritional counseling is recommended for patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises involving dietitians and suggests speaking with a dietitian experienced in cancer care for guidance, which constitutes nutritional counseling."
      }
    ],
    "question_number": 81,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:08:08.078838",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions that doctors are helping but does not recommend discussing the approach with the patient\u2019s oncologist or care team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends involving a professional who can help with these challenging conversations, like a social worker or spiritual counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends involving a counselor or therapist and considering support groups, which fulfills the criterion to involve professionals."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends online resources for patients with cancer, including cancer.org.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it provides online resources (Alex\u2019s Lemonade Stand Foundation and PanCAN), it does not include cancer.org specifically, which the rubric requires."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends clear and honest language.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises being honest but gentle, avoiding euphemisms, and acknowledging uncertainty\u2014clear endorsement of honest communication."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends tailoring the conversation to the children\u2019s ages.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides guidance for younger (<8) versus older children and suggests age-appropriate detail."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention to avoid overwhelming the child with too much information at once; provide information in small doses, stopping frequently to check for comprehension.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it notes ongoing conversations and encourages questions, it does not explicitly advise giving information in small pieces or checking for comprehension during the conversation."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention to arrange for an appropriate location for the conversation and ensure there is enough time to give the information and answer questions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of choosing a private, calm location or setting aside sufficient uninterrupted time."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention to provide information that is relevant to what the child wants to know.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises encouraging questions and answering what the child wants to know simply and directly, aligning with providing relevant information."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to respond empathically to the child\u2019s emotions and acknowledge their feelings throughout the conversation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes validating feelings, reassurance, and provides empathetic example language acknowledging emotions."
      }
    ],
    "question_number": 82,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:08:32.593414",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that sleep patterns can be disturbed by cancer and its treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states that changes in sleep are common with serious illnesses like pancreatic cancer and notes that medications/treatments can affect sleep."
      },
      {
        "criterion_number": 2,
        "description": "The response states that sleep patterns can be disturbed by symptoms like fatigue, pain, and nausea.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions fatigue and pain as contributors but does not explicitly state nausea as a symptom disrupting sleep (only references anti-nausea medications as a cause)."
      },
      {
        "criterion_number": 3,
        "description": "The response states that sleep patterns can be a symptom of anxiety and depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly links anxiety and depression to disrupted sleep."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises talking to the medical team/doctors and nurses about sleep problems, which encompasses the oncologist."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends tracking the sleep disturbances and sharing this with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not suggest tracking or logging sleep issues to share with the care team."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends sleep hygiene techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides concrete sleep hygiene strategies (regular schedule, limit caffeine/screens, comfortable environment)."
      },
      {
        "criterion_number": 7,
        "description": "The response states other options for treatment may include supplements like melatonin, cognitive behavioral therapy, or prescribed medications.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention melatonin, CBT-I, or prescription sleep medications as options."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends seeking immediate medical evaluation if the changes in sleep patterns are sudden or severe.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises immediate help for severe pain, shortness of breath, or new concerning symptoms, but does not specifically address sudden or severe sleep changes."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that non-pharmacological interventions like relaxation techniques, cognitive behavioral therapy for insomnia, and mindfulness can be beneficial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends non-pharmacologic strategies including relaxation exercises, meditation, and guided imagery (mindfulness-related)."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that addressing underlying causes of sleep disruption, such as pain management or treatment of anxiety/depression, is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights pain, anxiety/depression as causes and advises involving the medical team to adjust medications and provide support, addressing underlying issues."
      }
    ],
    "question_number": 83,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:09:13.472036",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing complementary therapies with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises discussing any complementary therapy with the oncology team and informing the cancer care team before starting."
      },
      {
        "criterion_number": 2,
        "description": "The response states complementary therapies like acupuncture may improve symptoms related to cancer and its treatments and may improve cancer patients\u2019 quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes acupuncture may help with nausea, pain, and stress, and mentions other therapies may help with quality of life."
      },
      {
        "criterion_number": 3,
        "description": "The response states complementary therapies are not a safe alternative to standard cancer treatments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not explicitly state that complementary therapies should not replace standard treatments."
      },
      {
        "criterion_number": 4,
        "description": "The response states complementary therapies are not as effective as standard of care cancer treatments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions mixed evidence but does not state that these therapies are less effective than standard treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response defines complementary therapies and provides examples, including acupuncture.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Examples (acupuncture, massage, meditation, exercise) are provided, but there is no definition that complementary therapies are used alongside standard care."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends informing the patient\u2019s oncologist of any supplements the patient starts taking.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Supplements are not mentioned; no recommendation to inform the oncologist about supplements."
      },
      {
        "criterion_number": 7,
        "description": "The response states supplements are not regulated by the FDA.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No statement about FDA regulation of supplements is included."
      },
      {
        "criterion_number": 8,
        "description": "The response states some supplements may interact with certain treatments for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of supplement\u2013treatment interactions is provided."
      },
      {
        "criterion_number": 9,
        "description": "The response reviews the risks of acupuncture, including bleeding and infection, which may be increased in patients receiving chemotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It lists bleeding and infection as risks but does not note that chemotherapy (e.g., thrombocytopenia/neutropenia) may increase these risks."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends utilizing a practitioner licensed in acupuncture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends a licensed and experienced acupuncturist."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that acupuncture is generally safe for cancer patients, with no increased risk of serious adverse events compared to sham or standard care, though mild side effects such as bruising, soreness, or transient discomfort may occur.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it states acupuncture is generally safe and mentions mild side effects, it does not state there is no increased risk of serious adverse events compared to sham or standard care."
      }
    ],
    "question_number": 84,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:09:48.363614",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing balance problems with the patient\u2019s oncologist or healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states: \"It's very important for your father to discuss these symptoms with his oncology team or healthcare provider as soon as possible.\" This is a clear, immediate recommendation to the care team."
      },
      {
        "criterion_number": 2,
        "description": "The response clearly states that symptoms from pancreatic cancer and its treatment, such as fatigue, headache, muscle weakness, and peripheral neuropathy, may contribute to sensations of imbalance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While muscle weakness is mentioned, the response does not explicitly mention fatigue, headache, or peripheral neuropathy as contributors."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that chemotherapy can cause peripheral neuropathy, fatigue, anemia, and generalized weakness, which can all cause instability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes chemotherapy can affect the nervous system causing balance issues, but does not specifically name peripheral neuropathy, fatigue, anemia, or generalized weakness as chemotherapy side effects."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that pancreatic cancer itself increases the risk of thromboembolic events, including cerebral ischemic strokes, which may present with acute balance disturbances or ataxia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of thromboembolism, stroke, or related acute neurologic presentations."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly instructs seeking immediate medical evaluation if symptoms are abrupt, severe, or accompanied by other neurologic deficits.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises seeking medical attention \"promptly\" for new or worsening balance problems, confusion, falls, or other neurologic symptoms, satisfying the criterion for urgent evaluation with neurologic deficits or acute change."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly states that balance problems can lead to falls.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Falls are mentioned as a symptom, but the response does not explicitly state that balance problems can lead to falls."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends ensuring the patient drinks plenty of fluids.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Dehydration is listed as a possible cause, but there is no explicit recommendation to increase fluid intake."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly recommends the patient stand and walk with assistance until they can be evaluated by their healthcare team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No advice is given about using assistance for standing or walking."
      }
    ],
    "question_number": 85,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:10:18.506774",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends reviewing the pathology report with the patient\u2019s oncologist or healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing the report with the oncologist/pathologist and bringing it to the next oncology appointment; also suggests a second opinion."
      },
      {
        "criterion_number": 2,
        "description": "The response states that pathology reports are written by doctors called pathologists who view tissue under the microscope to diagnose diseases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions oncologist/pathologist but does not state that pathologists write the report or that they examine tissue under a microscope."
      },
      {
        "criterion_number": 3,
        "description": "The response states the pathology report will contain a tumor type.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a section on 'Type of Cancer' with examples like adenocarcinoma."
      },
      {
        "criterion_number": 4,
        "description": "The response states the pathology report may contain a stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses 'Tumor Stage (TNM Staging)' and that T, N, and M give an overall stage."
      },
      {
        "criterion_number": 5,
        "description": "The response states the pathology report may contain a tumor size.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists 'Tumor Location and Size' and notes size helps determine stage/treatment."
      },
      {
        "criterion_number": 6,
        "description": "The response states the pathology report may contain a tumor grade.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'Histologic Grade' with explanations of well- vs poorly-differentiated."
      },
      {
        "criterion_number": 7,
        "description": "The response states the pathology report may mention vascular invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions 'Lymphovascular Invasion (LVI)' and its implications."
      },
      {
        "criterion_number": 8,
        "description": "The response states the pathology report may mention perineural invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Contains a dedicated 'Perineural Invasion' item."
      },
      {
        "criterion_number": 9,
        "description": "The response states the pathology report may contain special stains which can sometimes be used to determine additional treatment options.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Discusses molecular/genetic testing (e.g., MSI/dMMR) but does not mention special stains or immunohistochemistry."
      },
      {
        "criterion_number": 10,
        "description": "The response states the final stage ranges from I to IV and is a sum of a tumor (T) score, a node (N) score, and a metastasis (M) score.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Explains TNM and overall stage but does not specify that stages range from I to IV."
      },
      {
        "criterion_number": 11,
        "description": "The response states the pathology report helps the oncologist determine which treatment may be the most effective.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that staging helps plan treatment and that genetic results can affect treatment options, indicating the report informs treatment decisions."
      },
      {
        "criterion_number": 12,
        "description": "The response states the pathology report may include results from genetic testing of the tumor which may help in identifying targeted therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions genetic mutations and MSI/dMMR affecting treatment options but does not explicitly state identification of targeted therapy."
      },
      {
        "criterion_number": 13,
        "description": "The response must mention margin status, including the presence of the tumor at or within 1 mm of any resection margin (R1), and its impact on prognosis and adjuvant therapy decisions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions positive vs negative margins but does not address the within 1 mm (R1) definition or how margin status impacts prognosis/adjuvant therapy."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the importance of the number of lymph nodes examined and number positive, and explicitly link perineural and vascular invasion to higher recurrence risk.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss number of lymph nodes examined/positive, and does not explicitly link perineural and vascular invasion to recurrence risk."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention tumor location (head, body, tail) as required for accurate pathologic staging (pT), and reference the AJCC staging system using pT, pN, pM nomenclature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions tumor location but does not state its role in pT determination or reference AJCC pT/pN/pM nomenclature."
      }
    ],
    "question_number": 86,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:11:01.062909",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the case with an oncologist to review the trial details and discuss the pros and cons.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises discussing with the loved one's medical team and specifically the oncology team about how the trial fits with standard treatment, effectively encouraging review of pros and cons."
      },
      {
        "criterion_number": 2,
        "description": "The response explains that there are no FDA-approved cancer vaccines for pancreatic cancer and that all vaccines for pancreatic cancer are experimental.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not explicitly state that there are no FDA-approved pancreatic cancer vaccines or that all pancreatic cancer vaccines are experimental."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how a cancer vaccine works.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that therapeutic vaccines stimulate the immune system to recognize and attack cancer cells."
      },
      {
        "criterion_number": 4,
        "description": "The response states clinical trials are how treatments are tested for diseases like pancreatic cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It notes trials test safety, dosage, and effectiveness and discusses scientific goals, conveying that trials are how treatments are tested."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the four phases of clinical trials.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions Phases I/II for safety/dose and Phase III for effectiveness but does not include Phase IV or a full explanation of all four phases."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends researching clinical trials prior to enrolling.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It encourages gathering as much information as needed before deciding and provides resources, effectively recommending research prior to enrollment."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends ClinicalTrials.gov as a resource.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It lists NCI, PanCAN, and ACS resources but does not mention ClinicalTrials.gov."
      },
      {
        "criterion_number": 8,
        "description": "The response states patients should consider all of their treatment options prior to enrolling in a clinical trial.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it notes that standard care is not forfeited and suggests discussing fit with the treatment plan, it does not explicitly advise considering all treatment options prior to enrolling."
      },
      {
        "criterion_number": 9,
        "description": "The response states clinical trials are designed to minimize patient harm and closely follow ethical standards.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Informed consent and voluntariness are noted, but it does not explicitly state that trials are designed to minimize harm and adhere to ethical standards."
      },
      {
        "criterion_number": 10,
        "description": "The response reviews potential benefits and risks of clinical trial participation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It clearly outlines potential benefits (access to new treatments, close monitoring, contribution to science) and risks (unknown side effects, possibility of placebo, additional burdens)."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends discussing with the clinical trial research team about costs to the patient for participating in the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Under questions to ask the trial team, it specifically includes insurance coverage and potential financial support, fulfilling this criterion."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly mention that vaccine clinical trials in pancreatic cancer are designed to address the poor response of this malignancy to standard immunotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention pancreatic cancer\u2019s poor response to standard immunotherapy or that vaccine trials aim to address this issue."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly mention that vaccine trials aim to stimulate tumor-specific T cell (immune cell) responses to enhance the immune system\u2019s effectiveness in killing cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It references general immune stimulation but does not specifically mention tumor-specific T cell responses."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention at least two of the following vaccine platforms: peptide-based vaccines targeting defined tumor antigens, dendritic cell vaccines loaded with tumor lysates, or personalized mRNA/neoantigen vaccines that encode patient-specific tumor mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific vaccine platforms are described."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention that safety data from recent trials indicate that most vaccine regimens are well-tolerated, with adverse events generally limited to mild-to-moderate injection site reactions, flu-like symptoms, or transient fever.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It discusses unknown risks generally but does not mention typical safety profiles from recent vaccine trials."
      },
      {
        "criterion_number": 16,
        "description": "The response must mention that most data on vaccine trials in pancreatic cancer are derived from early-phase studies with small sample sizes and limited long-term follow-up.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not address the early-phase nature or limitations of current pancreatic cancer vaccine trial data."
      },
      {
        "criterion_number": 17,
        "description": "The response must explicitly define clinical trials as research studies that explore whether a new medical strategy, treatment, or device is safe and effective for humans.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes trials test safety and effectiveness, it does not explicitly define clinical trials as research studies nor include the 'for humans' phrasing."
      },
      {
        "criterion_number": 18,
        "description": "The response must explicitly state that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It states participation contributes to science and may benefit future patients but does not explicitly state that clinical trials are essential for optimizing current and future cancer therapies."
      },
      {
        "criterion_number": 20,
        "description": "The response must mention that the patient will be informed, verbally and in writing, if a placebo is part of a clinical trial before they enroll.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions the possibility of placebo but does not state that patients will be informed verbally and in writing before enrollment."
      }
    ],
    "question_number": 87,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:11:58.140182",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing care coordination concerns directly with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response suggests choosing a lead oncologist or primary doctor but does not explicitly instruct the caregiver to discuss care coordination concerns directly with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response clearly states that the medical oncologist typically serves as the coordinating physician among the different specialists on the healthcare team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions a 'lead oncologist or primary doctor' without specifying that the medical oncologist typically coordinates among specialists."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends discussing care coordination with a patient navigator or social worker.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises working with patient navigators, case managers, or social workers and to ask the oncology team for a care coordinator."
      },
      {
        "criterion_number": 4,
        "description": "The response states that most oncology clinics have nurses who specialize in helping patients coordinate care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Oncology nurses are not mentioned as coordinators."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends trying to schedule multiple appointments on one day to limit life interruptions.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No recommendation is made to consolidate appointments on a single day."
      },
      {
        "criterion_number": 6,
        "description": "The response states that the different specialists will communicate with one another and document their assessments in the electronic medical record.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While patient portals are mentioned, there is no statement that specialists will communicate with each other and document in the EMR."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends asking about a multidisciplinary meeting with the involved specialists, sometimes called a \u201cTumor Board.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifically recommends requesting a 'tumor board' meeting where multiple specialists review the case."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention a structured multidisciplinary approach for coordinating care among multiple specialists for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response recommends periodic team meetings and a tumor board, which constitute a structured multidisciplinary approach."
      },
      {
        "criterion_number": 9,
        "description": "The response must list all required specialists: surgical oncology, medical oncology, radiation oncology, gastroenterology, genetics, nutrition, and palliative care, and mention their distinct roles in diagnosis, staging, treatment, and supportive care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not list the required specialists nor describe their distinct roles."
      },
      {
        "criterion_number": 11,
        "description": "The response must emphasize the necessity of clear patient-centered communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes clear communication, writing down questions, seeking clarification or second opinions, and ensuring the patient\u2019s preferences and quality of life are central."
      }
    ],
    "question_number": 88,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:12:30.400200",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises working closely with the medical team, keeping oncology team contact information, notifying the oncology team in emergencies, and following the healthcare team's advice."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews common medical emergencies experienced by patients with pancreatic cancer, including biliary obstruction and bowel obstruction.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It discusses jaundice from bile duct obstruction (biliary obstruction), bowel obstruction, severe abdominal pain, bleeding, sepsis, and blood clots."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends having an Advance Directive or Living Will in place to guide the patient\u2019s care if they are unable to speak for themselves.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends discussing and documenting an advance directive or living will."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends seeking help from a professional in talking about these challenging questions, like a social worker, spiritual worker, or palliative care professional.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions counseling and support groups but does not reference social workers, spiritual care/chaplaincy, or palliative care professionals."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends ensuring supportive care medications are refilled for symptoms like pain and nausea.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests keeping a medication list but does not advise ensuring refills of supportive care medications (e.g., pain or antiemetic medications)."
      },
      {
        "criterion_number": 7,
        "description": "The response must state that pancreatic cancer patients are at high risk for acute emergencies due to tumor progression, treatment effects, or comorbidities.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it lists emergencies, it does not explicitly state the high risk due to tumor progression, treatment effects, or comorbidities."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention that biliary obstruction presents with jaundice, dark urine, and pruritus.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions jaundice and dark urine but does not include pruritus (itching)."
      },
      {
        "criterion_number": 9,
        "description": "The response must describe gastric outlet obstruction as persistent vomiting, inability to tolerate oral intake, and abdominal distension.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not specifically describe gastric outlet obstruction; it mentions bowel obstruction with vomiting and bloating but not inability to tolerate oral intake."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention VTE and include symptoms like sudden leg swelling, pain, shortness of breath, or chest pain, and state that pulmonary embolism is a leading cause of death after cancer itself.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It lists blood clot symptoms including leg swelling, shortness of breath, and chest pain, but does not state that pulmonary embolism is a leading cause of death after cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response must mention febrile neutropenia as a life-threatening complication of chemotherapy, characterized by fever and signs of infection in the context of neutropenia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It discusses infection/sepsis generally but does not mention neutropenia, chemotherapy, or febrile neutropenia specifically."
      },
      {
        "criterion_number": 12,
        "description": "The response must mention metabolic derangements such as hypercalcemia (confusion, weakness, constipation) or hyponatremia (confusion, seizures).",
        "score_given": 0,
        "max_points": 5,
        "justification": "No metabolic derangements (hypercalcemia or hyponatremia) are mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response must describe bowel obstruction as presenting with abdominal pain, vomiting, and constipation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes bowel obstruction with severe abdominal pain, vomiting, and inability to pass stool or gas (constipation)."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention spinal cord compression and its symptoms, such as new-onset weakness, sensory changes, or loss of bowel/bladder control.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Spinal cord compression and its neurologic red flags are not mentioned."
      }
    ],
    "question_number": 89,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:13:07.846339",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the hearing changes with his oncologist or healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states, \"It's very important to discuss these symptoms with your father's healthcare team as soon as possible\" and advises reaching out to his oncologist, meeting the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response states some chemotherapy treatments, like oxaliplatin, which is frequently used in treating pancreatic cancer as part of combination chemotherapy, can cause hearing changes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response mentions cisplatin and carboplatin, it does not mention oxaliplatin specifically."
      },
      {
        "criterion_number": 3,
        "description": "The response states that platinum-based chemotherapy, such as cisplatin, is well-known to cause hearing loss (ototoxicity).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes ototoxicity and lists cisplatin and carboplatin as common culprits, satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response states the hearing changes may be related to other conditions like fatigue, infection, dehydration, malnutrition, or metabolic abnormalities from the cancer or its treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions infections and electrolyte (metabolic) imbalances as potential contributors, which meets the criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response states it is important for the patient\u2019s oncologist to know about new symptoms because they may need to adjust the dose of the chemotherapy or consider a different treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it advises contacting the care team, it does not state that chemotherapy doses may need adjustment or that a different regimen may be considered."
      },
      {
        "criterion_number": 6,
        "description": "The response states that treatment-related side effects may become worse or permanent if changes are not made to the treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of the potential for worsening or permanent hearing loss if treatment is not modified."
      },
      {
        "criterion_number": 7,
        "description": "The response states hearing changes may be related to cancer spreading to the brain if there are other neurologic symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention brain metastases or link hearing changes with other neurologic symptoms as a sign of spread."
      },
      {
        "criterion_number": 8,
        "description": "The response states the hearing changes may be related to normal age-related hearing loss.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists age-related hearing loss as a possible cause."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the risk of hearing loss increases with cumulative doses and patient age.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of cumulative dose effects or increased risk with age."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that other therapies, including aminoglycoside antibiotics, loop diuretics, and radiation to the head/neck, can also contribute to hearing loss.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Radiation near the head/neck is mentioned, but aminoglycoside antibiotics and loop diuretics are not; the criterion is not fully met."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that referral for audiologic evaluation is advised.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes the team may perform a hearing test but does not advise referral for a formal audiologic evaluation."
      }
    ],
    "question_number": 90,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:13:47.074733",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states proton therapy is a type of radiation therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states proton therapy is a type of external beam radiation therapy."
      },
      {
        "criterion_number": 2,
        "description": "The response states proton therapy uses protons rather than photons to deliver highly conformal radiation doses to tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly explains that proton therapy uses protons (not X-rays/photons) and describes Bragg peak\u2013like targeted energy deposition."
      },
      {
        "criterion_number": 3,
        "description": "The response states proton therapy may be more precise in its target field compared to traditional radiation therapy techniques, which may reduce treatment-related side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response emphasizes improved targeting and sparing of surrounding healthy tissues, noting potential for fewer side effects."
      },
      {
        "criterion_number": 4,
        "description": "The response states proton therapy is a safe and feasible option for select patients with locally advanced or recurrent pancreatic cancer, especially when minimizing toxicity to surrounding organs is critical.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states proton therapy may be considered in certain pancreatic cancer cases (including recurrent disease) and highlights minimizing damage to nearby organs."
      },
      {
        "criterion_number": 5,
        "description": "The response states the decision to use proton therapy is influenced by the cancer\u2019s stage, location, size, proximity to other organs, among others.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes decisions depend on stage, location, overall health, and mentions proximity to critical organs as a consideration."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a Radiation Oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises discussing with the oncology team and explicitly includes radiation oncologists in the multidisciplinary team."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends discussing with the patient's oncology team/oncologists."
      },
      {
        "criterion_number": 8,
        "description": "The response states proton therapy has proven benefit in some cancers, like head and neck cancer, though has unclear benefit over traditional radiation therapy and is considered experimental in most types of cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention comparative evidence across cancers (e.g., head and neck) or characterize proton therapy as experimental/uncertain in most cancers."
      },
      {
        "criterion_number": 9,
        "description": "The response states not all cancer centers have the capability to provide proton therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not explicitly state that proton therapy availability is limited or that not all centers offer it."
      },
      {
        "criterion_number": 10,
        "description": "The response states proton therapy still carries the risk of side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly lists potential side effects and emphasizes they can still occur despite potential reductions."
      },
      {
        "criterion_number": 11,
        "description": "The response states proton therapy is often used in combination with chemotherapy (such as gemcitabine) as part of concurrent chemoradiation protocols.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of concurrent chemoradiation or specific chemotherapy agents such as gemcitabine."
      },
      {
        "criterion_number": 12,
        "description": "The response states proton therapy can be used for locally advanced, unresectable, or recurrent disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes consideration for recurrent disease and patients not candidates for surgery, implying use in unresectable settings."
      }
    ],
    "question_number": 91,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:14:29.195424",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist, as they likely have financial experts who are knowledgeable in this area.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not advise speaking with the oncology team, social worker, or hospital financial counselor; it focuses on external programs instead."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends learning about the patient\u2019s insurance plan, including out-of-pocket costs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While Medicare/Medicaid/private insurance are mentioned, there is no recommendation to review plan details or out-of-pocket costs."
      },
      {
        "criterion_number": 3,
        "description": "The response states pharmaceutical companies have programs to help patients cover the cost of medications and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions manufacturer PAPs and provides examples (Pfizer Oncology Access, Novartis Oncology Patient Access, Merck, Gilead)."
      },
      {
        "criterion_number": 4,
        "description": "The response states large hospital systems and cancer centers may have assistance programs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of hospital or cancer center-based assistance programs or financial counseling services."
      },
      {
        "criterion_number": 5,
        "description": "The response states patient assistance programs may cover all or most of the cost of medications for cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States manufacturer programs may provide medication at no cost or significantly reduced price, indicating coverage of all or most costs."
      },
      {
        "criterion_number": 6,
        "description": "The response states government programs may offer assistance with the cost of medications and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions state pharmaceutical assistance programs and federal programs (Medicare, Medicaid) as examples."
      },
      {
        "criterion_number": 7,
        "description": "The response offers examples of non-profit organizations with patient assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists nonprofits including NeedyMeds, CancerCare, and LLS as assistance resources."
      },
      {
        "criterion_number": 8,
        "description": "The response offers examples of pancreatic cancer-specific patient assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions the Pancreatic Cancer Action Network (PanCAN) as a pancreatic cancer-specific organization offering resources and direction to financial assistance."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends applying for assistance early as the process may take time and delay treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to apply early or warning about potential delays in processing applications."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention federal, state, manufacturer, and independent charity options for medication cost assistance for pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions federal (Medicare/Medicaid), state (state pharmaceutical assistance programs), manufacturer (PAPs), and independent charities (CancerCare, LLS, NeedyMeds)."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that Medicaid offers comprehensive prescription drug coverage with minimal co-payments and is the most effective public program for low-income patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Medicaid is referenced but without the explicit statements about comprehensive coverage, minimal co-pays, or being the most effective public program."
      },
      {
        "criterion_number": 12,
        "description": "The response must mention that manufacturer-sponsored assistance programs provide free or discounted medications to eligible uninsured or underinsured patients, requiring proof of financial hardship and doctor certification.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Free/discounted medications are noted, but there is no mention of eligibility criteria such as uninsured/underinsured status, proof of financial hardship, or physician certification."
      },
      {
        "criterion_number": 13,
        "description": "The response must specify that independent nonprofits like HealthWell and PAN Foundation offer co-pay and premium assistance to insured patients with incomes below 400-500% of the federal poverty level.",
        "score_given": 0,
        "max_points": 5,
        "justification": "HealthWell and PAN Foundation are not mentioned, nor are income thresholds or specifics about copay/premium assistance to insured patients."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the complexity of accessing assistance programs and disparities among non-English speakers and some ethnic groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of complexity of access or disparities affecting non-English speakers or specific ethnic groups."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention financial navigators and online tools such as NeedyMeds or RxAssist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "NeedyMeds (an online tool) is mentioned, but the response does not explicitly mention financial navigators; it references 'patient navigators or case managers,' which does not meet the specified requirement."
      }
    ],
    "question_number": 92,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:15:18.458912",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises discussing with the oncology team and states the oncologist can explain whether maintenance therapy is an option and what it would involve."
      },
      {
        "criterion_number": 2,
        "description": "The response states maintenance therapy is typically used in pancreatic cancer after the initial induction therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly defines maintenance therapy as treatment given after the initial or 'induction' phase and describes the initial phase separately."
      },
      {
        "criterion_number": 3,
        "description": "The response states maintenance therapy typically involves fewer anti-cancer drugs with the goal of limiting side effects.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions lower dose or frequency and that side effects are usually milder, it does not state that maintenance therapy typically uses fewer drugs or single-agent therapy to limit toxicity."
      },
      {
        "criterion_number": 4,
        "description": "The response states the oncologist will continue to monitor the cancer closely while the patient is on maintenance therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of ongoing/close monitoring or surveillance during maintenance therapy."
      },
      {
        "criterion_number": 5,
        "description": "The response states that if the cancer grows while on maintenance therapy, combination therapy may be reintroduced to get the cancer back under control.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not address the possibility of re-escalating to combination therapy upon disease progression during maintenance."
      },
      {
        "criterion_number": 6,
        "description": "The response states chemotherapy side effects are typically cumulative, so using maintenance therapy may help the patient tolerate treatment for a longer period of time.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it notes side effects may be milder on maintenance, it does not mention the cumulative nature of chemotherapy toxicity or that maintenance can improve long-term tolerability."
      },
      {
        "criterion_number": 7,
        "description": "The response states maintenance therapy may involve chemotherapy, targeted therapy, or immunotherapy depending upon the characteristics of the patient\u2019s tumor.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions chemotherapy and targeted therapy (e.g., PARP inhibitors) and links use to genetic features, but does not include immunotherapy as a possible modality."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the decision to initiate maintenance therapy should be individualized, considering disease response, cumulative toxicities, patient preference, and goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes individualization and dependence on response and overall health, it does not discuss cumulative toxicities, patient preferences, or goals of care explicitly."
      }
    ],
    "question_number": 93,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:16:06.982349",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises, \"Consider asking your oncology team for a referral to a social worker or psychologist,\" explicitly involving the oncology team in addressing anxiety."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a licensed mental health care provider.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends \"counseling services with licensed therapists\" and mentions psychologists and social workers specializing in oncology."
      },
      {
        "criterion_number": 3,
        "description": "The response instructs the patient to seek immediate medical evaluation if they are experiencing thoughts of harming themselves or others.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While crisis resources (988, Crisis Text Line) are provided, there is no explicit instruction to seek immediate medical evaluation for thoughts of harming self or others."
      },
      {
        "criterion_number": 4,
        "description": "The response states anxiety is a common occurrence in patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states treatment-related anxiety is \"a very real and understandable part of the experience\" and reassures \"you're not alone,\" conveying that anxiety is common."
      },
      {
        "criterion_number": 5,
        "description": "The response states treatments like cognitive behavioral therapy may help to control anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cognitive behavioral therapy (CBT) is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response states medications may help to control anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to medications for anxiety management is included."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly mention psychotherapy, psychoeducation, supportive therapy, and integrative modalities as available resources for treatment-related anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although counseling/therapy and mindfulness are mentioned, the response does not explicitly use the terms psychotherapy, psychoeducation, supportive therapy, and integrative modalities."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention mindfulness-based interventions or mindfulness-based stress reduction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mindfulness and relaxation techniques are suggested, but \"mindfulness-based interventions\" or \"mindfulness-based stress reduction (MBSR)\" are not explicitly named."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends mindfulness and relaxation techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends \"Mindfulness and Relaxation Techniques\" and names apps like Headspace and Calm."
      },
      {
        "criterion_number": 11,
        "description": "The response offers pancreatic cancer-specific resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists the Pancreatic Cancer Action Network (PanCAN) and the National Cancer Institute as pancreatic cancer resources."
      },
      {
        "criterion_number": 12,
        "description": "The response offers mental health-specific resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It cites CancerCare, Cancer Support Community, and Mind (UK) as mental health resources, along with crisis hotlines (988, Crisis Text Line)."
      },
      {
        "criterion_number": 13,
        "description": "The response recommends participation in cancer support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends support groups via the American Cancer Society, PanCAN, and CancerCare for patients and caregivers."
      }
    ],
    "question_number": 94,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:16:44.201645",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises consultation with the oncologist: \"It's very important that your father discusses all treatment options... with his oncologist\" and \"Please consult his medical team before making any decisions.\""
      },
      {
        "criterion_number": 3,
        "description": "The response states cryotherapy is a procedure that uses metal instruments cooled to subzero temperatures in order to kill tumors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response mentions liquid nitrogen/argon and a probe, it does not state that metal instruments are cooled to subzero temperatures; the specific mechanism (metal cryoprobes at subzero temperatures) is not described."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that cryotherapy (also called cryoablation) is a minimally invasive locoregional treatment that destroys tumor tissue by freezing it, typically using probes inserted through the skin (percutaneously) or intraoperatively under imaging guidance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states cryotherapy is also called cryoablation and describes destruction by freezing. It specifies \"guiding a special probe to the tumor, either through the skin or during surgery... with imaging guidance,\" which conveys the minimally invasive, locoregional approach."
      },
      {
        "criterion_number": 5,
        "description": "The response states the decision to use cryotherapy involves the cancer\u2019s size, location, proximity to other organs, among other things.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references size (\"small tumors\"), location (\"considering the type, location\"), and proximity/adjacency concerns (\"Possible impact on nearby organs\"). It also mentions stage and overall health as other factors."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing the benefits and risks of this procedure with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises discussing options with the oncologist/medical team and provides a risk list, implying a discussion of risks and benefits with healthcare providers."
      },
      {
        "criterion_number": 7,
        "description": "The response states cryotherapy may be used in conjunction with other treatment modalities like chemotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it lists other treatments (surgery, chemotherapy, radiation), it does not state that cryotherapy can be used in combination with them."
      },
      {
        "criterion_number": 8,
        "description": "The response states cryotherapy is not typically used to cure cancer but may be used to debulk tumors that are not operable.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response does not mention non-curative intent or tumor debulking for inoperable disease."
      },
      {
        "criterion_number": 9,
        "description": "The response states not all patients benefit from cryotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes cryotherapy is not standard and may not be appropriate for everyone, it does not explicitly state that not all patients benefit."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that in pancreatic cancer, cryotherapy is not a standard first-line therapy but is considered for patients with unresectable, locally advanced, or metastatic disease who are not candidates for surgical resection or have failed systemic therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It states cryotherapy is not standard and mentions \"certain metastatic settings\" but does not specify unresectable/locally advanced disease, surgical candidacy, or post-systemic therapy failure."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that its primary role is palliative, aiming to reduce tumor burden, alleviate pain, and potentially improve quality of life and local disease control.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of palliative intent, pain relief, quality of life improvement, or local disease control as primary goals."
      }
    ],
    "question_number": 95,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:17:33.149824",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to discuss with the oncology team and to ask the oncologist about serial monitoring and marker choices."
      },
      {
        "criterion_number": 2,
        "description": "The response states CA 19-9 is the tumor marker most commonly used to track disease status in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that CA 19-9 is the most commonly used tumor marker for pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response states other tumor markers, like CEA and CA 125, are less reliable than CA 19-9 for disease monitoring in pancreatic cancer and are used more frequently in other gastrointestinal or genitourinary cancers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes CEA is more associated with colorectal cancer and CA125 primarily with ovarian cancer, and calls CA125 less specific; suggests use when CA19-9 is not reliable, implying lesser reliability for pancreatic cancer monitoring."
      },
      {
        "criterion_number": 4,
        "description": "The response states tumor markers may be used to monitor the course of disease in patients with pancreatic cancer, along with imaging studies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States markers are used serially to monitor response/progression and emphasizes management includes imaging among other modalities."
      },
      {
        "criterion_number": 5,
        "description": "The response states tumor markers are not reliable markers of disease in all patients with pancreatic cancer, as not all tumors secrete the markers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains false positives/negatives, and that 5\u201310% of people (Lewis antigen negative) will not have elevated CA19-9 even with pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response states circulating tumor DNA (ctDNA) is an emerging technology aimed at detecting early cancer progression and recurrence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ctDNA is not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response states circulating tumor DNA (ctDNA) is not FDA approved for disease monitoring in pancreatic cancer and remains experimental.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ctDNA and its regulatory status are not discussed."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that CEA is elevated in 30-60% of pancreatic cancer cases and is particularly useful in Lewis-negative patients who do not secrete CA19-9.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not provide the 30\u201360% statistic or specifically note CEA\u2019s utility in Lewis-negative patients."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that both CEA and CA125 have demonstrated value for diagnosis, prognosis, and monitoring, especially when CA19-9 is not informative. CA125, when combined with CA19-9, improves diagnostic accuracy and is associated with tumor burden and metastatic disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state demonstrated value in diagnosis/prognosis/monitoring or synergy of CA125 with CA19-9 nor association with tumor burden/metastatic disease."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that emerging markers such as LAMC2, POSTN are not yet standard in routine clinical practice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of LAMC2, POSTN, or similar emerging markers."
      }
    ],
    "question_number": 96,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:18:16.859707",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that hand-foot syndrome is a common side effect of some chemotherapy drugs used to treat pancreatic cancer, including capecitabine and 5-FU.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response identifies capecitabine and 5-FU as causes and calls HFS a 'known side effect,' but does not state it is 'common' as specified."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s oncologist and healthcare team immediately.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It encourages consultation with the oncology team and reporting signs of infection 'promptly,' but does not clearly recommend contacting the team immediately."
      },
      {
        "criterion_number": 3,
        "description": "The response states that the patient\u2019s oncologist may recommend reducing the chemotherapy dose.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends dose reduction, delay, or treatment breaks for symptom control."
      },
      {
        "criterion_number": 4,
        "description": "The response instructs the patient to seek immediate medical evaluation if the patient experiences fever, chills, blisters, or pus draining from the affected area.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions fever and pus as infection signs and to report promptly, but does not include chills or blisters specifically, nor does it direct 'immediate' evaluation."
      },
      {
        "criterion_number": 5,
        "description": "The response states the patient\u2019s oncology team will grade the severity of the hand-foot syndrome, which will determine the recommended treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of formal grading of HFS severity or that grading informs treatment decisions."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends hand hygiene with a gentle soap.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises avoiding harsh soaps and excessive washing but does not recommend hand hygiene with a gentle soap."
      },
      {
        "criterion_number": 7,
        "description": "The response states pain may be controlled with over-the-counter medications like Tylenol or ibuprofen, though the patient should check with their healthcare team first.",
        "score_given": 0,
        "max_points": 5,
        "justification": "OTC options (acetaminophen/ibuprofen) are mentioned, but it does not instruct checking with the healthcare team before use (only for supplements)."
      },
      {
        "criterion_number": 8,
        "description": "The response states oral or topical prescription pain medications may be needed if pain is severe.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Topical numbing agents (lidocaine) are mentioned, but not framed as needed for severe pain and no mention of oral prescription analgesics."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends utilizing topical moisturizers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly recommends moisturizers and emollients and avoiding harsh products."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends skin protection with loose clothing and soft shoe soles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises avoiding tight/restrictive clothing but does not recommend soft shoe soles."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends cooling the skin with cold compresses.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends cool compresses to reduce pain and swelling, meeting the intent of cooling measures."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends avoiding hot showers and activities that cause rubbing on the skin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises avoiding hot water and avoiding tight clothing that may rub on affected areas."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that prevention strategies include celecoxib and urea cream.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of celecoxib or urea cream as preventive strategies."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that cooling procedures, such as frozen gloves or socks applied during taxane infusions, may prevent or reduce HFS severity and are recommended by the Oncology Nursing Society for taxane-based regimens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of frozen gloves/socks during taxane infusions or ONS recommendations."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that prevention strategies such as Pyridoxine (vitamin B6) and lactic acid have not shown consistent benefit for prevention or treatment of HFS in randomized trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of pyridoxine (B6) or lactic acid and their lack of consistent benefit."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that omeprazole (a proton pump inhibitor) and tipiracil (a thymidine phosphorylase inhibitor) may have prophylactic effects, but these are not yet standard practice.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of omeprazole or tipiracil as potential prophylactic strategies."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that management of established HFS includes topical urea and corticosteroids.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Topical steroids are mentioned, but topical urea is not; criterion requires both elements."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that Photobiomodulation (low-level laser therapy) has shown promise as an adjunct for pain and symptom control.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of photobiomodulation or low-level laser therapy."
      }
    ],
    "question_number": 97,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:19:30.562023",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The decision between a cancer center and community oncology is often based on the type and stage of cancer, the patient\u2019s insurance, location, and preference.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly lists key decision factors: stage/type of cancer, distance/logistics (location), insurance coverage, and trust/comfort (preference)."
      },
      {
        "criterion_number": 2,
        "description": "Cancer centers may have access to more advanced therapies and clinical trials than community oncology programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states cancer centers offer cutting-edge treatments, early access to new therapies, and clinical trials/experimental treatments."
      },
      {
        "criterion_number": 3,
        "description": "Pancreatic cancer requires multidisciplinary care involving medical oncology, radiation oncology, and surgical oncology, which may be more readily available at a large cancer center.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response highlights a multidisciplinary approach and access to multiple specialists, explicitly naming medical, surgical, and radiation oncology (plus gastroenterology), which aligns with pancreatic cancer needs."
      },
      {
        "criterion_number": 4,
        "description": "Cancer centers may be more equipped to handle complex care for advanced disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes advanced technology, research focus, subspecialty expertise, and tumor boards, and contrasts with community settings that may lack subspecialists for complex cases."
      },
      {
        "criterion_number": 5,
        "description": "Community oncology programs may be more convenient and closer to home.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states community practices are usually closer to home and make travel and follow-up easier."
      },
      {
        "criterion_number": 6,
        "description": "There may be differences in cost between cancer centers and community oncology programs based on the patient\u2019s insurance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions cancer centers may be more expensive and that insurance coverage can vary; it also advises checking insurance coverage."
      },
      {
        "criterion_number": 7,
        "description": "Cancer centers may offer more support services to patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists comprehensive support services at cancer centers (social work, nutrition, mental health, navigation) and notes community services may be less extensive."
      },
      {
        "criterion_number": 8,
        "description": "Most standard cancer care can be delivered at community oncology programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response indicates that community programs can manage care locally and coordinate with larger centers for specialized treatments, and states both settings can provide high-quality care\u2014implying standard care is feasible in the community."
      },
      {
        "criterion_number": 9,
        "description": "Cancer centers include NCI-designated comprehensive cancer centers and academic medical centers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes cancer centers as academic or comprehensive cancer centers and notes they are often university-affiliated, covering both comprehensive and academic categories."
      },
      {
        "criterion_number": 10,
        "description": "Cancer centers are often located in major cities, which can mean longer travel times, more complex scheduling, and larger, busier environments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states cancer centers are often in large cities requiring travel and accommodation and mentions potentially longer wait times."
      },
      {
        "criterion_number": 11,
        "description": "In some cases, initial treatment planning can be done at a cancer center, and follow-up care can be done at a community center closer to home.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not explicitly describe a shared-care model where initial planning occurs at a cancer center with follow-up in the community; it only mentions coordination for specialized treatments."
      }
    ],
    "question_number": 98,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:20:26.545160",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises consulting the oncologist or a nurse specializing in supportive care to discuss intimacy concerns and side effects."
      },
      {
        "criterion_number": 2,
        "description": "The response states patients undergoing treatment for pancreatic cancer may experience a decrease in libido related to symptoms from treatment or the cancer itself, like fatigue, nausea, pain, malnutrition, anxiety, and depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions 'changes in libido' and links them to treatment-related symptoms such as fatigue, pain, and nausea, and notes emotional shifts, fulfilling the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response specifically mentions at least one of the following changes in intimacy: decreased desire, arousal disorders, pain, erectile dysfunction, altered body image, or emotional distress.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references decreased sexual desire ('changes in libido' and 'sexual desire... fluctuate') and pain, as well as emotional shifts."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends open communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Section 1 is titled 'Open and Honest Communication' with clear guidance to talk openly and listen without judgment."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends seeking input from a professional trained in intimacy problems.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends a certified sex therapist or a counselor specializing in cancer and relationships."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends cancer support groups.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes that some cancer centers have support groups for patients and their partners."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly mentions at least one of the following interventions: psychosocial therapy, psychosexual therapy, or couples-based therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions sex therapists and counselors, it does not explicitly name psychosocial therapy, psychosexual therapy, or couples-based therapy."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly mentions at least one of the following referral options: medical sexologist, psycho-sexologist, social worker, or psychologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions social workers available at cancer centers."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly states that concerns about intimacy during treatment for a loved one with pancreatic cancer are common.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It reassures the user that these concerns are 'completely understandable' and says 'You're not alone,' conveying that such concerns are common."
      }
    ],
    "question_number": 99,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:21:12.436503",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines radiofrequency ablation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines RFA as a minimally invasive procedure using radiofrequency-generated heat via a needle electrode to destroy tissue, with imaging guidance."
      },
      {
        "criterion_number": 2,
        "description": "The response states radiofrequency ablation is minimally invasive and typically does not require surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly describes RFA as minimally invasive and notes it usually does not require large incisions, implying it is not open surgery."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing with the medical team/oncologist/surgical team for individualized guidance."
      },
      {
        "criterion_number": 4,
        "description": "The response states not all patients with pancreatic cancer benefit from radiofrequency ablation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States RFA is not common first-line, not suitable for all tumors, and may not be effective for many pancreatic cancers."
      },
      {
        "criterion_number": 5,
        "description": "The response considers the potential risks and benefits of radiofrequency ablation for the treatment of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists benefits (minimally invasive, shorter stays, repeatable) and risks/limitations (pain, bleeding, infection, injury to nearby tissue, limited effectiveness, not curative in most cases)."
      },
      {
        "criterion_number": 6,
        "description": "The response states radiofrequency ablation is typically used in a multidisciplinary treatment plan along with chemotherapy for the treatment of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions RFA is sometimes used with other treatments like chemotherapy but does not state it is typically used in a multidisciplinary plan."
      },
      {
        "criterion_number": 7,
        "description": "The response states radiofrequency ablation is a procedure performed by specially trained Interventional Radiologists.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not specify the proceduralist; no mention of Interventional Radiologists."
      },
      {
        "criterion_number": 8,
        "description": "The response states this is typically an outpatient procedure.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes many procedures can be done on an outpatient basis or with a short hospital stay, indicating it is often outpatient."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that in pancreatic cancer, RFA is most commonly delivered via endoscopic ultrasound guidance (EUS-RFA), allowing precise targeting of the tumor while minimizing injury to surrounding structures.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions imaging guidance generally (ultrasound/CT/MRI) but does not mention endoscopic ultrasound (EUS-RFA) specifically for pancreatic cancer."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that radiofrequency ablation is used in pancreatic cancer primarily for unresectable or inoperable tumors as a palliative or adjunctive therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses palliative use and combination therapy but does not state that it is primarily for unresectable or inoperable tumors."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that RFA is not a substitute for surgery or systemic therapy in resectable disease.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly state that RFA is not a substitute for surgery/systemic therapy in resectable cases."
      }
    ],
    "question_number": 100,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:22:18.822996",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises having the oncologist or pharmacist review all medications and to bring concerns to the healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response states it is normal for patients with pancreatic cancer to be on multiple medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states it is \"not uncommon\" to be on several medications and that this is a reality for many undergoing treatment, which conveys that it is typical."
      },
      {
        "criterion_number": 3,
        "description": "The response states patients undergoing treatment for pancreatic cancer may need medications for symptom control, including acid reflux, nausea, pain, diarrhea, and enzyme replacement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions nausea and pain medications, it does not mention acid reflux, diarrhea, or pancreatic enzyme replacement."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends utilizing a pill organizer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It directly recommends using a weekly pill organizer to keep track of doses."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends keeping an updated medication list with administration times.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests using apps for reminders and records but does not explicitly recommend maintaining an updated medication list with administration times."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends reviewing the patient\u2019s medication list with the healthcare team to identify strategies to make handling the medications easier.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends regular medication review by the oncologist or pharmacist and discusses simplifying, combining, or adjusting medications to reduce pill burden."
      }
    ],
    "question_number": 101,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:22:52.005784",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing yoga with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises consulting the oncologist/care team before starting yoga and reiterates this in the 'What to Do Next' section."
      },
      {
        "criterion_number": 2,
        "description": "The response states yoga may improve a cancer patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'Improved quality of life' with specifics like better mood and sleep."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends gentle and slow yoga practice to avoid injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends gentle/restorative/chair yoga, starting with short sessions, going slowly, and stopping if uncomfortable."
      },
      {
        "criterion_number": 4,
        "description": "The response states patients undergoing treatment for pancreatic cancer may be more prone to injury due to fatigue, malnutrition, dehydration, and pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions fatigue, nausea, and pain but does not note malnutrition or dehydration, nor explicitly link these factors to increased injury risk."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention or recommendation of cancer support groups."
      },
      {
        "criterion_number": 6,
        "description": "The response cites any studies it mentions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References 'some studies' for pain management but provides no specific study citations; links given are general resources, not study citations."
      },
      {
        "criterion_number": 7,
        "description": "The response states there are yoga classes specifically for cancer patients and provides resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that many cancer centers offer specialized classes and provides ACS and NCI resources."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that yoga is generally safe for people with cancer, including those undergoing treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that yoga is generally safe for people with cancer or during pancreatic cancer treatment; emphasizes individual caution instead."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that yoga may help reduce cancer-related fatigue, anxiety, and depression, and improve emotional well-being during and after treatment, though effects are typically small to moderate and the certainty of evidence is low to moderate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions reduced stress/anxiety and quality of life but does not address depression, reduction of cancer-related fatigue, or the magnitude/certainty of evidence."
      }
    ],
    "question_number": 102,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:23:42.189393",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly encourages involving the oncologist and supportive care team and urges talking with the medical team about expectations and management."
      },
      {
        "criterion_number": 2,
        "description": "The response states many side effects from cancer treatment improve and disappear once treatment stops.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response emphasizes persistence of side effects (e.g., fatigue for months or years) but does not state that many side effects improve or resolve after treatment ends."
      },
      {
        "criterion_number": 3,
        "description": "The response states some side effects like peripheral neuropathy may become permanent.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Peripheral neuropathy is mentioned, but there is no statement that neuropathy or other side effects may be permanent."
      },
      {
        "criterion_number": 4,
        "description": "The response states some side effects from treatment may take time to improve or disappear, as long as many months.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response notes certain effects can persist for months or years, it does not state that improvement/resolution may take months."
      },
      {
        "criterion_number": 5,
        "description": "The response states many side effects from treatment can be controlled with medications, for example pancreatic enzyme supplementation for pancreatic insufficiency or vitamins for malabsorption after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifically notes pancreatic enzyme supplementation after surgery to address digestive insufficiency, illustrating that some side effects can be controlled with medications."
      },
      {
        "criterion_number": 6,
        "description": "The response reviews potential side effects of surgery for pancreatic cancer (e.g., Whipple procedure).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It reviews long-term effects of surgery including digestive problems (steatorrhea, malabsorption), diabetes, bile duct issues, motility changes, and chronic pain."
      },
      {
        "criterion_number": 7,
        "description": "The response reviews potential side effects of chemotherapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists fatigue, neuropathy, organ damage (heart, kidneys, liver, lungs), cognitive effects, secondary cancers, and immune effects."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the potential for long-term heart or kidney damage and fertility issues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Potential long-term heart and kidney damage are mentioned, but fertility issues are not addressed."
      },
      {
        "criterion_number": 9,
        "description": "The response states the treating team will work within the patient\u2019s goals of care to maximize treatment efficacy while limiting side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although advance care planning and multidisciplinary care are suggested, the response does not explicitly state that the team will balance efficacy with minimizing side effects in alignment with goals of care."
      },
      {
        "criterion_number": 10,
        "description": "The response reviews potential side effects of radiation therapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Radiation-related fatigue, skin changes, GI strictures/ulcers/malabsorption, and secondary cancer risk are described."
      },
      {
        "criterion_number": 11,
        "description": "The response states some cancer treatments can increase the likelihood of developing second cancers in the future.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly notes a small risk of secondary cancers from chemotherapy and radiation."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends open communication with the patient\u2019s healthcare team about symptoms and symptom control to limit the long-term effects of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises honest conversations with the oncology team, asking about potential side effects and how to manage them, and engaging supportive services."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that long-term side effects are common in patients treated for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It states that concerns about long-term side effects are common, but does not explicitly state that long-term side effects themselves are common."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the cumulative impact of surgery, chemotherapy, radiation, and the underlying disease as sources of long-term side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it reviews each modality\u2019s effects and notes disease-related nutritional issues, it does not explicitly mention cumulative impact or the combined contribution of disease and treatments."
      }
    ],
    "question_number": 103,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:24:38.610087",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response offers recommendations for organizations and includes key initiatives of the organizations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response lists multiple organizations (PanCAN, ACS, Lustgarten Foundation, NPF, and another foundation) and describes key initiatives for each (research funding, patient support services, advocacy, collaborative research, early-career funding). Although there are concerns about accuracy for some entries (e.g., conflation of PCRF with Lustgarten and inclusion of a lesser-known foundation), the criterion is met: it provides recommendations and describes their initiatives."
      },
      {
        "criterion_number": 2,
        "description": "The response includes Charity Navigator ratings for the mentioned organizations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No Charity Navigator ratings or any third-party charity ratings are provided for any of the listed organizations."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly state that nonprofit organizations are vital for supporting innovative research in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response emphasizes supporting research and highlights nonprofit organizations, it does not explicitly state that nonprofit organizations are vital for supporting innovative pancreatic cancer research."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention that donations to nonprofit organizations can support research, clinical trials, and patient support initiatives.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions donations supporting research and patient services, and it references clinical trials in a separate suggestion to consult the medical team. However, it does not explicitly link donations to nonprofit organizations with support for clinical trials. Therefore, the criterion as stated is not fully met."
      }
    ],
    "question_number": 104,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:25:10.767844",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends contacting the patient\u2019s oncologist immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises discussing symptoms with the oncology team as soon as possible."
      },
      {
        "criterion_number": 2,
        "description": "The response instructs the patient to seek immediate medical evaluation if the vision changes are abrupt in onset, severe, or accompanied by other symptoms including dizziness, pain, confusion, fever, or other neurologic symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It instructs seeking immediate medical attention for sudden or severe vision changes and mentions confusion and difficulty walking (neurologic symptoms)."
      },
      {
        "criterion_number": 3,
        "description": "The response states vision changes related to treatment are not typical, though can be related to dry eyes or peripheral neuropathy from chemotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes vision changes are not commonly reported from treatment, it does not mention dry eyes or peripheral neuropathy as potential mechanisms."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that chemotherapy can cause vision changes (ocular toxicity). For example, gemcitabine and 5-fluorouracil have been associated with retinal findings including cotton-wool spots and other visual disturbances.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not identify chemotherapy ocular toxicity or give examples such as gemcitabine or 5-FU with retinal findings."
      },
      {
        "criterion_number": 5,
        "description": "The response states the oncologist may recommend dose reducing treatment or changing to a different treatment if the vision changes are felt to be treatment-related.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of dose reduction or switching therapies is included."
      },
      {
        "criterion_number": 6,
        "description": "The response states vision changes may be related to metastasis to the brain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions that cancer spreading to the brain could affect vision."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that ocular metastases may cause vision changes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions nerves near the eyes but does not state ocular/eye metastases as a cause."
      },
      {
        "criterion_number": 8,
        "description": "The response states vision changes may be related to paraneoplastic processes and explains what this is.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention or explanation of paraneoplastic processes is provided."
      },
      {
        "criterion_number": 10,
        "description": "The response states the patient\u2019s oncologist may prescribe medications to improve the vision changes, including eye drops, steroids, or antibiotics.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It does not discuss potential medications such as eye drops, steroids, or antibiotics to address vision changes."
      },
      {
        "criterion_number": 11,
        "description": "The response states the patient\u2019s vision changes may be due to infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Infection is not mentioned as a possible cause."
      },
      {
        "criterion_number": 12,
        "description": "The response states the patient\u2019s vision changes may be due to age-related vision changes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Age-related vision changes are not mentioned."
      }
    ],
    "question_number": 105,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:25:48.527881",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that telehealth appointments are generally as effective as in-person visits for many aspects of care for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response says effectiveness depends on several factors and lists scenarios where telehealth can be effective, but it does not explicitly state that telehealth is generally as effective as in-person visits for many aspects of care."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews the potential benefits of telehealth appointments, including reduced travel burden, lower costs, decreased infection risk, and improved access to expertise.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions convenience (reduced travel burden) and improved access to specialists, but does not mention lower costs or decreased infection risk."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the potential downsides of telehealth appointments, including potential differences in insurance reimbursement and challenges with physical examination.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Challenges with physical exam are discussed, but potential differences in insurance reimbursement are not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response states it can be challenging for a doctor to fully evaluate a patient via telehealth.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that physical exams may be difficult or impossible via telehealth and that complex symptom assessment can be harder remotely, indicating challenges to full evaluation."
      },
      {
        "criterion_number": 5,
        "description": "The response states telehealth can be a convenient alternative to in-office visits and may be helpful if the patient has mobility or transportation issues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes convenience and highlights that telehealth is helpful if the patient feels unwell or if travel is difficult, addressing mobility/transportation issues."
      },
      {
        "criterion_number": 6,
        "description": "The response states in-office visits may be more appropriate in certain situations, including for initial visits or when there are big changes to the patient\u2019s health or treatment plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifies that initial diagnosis/staging and procedures require in-person care and recommends in-person visits for new or concerning symptoms, covering initial visits and major health changes."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing telehealth options with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directly advises discussing telehealth with the mother's oncologist/care team and asks to seek their guidance."
      },
      {
        "criterion_number": 8,
        "description": "The response states not all oncologists offer telehealth appointments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention that some oncologists may not offer telehealth."
      },
      {
        "criterion_number": 9,
        "description": "The response offers tips for making the most out of a telehealth appointment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides practical tips: talk to the care team about telehealth, request a clear plan for when telehealth vs in-person is appropriate, and keep track of symptoms to discuss during telehealth visits."
      },
      {
        "criterion_number": 10,
        "description": "The response states medical emergencies are not appropriate for telehealth evaluations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly notes that emergency situations may require in-person or emergency care and advises seeking in-person care immediately for new or severe symptoms."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that telehealth may be less suitable for sensitive discussions, such as new diagnosis or end-of-life care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions initial diagnosis procedures require in-person care, it does not address sensitivity of discussions such as new diagnosis disclosure or end-of-life care."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that limitations of telehealth include technology barriers and occasional concerns about reduced personal connection or quality of interaction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No technology barriers or concerns about reduced personal connection/interaction quality are mentioned."
      }
    ],
    "question_number": 106,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:26:44.636771",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States, 'If hair loss is a major concern, it's worth discussing with the oncology team' and 'best to discuss them directly with their oncologist.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states some chemotherapy treatments for pancreatic cancer can cause hair loss, for example, FOLFIRINOX or gemcitabine.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions FOLFIRINOX and gemcitabine as common pancreatic cancer drugs that often cause hair loss."
      },
      {
        "criterion_number": 3,
        "description": "The response provides reported estimates of hair loss with FOLFIRINOX and gemcitabine and cites its sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No numerical incidence estimates or citations are provided."
      },
      {
        "criterion_number": 4,
        "description": "The response states hair typically grows back once the causative treatment is stopped.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'hair begins to regrow 2\u20133 months after chemotherapy is stopped.'"
      },
      {
        "criterion_number": 5,
        "description": "The response states cold caps are sometimes used to reduce hair loss but they can be expensive.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of scalp cooling/cold caps or cost."
      },
      {
        "criterion_number": 6,
        "description": "The response states hair loss from chemotherapy is a common and distressing side effect in patients undergoing treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes hair loss is 'a common concern' and 'can be emotionally difficult' in the context of pancreatic cancer chemotherapy."
      },
      {
        "criterion_number": 7,
        "description": "The response states other chemotherapy regimens or immunotherapy or targeted therapy cause hair loss at lower rates or not at all.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address lower hair-loss rates with other regimens, immunotherapy, or targeted therapies."
      },
      {
        "criterion_number": 8,
        "description": "The response states many cancer patients wear hats or wigs to help with appearances and self-esteem.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'Many people find wigs, hats, or scarves helpful for comfort and confidence.'"
      },
      {
        "criterion_number": 9,
        "description": "The response recommends cancer support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends 'Support groups, counseling, or talking with others who've been through similar experiences.'"
      },
      {
        "criterion_number": 10,
        "description": "The response reports expected timelines for hair loss after starting chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States hair loss typically starts 2\u20133 weeks after first session and peaks at 1\u20132 months."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that the severity and risk of hair loss is higher with multi-agent and taxane-containing protocols, and female patients are at increased risk.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of multi-agent/taxane protocols or sex-based risk differences."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that most cases of hair loss are reversible, with regrowth expected within 3-6 months after cessation of chemotherapy, but persistent or permanent alopecia can occur, especially after repeated or high-dose regimens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions regrowth beginning 2\u20133 months after cessation but does not warn about persistent/permanent alopecia or risk factors such as repeated/high-dose regimens."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that eyebrow and eyelash loss may also be seen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states eyebrows and eyelashes can also be affected."
      },
      {
        "criterion_number": 14,
        "description": "The response mentions that topical minoxidil may aid regrowth post-chemotherapy, though evidence for prevention is limited.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of topical minoxidil."
      }
    ],
    "question_number": 107,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:27:44.214463",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines oligometastatic disease in pancreatic cancer as a state where the cancer has spread to a limited number of sites, typically involving a single organ (e.g., liver or lung) and a small number of lesions, commonly defined as \u22643 to \u22645 metastases.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response correctly explains that oligometastatic disease involves a limited number of metastases and even provides a typical count (1\u20133). However, it does not mention the key element that it usually involves a single organ (e.g., liver or lung), which is part of the criterion. It also does not explicitly frame the definition in the pancreatic cancer context. Therefore, full credit cannot be awarded under the binary scoring."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises discussing details and treatment recommendations with the oncologist and the medical team, encouraging questions and clarification."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses the potential impact oligometastatic disease may have on treatment options, including the possibility of aggressive multimodal therapy such as systemic chemotherapy followed by local treatments like surgery, ablation, or stereotactic radiotherapy, if there is a good response to initial therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes that oligometastatic status can open options like surgery, stereotactic body radiation therapy, and chemotherapy with a consolidative aim, indicating a more aggressive, multimodal approach. While it doesn\u2019t explicitly state the sequence (systemic therapy followed by local therapy after a good response), it sufficiently conveys the concept of aggressive multimodal treatment options."
      },
      {
        "criterion_number": 4,
        "description": "The response contrasts oligometastatic disease to localized disease and widespread metastatic disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes oligometastatic disease as an \u201cin-between\u201d state\u2014beyond the primary site (not localized) but not widely spread\u2014and explicitly contrasts it with \u201cextensive metastatic disease.\u201d"
      },
      {
        "criterion_number": 5,
        "description": "The response mentions that patients with oligometastatic disease have the potential for an improved prognosis compared to widespread metastatic disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that treating all known metastases effectively may lead to a better outcome than if the cancer is very widespread, implying improved prognosis compared with extensive metastatic disease."
      }
    ],
    "question_number": 108,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:28:18.997728",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states it is common for patients to have low blood counts due to chemotherapy used in the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes that treatment delays due to low counts are common and explicitly links low blood counts to chemotherapy: 'many cancer treatments\u2014such as chemotherapy\u2014can suppress the bone marrow and lead to low blood counts.' This sufficiently conveys that chemo commonly causes low counts in this context."
      },
      {
        "criterion_number": 2,
        "description": "The response states treatment delays due to low blood counts are enacted to ensure the patient\u2019s safety.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states low counts make it unsafe to proceed and that teams pause or adjust treatment until counts recover to reduce risks of severe anemia, infections, or bleeding."
      },
      {
        "criterion_number": 3,
        "description": "The response states the oncologist may recommend dose reducing the chemotherapy or changing to a different treatment if the blood counts remain low.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions 'pause or adjust treatment' and 're-evaluating the treatment plan,' it does not explicitly mention dose reduction or switching to a different regimen."
      },
      {
        "criterion_number": 4,
        "description": "The response gives examples of chemotherapy known to cause low blood counts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific chemotherapy agents or regimens (e.g., FOLFIRINOX, gemcitabine/nab-paclitaxel) are named."
      },
      {
        "criterion_number": 5,
        "description": "The response lists the different types of low blood counts that may impact treatment, including anemia, neutropenia, thrombocytopenia, and low total white blood cell count, and explains why these cells are important in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It explains low RBCs (anemia), low WBCs (infection risk), and low platelets (bleeding), but does not explicitly list neutropenia, thrombocytopenia, or low total WBC count by name as required."
      },
      {
        "criterion_number": 6,
        "description": "The response states the oncologist may prescribe an injection medication (e.g., G-CSF) to help increase the neutrophil count.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions 'growth factors' generally but does not specify G-CSF or that an injection may be used to raise neutrophils."
      },
      {
        "criterion_number": 7,
        "description": "The response states if the red blood cell or platelet counts get too low, the oncologist may order a transfusion of red blood cells or platelets to keep these at safe levels.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of blood or platelet transfusions."
      },
      {
        "criterion_number": 8,
        "description": "The response instructs the patient to seek immediate medical evaluation if they have low blood counts and experience fever, chest pain, shortness of breath, leg swelling, blood in the urine, blood in the stool, or other uncontrollable bleeding.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests monitoring for infection, bleeding, or severe fatigue but does not instruct immediate medical evaluation or list specific red-flag symptoms."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends ensuring good nutrition to ensure the bone marrow can produce the required blood cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It briefly mentions addressing nutritional deficiencies but does not recommend ensuring good nutrition to support bone marrow specifically."
      },
      {
        "criterion_number": 10,
        "description": "The response must strongly recommend consulting with an oncologist or care team, providing specific questions or topics to discuss.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking the medical team for a clear explanation of blood count results and plan, and suggests consulting a hematologist or supportive care specialist, which are concrete topics for discussion."
      }
    ],
    "question_number": 109,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:29:15.329505",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises that the father should discuss hyperthermia with his oncology team and outlines what they can address."
      },
      {
        "criterion_number": 2,
        "description": "The response explains hyperthermia treatment for cancer in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear, accessible explanation of what hyperthermia is, how it works, and types of delivery using simple language."
      },
      {
        "criterion_number": 3,
        "description": "Specifies that hyperthermia treatment involves heating tumor tissue to a temperature range of 39-43\u00b0C to enhance the cytotoxic effects of chemotherapy and/or radiotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific temperature range (39\u201343\u00b0C) is stated."
      },
      {
        "criterion_number": 4,
        "description": "Mentions all three delivery methods: regional (including \u2018deep regional\u2019), intraoperative, and whole-body hyperthermia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions local, regional, and whole-body but omits intraoperative hyperthermia and does not specify deep regional."
      },
      {
        "criterion_number": 5,
        "description": "Reviews potential benefits and risks of hyperthermia treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes benefits (direct cytotoxicity, sensitization to radiation/chemo, possible immune effects) and risks (local pain, redness/swelling, fatigue, rare tissue damage)."
      },
      {
        "criterion_number": 6,
        "description": "States hyperthermia is not an effective alternative to standard of care treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly state it is not an effective alternative to standard of care; only notes it is not a standalone cure and is usually adjunctive."
      },
      {
        "criterion_number": 7,
        "description": "States hyperthermia is not a standard first-line therapy for pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit statement that it is not standard first-line therapy."
      },
      {
        "criterion_number": 8,
        "description": "States there is not robust evidence for the use of hyperthermia treatment in pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No discussion of the strength of evidence or lack thereof."
      },
      {
        "criterion_number": 9,
        "description": "Mentions that hyperthermia is used in pancreatic cancer as an adjunct to standard chemoradiotherapy for patients with locally advanced, unresectable, or metastatic disease, especially when conventional therapies have limited efficacy or are refractory.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not specify the disease settings (locally advanced/unresectable/metastatic) or explicitly reference adjunct use to standard chemoradiotherapy."
      },
      {
        "criterion_number": 10,
        "description": "States that adding hyperthermia to chemoradiotherapy may improve overall response rates and median survival compared to standard therapy alone, with acceptable safety profiles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement about potential improvement in response rates or median survival or safety profile when added to chemoradiotherapy."
      },
      {
        "criterion_number": 11,
        "description": "Explicitly states that the quality of evidence for hyperthermia is limited, it remains investigational, and there are ongoing trials evaluating its efficacy and optimal integration into multimodal treatment regimens.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention that evidence is limited, that hyperthermia remains investigational, or that ongoing trials are evaluating it."
      }
    ],
    "question_number": 110,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:30:03.639875",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consulting her treating doctor/oncologist and mentions their role in relating results to treatment and prognosis."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends meeting a genetic counselor and provides a resource (NSGC) to find one."
      },
      {
        "criterion_number": 4,
        "description": "The response explains genetic testing and why it is done in cancer treatment, using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explain what genetic testing is or why it\u2019s used (e.g., to guide treatment, assess hereditary risk) beyond noting results can be complex."
      },
      {
        "criterion_number": 5,
        "description": "The response includes that certain genetic mutations like BRCA2 may be targets for targeted cancer therapies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of BRCA2 or other targetable mutations, nor targeted therapies (e.g., PARP inhibitors)."
      },
      {
        "criterion_number": 6,
        "description": "The response states that certain genetic mutations are associated with inherited cancer predisposition syndromes which may affect the patient\u2019s relatives.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes counselors can discuss risk for relatives, it does not state that specific mutations are associated with inherited cancer predisposition syndromes."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that board-certified genetic counselors, medical geneticists, and oncologists can help determine the clinical significance of identified variants, discuss implications for surveillance, prevention, and treatment, and provide guidance for at-risk family members.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions oncologists and genetic counselors but not medical geneticists, does not specify board certification, and does not explicitly cover surveillance and prevention discussions."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that pathogenic variants in genes such as BRCA1, BRCA2, PALB2, ATM, CDKN2A, and others may influence both therapeutic decisions and recommendations for family screening.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No gene-specific examples or links to therapy or family screening are provided."
      }
    ],
    "question_number": 111,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:30:40.149808",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist or a nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises working with the oncology team and a registered dietitian; encourages keeping the medical team informed."
      },
      {
        "criterion_number": 2,
        "description": "The response states changes in taste are a common side effect of some chemotherapies used in the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States taste changes are common and specifically notes that some chemotherapy drugs are known to cause taste changes."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends trying different foods and drinks to identify flavor profiles that are appealing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages experimenting with different foods and mentions beverages (cold foods or beverages) to find what is enjoyable."
      },
      {
        "criterion_number": 4,
        "description": "The response states cold intolerance is a common side effect of oxaliplatin, so patients should avoid cold foods and drinks.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention oxaliplatin or cold intolerance; in fact suggests trying cold foods/beverages, which is contrary to oxaliplatin guidance."
      },
      {
        "criterion_number": 5,
        "description": "The response states changes in taste typically improve or disappear entirely when the causative medication is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement about taste changes improving after stopping the causative medication."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of maintaining proper nutrition and hydration while undergoing treatment for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Repeatedly emphasizes nutrition (smaller frequent meals, monitoring intake, supplements) and hydration (stay hydrated to prevent dry mouth)."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends nutritional supplements to ensure the patient is achieving their needs.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends oral nutritional supplements and even tube feeding if needed."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that improved oral hygiene and active swallowing exercises may also promote taste recovery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions improved oral hygiene but does not mention active swallowing exercises."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that a referral to a registered dietitian is recommended for tailored nutritional strategies, as taste changes often lead to reduced appetite, altered food preferences, and risk of malnutrition.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends working with an oncology dietitian for a personalized plan and notes decreased appetite and weight loss, supporting the need for tailored strategies."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that dietitians can assist with food texture modification, flavor enhancement, and strategies to maintain adequate caloric and protein intake.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not attribute texture modification, flavor enhancement, or caloric/protein strategies specifically to dietitians."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pharmacological and supplement-based interventions have been explored with mixed results. Further research is needed to establish standardized, effective interventions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions medications or rinses may help but does not discuss mixed results or the need for further research."
      }
    ],
    "question_number": 112,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:31:47.551948",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the exercise plan with the patient\u2019s oncologist or healthcare provider.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response repeatedly advises consultation with the oncology team and mentions a physiotherapist familiar with cancer care, including statements like 'Consult the medical team first' and 'individual recommendations should come from his oncologist or a physiotherapist.'"
      },
      {
        "criterion_number": 2,
        "description": "The response recommends gentle and slow exercise to avoid injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends a gentle, tailored approach, starting slowly, light walking, gentle stretching, chair exercises, gentle yoga/Tai Chi, avoiding overexertion, and resting as needed."
      },
      {
        "criterion_number": 3,
        "description": "The response states patients undergoing treatment for pancreatic cancer may be more prone to injury due to fatigue, malnutrition, dehydration, and pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes fatigue, weight loss, pain caution, and monitoring nutrition/hydration, it does not explicitly state increased injury risk due to fatigue, malnutrition, dehydration, and pain, nor does it explicitly mention malnutrition or dehydration."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention or recommendation of cancer support groups is provided."
      },
      {
        "criterion_number": 5,
        "description": "The response states gentle exercise participation may improve a cancer patient\u2019s quality of life and offers published research studies as evidence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it lists potential benefits (e.g., mood, physical function), it does not explicitly mention quality of life nor provide or reference published research studies."
      },
      {
        "criterion_number": 6,
        "description": "The response cites any studies it mentions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No peer-reviewed studies are mentioned or cited; only general web resources (ACS, NCI) are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response states there are exercise classes specifically for cancer patients and provides resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not state that cancer-specific exercise classes exist nor provide resources for such classes."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly mentions that ASCO recommends both aerobic and resistance exercise as safe and beneficial for patients with pancreatic cancer during chemotherapy, chemoradiotherapy, or neoadjuvant therapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no explicit mention of ASCO or its recommendations regarding aerobic and resistance exercise during pancreatic cancer treatments."
      },
      {
        "criterion_number": 9,
        "description": "The response clearly states that physical activity should be tailored to individual capacity and comorbidities, using terms like \u201cindividual capacity,\u201d \u201cpersonalized,\u201d or \u201ctailored.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it uses 'tailored' and 'personalized,' it does not explicitly state tailoring to individual capacity and comorbidities."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly states that aerobic exercise (e.g., walking, cycling, swimming) and resistance training (e.g., weights, resistance bands) improve cardiorespiratory fitness, physical function, and reduce symptoms like fatigue and mood disturbances.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response lists general benefits but does not explicitly tie them to both aerobic and resistance training, nor does it mention cardiorespiratory fitness or provide modality-specific examples like cycling, swimming, or resistance bands."
      }
    ],
    "question_number": 113,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:32:26.301077",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to work closely with the oncology team, attend appointments, and ask the medical team about monitoring and expectations."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends reporting any new symptoms to the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States: \u201creport them to your loved one\u2019s oncologist as soon as they appear,\u201d clearly recommending reporting new/worsening symptoms."
      },
      {
        "criterion_number": 3,
        "description": "The response states it is important to separate side effects of treatment from progression of disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention differentiating treatment-related side effects from disease progression."
      },
      {
        "criterion_number": 4,
        "description": "The response gives examples of new or worsening pain, jaundice, unintentional weight loss, and appetite changes as symptoms that may signify progression of disease.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes all four: worsening jaundice, severe/persistent abdominal pain, unexplained weight loss, and loss of appetite."
      },
      {
        "criterion_number": 5,
        "description": "The response states metastases to other sites in the body can have various symptoms and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that if the tumor has spread to the brain or spinal cord, symptoms such as headaches, seizures, vision changes, weakness, or numbness may occur."
      },
      {
        "criterion_number": 6,
        "description": "The response instructs the patient to seek immediate medical evaluation if they experience severe pain, jaundice, severe constipation, confusion, or neurologic changes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises immediate care for sudden/severe changes including confusion, chest pain, difficulty breathing, and sudden weakness, but does not explicitly include severe pain, jaundice, or severe constipation as urgent red flags."
      },
      {
        "criterion_number": 7,
        "description": "The response must mention at least 10 of the following signs and symptoms indicating disease progression in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 8 of the listed items: jaundice, abdominal pain, weight loss, anorexia (loss of appetite), fatigue, nausea/vomiting, diarrhea, and blood clots. It does not reach the required 10."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention gastrointestinal bleeding or rapidly declining performance status as alarm symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention GI bleeding or rapidly declining performance status."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state the importance of close monitoring of symptoms for timely intervention and supportive care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises to keep a close watch on symptoms and report them as soon as they appear (timely intervention) and also recommends palliative care to manage symptoms (supportive care)."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly mention early integration of supportive care to optimize quality of life and address complications.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends discussing a palliative care referral if not already involved, emphasizing it can help manage symptoms and improve quality of life at any stage."
      }
    ],
    "question_number": 114,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:33:31.119632",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define neoadjuvant therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly defines neoadjuvant therapy as treatment given before the main treatment to help the primary therapy be more effective."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that neoadjuvant treatment is given before the main treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states it is given before the main treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that neoadjuvant therapy usually occurs before surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States it is given before the main treatment, usually surgery, and outlines a sequence where surgery follows neoadjuvant therapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that neoadjuvant therapy is usually chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that for pancreatic cancer neoadjuvant therapy often involves chemotherapy (sometimes with radiation), indicating chemotherapy is the usual component."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that radiation therapy can sometimes be used for neoadjuvant therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions that radiation therapy can sometimes be included along with chemotherapy."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that oncologists often evaluate the response of a person\u2019s cancer after neoadjuvant therapy to determine the next steps.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes that after several weeks or months, scans are done to assess response and next steps (proceed to surgery or adjust plan) are determined."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that the main goals of neoadjuvant therapy are to treat micrometastases early, improve chances of margin-negative (R0) resection, downstage advanced tumors, and ensure patients receive systemic therapy, as many can\u2019t complete adjuvant treatment after surgery.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions shrinking the tumor and reducing the chance of residual cancer (related to downstaging/R0), it does not mention treating micrometastases early or ensuring systemic therapy due to potential inability to complete adjuvant therapy."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that patient selection, multidisciplinary coordination, and management of therapy-related toxicities are critical, as attrition during neoadjuvant therapy can preclude surgery.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No discussion of patient selection, multidisciplinary team coordination, toxicity management, or attrition potentially preventing surgery."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages asking more questions but does not explicitly recommend discussing with an oncologist or the oncology team."
      }
    ],
    "question_number": 115,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:34:12.637441",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that music therapy can help with symptoms associated with pancreatic cancer.",
        "score_given": 8,
        "max_points": 8,
        "justification": "The response explicitly notes that music therapy has benefits during cancer treatment, including for those with pancreatic cancer, and lists symptom relief (pain, nausea, fatigue, discomfort), indicating it can help with symptoms associated with pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that music therapy can help with anxiety.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly states that music therapy can reduce anxiety."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that music therapy can improve quality of life.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It directly mentions improved quality of life as a potential benefit."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that music therapy can help with depression.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly states that music therapy can help reduce depression."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that music therapy can help with pain.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It clearly notes reduction in pain and discomfort as a benefit."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that music therapy can help with fatigue.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It mentions distraction from symptoms such as fatigue, implying benefit for fatigue."
      },
      {
        "criterion_number": 7,
        "description": "The response states that music therapy is anti-cancer therapy.",
        "score_given": 0,
        "max_points": 0,
        "justification": "The response does not claim music therapy is anti-cancer and explicitly states it is not a replacement for conventional treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response should cite peer-reviewed publications with links.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No peer-reviewed citations or links are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the American Society of Clinical Oncology and the Society for Integrative Oncology recommend music therapy as a safe, non-invasive adjunct for managing anxiety and depression in adults with cancer, including those undergoing active treatment.",
        "score_given": 0,
        "max_points": 8,
        "justification": "There is no mention of ASCO/SIO guideline recommendations."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that emerging evidence suggests music therapy may also modulate immune responses and support overall treatment outcomes, but further research is needed to clarify its biological effects and optimal use in pancreatic cancer.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No discussion of immune modulation, biological effects, or emerging evidence is provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises asking the oncology care team and discussing with her doctor to ensure alignment with her treatment plan."
      }
    ],
    "question_number": 116,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:34:57.167920",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that pancreatic cancer is not contagious.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states 'Pancreatic cancer itself is not contagious.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should state that chemotherapy can weaken the immune system and make someone at increased risk of infection.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention that chemotherapy causes immunosuppression or increases infection risk."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pets can carry infections that could be harmful to immunocompromised persons.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not address pet-borne infections or risks to immunocompromised patients."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the patient discuss precautions related to chemotherapy excretion with a pharmacist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to consult a pharmacist about chemotherapy excretion precautions."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some chemotherapy drugs are excreted in urine.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions residues 'such as in urine' could be harmful if ingested by pets."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that some chemotherapy drugs are excreted in stool.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions residues 'such as in ... feces' could be harmful if ingested by pets."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that some chemotherapy drugs are excreted in saliva.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of saliva as a route of chemotherapy excretion."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some chemotherapy drugs are excreted in vomit.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of vomit as a route of chemotherapy excretion."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that pets should avoid contact with excreted medications.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Notes chemo residues in urine/feces could be harmful and advises safe disposal and keeping pets away from treatment areas, implying pets should avoid contact with excreted medications."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that pets should avoid contact with chemotherapy medications.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Advises storing medications securely and keeping pets away; clearly implies pets should avoid contact with chemotherapy medications."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that pets should avoid contact with all medications.",
        "score_given": 1,
        "max_points": 1,
        "justification": "States human medications can be toxic to pets and should be stored out of reach."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that pets provide significant emotional and psychological benefits to cancer patients.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Explicitly states pets provide comfort and emotional support and cites related resources."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that to reduce exposure to chemotherapy and radiation residues, patients should take precautions to limit the impacts on their pets.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises following safe disposal of medical waste and keeping pets away from treatment areas due to harmful residues."
      },
      {
        "criterion_number": 14,
        "description": "After chemotherapy, surfaces\u2014especially in bathrooms\u2014can remain contaminated for at least 48 hours, so thorough cleaning is advised.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of surface contamination duration or cleaning guidance."
      },
      {
        "criterion_number": 15,
        "description": "Hand hygiene is essential after contact with patient waste or contaminated areas.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not mention hand hygiene after contact with waste or contaminated areas."
      },
      {
        "criterion_number": 16,
        "description": "Immunocompromised patients should practice good hand hygiene after handling pets.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No recommendation about hand hygiene after handling pets."
      },
      {
        "criterion_number": 17,
        "description": "Immunocompromised patients should avoid contact with pet waste.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not advise immunocompromised patients to avoid pet waste."
      },
      {
        "criterion_number": 18,
        "description": "Immunocompromised patients should prevent pets from licking open wounds.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention of preventing pets from licking wounds."
      },
      {
        "criterion_number": 19,
        "description": "There is no strong evidence that pet ownership increases cancer risk or that pets need to be removed from the home during treatment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it notes cancer is not contagious and pets provide benefits, it does not explicitly state there is no evidence for increased cancer risk or need to remove pets during treatment."
      },
      {
        "criterion_number": 20,
        "description": "If patients are severely immunosuppressed, they should avoid contact with young animals, reptiles, or exotic pets, and seek assistance with pet care.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No guidance about avoiding young animals, reptiles, or exotic pets, nor seeking help if severely immunosuppressed."
      },
      {
        "criterion_number": 21,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Suggests consulting a veterinarian but does not recommend discussing with an oncologist."
      }
    ],
    "question_number": 117,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:35:54.136213",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define adjuvant therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines adjuvant therapy as treatment given after the main treatment for cancer, usually after surgery."
      },
      {
        "criterion_number": 2,
        "description": "The response should state the goal of adjuvant therapy is to prevent cancer recurrence.",
        "score_given": 6,
        "max_points": 6,
        "justification": "States the goal is to kill remaining cancer cells and reduce the risk that the cancer will come back (recur)."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that adjuvant therapy usually occurs after surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions adjuvant therapy is given after surgery."
      },
      {
        "criterion_number": 4,
        "description": "The response should include adjuvant therapy can be chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists chemotherapy as the most common adjuvant therapy for pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response should include adjuvant therapy can be radiation therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions radiation therapy can be used in combination with chemotherapy as adjuvant treatment."
      },
      {
        "criterion_number": 6,
        "description": "The response states that guidelines recommend all patients with resected pancreatic adenocarcinoma who did not receive preoperative therapy should be offered 6 months of adjuvant chemotherapy, unless there are medical or surgical contraindications.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not reference guideline recommendations, resected pancreatic adenocarcinoma, or the 6-month duration."
      },
      {
        "criterion_number": 7,
        "description": "The response states that adjuvant systemic therapy significantly improves survival compared to surgery alone.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No statement about survival benefit versus surgery alone."
      },
      {
        "criterion_number": 8,
        "description": "The response states that the choice of adjuvant regimen should be individualized based on patient fitness and risk of toxicity.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Notes decisions depend on overall health and that oncologists discuss benefits and side effects, implying individualization based on fitness and toxicity."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends that the user discuss this case with an oncologist or cancer specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages discussion with the oncologist and invites further questions."
      }
    ],
    "question_number": 118,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:36:33.844567",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing constipation with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises to consult the oncology or palliative care team and to keep the medical team informed about constipation and its severity."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing pain medications with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends reviewing and adjusting pain medications under the guidance of the medical team and states to consult the oncology or palliative care team before starting or changing any medication."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that constipation is a side effect of opioid pain medications.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response directly references 'opioid-induced constipation' and provides strategies to manage it."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of stimulant laxatives.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No stimulant laxatives (e.g., senna, bisacodyl) are mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of osmotic laxatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Osmotic laxatives such as polyethylene glycol, magnesium citrate, and lactulose are specifically listed."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of stool softeners.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Stool softeners (docusate) are explicitly mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that a combination of these treatments is sometimes needed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state that a combination approach may be necessary."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that there are prescription medications that can directly target opioid-associated constipation.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It states there are prescription medications specifically for opioid-induced constipation and lists examples."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend hydration to improve constipation.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It advises increasing fluid intake to help with constipation."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend physical activity to improve constipation.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It recommends gentle movement or light walking as tolerated."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that opioid-induced constipation is primarily due to reduced gut motility, and agents that increase water content or stimulate peristalsis directly address the underlying pathophysiology.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No explanation of the pathophysiology (reduced gut motility) or how treatments address it is provided."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that the American Gastroenterological Association recommends polyethylene glycol (PEG) and lactulose as effective osmotic agents, both of which significantly improve stool consistency and frequency compared to placebo.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to AGA recommendations or comparative efficacy versus placebo is included."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that soluble fiber may be considered only for patients with fiber-deficient diets, as it has limited efficacy in opioid-induced constipation due to its lack of effect on colonic motility.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Fiber is discussed generally, without noting its limited efficacy in opioid-induced constipation or the specific caveat about soluble fiber."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that enemas are reserved for rescue therapy and not for regular use.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Enemas are not mentioned."
      }
    ],
    "question_number": 119,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:37:39.650898",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that meditation and mindfulness can improve quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states that these practices can 'improve quality of life,' satisfying the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that meditation and mindfulness are not anti-cancer treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly labels meditation and mindfulness as 'complementary approaches' that 'should not replace conventional medical treatment,' which communicates they are not anti-cancer treatments."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that meditation and mindfulness can help emotional well-being.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes reductions in 'stress, anxiety, and depression,' directly addressing emotional well-being."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that meditation and mindfulness demonstrate moderate improvements in anxiety, depression, cancer-related fatigue, and overall quality of life in oncology populations, with effects maintained for at least several months post-intervention.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions improvements in anxiety, depression, and quality of life, it does not mention cancer-related fatigue or durability of effects for several months post-intervention."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that meditation and mindfulness are safe, feasible, and can be integrated alongside standard cancer care to help manage both physical and psychological symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response implies integration with standard care and mentions benefits for physical (pain) and psychological symptoms, but it does not explicitly state that these practices are safe and feasible; instead it advises discussing safety with an oncologist without making a general safety/feasibility statement."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It directly recommends discussing mindfulness/meditation with the father's oncologist or healthcare provider first."
      }
    ],
    "question_number": 120,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:38:28.382046",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing their concerns with an oncology nutritionist or dietitian.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises working with a registered dietitian who specializes in oncology or gastrointestinal health to create a personalized plan."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic enzyme supplements can help with digesting food when there is pancreatic enzyme deficiency.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that pancreatic enzyme supplements (e.g., Creon, Pancreaze) are often prescribed to help break down food and should be taken with meals."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that nutrition is important for maintaining strength or energy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It notes maintaining calorie and protein intake is crucial to preserve muscle mass and strength, supporting treatment tolerance and recovery."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that nutrition is important for supporting the immune system.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention is made of nutrition supporting the immune system."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that nutrition is important for maintaining weight.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it discusses weight loss and suggests calorie-dense foods, it does not explicitly state that nutrition is important for maintaining weight."
      },
      {
        "criterion_number": 6,
        "description": "The response should state the reasons for challenges with nutrition in patients with pancreatic cancer, including poor appetite.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It identifies loss of appetite as a common symptom contributing to nutritional challenges."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the reasons for challenges with nutrition in patients with pancreatic cancer, including digestion difficulties.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explains that pancreatic cancer can reduce enzyme production, leading to difficulty absorbing nutrients and digestion problems."
      },
      {
        "criterion_number": 8,
        "description": "The response should state the reasons for challenges with nutrition in patients with pancreatic cancer, including side effects of treatment like nausea.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It mentions nausea as common and notes that treatments can affect digestion and appetite; it also provides strategies for managing nausea."
      },
      {
        "criterion_number": 9,
        "description": "The response should state they should focus on protein intake.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It recommends maintaining adequate protein intake and emphasizes its importance."
      },
      {
        "criterion_number": 10,
        "description": "The response should state they should focus on calorie intake.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It recommends maintaining adequate calories and suggests calorie-dense foods."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend trying to manage nausea.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It offers concrete strategies to manage nausea (bland foods, avoiding strong smells/fatty foods)."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend hydration.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It emphasizes staying hydrated and suggests broths and oral hydration solutions."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that patients with pancreatic cancer undergoing treatment are at high risk of malnutrition, cachexia, and weight loss, necessitating early and ongoing nutritional assessment and intervention.",
        "score_given": 0,
        "max_points": 9,
        "justification": "It mentions weight loss as common but does not identify high risk of malnutrition/cachexia nor emphasize early and ongoing nutritional assessment/intervention."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that dietary strategies should prioritize enteral nutrition over parenteral nutrition when oral intake is inadequate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not discuss enteral versus parenteral nutrition."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that oral nutritional supplements, especially those enriched with omega-3 fatty acids, are beneficial for supporting body weight and lean body mass.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of oral nutritional supplements or omega-3 enriched formulas."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that diet composition should emphasize a plant-enriched diet for overall health and cancer risk reduction.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it mentions well-cooked vegetables and soft fruits as easy-to-digest options, it does not emphasize a plant-enriched diet for overall health or risk reduction."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that current evidence does not support ketogenic diets for treatment.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No discussion of ketogenic diets or evidence regarding their use."
      }
    ],
    "question_number": 121,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:39:25.790041",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that memory issues can be associated with chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states that chemotherapy drugs can cause 'chemo brain' and cognitive impairment, including memory problems."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing memory concerns with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises discussing symptoms with the medical team and specifically mentions bringing it up with the oncology team."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that memory issues can be associated with pain medications.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It notes that opioid pain medications can affect mental clarity and memory."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that memory issues can be associated with poor nutrition.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It mentions malnutrition as a contributor to confusion and memory problems."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that memory issues can be associated with dehydration.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly lists dehydration as a cause of confusion and memory problems."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that memory issues can be associated with anxiety.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It states that anxiety can affect memory and attention."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that memory issues can be associated with depression.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It states that depression can affect memory and attention."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that memory issues can be associated with fatigue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists fatigue as a contributor to cognitive changes."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that memory issues can be associated with stress.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions emotional stress as contributing to cognitive changes."
      },
      {
        "criterion_number": 10,
        "description": "The response should cite peer-reviewed articles with links.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No citations or links to peer-reviewed sources are provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that memory issues in pancreatic cancer patients are frequently related to cancer treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes memory issues could be related to treatment but does not state or imply that they are frequently related."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that biological mechanisms underlying chemotherapy-induced cognitive changes include direct neurotoxic effects of chemotherapy, neuroinflammation, changes in brain structure and connectivity, and involvement of specific biomarkers and genetic predispositions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mechanisms such as neurotoxicity, neuroinflammation, structural/functional brain changes, biomarkers, or genetic predispositions are discussed."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that cognitive impairment may also be influenced by the cancer itself, paraneoplastic effects, and other factors such as age, comorbidities, and emotional distress.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it mentions the cancer itself and emotional factors, it does not mention paraneoplastic effects, age, or comorbidities."
      }
    ],
    "question_number": 122,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:40:12.193097",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define ablative techniques in the context of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly defines ablation as destroying tumor tissue and applies it to pancreatic cancer, including rationale and goals."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that ablative techniques in pancreatic cancer are used when surgery isn\u2019t possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States these are considered when surgery is risky/not feasible or patients are not surgical candidates."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including radiofrequency ablation (RFA).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes RFA with mechanism (heat via electrical current) and image guidance."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including microwave ablation (MWA).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes microwave ablation as heating tissue to destroy tumor cells."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that ablative techniques are not curative.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states they are not a cure for advanced pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that ablative techniques in pancreatic cancer are used to manage symptoms.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States they may help with symptom relief and extending life."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including cryoablation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cryoablation is not mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that these techniques are typically considered after or in conjunction with systemic chemotherapy, which remains the first-line treatment for locally advanced pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of systemic chemotherapy as first-line or sequencing with ablation."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including irreversible electroporation (IRE).",
        "score_given": 0,
        "max_points": 5,
        "justification": "IRE is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including high-intensity focused ultrasound (HIFU).",
        "score_given": 0,
        "max_points": 5,
        "justification": "HIFU is not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that RFA delivers thermal energy via a probe to induce coagulative necrosis of tumor cells. RFA can be performed percutaneously, surgically, or via endoscopic ultrasound (EUS) guidance.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mentions thermal destruction via a needle but does not mention coagulative necrosis or that RFA can also be performed surgically or via EUS."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that RFA is the most studied thermal technique and has demonstrated feasibility and safety, with some evidence of improved survival and immune modulation.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No discussion of RFA evidence base, safety/feasibility, survival, or immune effects."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that MWA uses electromagnetic waves to generate heat and destroy tumor tissue.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States MWA uses microwaves to heat and destroy tissue; microwaves are electromagnetic waves."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that MWA is emerging as an alternative to RFA, with potential advantages in speed and ablation volume, but clinical data remain limited.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not compare MWA to RFA or discuss advantages or data limitations."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that IRE is a non-thermal technique that uses high-voltage electrical pulses to create permanent nanopores in cell membranes, leading to apoptosis.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of IRE or its mechanism."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that IRE is particularly attractive for tumors near critical structures, as it spares connective tissue and vessels. It is increasingly used in locally advanced pancreatic cancer and is under investigation in randomized trials.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of IRE\u2019s tissue-sparing properties, indications, or clinical trial status."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that HIFU delivers focused ultrasound waves to induce thermal and mechanical destruction of tumor cells.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of HIFU or its mechanism."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that HIFU is less commonly used but has shown feasibility in clinical studies.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No discussion of HIFU feasibility or usage frequency."
      },
      {
        "criterion_number": 19,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages discussion with the medical team and references the husband\u2019s oncology team."
      }
    ],
    "question_number": 123,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:41:24.904924",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends that the patient or family discuss goals of care (e.g., treatment goals, quality of life preferences, advanced care planning) with their oncologist or oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response encourages open communication with the medical team and includes an 'Advance Care Planning' section, it does not explicitly direct discussing goals of care with the oncologist/oncology team. The goals-of-care conversation is not clearly linked to the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing symptom management (e.g., pain, nausea, fatigue) with the oncology team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states, 'Discuss any symptoms or side effects promptly with the medical team; sometimes, medications or adjustments can help manage them,' which directly addresses discussing symptom management with the care team."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly includes information about palliative care (e.g., mentions \u201cpalliative care,\u201d \u201csupportive care,\u201d or \u201cpalliative care specialists\u201d as a resource for symptom or quality of life management).",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends referral to 'a palliative care or pain management specialist' and explains that 'Palliative care focuses on quality of life and can be provided alongside active treatment.'"
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly states or clearly implies that mental health professionals (e.g., counselor, psychologist, psychiatrist, mental health provider) can help patients deal with the emotional or psychological burden of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises, 'Consider involving a therapist or counselor who specializes in cancer care,' directly acknowledging the role of mental health professionals."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends discussing side effect management (e.g., side effects of treatment, managing adverse effects) with the oncology team or oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response says, 'Discuss any symptoms or side effects promptly with the medical team,' which explicitly covers side effect management with the care team."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that pancreatic cancer is an aggressive malignancy associated with a high symptom burden, including pain, gastrointestinal symptoms, fatigue, and significant psychological distress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although the response lists common symptoms (pain, nausea, fatigue, loss of appetite, mood changes), it does not explicitly characterize pancreatic cancer as an aggressive malignancy with a high symptom burden."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that palliative care is not synonymous with hospice; rather, it is an active, multidisciplinary approach to symptom management and psychosocial support that can be provided at any stage of disease, including during active cancer-directed therapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "The response notes that palliative care can be provided alongside active treatment, but it does not explicitly distinguish it from hospice nor emphasize the multidisciplinary nature and psychosocial support aspects."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that multidisciplinary collaboration can impact quality of life during treatment of pancreatic cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It references multiple disciplines (oncology team, palliative care/pain specialists, registered dietitian, speech-language pathologist, therapist/counselor), implying that collaborative, multidisciplinary care supports quality of life."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that advance care planning can impact quality of life during treatment of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The 'Advance Care Planning' section explicitly discusses conversations about goals, preferences, and values to guide decisions and reduce anxiety, indicating its positive impact on quality of life."
      }
    ],
    "question_number": 124,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:42:13.802993",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include the Pancreatic Cancer Action Network (PanCAN) as a major pancreatic cancer advocacy organization.",
        "score_given": 10,
        "max_points": 10,
        "justification": "PanCAN is explicitly named, linked, and described as a major U.S. organization with advocacy programs."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing advocacy options with their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response suggests reaching out to organizations but does not advise discussing advocacy options with the oncology team or care team."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that PanCAN is a leading national organization dedicated to patient advocacy, support, research funding, and public policy initiatives for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response calls PanCAN the largest U.S. nonprofit and notes advocacy and research funding, it does not explicitly mention public policy initiatives and does not clearly state all four elements together."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that PanCAN offers structured opportunities for patients and families to engage in advocacy, including legislative outreach, awareness campaigns, and peer support programs such as the Patient and Liaison Services (PALS) program.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It references advocacy activities and awareness events generally and for PanCAN, but does not explicitly tie legislative outreach to PanCAN and does not mention PALS or peer support programs."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the American Society of Clinical Oncology\u2019s patient-facing website, Cancer.Net, provides information on advocacy opportunities and connects patients to broader cancer advocacy networks.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Cancer.Net is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that both PanCAN and Cancer.Net are specifically recommended by the American Society of Clinical Oncology in its clinical practice guidelines as key resources for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention of ASCO\u2019s clinical practice guidelines or that they recommend PanCAN and Cancer.Net."
      }
    ],
    "question_number": 125,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:42:51.222011",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly notes that surgery depends on the stage, stating surgery is more likely if the cancer is localized and hasn't spread, indicating stage-dependent treatment decisions."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include surgery.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It states, \"Even if surgery is an option, it's often just one part of a comprehensive treatment plan,\" clearly describing multimodality care that includes surgery."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include chemotherapy.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Chemotherapy is listed as part of the comprehensive treatment plan."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include radiation.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Radiation therapy is included among treatment options and within a multimodality context."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that chemotherapy can be used before or after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states, \"Chemotherapy: Often used before or after surgery.\""
      },
      {
        "criterion_number": 6,
        "description": "The response should state that pancreatic cancer management should involve a multidisciplinary team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends consultation with a multidisciplinary team including surgical, medical, and radiation oncologists, among others."
      },
      {
        "criterion_number": 7,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe the Whipple procedure.",
        "score_given": 0,
        "max_points": 4,
        "justification": "It names the Whipple procedure as common for tumors in the head of the pancreas but does not describe the procedure or list other surgical types, falling short of the required description."
      },
      {
        "criterion_number": 8,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe distal pancreatectomy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Distal pancreatectomy is not mentioned or described."
      },
      {
        "criterion_number": 9,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe total pancreatectomy.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Total pancreatectomy is not mentioned or described."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that surgical resection is the only potentially curative option for pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "The response does not state that surgery is the only potentially curative option."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that deciding on surgery requires multidisciplinary evaluation and mention anatomical, biological, or patient factors.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists factors affecting surgery candidacy (tumor location, stage, overall health, tumor biology) and recommends consulting a multidisciplinary team, satisfying both elements."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises working closely with the oncology team, asking the oncologist for referral to a multidisciplinary team, and seeking a second opinion."
      }
    ],
    "question_number": 126,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:43:44.380535",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions that prognosis varies by stage but does not state that treatment decisions depend on stage."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the treatment of pancreatic cancer depends on the location of the cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention that tumor location (head vs body/tail or vascular involvement) influences treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes surgery.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although surgery is listed as a potential option, the response does not state that treatment is multimodality."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Chemotherapy is listed as a potential option, but the response does not state that treatment is multimodality."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes radiation.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Radiation therapy is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that early, multidisciplinary management is essential to optimize outcomes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit mention of early multidisciplinary management or coordination among a care team (surgery, medical oncology, radiation oncology, gastroenterology, palliative care)."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that care is best coordinated at high-volume centers with expertise in pancreatic malignancies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "High-volume or specialized centers are not referenced."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that symptom management is an important part of the care of patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Supportive presence and practical help are mentioned, but symptom management (pain control, nutrition, biliary obstruction, etc.) is not discussed."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe the basics of pancreatic cancer, including that the most common type is pancreatic adenocarcinoma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of pancreatic cancer subtypes or that adenocarcinoma is most common."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe how pancreatic cancer is staged based on the NCCN guidelines (version 2.2025)...",
        "score_given": 0,
        "max_points": 2,
        "justification": "No TNM/AJCC staging details are provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pancreatic cancer is an aggressive malignancy with a poor prognosis, often presenting at an advanced stage.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response avoids prognostic statements beyond noting variability; it does not state that pancreatic cancer is aggressive with generally poor prognosis."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend writing down questions in advance to ensure that all concerns are addressed during consultations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises writing down questions ahead of appointments and provides examples."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that advocacy for comprehensive testing is important, including somatic and germline genetic testing.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of somatic tumor profiling or germline genetic testing."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to inquire about clinical trial opportunities, as participation may provide access to novel therapies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Clinical trials are not mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that cancer.net and the Pancreatic Cancer Action Network (pancan.org) provide high-quality information, support services, and advocacy opportunities.",
        "score_given": 0,
        "max_points": 7,
        "justification": "PanCAN is cited, but cancer.net is not mentioned; criterion requires both."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests asking about specialists and seeking second opinions but does not explicitly recommend consulting an oncologist."
      }
    ],
    "question_number": 127,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:44:42.363401",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that pancreatic neuroendocrine tumors (pNETs) are usually sporadic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states that most cases are sporadic (not inherited)."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that pancreatic neuroendocrine tumors (pNETs) do tend to have a genetic component in a significant minority of cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that a subset have a genetic basis and cites a 10\u201330% figure for identifiable genetic causes."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that some cases of pancreatic neuroendocrine tumors (pNETs) are associated with hereditary syndromes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states association with hereditary syndromes and lists multiple examples."
      },
      {
        "criterion_number": 4,
        "description": "The response should include multiple endocrine neoplasia type 1 (MEN1).",
        "score_given": 3,
        "max_points": 3,
        "justification": "MEN1 is named and described as the most common hereditary syndrome associated with pNETs."
      },
      {
        "criterion_number": 5,
        "description": "The response should include von Hippel-Lindau disease (VHL).",
        "score_given": 3,
        "max_points": 3,
        "justification": "VHL is explicitly listed among syndromes linked to pNETs."
      },
      {
        "criterion_number": 6,
        "description": "The response should include neurofibromatosis type 1 (NF1).",
        "score_given": 3,
        "max_points": 3,
        "justification": "NF1 is included as a rare syndrome associated with pNETs."
      },
      {
        "criterion_number": 7,
        "description": "The response should include tuberous sclerosis complex (TSC).",
        "score_given": 3,
        "max_points": 3,
        "justification": "TSC is named as a rare genetic disorder that can increase the risk of pNETs."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that genetic testing is available for pancreatic neuroendocrine tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly says genetic testing is available and describes blood/saliva and tumor testing."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that they have concerns about the risk of cancer, they should talk with a genetic counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises discussing genetic testing with a genetic counselor and emphasizes their role."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that approximately 10\u201317% of pancreatic neuroendocrine tumors (pNETs) are associated with inherited syndromes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It gives a broader 10\u201330% estimate for identifiable genetic causes and does not state the specific 10\u201317% figure for inherited syndromes."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that these inherited syndromes often present at a younger age.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that genetic causes are more likely in younger patients."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that germline mutations are also found in sporadic-appearing pancreatic neuroendocrine tumors (pNETs), including mutations in DNA repair genes such as MUTYH, CHEK2, and BRCA2, as well as MEN1 and VHL.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention germline mutations in sporadic-appearing cases nor DNA repair genes MUTYH, CHEK2, or BRCA2; it only cites tumor-related genes (DAXX, ATRX) and MEN1 without the germline context."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that multigene panel testing is recommended, as it can identify both syndromic and non-syndromic germline variants relevant for familial risk assessment.",
        "score_given": 0,
        "max_points": 6,
        "justification": "It discusses genetic testing generally but does not mention or recommend multigene panel testing or its value for identifying both syndromic and non-syndromic germline variants."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the user discuss this case with a medical professional.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It recommends discussing with a genetic counselor or specialist in neuroendocrine tumors, which fulfills the criterion."
      }
    ],
    "question_number": 128,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:45:17.237801",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions the Pancreatic Cancer Action Network (PanCAN) as a source for survivor stories.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists 'Pancreatic Cancer Action Network (PanCAN) \u2013 Patient Stories' with a link as a source for narratives."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends asking the oncology team for additional support group recommendations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests joining support groups, it does not advise asking the oncology team for recommendations."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions Cancer Support Community (CSC) as a resource for support or survivor stories.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'Cancer Support Community \u2013 Inspiration Stories' with a link."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions Let\u2019s Win! Pancreatic Cancer survivor stories.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not reference Let\u2019s Win! Pancreatic Cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions the American Society of Clinical Oncology\u2019s patient-facing website (www.cancer.net) as a source for stories of hope.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention ASCO\u2019s Cancer.Net."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions that organizations provide patient and survivor stories, peer support networks, and opportunities to connect with others who have faced similar diagnoses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Cites organizations that offer stories (ACS, PanCAN) and recommends support groups (CancerCare, PanCAN, Inspire) that connect people with similar experiences."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that peer support and shared experiences are recognized as powerful tools for maintaining motivation and a sense of hope during the cancer journey.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that many find strength and hope through others' stories and that support groups help share stories of hope, emphasizing the value of peer support and shared experiences."
      }
    ],
    "question_number": 129,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:45:46.912172",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define stage IV pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response references stage IV but does not define it as metastatic disease with distant spread."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that the disease is not curable.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that these treatments do not cure stage IV disease."
      },
      {
        "criterion_number": 3,
        "description": "The response should include the goal of treatment is to control the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states chemotherapy can help control the cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should include the goal of treatment to improve symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly mentions that treatments can relieve symptoms and includes multiple symptom-management strategies."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the cornerstone of treatment for stage IV pancreatic cancer is systemic chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Chemotherapy is presented as the most common treatment approach for stage IV disease, implying it is the mainstay/systemic cornerstone."
      },
      {
        "criterion_number": 6,
        "description": "The response should include chemotherapy regimens listed in NCCN guidelines (version 2.2025) for treatment of metastatic pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists FOLFIRINOX and gemcitabine plus nab-paclitaxel (Abraxane), which are NCCN-recommended regimens, though it also mentions CAPEOX, which is not standard for pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should discuss that clinical trials are another option.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly recommends clinical trials and provides resources (clinicaltrials.gov and PanCAN)."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that there may be targeted treatments based on genetic mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes targeted therapies may be options if specific mutations are present."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend the tumor have genetic testing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises asking the oncologist about testing for biomarkers and mentions genetic testing of the tumor."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that early palliative care referral is recommended at diagnosis to optimize symptom management, psychological support, and advance care planning.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it endorses palliative care at any stage, it does not explicitly recommend early referral at diagnosis or tie it to optimizing psychological support and advance care planning."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that aggressive symptom management, such as management of pain, fatigue, nausea, and gastrointestinal symptoms is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes active management of pain, fatigue, and GI issues (nutrition/enzyme support). Although nausea is not named, symptom control is clearly highlighted."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that pancreatic enzyme replacement therapy should be considered for exocrine insufficiency, and nutritional support is important for maintaining weight and strength.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions pancreatic enzyme supplementation and working with a dietitian to address nutrition and weight loss."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that psychosocial support, including counseling and peer support, is critical for both patients and families.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends counseling, support groups, and involving social work for patients and families."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises care by a multidisciplinary team, seeking second opinions at specialized centers, and asking the oncologist about testing."
      }
    ],
    "question_number": 130,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:47:03.159086",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that management of pancreatic tumors involves a multidisciplinary team of surgeons, medical oncologists, and radiation oncologists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that the best care comes from a team approach including surgeons, medical and radiation oncologists."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that outcomes are significantly improved when care is delivered by a multidisciplinary team at high-volume centers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes that high volume correlates with better outcomes and separately emphasizes multidisciplinary team care as best practice, meeting the intent of improved outcomes with team-based care at high-volume centers."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information for the Pancreatic Cancer Action Network (PanCAN).",
        "score_given": 3,
        "max_points": 3,
        "justification": "PanCAN is recommended and a direct link (https://www.pancan.org/) is provided."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide information for the American Cancer Society (ACS).",
        "score_given": 3,
        "max_points": 3,
        "justification": "It includes a link to the American Cancer Society page on finding cancer specialists."
      },
      {
        "criterion_number": 5,
        "description": "The recommendation should provide a link to the NCI website for finding an NCI-designated cancer center.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It links to the NCI doctor database, not the NCI-designated cancer center finder page."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that high-volume centers\u2014defined as institutions performing at least 15 pancreatic resections annually\u2014demonstrate superior survival rates, lower postoperative morbidity, improved lymphadenectomy, shorter hospital stays, and better access to adjuvant therapies.",
        "score_given": 0,
        "max_points": 8,
        "justification": "It mentions that high volume correlates with better outcomes but does not define \u226515 resections/year or list the specific outcome advantages."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that high-volume centers are typically academic medical centers, National Cancer Institute-designated cancer centers, or hospitals with established pancreatic cancer programs.",
        "score_given": 0,
        "max_points": 8,
        "justification": "It does not characterize high-volume centers as academic/NCI-designated or established pancreatic cancer programs."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to request referrals from local oncologists or primary care providers, who can direct patients to high-volume centers and experienced teams.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises asking the primary care physician and local oncologists for recommendations."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends getting a second opinion for pancreatic cancer and consulting local oncologists, which constitutes advising discussion with an oncologist."
      }
    ],
    "question_number": 131,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:47:52.120862",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly states that some chemotherapy can have negative effects on the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that chemotherapy can affect the heart and that some chemotherapy drugs are more cardiotoxic."
      },
      {
        "criterion_number": 2,
        "description": "The response specifically mentions that 5-fluorouracil (or \u201c5-FU\u201d) can harm the heart.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Explicitly lists 5-fluorouracil among more cardiotoxic drugs."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends monitoring for shortness of breath.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes shortness of breath as a symptom to monitor and flags sudden shortness of breath for urgent care."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends monitoring for chest pain.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists chest discomfort/pain as a symptom to note and includes chest pain in the emergency warning signs."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends monitoring for fast heart rate.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions rapid or irregular heartbeat and palpitations as symptoms to monitor."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends monitoring for dizziness.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists dizziness under arrhythmias and blood pressure changes."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends monitoring for unusual fatigue.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically calls out fatigue or weakness and advises attention if new or severe."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly recommends discussing any new symptom with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises sharing new/worsening symptoms with the 'care team' and having open communication with oncology/cardiology, but does not explicitly state to discuss any new symptom with the oncology team."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly recommends discussing any concerning symptom with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Recommends emergency care for severe symptoms and communication with care teams, but does not explicitly direct discussing concerning symptoms with the oncology team."
      },
      {
        "criterion_number": 10,
        "description": "The response states that electrocardiograms can be used to monitor the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically recommends an electrocardiogram (ECG/EKG) to detect arrhythmias."
      },
      {
        "criterion_number": 11,
        "description": "The response states that echocardiogram can be used to monitor heart function.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends regular echocardiograms to check ejection fraction and mentions echo before and during treatment."
      },
      {
        "criterion_number": 12,
        "description": "The response states that blood pressure can be used to monitor the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends regular blood pressure checks for hypertension or hypotension."
      },
      {
        "criterion_number": 13,
        "description": "The response specifically mentions that capecitabine can harm the heart.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Capecitabine is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response specifically mentions that some targeted therapies can harm the heart.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Mentions trastuzumab (a targeted therapy) as part of regimens that are more cardiotoxic."
      },
      {
        "criterion_number": 15,
        "description": "The response explicitly states that pancreatic cancer treatments can cause at least three cardiac issues: heart failure, arrhythmias, hypertension, ischemia, or cardiomyopathy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Explicitly names arrhythmias and hypertension; other conditions (heart failure/cardiomyopathy/ischemia) are implied by symptoms but not explicitly stated."
      },
      {
        "criterion_number": 16,
        "description": "The response explicitly states that the risk of cardiac side effects is higher in patients with preexisting cardiovascular conditions or those receiving specific agents such as anthracyclines or fluoropyrimidines.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes higher concern with anthracyclines and 5-FU and suggests cardiology involvement especially with a history of heart disease or risk factors."
      },
      {
        "criterion_number": 17,
        "description": "The response explicitly recommends baseline cardiac risk assessment and regular monitoring with echocardiography, cardiac biomarkers, and clinical evaluation for early/asymptomatic cardiac dysfunction.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions echo before/during treatment and biomarkers (BNP, troponin), but does not explicitly recommend a baseline cardiac risk assessment or emphasize early/asymptomatic dysfunction evaluation."
      },
      {
        "criterion_number": 18,
        "description": "The response explicitly references recommendations from the American College of Cardiology and/or the American Society of Clinical Oncology, stating that pretherapy evaluation and ongoing surveillance are recommended for patients with cardiovascular risk factors or those receiving cardiotoxic agents.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of ACC or ASCO recommendations."
      },
      {
        "criterion_number": 19,
        "description": "The response explicitly recommends that the user discuss the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussing treatment options with the oncologist and maintaining open communication with the oncology team."
      }
    ],
    "question_number": 132,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:49:00.439402",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include that treatment decisions are personal decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that deciding about treatment is deeply personal and reiterates that the decision is ultimately the patient's."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend listening to their feelings.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises encouraging open conversations and to listen without judgment to feelings, fears, hopes, and goals."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend validating their feelings.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically instructs to validate their emotions."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend respecting their autonomy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Clearly states the decision is theirs and emphasizes supporting their autonomy and avoiding pressure."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend supporting their quality of life.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Recommends palliative care and hospice, both focusing on comfort and quality of life, and aligning care with what matters most to the patient."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend offering reassurance.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages offering emotional support and conveys reassuring messages (e.g., 'You\u2019re not alone'), guiding the caregiver to provide comfort."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that clear, compassionate communication about prognosis, treatment options, and goals of care is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes open and honest communication, checking understanding of diagnosis and treatment options, discussing goals of care, and clarifying expected outcomes of stopping treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that transitioning to hospice care may be appropriate when the focus shifts entirely to comfort and dignity.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Advises discussing hospice if stopping treatment and describes hospice focus on comfort and quality of life, indicating appropriateness when comfort is the priority."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that hospice provides intensive symptom management, psychosocial and spiritual support, and home-based care, while avoiding non-beneficial interventions such as hospitalization or aggressive procedures.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions hospice focus on comfort but does not specify intensive symptom management, psychosocial/spiritual support within hospice, home-based care, or avoidance of non-beneficial interventions."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention addressing practical issues related to end-of-life decision-making, such as managing costs and accessing resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends connecting with social workers or patient navigators for practical needs and provides resource links, addressing practical support and access to resources."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly advises involving the oncology team and consulting the healthcare team including physicians and palliative care specialists."
      }
    ],
    "question_number": 133,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:49:35.300048",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing legal planning with a qualified professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises consulting a qualified attorney and, in Next Steps, recommends an elder law or estate planning attorney to draft documents."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that laws can vary state to state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes advice should be tailored to 'local laws,' which conveys jurisdictional (state-by-state) variation."
      },
      {
        "criterion_number": 3,
        "description": "The response should include a description of an advance healthcare directive or living will.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a section on Advance Healthcare Directive/Living Will with purpose and examples (life-sustaining treatment, palliative care, organ donation)."
      },
      {
        "criterion_number": 4,
        "description": "The response should include a description of a medical power of attorney.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes appointing a Healthcare Proxy/Medical Power of Attorney to make medical decisions on one\u2019s behalf."
      },
      {
        "criterion_number": 5,
        "description": "The response should include a description of a durable power of attorney for finances.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains Financial Power of Attorney, including Durable and Springing types, for managing finances if incapacitated."
      },
      {
        "criterion_number": 6,
        "description": "The response should include a description of a last will and testament.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes a Last Will and Testament section describing asset distribution, executor appointment, and guardianship for minors."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that POLST forms translate preferences into actionable medical orders for emergency settings.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of POLST or Physician Orders for Life-Sustaining Treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that these documents ensure that care aligns with the patient\u2019s values and preferences, especially if the patient loses decision-making capacity due to disease progression or treatment effects.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that an advance directive outlines wishes for medical treatment if unable to communicate/make decisions, which ensures care aligns with the patient\u2019s preferences during incapacity."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that it is essential to have ongoing, structured conversations about goals of care, as patient preferences may change over time.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Advises discussing wishes and values together and to review/update documents regularly as circumstances or wishes change, indicating ongoing conversations as preferences evolve."
      }
    ],
    "question_number": 134,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:50:17.163510",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing their concerns with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises, \"Ask your oncologist or pharmacist about these programs,\" which recommends engaging the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing their concerns with a social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly says, \"Speak with Your Hospital Social Worker,\" and describes how they can help with financial assistance navigation."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend discussing their concerns with a financial counselor.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions the hospital's financial services/patient advocacy department, it does not explicitly recommend speaking with a financial counselor."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that patient advocacy organizations can help and include information on the Pancreatic Cancer Action Network (PanCAN).",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists PanCAN with a brief description and website link (pancan.org), indicating advocacy support."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that patient advocacy organizations can help and include information on CancerCare.org.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It includes CancerCare with services described and contact details (cancercare.org and phone)."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that patient advocacy organizations can help and include information for the American Cancer Society.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It includes the American Cancer Society with types of assistance and contact info (cancer.org and phone)."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that patients with pancreatic cancer who are facing significant medical bills have access to several financial assistance options.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It states there are several types of financial assistance available for those facing high medical bills and frames the discussion in the context of pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that financial assistance options include patient assistance programs (PAPs) from independent charity foundations, pharmaceutical company programs, and direct grants from nonprofit organizations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions pharmaceutical manufacturer assistance programs and nonprofit aid but does not mention independent charity foundation PAPs."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that these programs may provide co-payment assistance, help with insurance premiums, and sometimes support for non-medical expenses such as transportation or housing.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes assistance with copays and transportation (and home care), but does not mention help with insurance premiums or housing."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that eligibility is generally based on annual household income (often up to 400\u2013500% of the federal poverty level), insurance status, and physician endorsement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not describe general eligibility criteria such as FPL thresholds, insurance status, or physician endorsement for assistance programs."
      }
    ],
    "question_number": 135,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:51:01.707281",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe PARP inhibitors as a class of targeted agents that block the PARP enzyme, which is involved in repairing single-strand DNA breaks.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response correctly states that PARP inhibitors are targeted therapies that block the PARP enzyme involved in DNA repair, but it does not specify that PARP repairs single-strand DNA breaks, which is required by the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that PARP inhibitors can be used in advanced pancreatic cancer when there is a germline mutation in a BRCA gene.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response mentions BRCA1/2 mutations in pancreatic cancer, it does not specify germline mutations nor explicitly state their use in advanced pancreatic cancer; it frames use as being studied or via clinical trials."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that PARP inhibitors are used as maintenance therapy in patients with metastatic pancreatic cancer who have a germline BRCA1 or BRCA2 mutation and whose cancer has not progressed after at least 16 weeks of first-line platinum-based chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses maintenance therapy in other cancers and notes trials in pancreatic cancer but does not describe the specific approved maintenance indication (metastatic, germline BRCA1/2, no progression after \u226516 weeks of platinum-based chemotherapy)."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that comprehensive germline testing for BRCA mutations is recommended for all patients with pancreatic cancer to identify those eligible for this targeted approach.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response suggests asking if the tumor was tested for BRCA or DNA repair gene mutations but does not mention comprehensive germline testing recommended for all pancreatic cancer patients."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the American Society of Clinical Oncology specifically recommends olaparib, based on the POLO trial, which demonstrated a significant improvement in progression-free survival compared to placebo, without compromising quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of ASCO guidance, the POLO trial, progression-free survival benefit, or quality-of-life findings."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that other PARP inhibitors and combination strategies are under investigation, but their use remains investigational at this time. Based on the NCCN Guidelines Version 2.2025: Principles of Systemic Therapy for Pancreatic Adenocarcinoma (Metastatic Disease, First-Line Therapy) across performance status groups. For Good PS (0\u20131), preferred regimens include FOLFIRINOX (category 1 or modified FOLFIRINOX), Gemcitabine + albumin-bound paclitaxel (category 1), and NALIRIFOX (category 1). For patients with BRCA1/2 or PALB2 mutations, preferred options are FOLFIRINOX (category 1 or modified FOLFIRINOX) and Gemcitabine + cisplatin (category 1). Other recommended regimens include Gemcitabine (category 1), Gemcitabine + erlotinib (category 1), Gemcitabine + capecitabine, Gemcitabine + albumin-bound paclitaxel + cisplatin, Fluoropyrimidine + oxaliplatin, CapeOx (category 2B), OFF (category 2B), and GTX (category 2B). For Intermediate PS (2), preferred regimens include Gemcitabine + albumin-bound paclitaxel (category 1), Capecitabine, Gemcitabine, 5-FU + leucovorin + oxaliplatin (FOLFOX), 5-FU + leucovorin + irinotecan (FOLFIRI), and CapeOx. For Poor PS (3), Palliative and best supportive care is recommended, though options include Capecitabine (category 2B), continuous infusion 5-FU (category 2B), and Gemcitabine (standard or fixed-dose-rate infusion). Across all PS groups, therapies useful in certain circumstances include targeted agents: Entrectinib, Larotrectinib, and Repotrectinib (for NTRK gene fusion\u2013positive tumors); Pembrolizumab (for MSI-H, dMMR, or TMB-H \u226510 mut/Mb); Selpercatinib (for RET gene fusion\u2013positive tumors); and Dabrafenib + trametinib (for BRAF V600E mutation\u2013positive cases). The guidelines note that all regimens are category 2A unless otherwise indicated, and patients with poor PS derive marginal benefit from systemic therapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "The response notes that PARP inhibitors are under study and lists examples, but it does not reference that their broader use remains investigational nor does it mention the NCCN Version 2.2025 systemic therapy recommendations across performance status groups."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises that use should be guided by a specialist and encourages the user to ask their oncology team specific questions, which constitutes a clear recommendation to discuss with an oncologist."
      }
    ],
    "question_number": 136,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:51:38.013282",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend considering proximity to the treatment center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly addresses proximity under 'Distance and Logistics' with 'Proximity to Home: Consider how far you'd be moving...'."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend considering housing options near the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions 'Housing: Availability and cost of housing near the cancer center' and 'Consider Temporary Moves' with temporary housing options."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend considering transportation to and from the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'Transportation Access: Is the cancer center easily accessible by car, public transportation, or both?' and 'Travel Burden' considerations."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend considering financial considerations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Contains a dedicated 'Insurance and Cost' section and a 'Practical Steps' item to evaluate financial impact and meet with a financial counselor."
      },
      {
        "criterion_number": 5,
        "description": "The response should include insurance coverage.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Advises checking insurance coverage for out-of-network care, travel, lodging, and experimental treatments."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend considering the social support system near the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses 'Support Network: Will you have family or friends nearby?' and mentions support services like counseling and support groups."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide information for the Pancreatic Cancer Action Network (PanCAN) Patient services.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists 'Pancreatic Cancer Action Network (PanCAN)' with description and website 'pancan.org'."
      },
      {
        "criterion_number": 8,
        "description": "The response should provide information for the American Cancer Society (ACS) page on finding a doctor.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes 'American Cancer Society: Offers guidance on finding cancer care and support (cancer.org)'."
      },
      {
        "criterion_number": 9,
        "description": "The recommendation should provide a link to the NCI website for finding an NCI-designated cancer center.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions 'National Cancer Institute (NCI)' and 'cancer.gov' generally, but does not provide a specific link to the NCI-designated cancer center finder."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that the NCCN Panel (version 2.2025) recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not reference NCCN, version 2.2025, high-volume centers, or high-volume imaging recommendations explicitly."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly mentions patient preferences, goals of care, or quality of life as central to the decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a 'Quality of Life' section addressing environment, safety, and community fit, emphasizing QoL in decision-making."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly addresses open communication about expectations, prognosis, or the impact of relocation on daily life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises consulting the current oncologist about benefits of moving and discusses daily-life impacts (schools, employment, community)."
      },
      {
        "criterion_number": 13,
        "description": "The response explicitly mentions continuity of care, transferring medical records, coordinating with the current care team, or ensuring uninterrupted access to medications/supportive services.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not mention transferring records, continuity of care logistics, or ensuring uninterrupted medications/supportive services."
      },
      {
        "criterion_number": 14,
        "description": "The response explicitly mentions access to multidisciplinary care and/or clinical trials as important factors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights 'multidisciplinary teams' and 'Clinical Trials Access' under 'Quality and Specialization of Care'."
      },
      {
        "criterion_number": 15,
        "description": "The response explicitly recommends discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'Consult Your Current Oncologist' to get input on benefits of moving."
      }
    ],
    "question_number": 137,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:52:14.188973",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing the anxiety with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises open communication with the healthcare team about fears and concerns and having questions answered; this reasonably encompasses the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response should include considering relaxation techniques prior to the scan.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly recommends deep breathing, guided imagery, and progressive muscle relaxation before and during the scan."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend asking the oncology team about what will happen during the scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests learning what the scan involves and encourages asking the healthcare team questions, which covers asking about what will happen during the scan."
      },
      {
        "criterion_number": 4,
        "description": "The response should include talking to a mental health professional.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends reaching out to a therapist or counselor, noting cancer center psychologists and counseling resources."
      },
      {
        "criterion_number": 5,
        "description": "The response should include talking to a social worker.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It specifically mentions hospital social workers who can offer support."
      },
      {
        "criterion_number": 6,
        "description": "The response should discuss medical interventions to help with anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No pharmacologic or medical interventions (e.g., anxiolytics, premedication) are discussed."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly states that severe anxiety related to upcoming scans is highly prevalent or very common among patients with pancreatic cancer or cancer in general.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It normalizes anxiety but does not explicitly state high prevalence or that severe anxiety is common."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly mentions at least two of the following resource types for managing treatment-related anxiety: psychotherapy, psychoeducation, supportive therapy, or integrative modalities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends psychotherapy (therapist/counselor) and integrative modalities (mindfulness, guided imagery, relaxation). It also includes educational preparation (psychoeducation)."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly identifies Cognitive Behavioral Therapy (CBT) as the first-line or primary intervention for treatment-related anxiety in pancreatic cancer or cancer patients, and attributes this recommendation to a major oncology guideline.",
        "score_given": 0,
        "max_points": 6,
        "justification": "CBT and guideline attribution are not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly mentions mindfulness-based interventions (MBIs) or mindfulness-based stress reduction (MBSR) as recommended for anxiety in cancer patients, and attributes this recommendation to a major oncology guideline.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mindfulness is mentioned, but not MBIs/MBSR nor guideline attribution."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly states that pharmacologic therapy may be considered for severe anxiety or when first-line psychological interventions are insufficient, and that this is a secondary option with weaker evidence, as per a major oncology guideline.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of pharmacologic therapy or its secondary role per guidelines."
      }
    ],
    "question_number": 138,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:52:58.961600",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include open communication with the family.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicit section on 'Open Communication' with guidance on age-appropriate conversations and family meetings to share updates and feelings."
      },
      {
        "criterion_number": 2,
        "description": "The response should include maintaining daily routines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clear recommendations to establish routines, keep regular mealtimes/bedtimes, and maintain daily activities."
      },
      {
        "criterion_number": 3,
        "description": "The response should include continuing to do activities that bring enjoyment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Advises continuing enjoyable activities (e.g., morning walks, family game nights) and 'Create Positive Memories' to build positive experiences."
      },
      {
        "criterion_number": 4,
        "description": "The response should include letting the support system help.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages delegating tasks and accepting help from friends, neighbors, and support groups with examples of practical help (meals, rides, errands)."
      },
      {
        "criterion_number": 5,
        "description": "The response should include ensuring self-care for the patient.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No explicit recommendations for the patient's self-care (e.g., symptom control, rest, nutrition, activity pacing); focuses on family emotional well-being and caregiver self-care."
      },
      {
        "criterion_number": 6,
        "description": "The response should include ensuring self-care for the support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Dedicated 'Self-Care for the Caregiver' section advising breaks and joining caregiver support groups."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that pancreatic cancer imposes profound emotional, social, and practical upheaval on both the patient and family, disrupting established routines, roles, and relationships.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Acknowledges the situation is challenging and normalcy may look different, but does not explicitly describe the profound emotional, social, and practical upheaval or disruption of roles and relationships."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that early integration of supportive and palliative care is recommended.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of early palliative or supportive care integration."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that referrals to registered dietitians and symptom management specialists can help minimize disruptions to family life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No referral recommendations to dietitians or symptom management specialists are included."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that caregiver and family support resources can provide education, emotional support, and practical assistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists ACS, PanCAN, and CancerCare; notes counseling/support groups (emotional support) and information (education). Also ties support groups and community help to practical assistance (meals, rides, errands), indicating resources can provide practical help."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the literature notes persistent gaps in support for caregivers and families affected by pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of evidence or literature about gaps in caregiver/family support."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not advise discussing strategies with the treating oncologist."
      }
    ],
    "question_number": 139,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:53:44.952707",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing genetic counseling with the oncology team or healthcare provider in the context of pancreatic cancer care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises speaking with the oncologist or primary care provider for a referral to a genetic counselor experienced in pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should accurately describe the role of a genetic counselor as a trained professional who helps individuals and families understand the genetic aspects of disease, provides information, guidance, and support for informed decision-making, and assists with risk assessment and testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that genetic counseling helps understand genetic aspects; details risk assessment, testing explanation, informed consent, result interpretation, next steps, and emotional support by trained counselors."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that genetic counseling involves a structured evaluation of personal and family cancer history.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a section on assessing personal and family medical history to identify hereditary patterns."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that genetic counseling involves education about hereditary cancer syndromes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Discusses hereditary risk and genes associated with pancreatic cancer (e.g., BRCA2, PALB2), conveying education about hereditary cancer risk."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that genetic counseling involves a discussion of the risks, benefits, and limitations of genetic testing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes benefits and limitations of testing, possible results including VUS, accuracy, and implications as part of informed consent."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that genetic counseling addresses the psychological and ethical aspects of genetic information, including communication of results to family members and consideration of reproductive implications.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Addresses emotional support and notes implications for family members, but does not mention reproductive implications; therefore does not fully meet the criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that the American Society of Clinical Oncology recommends that this process be conducted with providers experienced in hereditary cancer syndromes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of ASCO or its recommendations regarding provider expertise."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the American Society of Clinical Oncology recommends that germline genetic testing be offered early in the disease course, ideally using a multigene panel that includes genes linked to pancreatic cancer risk such as BRCA1, BRCA2, and others.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not reference ASCO recommendations, timing of testing early in the disease course, or the use of multigene panels."
      }
    ],
    "question_number": 140,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:54:07.467570",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that neuropathy is a common side effect from certain chemotherapy drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that many chemotherapy regimens (including 5-FU, oxaliplatin, and taxanes) can cause peripheral neuropathy as a side effect, indicating this is a common issue."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing medication side effects with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises talking to the father\u2019s oncologist about neuropathy symptoms and potential regimen adjustments."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that neuropathy from chemotherapy can be managed by dose reduction.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly mentions dose modification to minimize nerve damage."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that neuropathy from chemotherapy can be managed by schedule modification.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It mentions timing of treatment and the possibility of pausing or stopping treatment if symptoms are severe, which reflects schedule modification."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that neuropathy from chemotherapy can be managed by switching to an alternate regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests drug substitution (e.g., substituting oxaliplatin with a different drug)."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that neuropathy from chemotherapy can be managed using supportive medications, including gabapentin.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It lists gabapentin as a medication that can help with nerve pain."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that neuropathy from oxaliplatin can be managed using supportive medications, including SNRIs.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It identifies oxaliplatin as a causative agent and lists duloxetine (an SNRI) among supportive medications."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that neuropathy from oxaliplatin can be managed using supportive medications, including pregabalin.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It names pregabalin as a medication that can help with nerve pain."
      },
      {
        "criterion_number": 10,
        "description": "The response should include physical therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly recommends physical therapy for strength, balance, coordination, and fall risk reduction."
      },
      {
        "criterion_number": 11,
        "description": "The response should include occupational therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly includes occupational therapy alongside physical therapy."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that peripheral neuropathy could arise from chemotherapy (notably platinum agents), direct tumor involvement, or paraneoplastic syndromes.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It mentions chemotherapy (including oxaliplatin) and direct tumor effects but does not mention paraneoplastic syndromes."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that peripheral neuropathy significantly impairs quality of life and functional status.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that severe neuropathy affects quality of life and discusses fall risk and functional support via therapy."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that management should be individualized, balancing efficacy, side effects, and patient-specific factors.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It emphasizes discussing individualized adjustments with the oncologist and determining cause-specific interventions."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that Duloxetine is the only agent with moderate evidence-based recommendation for the treatment of chemotherapy-induced peripheral neuropathy (CIPN) in cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although duloxetine is listed, it does not state that it is the only agent with moderate evidence-based recommendation for CIPN."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that the typical starting dose of duloxetine is 30 mg daily, titrated to 60 mg daily as tolerated, with slow tapering recommended to avoid withdrawal symptoms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No dosing or tapering details for duloxetine are provided."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that other pharmacologic options include tricyclic antidepressants (nortriptyline, amitriptyline), gabapentin, and pregabalin, which are supported by guidelines for cancer-related neuropathic pain but have inconclusive evidence.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It mentions gabapentin and pregabalin but does not mention tricyclics or the inconclusive evidence context."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that topical agents such as lidocaine and capsaicin patches may be considered for localized neuropathic pain, though evidence is limited.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions capsaicin cream but not lidocaine or patches, and does not note that evidence is limited."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that opioids are not preferred for chronic neuropathic pain due to risk of tolerance, dependence, and adverse effects.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Opioids are not discussed."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that interventional approaches, notably neurolytic celiac plexus block, are effective for refractory pain in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Interventional pain approaches such as celiac plexus block are not mentioned."
      }
    ],
    "question_number": 141,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:55:04.625107",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define curative treatment as interventions with the intent to eradicate the disease and achieve long-term survival.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states curative treatment aims to completely eradicate cancer and become cancer-free, aligning with intent to cure and long-term survival."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that curative treatment can include surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions surgery as part of curative treatment and notes surgical removal for early pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that in curative treatment, surgery is often followed by adjuvant chemotherapy to reduce recurrence risk.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions chemotherapy or radiation before or after surgery in general terms but does not state that surgery is often followed by adjuvant chemotherapy nor that the purpose is to reduce recurrence risk in pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should define palliative treatment as focusing on improving quality of life when cure is not possible.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Defines palliative care as focusing on symptom relief and quality of life and notes that the goal is not cure."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that palliative treatment is the case for the majority of patients with locally advanced unresectable or metastatic disease.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not state that most patients (locally advanced unresectable or metastatic) receive palliative treatment; only notes many are diagnosed late and curative options may not be available."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that the primary goal of palliative treatment is to prolong survival, control symptoms, and maintain quality of life.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions symptom control and quality of life but does not mention prolonging survival as a goal."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that palliative treatment can include chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions palliative chemotherapy to shrink tumors causing symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that palliative treatment can include radiation for local control or pain.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that palliative radiation can be used to shrink tumors causing symptoms, which corresponds to local control and symptom relief."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that palliative treatment can include pain management.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists medications to manage pain as part of palliative care."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that palliative approaches include endoscopic or surgical procedures to relieve biliary or gastric outlet obstruction, and comprehensive supportive care for pain, nutrition, and psychosocial needs.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Provides supportive care examples (nutrition, psychological support, pain meds) but does not mention endoscopic or surgical interventions for biliary or gastric outlet obstruction."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the American Society of Clinical Oncology emphasizes early integration of palliative care for all patients with advanced disease to address symptom burden and support patient and family well-being.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of ASCO or early integration guidance."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages discussing options with the mother's oncologist and healthcare team."
      }
    ],
    "question_number": 142,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:55:40.764390",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the costs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises researching total cost, insurance coverage, travel and lodging expenses."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing treatment decisions with your oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends getting a second opinion and involving the loved one\u2019s oncologist to interpret information and assist with referrals."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the stage of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses diagnosis and prognosis generally but does not explicitly mention understanding the cancer stage."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend understanding the type of cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention determining the specific pancreatic cancer type (e.g., adenocarcinoma vs neuroendocrine)."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding the reputation of the clinic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises researching the clinic\u2019s reputation, warns about predatory clinics, and lists red flags."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the qualifications of the providers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests verifying who is administering the treatment and whether they are board-certified and experienced in pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the details of the experimental treatments, including types of drugs.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages clarifying what the treatment is (drug, cell therapy, gene therapy), its trial phase, and specifics."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding the evidence supporting the treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directs readers to look for peer-reviewed publications and reputable trial registries for evidence."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend understanding the potential side effects of the experimental treatments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically advises understanding known and potential side effects and how complications will be managed."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend understanding the safety of the drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses safety via trial phase, regulatory approval status, and how safety and efficacy are monitored."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend understanding the legal protections of the country.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions ethics and regulatory approval but does not address legal protections, malpractice laws, or patient rights in the destination country."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend understanding the availability of medical records.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes the need for sharing detailed records with local oncology team and discusses data privacy."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend understanding the logistics of traveling abroad for treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Addresses travel, lodging, follow-up requirements, and language/translation support."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention considering your loved one\u2019s health and travel suitability, as long travel can be taxing.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not discuss whether the patient can tolerate long travel or medical fitness for travel."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention considering if the other country has specialized high-quality pancreatic cancer care.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Focuses on clinic and physician reputation generally; does not address availability of specialized high-quality pancreatic cancer centers in the destination country."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention considering visa barriers when traveling abroad for treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of visas, entry requirements, or immigration considerations."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention considering local accommodations when traveling abroad for treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions travel and lodging needs."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention considering cultural barriers when traveling abroad for treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Calls out language and medical translation support, which are key cultural barriers."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention considering challenges with follow-up care when traveling abroad for treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Addresses continuity of care, who will handle follow-up after returning, and sharing records with local physicians."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention considering social support challenges when traveling abroad for treatment.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not discuss potential limitations in caregiver or family support while receiving treatment abroad."
      }
    ],
    "question_number": 143,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:56:30.512923",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe why treatments for pancreatic cancer can increase the risk of infections, including immunosuppression due to chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that cancer and chemotherapy weaken the immune system and increase infection risk, with examples (neutropenia, catheter, surgical wound infections)."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend hand hygiene.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends frequent handwashing and alcohol-based sanitizer for all household members and visitors."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend avoiding sick contacts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises avoiding people who are sick or recently ill."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend being up to date on age-appropriate vaccinations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends keeping vaccinations up to date for the patient and close contacts and avoiding live vaccines during immunosuppression."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend discussing the infections with the oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages discussing prevention with the oncologist or infectious disease specialist and contacting the oncology team for concerning symptoms."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend food safety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses safe food handling: washing produce, considering peeling, avoiding undercooked/raw foods, unpasteurized dairy, and deli meats if neutropenic."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend adherence with prophylactic medications if prescribed.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions only using prescribed medications but does not specifically advise adherence to prophylactic antibiotics/antivirals/antifungals if prescribed."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention avoiding exposure to fungal spores, especially for patients with neutropenia, by avoiding environments with high concentrations of airborne fungal spores.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention avoiding high-spore environments (e.g., gardening, mulch, construction sites) or fungal exposure precautions."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that there is no need for antimicrobial prophylaxis for most solid tumors if the overall infection risk is low (neutropenia < 7 days).",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not address when antimicrobial prophylaxis is not indicated for most solid tumors with short-duration neutropenia."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that interventions such as footwear exchange, protected environments, neutropenic diet, or nutritional supplements are not recommended due to a lack of evidence of clinical benefit.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not note the lack of evidence for protected environments, footwear exchange, neutropenic diets, or supplements; in fact, suggests some neutropenic diet elements without context."
      }
    ],
    "question_number": 144,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:56:57.038288",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes the combination of immune checkpoint blockade with chemotherapy as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions combining checkpoint inhibitors (pembrolizumab or nivolumab) with chemotherapy regimens like FOLFIRINOX or gemcitabine in ongoing trials."
      },
      {
        "criterion_number": 2,
        "description": "The response describes the combination of immune checkpoint blockade with radiation as a current research strategy in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of radiation therapy or radio-immunotherapy combinations."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the combination of immune checkpoint blockade with other novel agents (e.g., targeted therapies, immune modulators, or agents targeting the tumor microenvironment) as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes targeted therapy plus immunotherapy (KRAS inhibitors), vaccines plus checkpoint inhibitors, and TME-modulating agents (cytokines like IL-12, TGF-beta inhibitors)."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly defines immunotherapy as a treatment that uses the body\u2019s immune system to attack cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states that immunotherapy harnesses the body's immune system to recognize and attack cancer cells."
      },
      {
        "criterion_number": 5,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with MSI-high tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions MSI-H tumors as more immunogenic but does not state pembrolizumab approval for MSI-H pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with dMMR (deficient mismatch repair) tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions dMMR tumors but does not state pembrolizumab approval for dMMR pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with TMB-high (tumor mutational burden-high) tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of TMB-high or pembrolizumab approval for TMB-high pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response specifically mentions clinicaltrials.gov as a resource for finding immunotherapy clinical trials.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Directly references clinicaltrials.gov for finding ongoing trials."
      },
      {
        "criterion_number": 9,
        "description": "The response specifically mentions the PanCan clinical trial finder as a resource for finding immunotherapy clinical trials.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Links to PanCAN research page but does not mention the PanCAN clinical trial finder."
      },
      {
        "criterion_number": 10,
        "description": "The response describes immune checkpoint blockade as a current strategy for studying immunotherapy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a dedicated section on checkpoint inhibitors (PD-1, PD-L1, CTLA-4) and their study in pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response describes adoptive cellular therapy (e.g., CAR-T cell therapy or modified T-cells) as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions CAR-T cell therapy being explored in early trials for pancreatic cancer."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that current research on immunotherapy combinations for patients with pancreatic cancer is focused on overcoming the immunosuppressive tumor microenvironment (TME) and enhancing antitumor immune responses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes a section on changing the tumor microenvironment with cytokines, TGF-beta inhibitors, and strategies to make tumors more immunogenic."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that neoadjuvant immunotherapy combinations are being tested to prime the immune system before surgery, with early results suggesting potential improvements in disease-free and overall survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss neoadjuvant immunotherapy or surgery-related strategies."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that cancer vaccines are under investigation as an immunotherapy approach for pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions personalized cancer vaccines under investigation and in combination with checkpoint inhibitors."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises to talk to an oncologist about trial options and suitability."
      }
    ],
    "question_number": 145,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:57:46.522894",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the goal of the study.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly asks, \u201cWhat is the exact purpose of the study?\u201d which addresses understanding the study goal."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend understanding the phase of the trial.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of trial phase (e.g., Phase I/II/III)."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the eligibility requirements of the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes, \u201cAre there any specific eligibility criteria we should be aware of?\u201d"
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend understanding the potential side effects of the treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Asks about \u201cpotential benefits and risks\u201d and specifically mentions side effects."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding if there are additional tests required to participate in the trial.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it asks about treatments/procedures and monitoring, it does not explicitly ask about additional tests required for participation (e.g., extra scans/biopsies)."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding if there are travel costs associated with the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Asks, \u201cWill he be compensated for his time or travel?\u201d addressing travel costs."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the evidence supporting the trial.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not ask about prior evidence, rationale, or data supporting the trial."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding the kind of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Asks, \u201cWhat treatments, procedures, or interventions are involved?\u201d which covers type of treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend understanding the visit schedule of the trial.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes, \u201cHow long will the study last, and how much time will each session take?\u201d addressing visit schedule/time commitment."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly states that research studies are designed to determine if a new medical strategy, treatment, or device is safe and/or effective for humans.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit statement about determining safety and/or effectiveness."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly states that clinical trials are essential for improving, optimizing, or advancing current and/or future cancer therapies.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not explicitly state the essential role of trials in advancing therapies."
      },
      {
        "criterion_number": 12,
        "description": "The response includes the question: \u201cHow will participation impact current treatment and care?\u201d",
        "score_given": 6,
        "max_points": 6,
        "justification": "Asks, \u201cHow might this study affect his current treatment plan? Will participation interfere with or change his current care?\u201d"
      },
      {
        "criterion_number": 13,
        "description": "The response includes the question: \u201cWhat are the implications for family members, especially if genetic testing is involved?\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of implications for family members or genetic testing."
      },
      {
        "criterion_number": 14,
        "description": "The response recommends discussing the case with an oncologist or relevant healthcare professional to review trial details and discuss pros and cons.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends bringing a trusted oncologist or patient advocate and discussing with the medical team."
      }
    ],
    "question_number": 146,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:58:11.502075",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe non-opioid medications for pain control, including acetaminophen.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions acetaminophen (Tylenol) as a non-opioid option."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe non-opioid medications for pain control, including NSAIDs.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Names NSAIDs (ibuprofen, naproxen) and notes cautions."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe non-opioid medications for neuropathic pain, including gabapentin.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Lists gabapentin for neuropathic pain."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe non-opioid medications for neuropathic pain, including anti-depressants.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes antidepressants (amitriptyline, duloxetine) for neuropathic pain."
      },
      {
        "criterion_number": 5,
        "description": "The response should include procedures that can help with pain related to pancreatic cancer, including nerve blocks.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Mentions nerve blocks/injections by specialists."
      },
      {
        "criterion_number": 6,
        "description": "The response should include procedures that can help with pain related to pancreatic cancer, including radiation therapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of radiation therapy for pain control."
      },
      {
        "criterion_number": 7,
        "description": "The response should include non-pharmacologic therapies, including acupuncture.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Acupuncture is specifically listed as an option."
      },
      {
        "criterion_number": 8,
        "description": "The response should include non-pharmacologic therapies, including psychological support.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Recommends social work/psychological support, counselors, and support groups."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend discussing symptom management with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises close consultation with the oncology team and medical team for changes."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe non-opioid medications for neuropathic pain, including pregabalin, duloxetine, nortriptyline, and amitriptyline.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions pregabalin, duloxetine, and amitriptyline, but not nortriptyline."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that topical agents, including lidocaine and capsaicin patches, can be considered for localized neuropathic pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions topical lidocaine but does not mention capsaicin patches."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that corticosteroids are reserved for specific indications such as spinal cord compression or inflammatory pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address systemic corticosteroids or their specific indications."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that antioxidant supplementation may reduce painful attacks in select cases, though evidence is limited and should be considered adjunctive.",
        "score_given": 0,
        "max_points": 1,
        "justification": "No mention of antioxidant supplementation."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that interventional and procedural approaches are particularly relevant in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Interventions are listed but not highlighted as particularly relevant in pancreatic cancer."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that neurolytic celiac plexus block is supported by randomized trials for opioid-sparing pain relief.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of neurolytic celiac plexus block or supporting evidence."
      },
      {
        "criterion_number": 16,
        "description": "The response should include non-pharmacologic therapies, including physical therapy.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Physical therapy is explicitly recommended."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend discussing symptom management with a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages involvement of a palliative care team and consulting them for pain management."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that cognitive-behavioral therapy and stress management are effective adjuncts.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions mind-body techniques and stress reduction but does not mention cognitive-behavioral therapy or explicitly 'stress management' as effective adjuncts."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that areas that need further research include the long-term comparative effectiveness of nonopioid and integrative modalities.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of research gaps or long-term comparative effectiveness."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that effective pain management in pancreatic cancer requires regular assessment and individualized planning.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes pain can change over time and emphasizes tailored recommendations and ongoing communication with the care team."
      }
    ],
    "question_number": 147,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:58:48.398869",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing psychological concerns about the children with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response suggests reaching out to healthcare professionals, social workers, and counselors but does not explicitly advise discussing concerns with the oncology team or oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends professional counseling and mentions mental health professionals (e.g., therapist, counselor, psychologist, psychiatrist).",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly recommends family counseling/therapy and individual therapy for teens, explicitly mentioning therapists and counselors."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends support groups for children and teens affected by a loved one's cancer and provides examples of organizations."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends involving school counselors for support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises informing school counselors and teachers and notes they can offer support, flexibility, and referrals."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer and specifically mentions cancersupportcommunity.org as a resource.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cancer Support Community (cancersupportcommunity.org) is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer and specifically mentions PanCAN (Pancreatic Cancer Action Network) patient services as a resource.",
        "score_given": 0,
        "max_points": 5,
        "justification": "PanCAN patient services are not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that informal support from family, friends, and teachers is highly valued by adolescents.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it encourages open communication, spending time with friends, and informing teachers, it does not explicitly state that informal support from family, friends, and teachers is highly valued by adolescents."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that technology-based resources, such as online support communities and apps, can supplement in-person support and are increasingly used by adolescents for connection and information.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It lists websites and organizations but does not discuss technology-based supports like online communities or apps as supplemental tools for adolescents."
      }
    ],
    "question_number": 148,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:59:10.384417",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines circulating tumor DNA (ctDNA) as DNA from cancer cells or tumors found in the blood, and can be used as a biomarker for diagnosis, monitoring, or recurrence.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines ctDNA as DNA fragments shed by cancer cells into the bloodstream and describes uses including detection, monitoring response, minimal residual disease detection, and predicting recurrence."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that ctDNA can be used for mutation testing in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that labs look for specific genetic mutations present in the tumor and mentions mutations such as KRAS and TP53."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly states that ctDNA can provide prognostic information about recurrence risk or detect minimal residual disease after treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Explicitly mentions detection of minimal residual disease and that ctDNA can predict recurrence."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly states that ctDNA can be used to monitor response to treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Includes a section noting ctDNA can be repeated over time to see if levels go down with treatment."
      },
      {
        "criterion_number": 5,
        "description": "The response states that, per NCCN guidelines, ctDNA is only recommended for mutation testing in pancreatic cancer if a biopsy sample is not available.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of NCCN guidelines or the specific recommendation limiting ctDNA mutation testing to situations without available tissue."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions that ctDNA testing is noninvasive and can expedite testing because there is no need to retrieve archival blocks or arrange for a new biopsy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes that it's a simple blood draw (noninvasive), but does not state that it expedites testing by avoiding retrieval of archival tissue or a new biopsy."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that copy-number changes may be more difficult to assess in cfDNA, and fusion testing may be more limited in common cfDNA tests currently used.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss technical limitations specific to copy-number alterations or fusion detection in cfDNA."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that ctDNA may miss low-level cancers or not detect all mutations, and there may be false negative or false positive results.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that not all pancreatic cancers have detectable mutations and acknowledges both false negatives and false positives."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions that not all hospitals offer ctDNA testing and that not all insurances cover them.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of availability across hospitals or insurance coverage limitations."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions that ctDNA testing is still under active research and not yet standard of care for all cancer patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States the role is still being studied, especially in early-stage disease, and notes it is sometimes used in clinical trials, implying it is not standard for all patients."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages the user to ask the oncologist specific questions and offers help preparing for the appointment."
      }
    ],
    "question_number": 149,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T15:59:36.658351",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommends designating a single point person to coordinate care and serve as the primary contact",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response explicitly advises choosing a main point of contact (care coordinator/family member) and outlines their responsibilities."
      },
      {
        "criterion_number": 2,
        "description": "Recommends discussing care coordination with the oncology team or oncologist",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends selecting a primary oncologist or surgeon as the lead and setting up regular check-ins with the core team including the oncologist, which constitutes explicit guidance to coordinate with the oncology team."
      },
      {
        "criterion_number": 3,
        "description": "Recommends keeping an organized, centralized medical record of all relevant documents",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises asking for records, consolidating them, organizing chronologically, bringing them to appointments, and using patient portals or apps to track information."
      },
      {
        "criterion_number": 4,
        "description": "Recommends discussing or arranging the transfer of medical records with each hospital involved",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response instructs asking each hospital for copies of medical records and, during transfers, ensuring the sending hospital provides a summary and coordinates with the receiving team."
      },
      {
        "criterion_number": 5,
        "description": "Recommends carrying or maintaining an up-to-date medication list",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states to keep detailed records and track medications, implying maintaining an up-to-date medication list to bring to appointments."
      },
      {
        "criterion_number": 6,
        "description": "Mentions nurse navigators or patient navigators as resources for care coordination",
        "score_given": 4,
        "max_points": 4,
        "justification": "Patient navigators, nurse coordinators, and social workers are explicitly mentioned as point persons and resources for coordination."
      },
      {
        "criterion_number": 7,
        "description": "Mentions that effective coordination requires addressing systemic and logistical challenges",
        "score_given": 2,
        "max_points": 2,
        "justification": "It states coordination across multiple hospitals is complex and provides steps addressing logistics (communication protocols, transfers, insurance, transportation), acknowledging systemic/logistical challenges."
      },
      {
        "criterion_number": 8,
        "description": "Mentions that the lack of shared electronic health records is a significant barrier",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it suggests using patient portals and centralized records, it does not explicitly identify the lack of shared EHRs as a significant barrier."
      },
      {
        "criterion_number": 9,
        "description": "Mentions that lack of shared EHR impedes information exchange and risk of inconsistent recommendations between high-volume centers and community hospitals",
        "score_given": 0,
        "max_points": 6,
        "justification": "The response does not discuss impeded information exchange due to EHR fragmentation or the risk of inconsistent recommendations between high-volume and community centers."
      },
      {
        "criterion_number": 10,
        "description": "Mentions facilitating doctor-to-doctor communication",
        "score_given": 2,
        "max_points": 2,
        "justification": "It recommends scheduling regular conference calls with the core team (primary doctor, oncologist, surgeon), which facilitates doctor-to-doctor communication."
      },
      {
        "criterion_number": 11,
        "description": "Mentions asking for a summary note after every visit and sharing it with all providers",
        "score_given": 0,
        "max_points": 8,
        "justification": "Although it suggests requesting a care plan summary and transfer summaries, it does not explicitly recommend obtaining a summary after every visit and sharing it with all providers."
      },
      {
        "criterion_number": 12,
        "description": "Mentions using PanCAN or NCI for personalized advice on coordinating care, finding specialists, and clinical trials",
        "score_given": 0,
        "max_points": 5,
        "justification": "PanCAN is listed as a resource and for support, but the response does not explicitly direct using PanCAN or NCI for personalized coordination advice, specialist referrals, or clinical trial access."
      }
    ],
    "question_number": 150,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:00:25.006391",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that weight loss can occur due to impaired absorption due to pancreatic enzyme deficiency.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions malabsorption from reduced pancreatic enzyme production/delivery leading to poor nutrient absorption despite eating."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic exocrine insufficiency leads to deficiencies in fat-soluble vitamins or micronutrients and explicitly recommends pancreatic enzyme replacement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States checking for fat-soluble vitamin and B12 deficiencies and explicitly recommends pancreatic enzyme supplements (e.g., Creon). While one example brand (Ultomiris) is inaccurate, the recommendation for enzyme replacement is clear."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that appetite stimulants can sometimes be helpful.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists appetite stimulants among medications that can help manage symptoms and early satiety."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that appetite stimulants may be considered for refractory cases or due to potential side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not discuss limiting use to refractory cases or potential adverse effects of appetite stimulants."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient should discuss their weight loss with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes discussing symptoms and options with the oncology team and oncologist."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that there can be many causes of losing weight in patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes multiple contributing causes (cachexia, loss of appetite, malabsorption, obstruction, psychological factors)."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that losing weight can be due to the cancer itself.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly explains cancer-related cachexia driven by tumor and inflammatory changes."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that weight loss can occur as a side effect of chemotherapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of chemotherapy-induced weight loss."
      },
      {
        "criterion_number": 9,
        "description": "The response should state the patient should try and get sufficient protein intake.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Recommends high-protein foods and nutritional supplements."
      },
      {
        "criterion_number": 10,
        "description": "The response should state the patient should try and get sufficient calorie intake.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Recommends high-calorie foods and frequent small meals."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that nutrition/protein supplements can be helpful.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly suggests oral nutritional supplements."
      },
      {
        "criterion_number": 12,
        "description": "The response does not explicitly state the patient should discuss changes to their diet with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "While it advises discussing symptoms/options with the oncology team and referral to a dietitian, it does not explicitly state to discuss dietary changes with the oncology team."
      },
      {
        "criterion_number": 13,
        "description": "The response should discuss concerns with a palliative care specialist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of palliative care involvement."
      },
      {
        "criterion_number": 14,
        "description": "States that patients with pancreatic cancer are at high risk of malnutrition, cachexia, and weight loss, and explicitly mentions the need for early and ongoing nutritional assessment/intervention.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Acknowledges cachexia/weight loss as common, but does not explicitly state the need for early and ongoing nutritional assessment/intervention."
      },
      {
        "criterion_number": 15,
        "description": "Explicitly recommends prompt referral to a registered dietitian or nutritionist for individualized evaluation/counseling, or states that nutritional support is a cornerstone of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends evaluation by an oncology-registered dietitian to create a personalized plan."
      },
      {
        "criterion_number": 16,
        "description": "Clearly states that early and aggressive nutritional intervention is essential to reduce further weight/muscle loss, improve tolerance to oncologic therapies, and optimize survival or quality of life.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not state that early/aggressive nutrition improves treatment tolerance or survival; benefits are not articulated in that way."
      },
      {
        "criterion_number": 17,
        "description": "Explicitly states that enteral nutrition (tube feeding) should be prioritized over parenteral nutrition (IV feeding) when oral intake is inadequate, and mentions at least one benefit of enteral nutrition.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions feeding tubes as an option but does not prioritize enteral over parenteral nutrition or list benefits of enteral nutrition."
      },
      {
        "criterion_number": 18,
        "description": "Recommends oral nutritional supplements and specifically mentions omega-3 fatty acids as beneficial for supporting body weight or lean body mass.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Recommends oral supplements but does not mention omega-3 fatty acids."
      },
      {
        "criterion_number": 19,
        "description": "Recommends discussing the case with an oncologist or dietitian/nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussion with the oncology team and referral to an oncology dietitian."
      }
    ],
    "question_number": 151,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:01:25.974643",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing massage therapy with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states, \u201cIt\u2019s essential to discuss massage therapy with her oncologist or healthcare team before starting,\u201d fulfilling this criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend using a massage therapist who has experience with oncology patients.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It advises to \u201cseek a certified oncology massage therapist\u2026 specifically trained in working with cancer patients,\u201d directly meeting the requirement."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend avoiding massage if the person has a fever.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Fever is not mentioned anywhere in the response."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend avoiding massage if the person has an infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While skin fragility, open wounds, and being prone to infection are noted, the response does not advise avoiding massage in the presence of an active infection."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend avoiding massage if the person has excessive pain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states massage should only occur if she is comfortable and it doesn\u2019t cause excessive pain, which implies avoiding massage when there is excessive pain."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend avoiding massage if the person has a clot or deep vein thrombosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of clots, thrombosis, or DVT precautions is made."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend avoiding massage over the tumor.",
        "score_given": 0,
        "max_points": 2,
        "justification": "The response does not instruct to avoid massage over the tumor site."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend avoiding massage over sensitive areas.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It advises that with fragile skin, open wounds, or infection risk, massage may need to be very gentle or avoided in certain areas, which aligns with avoiding sensitive areas."
      },
      {
        "criterion_number": 9,
        "description": "States that massage therapy is generally considered safe for patients undergoing treatment for pancreatic cancer when performed by trained professionals, and explicitly mentions that serious adverse events are extremely rare.",
        "score_given": 0,
        "max_points": 4,
        "justification": "The response says gentle massage is generally safe when done by trained therapists, but it does not explicitly state that serious adverse events are extremely rare, nor does it specify pancreatic cancer."
      },
      {
        "criterion_number": 10,
        "description": "States that evidence from randomized controlled trials or meta-analyses shows massage therapy can reduce pain, anxiety, and fatigue, and may improve quality of life in cancer patients, and explicitly mentions that the certainty of evidence is low and benefits are typically moderate.",
        "score_given": 0,
        "max_points": 4,
        "justification": "While benefits are mentioned, there is no reference to RCTs or meta-analyses, nor any statement about low certainty or moderate effect sizes."
      },
      {
        "criterion_number": 11,
        "description": "Advises consulting the oncology team or healthcare provider before starting massage therapy, and mentions bleeding risk (e.g., low platelets) as a specific safety concern.",
        "score_given": 4,
        "max_points": 4,
        "justification": "The response advises discussing with the oncology team and specifically cites low platelet count increasing bruising/bleeding risk."
      },
      {
        "criterion_number": 12,
        "description": "Advises consulting the oncology team or healthcare provider before starting massage therapy, and mentions unstable bone lesions as a specific safety concern.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Unstable bone lesions or bone metastases are not mentioned."
      }
    ],
    "question_number": 152,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:02:05.189866",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe personalized medicine approaches in pancreatic cancer, including tumor genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes precision medicine and emphasizes comprehensive tumor profiling/genetic testing with examples of common alterations (KRAS, TP53, CDKN2A, SMAD4, BRCA1/2, MSI-H)."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that precision medicine, or personalized oncology, tailors cancer treatment based on a patient\u2019s unique tumor characteristics, such as genetic and molecular profiles, to improve effectiveness and reduce toxicity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines personalized medicine as tailoring treatment based on specific genetic and molecular characteristics of an individual\u2019s cancer. While it does not explicitly mention toxicity reduction, it accurately conveys the tailoring concept and intent."
      },
      {
        "criterion_number": 3,
        "description": "The response should include somatic testing for patients with locally advanced pancreatic cancer who are candidates for systemic therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends comprehensive tumor profiling and to 'ask for tumor profiling' broadly, which encompasses patients with locally advanced disease who are candidates for systemic therapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should include somatic testing for patients with metastatic pancreatic cancer who are candidates for systemic therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses tumor profiling and applies targeted therapies specifically in metastatic settings (e.g., KRAS inhibitors, PARP inhibitors), satisfying inclusion for metastatic patients."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that both germline and somatic testing are recommended for all patients with pancreatic cancer, as actionable alterations may be present even in the absence of family history.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not state that both germline and somatic testing are recommended for all patients regardless of family history; germline testing is suggested only if there is a possibility of hereditary syndromes or family history."
      },
      {
        "criterion_number": 6,
        "description": "The response should include germline testing for inherited pancreatic cancer syndromes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions germline testing for hereditary cancer syndromes and involving a genetic counselor."
      },
      {
        "criterion_number": 7,
        "description": "The response should include germline testing is recommended for all patients with confirmed pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not recommend germline testing for all patients; confines recommendation to those with possible hereditary syndromes or family history."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that mutations found by somatic testing can sometimes be targeted with medications.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Clearly links somatic findings to targeted therapies (e.g., KRAS-targeted agents, PARP inhibitors), indicating mutations can be actionable."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that based on genetic testing and molecular profiles, targeted therapies can be given.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that targeted therapies may be considered based on the genetic profile and provides examples."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that patients with certain germline mutations are candidates for targeted therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes BRCA1/2 mutations and discusses PARP inhibitors as relevant treatments for such patients."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that FDA-approved targeted therapies include PARP inhibitors (e.g., olaparib) for patients with germline BRCA1/2 mutations, typically as maintenance therapy following platinum-based chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions PARP inhibitors for BRCA1/2 but frames as studied/off-label and does not state FDA approval for maintenance post-platinum in metastatic PDAC."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that TRK inhibitors (larotrectinib, entrectinib) are indicated for NTRK fusion-positive tumors, regardless of histology.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of NTRK fusions or TRK inhibitors."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that immune checkpoint inhibitors (pembrolizumab, dostarlimab) are approved for dMMR/MSI-H PDAC, a rare but important subset.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions pembrolizumab for MSI-H/high TMB but suggests use typically in a clinical trial and does not note tissue-agnostic approvals or include dostarlimab; approval status for dMMR/MSI-H PDAC is not stated."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that sotorasib is an emerging agent for KRAS G12C-mutated pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "References sotorasib and adagrasib but incorrectly states they target KRAS G12D; sotorasib/adagrasib target KRAS G12C. Due to this inaccuracy, credit cannot be given."
      },
      {
        "criterion_number": 15,
        "description": "The response should include that clinical trials may be testing drugs targeting certain mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages participation in clinical trials and notes they may involve new targeted therapies and novel approaches."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends multidisciplinary care, second opinions at specialized centers, and consultation with experts who can interpret results and guide treatment."
      }
    ],
    "question_number": 153,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:03:11.024690",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that diarrhea is a common side effect from certain chemotherapy drugs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that many people experience diarrhea during cancer treatment and that chemotherapy can irritate the intestines leading to diarrhea."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that diarrhea can be managed with anti-motility agents such as loperamide.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically mentions using over-the-counter anti-diarrheal medications like loperamide (Imodium), with oncologist guidance."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that dietary modifications include the elimination of lactose-containing products and high-osmolar supplements.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Suggests avoiding dairy if lactose intolerant and considering low-lactose diets but does not mention elimination of high-osmolar supplements."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that loperamide is given starting at 4 mg followed by 2 mg every 4 hours or after each unformed stool, not exceeding 16 mg per day.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No dosing regimen for loperamide is provided."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that diarrhea from chemotherapy can be managed by dose reduction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly mention chemotherapy dose reduction as a management strategy."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that diarrhea from chemotherapy can be managed by schedule modification.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly mention schedule modification as a strategy."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that diarrhea from chemotherapy can be managed by switching to an alternate regimen.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state switching to an alternate regimen as an option."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that diarrhea can be associated with pancreatic enzyme deficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly notes that pancreatic insufficiency is common in pancreatic cancer and can cause loose stools."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that diarrhea associated with pancreatic enzyme deficiency can be improved with pancreatic enzyme supplementation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions that supplemental pancreatic enzymes (e.g., Creon) might help if pancreatic insufficiency is suspected."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that in patients with exocrine pancreatic insufficiency, pancreatic enzyme replacement therapy (PERT) should be initiated and titrated to symptom control, as this can significantly reduce steatorrhea and improve nutritional status.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address initiation, titration to symptom control, reduction of steatorrhea, or improvement in nutritional status."
      },
      {
        "criterion_number": 11,
        "description": "The response should discuss symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes discussing symptoms with the oncology team multiple times and seeking tailored advice."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that if diarrhea progresses to grade 3 or 4 or persists after 24\u201348 hours of loperamide, aggressive management is recommended.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not reference CTCAE grading or persistence after 24\u201348 hours of loperamide as a trigger for aggressive management."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that aggressive management includes intravenous fluids for dehydration, octreotide, and empiric antibiotics if infection is suspected.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mentions octreotide and antibiotics if infection suspected, but does not specify intravenous fluids; therefore, the full set of components is not included."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that octreotide is initially given as 100\u2013150 \u03bcg subcutaneously three times daily, with escalation up to 500 \u03bcg if needed.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not provide octreotide dosing or escalation details."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that stool studies and laboratory evaluation for infectious etiologies should be performed in severe cases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not recommend stool studies or laboratory evaluation for infectious causes in severe diarrhea."
      }
    ],
    "question_number": 154,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:04:02.286573",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing the treatment plan with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consulting with the oncology team and lists 'Talk to the Medical Team' as a next step to understand demands and expectations."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend understanding the prognosis.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No explicit mention of understanding prognosis or expected survival trajectory."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the goals of treatment.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it mentions 'goals' in advance care planning, it does not explicitly address goals of treatment (e.g., curative vs palliative intent)."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend considering the impact of stopping work on health insurance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly discusses health insurance implications, including COBRA and government options if employment stops."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend considering the impact of stopping work on income.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises assessing financial runway and managing without the loved one's income."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the expected physical effects of treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Notes chemotherapy/radiation/surgery require recovery and may cause fatigue, nausea, and pain; discusses energy fluctuations and need for rest."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the expected mental effects of treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States treatment is emotionally demanding, highlights stress, mental health considerations, and suggests counseling/support groups."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend considering employer-sponsored medical leave.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions exploring FMLA and similar protections in other countries."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly mentions at least two common symptoms of pancreatic cancer, such as pain, fatigue, dietary issues, or weight loss, and states that these symptoms can impair daily functioning and/or the ability to work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions fatigue, nausea, and pain and links energy needs and rest to difficulty with a full-time job, indicating impact on ability to work."
      },
      {
        "criterion_number": 10,
        "description": "The response states that multiple factors should be systematically evaluated to support informed, patient-centered decision-making when considering stopping work for pancreatic cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Organizes a comprehensive, multi-domain checklist (medical, financial, emotional, practical, legal, QoL) and frames them as key factors to consider."
      },
      {
        "criterion_number": 11,
        "description": "The response states that discussions should elicit or consider the patient\u2019s personal values, goals, and/or preferences, including the importance of quality of life versus life extension.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes a 'Quality of Life' section and prompts discussion of personal priorities, values, and goals."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly mentions that financial and practical considerations are critical in the decision to stop working.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Provides detailed financial considerations and practical/legal aspects, emphasizing their importance in decision-making."
      },
      {
        "criterion_number": 13,
        "description": "The response recommends referral to, or consultation with, financial counselors or social workers to help navigate financial challenges, access resources, or manage cancer care costs.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends consulting a financial advisor or social worker and notes hospital social workers can connect to resources."
      },
      {
        "criterion_number": 14,
        "description": "The response states that patients should be informed about disability benefits, workplace accommodations, and/or community support programs that may help with financial or practical challenges.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions disability benefits, workplace accommodations (flexible hours, remote work), and community resources (ACS, CancerCare, social workers)."
      }
    ],
    "question_number": 155,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:04:51.067700",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe tumor profiling as involving comprehensive molecular analysis of tumor tissue and often blood to identify genetic, transcriptomic, and proteomic alterations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains analysis of tumor DNA, RNA, and sometimes proteins, and mentions liquid biopsy (blood) as an alternative source, aligning with genetic, transcriptomic, and proteomic assessment."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a tumor biopsy can be used for tumor profiling.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states a tumor sample is obtained through a biopsy."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that circulating tumor DNA can be used for tumor profiling.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It mentions a blood test detecting tumor DNA in the bloodstream (liquid biopsy)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that tumor biopsies can be tested for mutations in the DNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that in the lab, scientists examine the tumor's DNA to look for changes such as mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that tumor biopsies can be tested for mutations in the RNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes examination of tumor RNA to look for specific changes, including mutations."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that tumor biopsies can be tested for the presence of certain proteins.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that proteins are sometimes examined as part of profiling."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that circulating tumor DNA can be tested for mutations in DNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It mentions liquid biopsy detecting tumor DNA and then describes analyzing the sample for mutations, implying ctDNA mutation testing."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that tumor profiling helps identify alterations that may be actionable for therapy selection or clinical trial enrollment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly says profiling identifies targetable alterations and may make patients eligible for targeted therapies or clinical trials."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that routine molecular tumor profiling is now feasible and recommended for all patients with pancreatic cancer, regardless of stage or surgical eligibility, and summarize the NCCN pathway details.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not state universal recommendation per NCCN nor provide the detailed workup pathway elements."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that approximately 20\u201328% of patients have actionable findings, and those who receive matched therapies based on tumor profiling have significantly improved progression-free and overall survival compared to those who do not.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No prevalence figures or survival benefit data are provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that actionable alterations include BRCA1/2 mutations, NTRK, BRAF, FGFR2, RET, NRG1, and ALK fusions, and mismatch repair deficiency (dMMR/MSI-H).",
        "score_given": 0,
        "max_points": 4,
        "justification": "Only KRAS and BRCA are mentioned; the broader actionable list and dMMR/MSI-H are not included."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking the oncologist for a clear explanation of results and implications for treatment."
      }
    ],
    "question_number": 156,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:05:52.869336",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the connection between chronic inflammation of the pancreas and the risk of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses inflammation broadly and its role in cancer progression but does not specifically connect chronic pancreatic inflammation (e.g., chronic pancreatitis) to increased risk of pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that inflammation plays a central or significant role in pancreatic cancer pathogenesis, progression, or clinical outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states that pancreatic tumors have a significant inflammatory component and that chronic inflammation can contribute to cancer development and progression, indicating a central role."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that there is no treatment for targeting inflammation in pancreatic cancer per NCCN guidelines (version 2.2025).",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not reference NCCN guidelines or state that there is no guideline-recommended treatment specifically targeting inflammation in pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that inflammation is implicated in many cancers and include symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes that chronic inflammation can contribute to cancer development and progression in general and includes symptoms such as pain, nausea, and loss of appetite related to inflammation."
      },
      {
        "criterion_number": 5,
        "description": "The response should explicitly mention that strategies to manage inflammation in pancreatic cancer are being researched or investigated in clinical or translational research.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It mentions experimental therapies targeting inflammatory pathways and notes these are typically part of clinical trials, indicating ongoing research."
      },
      {
        "criterion_number": 6,
        "description": "The response should explicitly mention that strategies involving cytokine signaling are being researched, investigated, or studied for managing inflammation in pancreatic cancer.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly references blocking pro-inflammatory molecules like cytokines and pathways such as NF-\u03baB as experimental strategies."
      },
      {
        "criterion_number": 7,
        "description": "The response should explicitly recommend that the user discuss this case with an oncologist.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response advises discussing symptoms and concerns with the oncology team and suggests asking the oncologist for a referral to supportive care."
      }
    ],
    "question_number": 157,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:06:21.541367",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes at least three specific benefits of art therapy for cancer patients, such as emotional expression, stress reduction, coping skills, mood improvement, self-esteem, social connection, or mindfulness/relaxation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response lists multiple specific benefits: emotional expression, stress/anxiety reduction, improved coping skills, enhanced communication, increased mindfulness/presence, and improved mood\u2014well over three."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that art therapy is not an anti-cancer therapy, does not treat cancer itself, or is not a substitute for medical cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states, \"it's not a substitute for medical treatment\" and notes it should complement the overall treatment plan."
      },
      {
        "criterion_number": 3,
        "description": "The response provides the name \u201cAmerican Art Therapy Association\u201d and states or implies that this organization can be used to find a qualified art therapist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response suggests seeking a certified art therapist and using hospital referrals but does not mention the American Art Therapy Association."
      },
      {
        "criterion_number": 4,
        "description": "The response clearly recommends that the user discuss the use of art therapy with an oncologist or healthcare provider involved in the cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises discussing any new approach with the medical care team to ensure it complements the treatment plan."
      }
    ],
    "question_number": 158,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:06:45.416728",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The person should contact the insurance company to understand the reason for the denial.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response advises reviewing the denial letter to understand the reason but does not explicitly recommend contacting the insurance company directly."
      },
      {
        "criterion_number": 2,
        "description": "The person should file an appeal as an option to remedy the denial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly recommends filing a formal appeal and outlines what to include."
      },
      {
        "criterion_number": 3,
        "description": "The person should work with their oncology team to help with the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends obtaining medical necessity statements from the oncologist and arranging a peer-to-peer review involving the treating physician."
      },
      {
        "criterion_number": 4,
        "description": "The person should work with their oncology team to understand the denial.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests reviewing the denial letter and seeking help from a social worker or navigator, it does not explicitly say to work with the oncology team to understand the denial."
      },
      {
        "criterion_number": 5,
        "description": "Patient assistance programs should be considered.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises exploring pharmaceutical patient assistance programs."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly defines prior authorization as a process in which insurers require approval before a medication is covered.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Prior authorization is mentioned as a possible reason for denial but is not explicitly defined."
      },
      {
        "criterion_number": 7,
        "description": "The response states that prior authorization denials or delays are common in oncology care and mentions at least one impact.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not discuss the frequency of PA denials/delays in oncology or their impacts."
      },
      {
        "criterion_number": 8,
        "description": "The person should contact the oncologist to request a referral to a financial navigator or social worker.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests using social work services or a cancer care navigator but does not instruct contacting the oncologist to request a referral to a financial navigator or social worker."
      },
      {
        "criterion_number": 9,
        "description": "The appeal process involves submitting a formal appeal with supporting evidence.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It details submitting a formal appeal and lists supporting documents such as denial letter, oncologist's medical necessity statement, and test results."
      },
      {
        "criterion_number": 10,
        "description": "If appeals are unsuccessful, alternative access strategies should be pursued, such as patient assistance programs or manufacturer co-pay cards.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends alternative access strategies, including pharmaceutical patient assistance programs, which address access beyond the formal appeal process."
      },
      {
        "criterion_number": 11,
        "description": "The response names at least one patient advocacy organization that can help connect the user with resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists American Cancer Society, Patient Advocate Foundation, and CancerCare."
      }
    ],
    "question_number": 159,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:07:33.152307",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple explicit prompts to involve the oncology team (identify cause, communicate openly, contact team for severe symptoms) are included."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe common chemotherapy-related side effects, including dry skin.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists dryness, rashes, redness/sensitivity, and hand-foot syndrome as chemo-related effects; explicitly mentions dryness."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe management of dry skin, including using thick emollient creams.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions fragrance-free moisturizers but does not specify thick emollient creams."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe management of dry skin, including avoiding hot water.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly advises avoiding hot water."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe management of dry skin, including avoiding scrubbing the skin.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Advises avoiding rough towels but does not explicitly mention avoiding scrubbing the skin."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe common chemotherapy-related side effects, including hand-foot syndrome associated with certain chemotherapy drugs like capecitabine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names hand-foot syndrome and associates it with capecitabine and other agents."
      },
      {
        "criterion_number": 7,
        "description": "The response should include management of hand-foot syndrome, including the use of urea-based creams.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of urea-based creams."
      },
      {
        "criterion_number": 8,
        "description": "The response should include management of hand-foot syndrome, including the use of lanolin-based creams.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of lanolin-based creams."
      },
      {
        "criterion_number": 9,
        "description": "The response should include management of hand-foot syndrome, including the use of supportive footwear.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Supportive footwear is not discussed."
      },
      {
        "criterion_number": 10,
        "description": "The response should include management of hand-foot syndrome, including the use of gloves at night.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Gloves at night are not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response should include management of hand-foot syndrome, including avoiding friction on affected areas.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Avoiding friction is not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response should include management of hand-foot syndrome, including dose reduction of chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends dose adjustment/temporary pause for severe skin problems, which includes dose reduction."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe radiation dermatitis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Radiation dermatitis is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe management of radiation dermatitis, including the use of creams approved by the radiation team.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of radiation dermatitis or radiation team-approved creams."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe management of radiation dermatitis, including avoiding sun exposure.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of sun avoidance in the context of radiation dermatitis."
      },
      {
        "criterion_number": 16,
        "description": "The response explicitly names at least one chemotherapy agent as a cause of skin changes, such as gemcitabine, FOLFIRINOX, or nab-paclitaxel.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly names 5-fluorouracil, capecitabine, and taxanes as causing skin changes."
      },
      {
        "criterion_number": 17,
        "description": "The response lists at least four distinct manifestations of chemotherapy-related skin changes, with at least two from the specified list.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists dryness, rashes, sensitivity, redness, and hand-foot syndrome (\u22654 manifestations; includes common items from standard lists)."
      },
      {
        "criterion_number": 18,
        "description": "The response states that skin changes may also be due to other causes such as infection, other medications, or unrelated skin disorders/systemic diseases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state alternative etiologies; mentions infection only as a warning sign, not as a potential cause of the skin changes."
      },
      {
        "criterion_number": 19,
        "description": "The response states that prevention of skin problems is important and should begin at or before therapy initiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit mention of preventive measures starting at or before therapy initiation."
      },
      {
        "criterion_number": 20,
        "description": "The response recommends using gentle, pH-balanced cleansers, regular moisturization, and broad-spectrum sun protection.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Recommends mild, soap-free cleansers and moisturizers but does not specify pH-balanced or broad-spectrum sun protection."
      },
      {
        "criterion_number": 21,
        "description": "The response mentions prophylactic cooling measures during taxane infusions for hand-foot syndrome, supported by guidelines or evidence.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of prophylactic cooling during taxane infusions."
      },
      {
        "criterion_number": 22,
        "description": "The response states that correct identification of skin changes is important to ensure appropriate management and to avoid unnecessary discontinuation of effective cancer therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Emphasizes identifying the cause and tailoring management but does not state avoidance of unnecessary discontinuation."
      },
      {
        "criterion_number": 23,
        "description": "The response recommends hydration with emollients, topical corticosteroids, antihistamines, and oatmeal baths for dry skin and itch.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions moisturizers, topical steroids, and antihistamines but does not include oatmeal baths."
      },
      {
        "criterion_number": 24,
        "description": "The response states that for acne-like rash, oral tetracyclines and topical steroids are effective treatments.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Acneiform rash management with oral tetracyclines is not discussed."
      },
      {
        "criterion_number": 25,
        "description": "The response states that for hand-foot syndrome, urea creams, topical steroids, and cooling procedures are beneficial.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention urea creams, topical steroids for HFS, or cooling procedures for HFS."
      },
      {
        "criterion_number": 26,
        "description": "The response states that mild immune-related rashes can be managed with topical corticosteroids, urea-containing creams, and antihistamines for pruritus.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Immune-related rash management is not outlined; no mention of urea-containing creams for this context."
      },
      {
        "criterion_number": 27,
        "description": "The response states that severe immune-related rashes can be managed with systemic corticosteroids and, if refractory, immunomodulators, and that therapy interruption may be necessary for severe reactions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of systemic corticosteroids/immunomodulators for severe immune-related rashes or therapy interruption in this context."
      }
    ],
    "question_number": 160,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:09:03.800354",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the tumor microenvironment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines the tumor microenvironment (cells, molecules, extracellular matrix) and explains its role in tumor growth, spread, and treatment response."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that the tumor microenvironment in pancreatic cancer critically influences both treatment options and outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that understanding the TME is crucial for considering treatment options and outcomes in pancreatic cancer and links TME features to treatment efficacy."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that the pancreatic cancer tumor microenvironment has a dense desmoplastic stroma which can act as a physical barrier.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions a dense, abnormal TME impeding drug delivery, but does not specifically mention the characteristic desmoplastic stroma of pancreatic cancer or explicitly call it a physical barrier."
      },
      {
        "criterion_number": 4,
        "description": "The response should include a description of stromal cells, including fibroblasts.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies stromal cells and specifically mentions fibroblasts as connective tissue cells that can promote tumor growth."
      },
      {
        "criterion_number": 5,
        "description": "The response should include a description of stromal cells, including pancreatic stellate cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Pancreatic stellate cells are not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should include a description of immune cells within the tumor microenvironment of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes immune cells as pro\u2011 or anti\u2011tumor and discusses their role in modulating immunotherapy responses in pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer can be immunosuppressive.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly states that many pancreatic tumors create an immunosuppressive TME hindering effective immune responses."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the tumor microenvironment architecture creates physical and biochemical barriers that limit drug delivery, promote immune evasion, and drive resistance to chemotherapy, targeted therapy, and immunotherapy.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Notes difficult drug delivery due to dense TME, immune suppression limiting immunotherapy, and resistance mechanisms affecting chemotherapy and targeted therapy."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly states that the TME contributes to drug resistance and provides examples (immune suppression, stromal support, altered blood flow)."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in metastasis.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that the TME promotes angiogenesis and the spread of cancer cells (metastasis)."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in relapse.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention relapse or recurrence in relation to the TME."
      },
      {
        "criterion_number": 12,
        "description": "The response should include that drugs targeting the tumor microenvironment in pancreatic cancer have not yet shown benefit to patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses ongoing trials and TME\u2011targeting approaches but does not state that these have not yet shown patient benefit."
      },
      {
        "criterion_number": 13,
        "description": "The response should include that many studies are underway evaluating the role of tumor microenvironment-targeted therapies in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions ongoing clinical trials targeting the TME and combination regimens including TME\u2011modifying agents."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that current and emerging treatment strategies increasingly focus on remodeling the tumor microenvironment to improve therapeutic efficacy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Notes efforts to 'reprogram' the TME and the strategy of combining therapies to modify it to enhance treatment responses."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that locoregional therapies such as radiation and ablation may also alter the tumor microenvironment, increasing antigen presentation and immune response.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss radiation, ablation, or their effects on antigen presentation or immune activation."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly encourages discussion with the oncology team and offers to help prepare questions."
      }
    ],
    "question_number": 161,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:10:09.599415",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Pet therapy can offer emotional benefits for patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly notes emotional support, comfort, reduced loneliness, and improved mood from pet therapy."
      },
      {
        "criterion_number": 2,
        "description": "Pet therapy can offer psychological benefits for patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions reduced stress and anxiety, potential help with depression, and release of endorphins/oxytocin."
      },
      {
        "criterion_number": 3,
        "description": "Treatment of cancer can cause immune suppression.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that chemotherapy often weakens the immune system, increasing infection risk."
      },
      {
        "criterion_number": 4,
        "description": "Pets can carry diseases that can harm immunosuppressed people.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It highlights infection risks from animals (bites, scratches, bacteria in fur or saliva) for immunosuppressed patients."
      },
      {
        "criterion_number": 5,
        "description": "Patients should avoid exposing open wounds to pets or animals.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention precautions regarding open wounds."
      },
      {
        "criterion_number": 6,
        "description": "Patients should avoid exposing port sites to animals.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No guidance is provided about protecting port sites from animal exposure."
      },
      {
        "criterion_number": 7,
        "description": "Patients should discuss the safety of pet therapy with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It recommends consulting the oncologist and care team to assess risks and arrange certified pet therapy visits."
      },
      {
        "criterion_number": 8,
        "description": "Pet therapy visits are beneficial and generally safe for patients undergoing treatment for pancreatic cancer when conducted with certified therapy animals under appropriate infection control protocols.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response concludes pet therapy can be beneficial if conducted by certified teams with strict health/safety protocols and hygienic supervision."
      },
      {
        "criterion_number": 9,
        "description": "To reduce exposure to chemotherapy and radiation residues, patients should take precautions to limit the impacts on pets.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no mention of protecting pets from chemotherapy or radiation residues."
      },
      {
        "criterion_number": 10,
        "description": "Immunocompromised patients with pancreatic cancer receiving chemotherapy or radiation therapy should practice good hand hygiene after handling pets, avoid contact with pet waste, and prevent pets from licking open wounds.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Specific practices such as hand hygiene, avoiding pet waste, and preventing licking of open wounds are not discussed."
      },
      {
        "criterion_number": 11,
        "description": "If patients are severely immunosuppressed, they should avoid contact with young animals, reptiles, or exotic pets.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response does not advise avoiding young animals, reptiles, or exotic pets in severe immunosuppression."
      }
    ],
    "question_number": 162,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:10:43.420962",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing financial concerns with a social worker associated with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response explicitly advises engaging hospital/oncology social workers and states, 'Ask your oncology social worker about financial navigators who can help with insurance issues,' which directly addresses discussing financial concerns with a social worker on the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response should include information for the American Cancer Society Road to Recovery program.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It names the ACS Road to Recovery program, describes it as offering free rides to and from treatment, and provides a link."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information on travel grants through national patient advocacy organizations, including the Pancreatic Cancer Action Network.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although PanCAN is listed as a resource, the response does not state that PanCAN provides travel grants/assistance. It mentions other organizations' financial help, but the criterion specifically requires travel grant information including PanCAN."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing financial concerns with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Within the 'Insurance and Financial Assistance' section, it advises: 'Ask your oncology social worker about financial navigators who can help with insurance issues,' which constitutes discussing financial concerns with the oncology team."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend discussing financial concerns with a financial counselor associated with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It recommends connecting with 'financial navigators' via the oncology social worker. Financial navigators/counselors serve this role; the advice is clearly linked to the oncology team."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend discussing lodging assistance programs with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It states 'Hospital Social Workers... are experts in helping patients with transportation, lodging,' and encourages contacting the oncologist or hospital social worker, effectively recommending discussion of lodging assistance with the care team."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide information on travel grants through national patient advocacy organizations, including Cancer Care.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response names CancerCare and states it 'offers financial assistance for transportation, lodging, and other needs,' which satisfies the criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that resources include hospital-based transportation programs.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It notes that hospital social workers can help with transportation and suggests using hospital patient services teams/patient navigators, implying hospital-based transportation resources."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that resources include philanthropic or grant-funded travel assistance.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It cites CancerCare and PAN Foundation for financial assistance with travel and lodging, which are philanthropic/grant-funded supports."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that telemedicine is increasingly used to reduce the need for travel, allowing for virtual visits, remote symptom monitoring, and tele-rehabilitation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Telemedicine/telehealth and its role in reducing travel are not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that telehealth appointments are generally as effective as in-person visits for many aspects of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement about comparative effectiveness of telehealth versus in-person visits is included."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that telehealth offers benefits, including reduced travel burden, lower costs, decreased infection risk, and improved access to expertise.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No benefits of telehealth are discussed."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that telehealth may be less suitable for initial diagnosis, physical examinations, or sensitive discussions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No limitations or suitability considerations of telehealth are discussed."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention limitations of telehealth, including challenges with physical examination, technology barriers, and occasional concerns about reduced personal connection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No telehealth limitations are mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that the CDC recommends developing a personal travel health plan, ensuring adequate medication supply, and considering supplemental medical or evacuation insurance.",
        "score_given": 0,
        "max_points": 2,
        "justification": "CDC travel health planning, medication supply, and supplemental insurance are not addressed."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises, 'Ask the oncologist or hospital social worker about patient navigation services,' which recommends discussing the situation with an oncologist."
      }
    ],
    "question_number": 163,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:12:02.436883",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapies together.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states combination immunotherapy can involve using two or more immunotherapy drugs."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists checkpoint inhibitors plus chemotherapy (e.g., FOLFIRINOX) as an example."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with targeted therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes immunotherapy plus targeted therapy as an example."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with other new agents.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions combining with other agents that make tumors more visible and participation in trials testing new drugs."
      },
      {
        "criterion_number": 5,
        "description": "The response should include the definition of immunotherapy per the NCI definition of cancer terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It provides a general description of immunotherapy but does not cite or align with the specific NCI definition."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors are MSI high.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Pembrolizumab is mentioned as an example agent, but no approvals for MSI-H pancreatic cancer are noted."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors are mismatch repair deficient.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of dMMR-specific approval for pembrolizumab in pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors have a high tumor mutational burden.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of TMB-high indication for pembrolizumab."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that other immunotherapies are investigational.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It emphasizes that combination immunotherapy evidence is still developing and many approaches are being tested in clinical trials, indicating investigational status."
      },
      {
        "criterion_number": 10,
        "description": "The response should include information for clinicaltrial.gov for current trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Resources include ACS, PanCAN, and NCI but do not reference ClinicalTrials.gov."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend understanding what type of combination immunotherapy is being tested.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Under questions to ask, it says to clarify the specific combination therapy being recommended or offered in a trial."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend understanding the evidence behind the combination immunotherapy in the trial.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly recommends discussing the evidence supporting the approach."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend understanding the potential side effects of the combination immunotherapy in the trial.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It details potential side effects and includes a question about typical side effects and their management."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe eligibility criteria for clinical trials, including the stage of disease.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It notes that eligibility may be based on cancer stage among other factors."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe eligibility criteria for clinical trials, including the site of disease.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It does not mention disease site or location-specific eligibility."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe eligibility criteria for clinical trials, including prior treatments.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It includes previous treatments as part of trial eligibility criteria."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe eligibility criteria for clinical trials, including required testing.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Although it mentions genetics, it does not explicitly address required testing for eligibility."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that research trials explore whether a new medical strategy, treatment, or device is safe and effective for humans.",
        "score_given": 0,
        "max_points": 4,
        "justification": "It does not state that trials assess safety and effectiveness in humans."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 4,
        "justification": "While it says many advances occur through trials, it does not explicitly state that trials are essential for optimizing current and future therapies."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that trials are divided into phases (phase I - phase IV).",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention of trial phases."
      },
      {
        "criterion_number": 21,
        "description": "The response should explain the different phases of clinical trials.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No explanation of trial phases is provided."
      },
      {
        "criterion_number": 22,
        "description": "The response should mention that current research on immunotherapy combinations for pancreatic cancer is focused on overcoming the immunosuppressive tumor microenvironment and enhancing antitumor immune responses.",
        "score_given": 0,
        "max_points": 6,
        "justification": "It notes tumors are 'cold' and aims to overcome immune resistance, but does not explicitly reference the immunosuppressive tumor microenvironment or enhancing antitumor responses."
      },
      {
        "criterion_number": 23,
        "description": "The response should mention promising strategies include combining immunotherapy with chemotherapy, TME-modifying agents, and other immune stimulants.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Chemotherapy combinations are mentioned, but TME-modifying agents and immune stimulants are not."
      },
      {
        "criterion_number": 24,
        "description": "The response should mention that neoadjuvant immunotherapy combinations are being tested to prime the immune system before surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of neoadjuvant immunotherapy before surgery."
      },
      {
        "criterion_number": 25,
        "description": "The response should mention that cancer vaccines are under investigation as an approach for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cancer vaccines are not discussed."
      },
      {
        "criterion_number": 26,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking the oncologist about trials and emphasizes working with the medical team and seeking second opinions."
      }
    ],
    "question_number": 164,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:12:58.689267",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the current treatment plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises to work closely with the oncology team to understand the treatment plan and to request written summaries/care plans."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing the treatment schedule with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States to organize medical and treatment schedules and to work closely with the oncology team; suggests obtaining written summaries to coordinate scheduling, which implies discussing the schedule."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend open communication with the care team about work, family, and personal goals.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages working closely with the oncology team and asking for written care plans to coordinate with employers/family, indicating open communication about life needs."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend open communication with work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly advises speaking with HR/supervisors about flexible hours, remote work, and medical leave options."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding side effects of treatments.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically recommends understanding potential side effects that might impact daily life."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the timing of side effects.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention timing or typical onset windows of side effects; only references tracking recovery periods."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend utilizing a support system, including talking with a social worker.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions social work services at cancer centers and recommends support groups and counseling."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend utilizing a support system, including talking with a patient navigator.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not mention patient navigators."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that early referral to palliative care is recommended for symptom management, emotional support, and caregiver assistance, and is not synonymous with hospice.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of palliative care or distinction from hospice."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that practical strategies for managing treatment schedules include leveraging telehealth, app-based, and telephone support to increase flexibility and reduce travel burden.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not reference telehealth or telephone-based clinical support; mentions a calendar app for organization, which does not meet the criterion."
      }
    ],
    "question_number": 165,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:13:24.960262",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention that treatment-related mouth problems, particularly oral mucositis, are common in patients with pancreatic cancer receiving chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states mucositis/stomatitis are common during chemotherapy or radiation, especially for pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing their mouth problems with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises consulting the oncology team, regular check-ins, and contacting the medical team urgently for severe issues."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend maintaining good oral hygiene.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides specific oral hygiene measures (soft toothbrush, gentle brushing, flossing, mouth rinses)."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that meeting with an oral medicine provider can be helpful.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends evaluation by a dentist/oral surgeon experienced with cancer patients and follow-up with dental care."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend staying hydrated.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Suggests sipping water and using saliva substitutes; mentions ice chips for moisture."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend getting regular dental care.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises a pre-treatment dental evaluation and ongoing follow-up with a dentist."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that oral cryotherapy (holding ice chips in the mouth during and after administration of agents such as 5-fluorouracil) is effective for prevention of mucositis for select chemotherapy regimens.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions ice chips for moisture but does not identify oral cryotherapy during specific chemotherapy infusions (e.g., 5-FU) as an evidence-based preventive measure."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that benzydamine mouthwash is supported for prevention, especially in patients receiving radiotherapy or chemoradiotherapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of benzydamine mouthwash."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that chlorhexidine mouthwash is not recommended for prevention in most adult cancer populations.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Suggests chlorhexidine as an option without stating it is not recommended for prevention, which is inaccurate per guidelines."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that bland mouth rinses (e.g., sodium bicarbonate or saline) are preferred for routine care and symptom management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends saline and saltwater rinses for routine care and soothing; aligns with bland rinses guidance."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that topical anesthetics and mixed medication mouthwashes may be used for pain control.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions topical anesthetics (lidocaine/benzocaine) but does not mention mixed medication mouthwashes (e.g., magic mouthwash, doxepin)."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that gabapentin may be considered for mucositis-related pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of gabapentin."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that topical and systemic antifungals are indicated for secondary candidiasis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address antifungal therapy or candidiasis."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that antibiotics are reserved for documented secondary bacterial infections.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Advises antibiotics for signs of infection generally without specifying reservation for documented bacterial infections."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that management often involves over-the-counter pain relief such as acetaminophen or ibuprofen.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically recommends acetaminophen or ibuprofen for pain control, with caution to check with the medical team."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that multidisciplinary and supportive care is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes coordination with oncology, dental providers, and a speech-language pathologist; underscores tailored care by the team."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that management could include dietary adjustments such as soft or liquid diets, small frequent meals, and nutritional support.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends soft foods, liquid meals, avoiding irritants, and considering nutritional supplements or feeding tubes with dietitian support."
      }
    ],
    "question_number": 166,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:14:20.320693",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define minimal residual disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines minimal residual disease as small numbers of cancer cells that remain after treatment and may not be visible on imaging, and explains detection via markers/genetic material in blood (ctDNA/CTCs)."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that minimal residual disease testing in pancreatic cancer is investigational.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States MRD testing is not yet standard for every pancreatic cancer patient and is often available at specialized centers or via clinical trials, which conveys its investigational status."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing minimal residual disease testing with an oncologist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly recommends discussing MRD testing with the mother's oncologist and offers to help prepare questions."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that NCCN guidelines do not recommend minimal residual disease testing in pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention NCCN guidelines or state that NCCN does not recommend MRD testing in pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that insurance may not cover minimal residual disease testing.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of insurance coverage or potential lack thereof for MRD testing."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that postoperative ctDNA positivity is associated with a higher risk of early recurrence and worse survival in resected pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes MRD positivity predicts recurrence, it does not specifically address postoperative ctDNA positivity, early recurrence, or worse survival in resected pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that serial minimal residual disease testing can provide dynamic risk stratification.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not discuss serial testing or dynamic risk stratification over time."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that minimal residual disease testing may identify patients who could benefit from intensified surveillance or additional therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States MRD can guide treatment decisions, influence whether additional treatments are needed, and help tailor follow-up care, aligning with the concept of identifying patients for intensified surveillance or additional therapy."
      }
    ],
    "question_number": 167,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:14:51.369057",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend asking the oncology team for spiritual care professionals.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly advises asking the loved one\u2019s care team to connect them with a chaplain or spiritual counselor."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend reaching out to local places of worship.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Clearly recommends contacting one's place of worship or faith community for support."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend reaching out to community support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions support groups through organizations (ACS, CancerCare) and suggests community-based support options."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend national cancer support organizations, including the American Cancer Society.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically names the American Cancer Society as a resource."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend national cancer support organizations, including Cancer Care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically names CancerCare as a resource."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that spiritual counseling and support can be accessed through hospital-based chaplaincy services.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States that hospitals and cancer centers often have chaplaincy/spiritual care services and suggests connecting via the care team."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that spiritual counseling and support can be accessed through interdisciplinary palliative care teams.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention palliative care teams; references hospice groups but not interdisciplinary palliative care."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that interventions such as prayer, mindfulness/meditation, and facilitated sessions with trained providers, including both individual and group formats, have demonstrated benefits for spiritual well-being, hope, and meaning in cancer care.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions mindfulness-based approaches and support groups but does not state evidence of demonstrated benefits nor include prayer and individual vs group formats explicitly."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that cancer.net and the Pancreatic Cancer Action Network (pancan.org) provide high-quality information and support services.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not reference Cancer.Net or the Pancreatic Cancer Action Network."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Suggests talking to the care team but does not specifically recommend discussing with an oncologist."
      }
    ],
    "question_number": 168,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:15:34.774297",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend learning about pancreatic cancer, including diagnosis",
        "score_given": 0,
        "max_points": 2,
        "justification": "The response does not advise the caregiver to learn about the diagnosis specifics or provide guidance on understanding the diagnostic process."
      },
      {
        "criterion_number": 2,
        "description": "Recommend learning about pancreatic cancer, including staging",
        "score_given": 0,
        "max_points": 2,
        "justification": "Staging is not mentioned; there is no recommendation to learn about or discuss staging."
      },
      {
        "criterion_number": 3,
        "description": "Recommend learning about pancreatic cancer, including treatment options",
        "score_given": 0,
        "max_points": 2,
        "justification": "Treatment options are not explicitly discussed or recommended as a topic to learn about."
      },
      {
        "criterion_number": 4,
        "description": "Recommend national patient support resources, including PanCAN",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly recommends national organizations, including the American Cancer Society and the Pancreatic Cancer Action Network (PanCAN)."
      },
      {
        "criterion_number": 5,
        "description": "Recommend open communication within the couple and with the care team",
        "score_given": 8,
        "max_points": 8,
        "justification": "It explicitly encourages the couple to \"Talk openly\" and to \"Work closely with your healthcare team,\" supporting communication on both fronts."
      },
      {
        "criterion_number": 6,
        "description": "Recommend building a support system",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises delegating tasks to friends/family, joining support groups, connecting with organizations, and using online communities."
      },
      {
        "criterion_number": 7,
        "description": "Explicitly state that significant lifestyle changes are common for both patients and spouses/partners after a pancreatic cancer diagnosis",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states pancreatic cancer brings lifestyle changes and notes, \"Many people face similar situations,\" addressing both the patient and spouse (\u201cyou and your husband\u201d) and normalizing these changes."
      },
      {
        "criterion_number": 8,
        "description": "Explicitly mention at least two: uncertainty about the future, role changes, emotional upheaval, or altered daily routines",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions emotional upheaval (\"Share your fears, hopes, and frustrations\") and altered daily routines (\"Establish routines,\" \"Plan for fatigue,\" and adjust activities)."
      },
      {
        "criterion_number": 9,
        "description": "Recommend early integration of supportive and/or palliative care",
        "score_given": 0,
        "max_points": 8,
        "justification": "Supportive/palliative care is not mentioned; counseling and social work are discussed but not framed as early palliative/supportive care integration."
      },
      {
        "criterion_number": 10,
        "description": "State that palliative/supportive care should be offered to all patients regardless of stage or prognosis",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement is made about universal offering of palliative/supportive care irrespective of stage."
      },
      {
        "criterion_number": 11,
        "description": "State that both dietary and exercise interventions are important for quality of life and optimizing outcomes",
        "score_given": 0,
        "max_points": 5,
        "justification": "While nutrition and gentle exercise are recommended, the response does not explicitly connect both to maintaining quality of life and optimizing outcomes."
      },
      {
        "criterion_number": 12,
        "description": "State that regular exercise and healthy lifestyle changes are associated with improved physical and psychological outcomes",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response suggests gentle exercise but does not explicitly state associations with improved physical and psychological outcomes."
      },
      {
        "criterion_number": 13,
        "description": "Recommend discussing the case with an oncologist",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly advises to \"Work closely with your healthcare team. Oncologists...\" indicating discussion and coordination with the oncologist."
      }
    ],
    "question_number": 169,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:16:28.121450",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe tumor heterogeneity, including diverse genetic, epigenetic, transcriptomic, and microenvironmental features both between patients (inter-tumoral) and within a single tumor (intra-tumoral).",
        "score_given": 0,
        "max_points": 8,
        "justification": "The response defines heterogeneity and mentions genetic differences, growth patterns, and intra- vs. inter-patient variability, but does not address epigenetic, transcriptomic, or microenvironmental features."
      },
      {
        "criterion_number": 2,
        "description": "Include that tumor heterogeneity can include differences in genetic mutations within a tumor.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly states that within a single tumor there can be differences in genetic mutations among cancer cells (intra-tumor heterogeneity)."
      },
      {
        "criterion_number": 3,
        "description": "Include that tumor heterogeneity can include differences in genetic mutations between tumor sites.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While inter-patient (inter-tumor) variability is mentioned, differences in mutations between tumor sites within the same patient (e.g., primary vs. metastatic sites) are not specifically addressed."
      },
      {
        "criterion_number": 4,
        "description": "Include that tumor heterogeneity can include differences in cellular growth between cancer sites.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response references differences in growth patterns among cells but does not tie this to differences between distinct cancer sites."
      },
      {
        "criterion_number": 5,
        "description": "Include that tumor heterogeneity can include differences in microenvironment between tumor sites.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Microenvironmental heterogeneity between sites is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "Mention that tumor heterogeneity is a major driver of variable treatment response, therapy resistance, and clinical outcomes in pancreatic ductal adenocarcinoma.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It links heterogeneity to resistance to treatment, variable responses, disease progression, and difficulty predicting prognosis in pancreatic cancer, satisfying the intent despite not naming PDAC explicitly."
      },
      {
        "criterion_number": 7,
        "description": "Include that tumor heterogeneity is thought to contribute to drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Clearly states that some subpopulations are more resistant and can survive treatment, leading to regrowth and more resistant disease."
      },
      {
        "criterion_number": 8,
        "description": "Include that tumor heterogeneity is thought to contribute to the use of multiple chemotherapy agents.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Although combination therapies are suggested, the response does not specifically state that heterogeneity leads to using multiple chemotherapy agents."
      },
      {
        "criterion_number": 9,
        "description": "Mention that phenotypic plasticity allows tumor cells to shift between subtypes, especially under therapeutic or microenvironmental stress, contributing to acquired resistance and disease progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Phenotypic plasticity and subtype switching under stress are not discussed."
      },
      {
        "criterion_number": 10,
        "description": "Mention that tumor heterogeneity limits the effectiveness of one-size-fits-all approaches and underlies the need for molecular profiling and personalized treatment strategies.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It highlights the limitations of single-target therapies, advocates for personalized/adaptive treatment, and recommends comprehensive genomic profiling."
      },
      {
        "criterion_number": 11,
        "description": "Recommend discussing genetic testing with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises asking the oncologist about the tumor\u2019s genetic profile and comprehensive genomic testing."
      },
      {
        "criterion_number": 12,
        "description": "Mention that research efforts focus on integrating genomic, transcriptomic, and single-cell analyses to better classify tumors and guide therapy selection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Research efforts involving transcriptomics and single-cell analyses are not mentioned; only genomic profiling and liquid biopsies are cited."
      },
      {
        "criterion_number": 13,
        "description": "Recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly encourages discussing details with the oncologist and emphasizes conversations with the medical team."
      }
    ],
    "question_number": 170,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:17:19.385258",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include the definitions of different types of research studies, including randomized clinical trials and observational studies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it lists categories like therapeutic, diagnostic, QoL/supportive care, and biomarker studies, it does not define randomized clinical trials or observational studies and does not explain these study designs."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain that not all research studies are clinical trials, and some explore ancillary aspects of cancer care such as symptom control or mental health.",
        "score_given": 0,
        "max_points": 6,
        "justification": "It mentions quality-of-life/supportive care studies but frames them within clinical trials and does not explicitly state that not all research studies are clinical trials or discuss non-trial ancillary research (e.g., mental health studies)."
      },
      {
        "criterion_number": 3,
        "description": "The response should include links and references to informational websites about clinical trials being held across the United States, such as the National Cancer Institute (NCI).",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides national resources and links (ClinicalTrials.gov, American Cancer Society, PanCAN) that list U.S. clinical trials. Although NCI is not specifically cited, the criterion is met by including appropriate national resources."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient ask their oncologist about locations where clinical trials are being held and consider a referral to institutions where trial participation is possible.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises speaking with the oncologist about eligibility and recommendations but does not explicitly suggest asking about trial locations or requesting a referral to another institution."
      },
      {
        "criterion_number": 8,
        "description": "The response should include definitions of phases 1, 2, and 3 clinical trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion or definitions of trial phases are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that clinical trials are most commonly done at academic medicine institutions.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It highlights academic medical centers/cancer hospitals (e.g., MD Anderson, MSK, Dana-Farber, Johns Hopkins, UCSF) as places with ongoing trials, indicating trials are commonly conducted at such institutions."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that clinical trials may include an experimental treatment or placebo, and the efficacy may not be known as compared to standard of care treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises asking about risks/benefits but does not mention experimental treatments, placebos, or the uncertainty of efficacy versus standard of care."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly mention clinical trials as a research opportunity.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clinical trials are explicitly and repeatedly mentioned as a key research opportunity."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly mention patient registries or biorepositories as opportunities for further studies.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no mention of patient registries, biobanks, or biorepositories."
      }
    ],
    "question_number": 171,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:18:09.414085",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe how cells that acquire mutations that can go on to form a cancer in our bodies can evade the immune system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explains that cancer cells can hide from the immune system or shut it down and that pancreatic tumors create an immunosuppressive environment that prevents immune cells from recognizing or entering the tumor."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the immune system\u2019s role in protecting the body from mutated cells that have oncogenic potential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states that the immune system defends against abnormal cells and that immune cells normally recognize and destroy cancerous cells."
      },
      {
        "criterion_number": 3,
        "description": "The response should include a definition of immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Immunotherapy is defined as treatments that help the immune system fight cancer more effectively, which is a correct, clear definition."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the mechanism of action of immunotherapies in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanisms are described for checkpoint inhibitors (releasing immune brakes via PD-1/CTLA-4 blockade), cancer vaccines (training the immune system), CAR-T cells (genetically modifying T cells to recognize cancer), and combination strategies to prime tumors."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe features of pancreatic cancer that make this malignancy difficult to treat with immunotherapy.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It notes pancreatic cancer\u2019s immunosuppressive tumor microenvironment, immune cell exclusion, and historically poorer responses to checkpoint inhibitors, all of which make immunotherapy challenging."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that there is research being done on the role of the immune system in pancreatic cancer treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response references ongoing research, early trials for vaccines and CAR-T, and suggests considering clinical trials, indicating active investigation."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient speak with his/her oncologist about clinical trials that might utilize immunotherapy for pancreatic cancer, or consider a referral to a center that does clinical trials.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions that clinical trials are an option and provides a resource, it does not explicitly recommend discussing clinical trials with the oncologist or seeking referral to a trials center."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that a limited number of pancreatic cancer cases have features that do make it respond to immunotherapy, such as MSI-H or mismatch repair deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that some patients benefit when tumors have certain features, explicitly mentioning MSI-H and noting biomarker testing for MSI-H or DNA repair defects, implying a limited subset responds."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that they should ask the oncologist if her mother\u2019s tumor has MSI-H or mismatch repair deficiency.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although biomarker testing is discussed and MSI-H is mentioned, it does not explicitly instruct the reader to ask the oncologist whether the tumor is MSI-H or mismatch repair deficient."
      }
    ],
    "question_number": 172,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:19:03.818048",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define caregiver burnout as physical, emotional, and mental exhaustion, and normalize it as common.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response notes caregiving is emotionally and physically exhausting and normalizes burnout as common, but it does not explicitly include 'mental' exhaustion as part of the definition."
      },
      {
        "criterion_number": 2,
        "description": "Link to no-cost support services for caregivers, such as support groups or online peer groups.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It links to multiple free resources and support groups (American Cancer Society, PanCAN, CancerCare, Cancer Support Community) and mentions helplines and online communities."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly mention insurance-covered caregiver assistance and advise inquiring with the insurance carrier about coverage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions social workers who help navigate insurance, it does not state that caregiver assistance may be insurance-covered nor advise contacting the insurance carrier to verify coverage."
      },
      {
        "criterion_number": 5,
        "description": "Provide resources for mental wellbeing, specifically mentioning therapists through Psychology Today\u2019s website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Therapy/counseling is recommended, but Psychology Today is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "Describe using family members and friends to help with caretaking responsibilities.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly advises asking friends and family for help and provides examples (meals, rides, listening)."
      },
      {
        "criterion_number": 7,
        "description": "Recommend reaching out to the oncology team to inquire if social work resources can help determine if in-home or respite services are financially covered by the patient\u2019s insurance.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it mentions social workers at cancer centers, it does not direct contacting the oncology team nor discuss assessing insurance coverage for in-home or respite services."
      },
      {
        "criterion_number": 8,
        "description": "Mention that Hospice services offer varying degrees of in-home support and caregiver support, if/when appropriate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hospice is mentioned as potentially providing 'some assistance,' but it does not specify varying degrees of in-home support or caregiver support."
      },
      {
        "criterion_number": 9,
        "description": "State that there are options for professional caregiver support to give a break to family members/loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Respite care is described as temporary care to give a break, with hospitals and home health agencies as sources, meeting the criterion."
      },
      {
        "criterion_number": 10,
        "description": "State that palliative care involvement can help optimize symptom management and reduce caregiver burden.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Palliative care is not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "State they should make sure to take time for self-care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a dedicated 'Self-Care Strategies' section encouraging breaks, boundaries, and prioritizing well-being."
      }
    ],
    "question_number": 173,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:19:43.199127",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should explain what liquid biopsies are and how they are different from traditional biopsies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines liquid biopsy as blood-based testing and contrasts it with traditional tissue biopsies, noting invasiveness and risk differences."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that \u201cliquid biopsy\u201d involves taking a sample of blood to analyze either circulating tumor DNA or circulating tumor cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states it is a blood draw and mentions analysis of circulating tumor DNA (ctDNA)."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain the different uses of liquid biopsies in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes multiple uses: detecting presence/changes, monitoring treatment response, identifying mutations, and reducing need for repeat tissue biopsies."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention if liquid biopsy is FDA approved for any uses in pancreatic adenocarcinoma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address FDA approval status for pancreatic adenocarcinoma."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe that liquid biopsies are used as an adjunct to traditional cancer monitoring techniques.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that liquid biopsy is used alongside standard monitoring (e.g., imaging); frames it primarily as a less invasive alternative."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that this is not sufficient to establish whether or not the cancer is responding to treatment and that it has to be used in addition to imaging tests.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that imaging is required or that liquid biopsy alone is insufficient to establish response."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe advantages of liquid biopsy over traditional biopsy, but should state that liquid biopsy cannot be used to diagnose cancer at this time.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Advantages (less invasive, avoids repeated biopsies) are described, but it does not state that liquid biopsy cannot be used to diagnose cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe that liquid biopsies can provide information about the genetic mutations in a cancer which can impact treatment options.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly notes detection of genetic changes that can guide treatment selection or explain resistance."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the role of liquid biopsy in cancer care is being heavily studied.",
        "score_given": 0,
        "max_points": 11,
        "justification": "Does not mention ongoing research or that the field is under active investigation."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that liquid biopsy meaningfulness is different across cancer types and sometimes among patients with the same cancers, as some tumors do not shed material as much as others.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of variability in tumor shedding or differences across and within cancer types."
      },
      {
        "criterion_number": 14,
        "description": "The response should also state that the approach is not established as standard of care and would likely be offered in the context of a research study.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions it is not standard of care for all pancreatic cancer patients but does not state that it would likely be offered in a research study context."
      }
    ],
    "question_number": 174,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:20:38.596096",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should emphasize the importance of managing treatment and disease-related side effects to preserve independence and quality of life.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it focuses on autonomy and safety, it does not explicitly emphasize managing treatment or disease-related side effects to preserve independence."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the expected side effects of pancreatic cancer treatment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No specific treatment side effects (e.g., fatigue, nausea, neuropathy) are described."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe common symptoms that patients experience from pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Common disease symptoms (e.g., jaundice, weight loss, pain, steatorrhea) are not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response should suggest ways to use technology to help with everyday tasks in the home.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends alarms/smartphone apps for medication reminders and telehealth to reduce travel burden."
      },
      {
        "criterion_number": 5,
        "description": "The response should suggest ways to make modifications in the home to allow the patient to traverse and use their home independently.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests grab bars, non-slip mats, stair railings, removing tripping hazards, and adaptive tools to improve safety and independence."
      },
      {
        "criterion_number": 6,
        "description": "The response should emphasize the importance of maintaining autonomy and some control for the patient regarding their everyday tasks and life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Emphasizes involving the patient in decisions, respecting preferences, and allowing them to do as much as possible independently."
      },
      {
        "criterion_number": 7,
        "description": "The response should make recommendations for how to assist an individual suffering from pancreatic cancer treatment or disease-related side effects on their activities of daily living.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Provides concrete ADL strategies: prioritizing tasks, breaking tasks into steps, energy conservation, meal preparation support, medication management tools, and intermittent home health aide support."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of maintaining good mental health by the patient and caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights emotional/social support, cancer support groups, staying connected, and caregiver respite to prevent burnout."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention resources for in-home assistance such as paid caregivers or Hospice services.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions home health care, home health aides, hospice services, and local agencies as resources."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest asking the oncology team if there is social work support available, and/or if anyone can assist in determining if the patient\u2019s insurance will cover the cost of an in-home paid caregiver.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions social workers/patient navigators and financial assistance in general but does not explicitly advise asking the oncology team or address insurance coverage for in-home caregivers."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that physical independence can be promoted by maintaining strength with rehab and exercises.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of physical therapy, occupational therapy, or exercise/strengthening to maintain independence."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that assistance devices and equipment such as shower chairs and grabbing bars can be used to help maintain independence.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions grab bars and other adaptive tools; meets the assistive devices criterion."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that emotional support including participating in patient groups is another good way of maintaining independence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages emotional support and joining cancer support groups to reduce isolation and receive practical advice."
      }
    ],
    "question_number": 175,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:21:31.062313",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include a definition of genetic testing for heritable cancer syndromes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explains that genetic testing provides information about hereditary cancer syndromes and can identify mutations that can be looked for in relatives, effectively defining genetic testing in the hereditary context."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that genetic testing for inherited mutations is recommended for all patients with pancreatic adenocarcinoma at diagnosis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not state universal germline testing for all patients with pancreatic adenocarcinoma at diagnosis; it only suggests testing be 'considered' after diagnosis and does not specify adenocarcinoma."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient discuss genetic testing for inherited cancer syndromes and molecular testing of tumor tissue with their oncologist and oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises consultation with a genetic counselor and discussion with the medical team, it does not mention molecular/tumor tissue testing or explicitly recommend discussing both germline and tumor testing with the oncology team."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe why family members at risk of inheriting a genetic mutation should be aware if they have it.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that results can impact decisions about family planning, cancer screening, and prophylactic surgery, explaining why knowing mutation status matters to at-risk relatives."
      },
      {
        "criterion_number": 7,
        "description": "The response should list cancer syndromes and mutated genes that are associated with an increased risk of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists BRCA2, PALB2, Lynch syndrome, CDKN2A, and ATM, which are associated with increased pancreatic cancer risk."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly mention that BRCA1 and BRCA2 testing can be considered, particularly if there are other first-degree relatives with malignancies such as breast or prostate cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "BRCA2 is mentioned but BRCA1 is not, and there is no explicit statement about considering BRCA1/2 testing in the context of first-degree relatives with breast or prostate cancer."
      },
      {
        "criterion_number": 11,
        "description": "If a patient\u2019s genetic testing for inherited mutations returns positive for a pathogenic mutation or they have a strong family history for cancer (regardless of mutation status), they should be referred to a genetic counselor.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it recommends seeing a genetic counselor in general, it does not explicitly state referral specifically when testing is positive for a pathogenic mutation or when there is a strong family history."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that some family members of a patient with a positive pathogenic mutation may be at increased risk for certain cancers and should consider genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that if a mutation is found, testing can be offered to at-risk relatives and explains that hereditary syndromes increase risk of pancreatic and other cancers, satisfying the requirement."
      }
    ],
    "question_number": 176,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:22:34.938705",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the phenomenon known as \u201cchemo-brain,\u201d or cognitive issues experienced by individuals undergoing chemotherapy treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly names 'chemo brain' and describes symptoms (memory, attention, concentration, executive function) as part of cancer treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that treatment-related cognitive changes are a known side effect of treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States these cognitive changes are a 'real and challenging side effect' for many undergoing cancer treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should include information about impaired cognition related to chemotherapy treatment and how long it is expected to last once treatment is completed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that symptoms often improve after treatment ends, may resolve within months, or persist for a year or longer."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the cognitive changes can be from the chemotherapy drugs or from the cancer itself.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions chemotherapy and other factors (fatigue, anxiety, depression, hormonal/metabolic issues) but does not explicitly state that the cancer itself can cause cognitive changes."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that some medications, such as opioids, used for symptom management can cause depressed cognition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention opioids or other symptom-management medications as contributors to cognitive impairment."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that other etiologies of impaired cognition may also be present, such as organ dysfunction, age-related cognitive decline, poor nutritional status, or medication side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically notes other potential causes (fatigue, anxiety, depression, hormonal changes, and 'metabolic issues'), fulfilling the requirement to acknowledge other etiologies."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that depression is related to cognitive impairment, especially in the elderly population.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies depression as a contributor to cognitive symptoms and recommends screening for it, satisfying the core of this criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some causes of cognitive impairment are reversible, while others are not.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'some improvement is common' and 'not all are fully reversible,' directly addressing partial reversibility."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient or family member discuss cognitive impairment with the patient\u2019s oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing symptoms with the oncology team and supportive care specialists."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that symptoms can be managed with \u201ccognitive rehabilitation,\u201d which can include exercises such as puzzles and word games.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends cognitive rehabilitation and mental stimulation; while it doesn\u2019t list puzzles/word games explicitly, it clearly endorses cognitive rehab."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that optimizing lifestyle changes, such as good sleep and exercise, can help manage symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends physical exercise, good sleep, mental stimulation, and healthy diet as supportive strategies."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that in some cases, the treatment team may consider prescribing a stimulant such as methylphenidate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of stimulant medications like methylphenidate."
      }
    ],
    "question_number": 177,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:23:37.171201",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe what cancer stem cells are.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines CSCs as a small subpopulation within a tumor with self-renewal and differentiation abilities and ability to initiate tumor growth."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the role that cancer stem cells play in tumorigenesis and metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States CSCs drive tumor growth and progression and are involved in metastasis and recurrence, explaining their role in tumorigenesis and spread."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe what is known about cancer stem cells in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically addresses PDAC: CSCs are a small fraction that drive growth, are more treatment-resistant, and may mediate metastasis and recurrence."
      },
      {
        "criterion_number": 5,
        "description": "The response should reference research on pancreatic cancer stem cells and include real citations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides a peer-reviewed PMC link on pancreatic cancer stem cells and reputable sources (ACS, NCI)."
      },
      {
        "criterion_number": 6,
        "description": "The response should clearly state what is known about how pancreatic cancer stem cells affect treatment efficacy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that CSCs are more resistant to chemo/radiation, may survive treatment, and contribute to recurrence, impacting efficacy."
      },
      {
        "criterion_number": 9,
        "description": "Must state CSCs are a subpopulation with self-renewal and differentiation, and clearly mention persistence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes CSCs are a subpopulation with self-renewal/differentiation and that they can survive treatment and cause recurrence (persistence)."
      },
      {
        "criterion_number": 10,
        "description": "Must state CSCs are more resistant to conventional therapies and mention at least two mechanisms (e.g., quiescence, efflux pumps, DNA repair, microenvironment).",
        "score_given": 0,
        "max_points": 7,
        "justification": "States increased resistance and mentions slow division/quiescence, but does not mention a second mechanism such as efflux pumps, enhanced DNA repair, or microenvironmental protection."
      },
      {
        "criterion_number": 12,
        "description": "Must state there are currently no standard of care treatments directly targeting CSCs, but it is an active area of research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states there are no standard CSC-targeting treatments in pancreatic cancer and that research is ongoing."
      }
    ],
    "question_number": 178,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:24:15.474163",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe different types of support groups such as in-person, virtual, and telephone.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions in-person and online/virtual options but does not mention telephone-based support groups."
      },
      {
        "criterion_number": 2,
        "description": "List resources with website links (e.g., PanCAN, NCI, NCCN) that provide free or insurance-covered support group information.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides multiple linked resources including PanCAN (pancan.org), ACS (cancer.org), Gilda's Club (gildasclub.org), CancerCare (cancercare.org), Smart Patients, and Inspire. Gilda\u2019s Club explicitly noted as free."
      },
      {
        "criterion_number": 3,
        "description": "Recommend inquiring with the oncology team about support group resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises asking the oncology team for recommendations."
      },
      {
        "criterion_number": 4,
        "description": "Describe the importance of maintaining mental health support for patients and caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights caregiver support groups and therapy/counseling groups focusing on coping skills and emotional well-being."
      },
      {
        "criterion_number": 5,
        "description": "Mention websites for people to find support groups local to their home.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists ACS, PanCAN, and Gilda\u2019s Club websites, which can help locate local resources; also mentions CancerCare and other directories."
      },
      {
        "criterion_number": 6,
        "description": "Mention ways in which support groups can be helpful.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes emotional, practical, and informational help; discussion of treatment, side effects, coping strategies; caregiver advice."
      },
      {
        "criterion_number": 7,
        "description": "Normalize the use of support groups for people affected by cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States seeking support is a wise and important step and reassures they don\u2019t have to go through it alone."
      },
      {
        "criterion_number": 8,
        "description": "State that support groups can be used at different cancer stages and that mental health challenges can occur during survivorship.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention different cancer stages or survivorship-related mental health challenges."
      },
      {
        "criterion_number": 9,
        "description": "Emphasize that support groups can help people feel less isolated or alone.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Conveys that they don\u2019t have to go through this alone in the context of support groups, emphasizing reduced isolation."
      },
      {
        "criterion_number": 10,
        "description": "Mention that faith-based support groups exist.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of faith-based support groups."
      },
      {
        "criterion_number": 11,
        "description": "State that support groups are not a substitute for mental health services if depressed, and describe what depression is.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not address depression or clarify that support groups are not a substitute for clinical mental health care."
      },
      {
        "criterion_number": 12,
        "description": "Mention other avenues for support including palliative medicine and Hospice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of palliative care or hospice resources."
      },
      {
        "criterion_number": 14,
        "description": "State that virtual options include Facebook groups and PanCAN virtual support groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions online communities but does not specifically reference Facebook groups or PanCAN virtual support groups."
      }
    ],
    "question_number": 179,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:25:04.706579",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 2,
        "description": "The response must explicitly describe how malignant cells evade the body\u2019s immune system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response includes a dedicated section titled 'Immune System Evasion' and explicitly states that cancer cells can 'hide from or suppress the immune response,' which directly addresses immune evasion."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly describe the mechanisms of action for chemotherapy, immunotherapy, and radiation in killing cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response mentions chemotherapy and immunotherapy, it does not explain how they kill cancer cells. Radiation is not discussed at all. No mechanisms (e.g., DNA damage by chemo/radiation, checkpoint blockade for immunotherapy) are described."
      },
      {
        "criterion_number": 4,
        "description": "The response must thoroughly cover multiple mechanisms of treatment resistance, including genetic mutations, tumor heterogeneity, drug efflux, alterations in drug targets, epigenetic changes, adaptive responses, and the tumor microenvironment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response covers several mechanisms (tumor heterogeneity, genetic/acquired mutations, tumor microenvironment, drug efflux, altered drug targets, enhanced DNA repair). However, it does not explicitly mention epigenetic changes or adaptive stress responses. Because the rubric requires thorough coverage including these elements, full credit cannot be awarded under the binary scoring rule."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly mention cancer stem cells and connect them to specific resistance mechanisms such as drug efflux pumps, enhanced DNA repair, or immune evasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cancer stem cells are mentioned as being more resistant, but there is no explicit linkage to specific mechanisms like efflux pumps, enhanced DNA repair, or immune evasion."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that surviving resistant cells can repopulate the tumor after most cells are killed by treatment.",
        "score_given": 4,
        "max_points": 4,
        "justification": "The response states that some cells survive treatment and 'can keep growing, leading the tumor to come back or get stronger,' which clearly conveys the concept of repopulation by resistant cells."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly describe that with every treatment, a selective pressure is applied to cancer cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although evolution under treatment is implied, the response never explicitly states that treatment exerts selective pressure on cancer cell populations."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that this topic is being widely researched and cite at least one source from the literature.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response notes that research and clinical trials are ongoing but does not provide any literature citations."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly defines treatment resistance as the phenomenon where cancer cells over time no longer respond to therapies.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While treatment resistance is discussed and implied as treatments 'stop working,' there is no explicit, definitional statement that treatment resistance is when cancer cells over time no longer respond to therapy."
      }
    ],
    "question_number": 180,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:25:36.321127",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe specific biomarkers for pancreatic cancer, explicitly mentioning both CA 19-9 and CEA.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response discusses multiple genomic biomarkers (KRAS, BRCA1/2, MSI, HER2, etc.) but does not mention CA 19-9 or CEA at all."
      },
      {
        "criterion_number": 2,
        "description": "The response must explain what circulating tumor DNA (ctDNA) is and how it is considered a cancer biomarker in some malignancies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ctDNA is not mentioned or explained in the response."
      },
      {
        "criterion_number": 3,
        "description": "The response must summarize how ctDNA enters the bloodstream and is detected through blood tests.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no discussion of ctDNA shedding into blood or its detection via blood tests."
      },
      {
        "criterion_number": 4,
        "description": "The response must include ways that ctDNA detection can enhance existing modalities for cancer monitoring, including detection of new and potentially targetable mutations in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of ctDNA applications for monitoring, minimal residual disease, or detection of emergent targetable mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response must include at least one link to existing scientific literature regarding ctDNA use in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The provided links are to ACS and NCCN general resources and do not specifically reference ctDNA literature in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response must suggest that the patient discuss pancreatic cancer biomarker testing with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises asking the oncologist which biomarkers will be tested and to discuss specific test results with the medical team."
      },
      {
        "criterion_number": 7,
        "description": "The response must define biomarkers for cancer in general terms, including at least one example of a measurable indicator (e.g., proteins, genes, or mutations).",
        "score_given": 0,
        "max_points": 10,
        "justification": "While examples of biomarkers (genes/proteins) are listed, there is no general definition of what a biomarker is."
      },
      {
        "criterion_number": 8,
        "description": "The response must describe how biomarkers are used in pancreatic cancer care and explicitly state that they are an adjunct to traditional imaging and biopsy interventions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response states biomarkers guide treatment choices and mentions tissue analysis, but does not explicitly state that biomarkers are adjuncts to imaging and biopsy."
      },
      {
        "criterion_number": 9,
        "description": "The response must discuss that biomarker reliability varies between individuals with cancer and are not always interpretable, including a specific example of variability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of variability in biomarker reliability or interpretability, and no specific example is provided."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that biomarkers can have false positives and false negatives.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of false positives or false negatives in biomarker testing."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that BRCA and HRD genes are key biomarkers as they can predict response to platinum chemotherapy and PARP inhibitors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions BRCA/HRR mutations and possible benefit from PARP inhibitors but does not state their predictive value for platinum chemotherapy."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that MSI/MMR is an important biomarker as it can identify the small percentage of patients that may respond to immunotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "MSI is mentioned as making patients eligible for immunotherapy, but the response does not state that it identifies a small percentage of patients."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that testing can be done on a blood sample or from tumor tissue.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions tumor tissue testing (NGS, IHC) but does not mention blood-based testing."
      }
    ],
    "question_number": 181,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:26:22.703874",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "At least two management strategies for osteopenia and osteoporosis (e.g., bisphosphonates, denosumab, calcium, vitamin D).",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response recommends bisphosphonates (zoledronic acid, pamidronate), denosumab, calcium, vitamin D, and weight-bearing exercise, clearly meeting the requirement."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly describe at least two types of bone and bone density problems during cancer treatment (e.g., osteopenia, osteoporosis, bone metastases).",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly lists osteopenia, osteoporosis, osteonecrosis, and metastatic bone disease."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly mention bone metastases and at least two treatment options (e.g., systemic therapy, observation, radiation, surgery).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Bone metastases are mentioned. Two treatment options are discussed: radiation therapy for painful bone metastases and bisphosphonates for bone pain and fracture risk from metastases."
      },
      {
        "criterion_number": 4,
        "description": "State that bone metastases can be painful and/or asymptomatic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that metastatic bone disease can cause pain and weaken bones, satisfying the \u2018can be painful\u2019 component."
      },
      {
        "criterion_number": 5,
        "description": "Mention the frequency or rarity of pancreatic cancer metastasizing to the bone.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes pancreatic cancer can sometimes metastasize to the bones, indicating frequency (not universal/common)."
      },
      {
        "criterion_number": 6,
        "description": "Define or describe osteopenia and osteoporosis.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Osteoporosis and osteopenia are described as decreased bone density with increased fracture risk."
      },
      {
        "criterion_number": 7,
        "description": "Identify at least one risk factor for osteopenia/osteoporosis and explain testing (e.g., DEXA scan).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Risk factors discussed include certain cancer treatments, smoking, and excessive alcohol. Testing with bone density tests (DEXA scans) is explicitly mentioned."
      },
      {
        "criterion_number": 8,
        "description": "Mention granulocyte colony stimulating factor and its potential side effect of temporary bone pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "G-CSF and its association with transient bone pain are not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "Emphasize that pain related to cancer or its treatment is taken seriously and should be discussed with the oncology team.",
        "score_given": 8,
        "max_points": 8,
        "justification": "The response advises discussing with the oncology team, notes pain management strategies, and urges prompt reporting of new bone pain."
      },
      {
        "criterion_number": 10,
        "description": "Mention that palliative medicine is a specialty for symptom management and that a referral can be requested.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Palliative medicine or referral to that specialty is not mentioned."
      }
    ],
    "question_number": 182,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:27:15.313854",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define epigenetics.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines epigenetics as chemical modifications that do not change DNA sequence but regulate gene activity (\"switches or dimmers\"), accurately capturing the concept."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how epigenetic changes can happen in normal cells, including gene silencing, activation, and DNA methylation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes DNA methylation, histone modifications, and non-coding RNAs; explains that methylation often turns genes off and that epigenetic changes can turn genes on or off. While not explicitly labeled as occurring in normal cells, the mechanisms are correctly described and applicable to normal cellular regulation."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how epigenetic changes impact the cell\u2019s function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that epigenetic changes alter gene accessibility and activity, affecting pathways like cell growth, division, and survival; also mentions effects on the tumor microenvironment, demonstrating functional cellular impact."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of epigenetic changes in cancer cells.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Provides specific roles in cancer: silencing tumor suppressors, activating cancer-promoting genes, contributing to aggressiveness, and shaping the tumor microenvironment, all directly tied to pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that epigenetic changes can lead to inactivation of silencing tumor-suppressor genes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that promoter hypermethylation leads to silencing of tumor suppressor genes in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that epigenetic changes can lead to activation of oncogenes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that epigenetic changes can activate genes promoting cell division, survival, and metastasis. Though the term 'oncogene' is not used verbatim, 'cancer-promoting genes' conveys the same concept."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that epigenetic changes can contribute to changes in the behavior of the tumor, such as increased propensity to spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes association with more aggressive disease and explicitly mentions activation of genes that enhance the ability to metastasize."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that epigenetic changes can impact treatment response.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions that certain epigenetic patterns predict resistance to treatment, directly addressing treatment response."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that targeting epigenetic changes in pancreatic cancer is an experimental topic that is being actively researched.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that epigenetic therapies (DNMT inhibitors, HDAC inhibitors) are being studied in pancreatic cancer and emphasizes that their effectiveness is still under investigation."
      }
    ],
    "question_number": 183,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:27:40.295970",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that patients consider care agencies that are accredited and have a good reputation.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It explicitly advises ensuring the agency is licensed and accredited (e.g., Joint Commission, NAHC) and to check references and online reviews, addressing both accreditation and reputation."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend that patients consider care agencies that provide a broad range of services, as the patient may have evolving needs as their treatment progresses.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It details medical care, therapies (PT/OT/speech), personal care, and social work, and highlights customizable schedules and adapting to evolving needs."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient inquire with his oncology team if there is social work support available to assist in seeking home health care that is covered by the patient\u2019s insurance carrier.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it mentions social work and coordination with the medical team, it does not instruct the patient to ask the oncology team about social work support or assistance with insurance-covered home health options."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that there is a broad range of types of in-home care and that the patient and family should consider what tasks they need assistance with.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights a broad 'Range of Services' and lists specific assistance (ADLs, therapies, medical care), implying families should consider needed tasks and includes a trial period to assess fit."
      },
      {
        "criterion_number": 5,
        "description": "The response should summarize common types of assistance that cancer patients benefit from such as cooking, cleaning, general home upkeep, shopping.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions meal preparation and ADLs but does not explicitly include cleaning, shopping, or general home upkeep."
      },
      {
        "criterion_number": 6,
        "description": "The response should provide links to websites where patients can learn more about the types of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides relevant links (NHPCO, American Cancer Society Home Care and Support, Eldercare Locator)."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention Hospice as a service that provides care in the home for patients with a prognosis of 6 months or less.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hospice is mentioned, but the response does not state the 6-month prognosis criterion or explicitly that hospice provides care in the home."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention that home health services include skilled nursing care and in-home therapies, such as physical and occupational therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It clearly references skilled nursing care and in-home therapies including physical and occupational therapy."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that they should seek agencies with experience in caring for cancer patients, specifically mentioning oncology-trained staff.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly recommends oncology experience and nurses with oncology or palliative care experience, including specific mention of pancreatic cancer."
      }
    ],
    "question_number": 184,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:28:05.391856",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define angiogenesis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines angiogenesis as the formation of new blood vessels from pre-existing ones and explains its purpose in the tumor context."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the role of angiogenesis in solid tumors.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that tumors require blood supply for oxygen and nutrients, and that tumors signal for new vessel growth to support growth and spread."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of angiogenesis in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Addresses pancreatic cancer specifically, stating angiogenesis contributes to tumor growth and rapid progression and mentions its relevance at advanced stages."
      },
      {
        "criterion_number": 4,
        "description": "The response should discuss how angiogenesis is a target for cancer treatment in some cancers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes anti-angiogenic therapies, provides examples (e.g., bevacizumab targeting VEGF), and notes use alongside chemotherapy or in trials."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that anti-angiogenesis drugs are not used routinely in pancreatic cancer as they have not been shown to significantly improve outcomes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes modest impact and mentions clinical trials, it does not explicitly state that anti-angiogenic drugs are not used routinely in pancreatic cancer or that they have not significantly improved outcomes."
      },
      {
        "criterion_number": 6,
        "description": "The response should link to randomized control trials studying the effect of anti-angiogenic therapies in pancreatic cancer, with summaries.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No randomized controlled trials are cited or summarized; only general resource links (ACS and NCI) are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss treatment options with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly encourages discussion with the oncology team about how treatments fit into the care plan and emphasizes open communication with healthcare providers."
      }
    ],
    "question_number": 185,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:28:30.493316",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that liver function is routinely monitored during treatment using labs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states that LFTs (ALT, AST, ALP, bilirubin, albumin) are checked regularly, often before each chemotherapy cycle."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe ways in which pancreatic cancer and pancreatic cancer treatment can affect the liver.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that cancer and treatments can affect the liver; mentions hepatotoxic chemotherapy, drug-induced hepatitis, and liver metastases."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that changes in liver function labs will often be investigated further with imaging studies.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes imaging (ultrasound, CT, MRI, contrast-enhanced) as part of monitoring for structural changes, implying follow-up imaging when concerns arise."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe ways in which liver injury can be treated, such as dose reduction in systemic treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifies delaying, dose-reducing, or stopping hepatotoxic chemotherapy, and mentions managing drug-induced liver injury and occasional steroid use."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe ways in which liver injury can be treated, such as local therapy to tumors in the liver.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention any liver-directed local therapies (e.g., ablation, embolization, SBRT, surgery)."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe ways in which liver injury can be treated, such as biliary stenting.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of biliary obstruction management or stenting/ERCP."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe ways in which liver injury can be treated, such as elimination of offending medications or supplements.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that the offending drug is stopped or reduced in cases of drug-induced liver injury; acknowledges other medications as causes."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe ways in which liver injury can be treated, such as treatment of infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies infections like hepatitis as causes and notes that specific treatments may be given."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that in rare cases, biopsy of liver tissue is needed to understand the cause of liver injury.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of liver biopsy."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that many different medications and supplements can cause liver toxicity, and the patient should discuss all medications and supplements they take while undergoing cancer treatment to ensure no interactions.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not advise disclosing all medications and supplements to check for interactions."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe red flag symptoms for liver injury.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists jaundice, confusion, bleeding/bruising, dark urine, pale stools, and severe abdominal pain as reasons to seek immediate care."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend the patient discuss any new or worrisome symptoms with a member of their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages asking the oncology team questions, maintaining open communication, and seeking immediate medical attention for concerning symptoms."
      },
      {
        "criterion_number": 13,
        "description": "The response should emphasize the importance of exercise, nutrition, and sleep in mitigating treatment-related toxicities and side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions nutritional support but does not address exercise or sleep."
      }
    ],
    "question_number": 186,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:29:21.938657",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should discuss what tumor dormancy is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines tumor dormancy as a state where cancer cells are present but not actively growing/dividing and may be undetectable on standard tests."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the implications of tumor cells that can enter dormancy, such as disease recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states dormant cells can later reactivate and lead to recurrence or metastasis."
      },
      {
        "criterion_number": 3,
        "description": "The response should outline that there is ongoing study on the subject of tumor dormancy, though it is not fully understood at this time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that mechanisms are still being studied and highlights active ongoing research."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention that dormancy can occur due to microenvironmental factors such as changes in the tumor microenvironment, lack of nutrients, or the presence of certain immune cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions lack of nutrients/oxygen and immune system control as contributors to dormancy, satisfying microenvironmental factors."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that dormant cells are often less susceptible to chemotherapy than rapidly dividing cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Only generally mentions that dormant cells may hide from the effects of treatments; does not specifically state reduced susceptibility to chemotherapy compared with rapidly dividing cells."
      },
      {
        "criterion_number": 6,
        "description": "The response should reference evidence from the scientific literature that discusses tumor dormancy in pancreatic cancer, and only references with a PubMed identification number (PMID) should be included.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No scientific literature or PMIDs are cited."
      },
      {
        "criterion_number": 7,
        "description": "The response should indicate whether or not it is possible to detect dormant cancer cells in the body in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that dormant cancer cells may not be detectable by standard imaging or tests, indicating detection limitations."
      }
    ],
    "question_number": 187,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:29:52.500000",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe what an advance directive is and why people create them.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that advance directives ensure a person's wishes are respected if they cannot communicate or make decisions, and outlines their purpose in serious illness. Provides context and examples (living will, proxy, DNR) demonstrating understanding of what they are and why they are used."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend that the patient and family ask their oncology team if there are resources available to assist in the creation of advance directives, such as social work.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions discussing with the care team and that hospitals/clinics have social workers and patient advocates, it does not explicitly recommend asking the oncology team for resources or social work support."
      },
      {
        "criterion_number": 3,
        "description": "The response should direct the patient to consider what medical treatments they would accept in the event of an emergency or if they became too sick to make decisions on their own, including wishes surrounding CPR, invasive medical procedures such as dialysis, artificial nutrition, and noninvasive medical treatments such as intravenous fluids or antibiotics. This is also referred to as a living will.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It covers living will content with examples like dialysis, ventilators, and feeding tubes and mentions DNR/CPR, but does not address noninvasive treatments such as IV fluids or antibiotics, which are specifically required by the rubric."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient elect a specific person to be their durable power of attorney for healthcare, or a person who would make medical decisions for them if they were too sick to make their own decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly describes Healthcare Proxy/Durable Power of Attorney for Healthcare, naming a trusted agent and providing guidance for the agent."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient should also complete a POLST, or a physician order for life-sustaining treatment, with their oncologist or other health practitioner, and should have this in their home in an easy-to-see location.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of POLST, completing it with a clinician, or having it visible at home."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the advance directives should include a DNR order if desired.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a distinct section on Do Not Resuscitate (DNR) orders and explains their purpose."
      },
      {
        "criterion_number": 7,
        "description": "The response should encourage patients to complete advance directives as soon as possible, even if their cancer is in remission or cured.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly encourage completing advance directives as soon as possible or address doing so even if disease is in remission or cured."
      },
      {
        "criterion_number": 8,
        "description": "The response should explain the logistics of completing an advance directive and recommend that the patient turn in a completed copy of the form to their oncology team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions legal requirements, consulting professionals, and distributing copies to healthcare providers, it does not specifically advise submitting a completed copy to the oncology team."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize to patients with pancreatic cancer the importance of future planning, as this disease is difficult to cure and can be aggressive.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It offers general guidance and empathy but does not explicitly emphasize pancreatic cancer\u2019s aggressiveness or the heightened importance of future planning due to its prognosis."
      }
    ],
    "question_number": 188,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:30:48.491824",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define what targeted therapy is in oncologic treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines targeted therapy as drugs that target specific molecules involved in cancer cell growth and contrasts it with chemotherapy."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain what combination targeted therapy is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that combination targeted therapy uses two or more targeted drugs together to block multiple pathways and potentially overcome resistance."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe what kinds of targeted therapy options exist in pancreatic cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides examples of targets (BRAF, HER2) and notes that therapies are chosen based on tumor markers/mutations, indicating types of targeted options used in pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should illustrate why more than one targeted medication might be used at the same time to treat cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that blocking multiple pathways can improve effectiveness and help overcome resistance, which justifies using more than one targeted agent concurrently."
      },
      {
        "criterion_number": 5,
        "description": "The response should explain why the patient\u2019s tumor tissue needs to undergo molecular testing to understand what targeted therapies are indicated.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that if testing shows specific mutations or markers, certain targeted drugs may be recommended, indicating the need for molecular testing to guide therapy."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain that some targeted therapies may not work on the patient\u2019s tumor due to lack of targetable mutations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not explicitly state that targeted therapies may not be effective if the tumor lacks targetable alterations."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain that targeted therapies do not always work in pancreatic cancer due to tumor heterogeneity.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention tumor heterogeneity as a reason targeted therapies may fail in pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe that targeted therapies are sometimes used at the same time as traditional chemotherapies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that targeted therapies may be combined with conventional chemotherapy."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient discuss this further with their oncologist as targeted therapies are individualized to each patient\u2019s cancer, and not all targeted therapies are treatment options for all patients with pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly encourages discussion with the oncology team, emphasizes individualized treatment, and implies that therapy depends on specific tumor findings."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention KRAS inhibitors as a current area of research in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "KRAS inhibitors or KRAS research are not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response must mention PARP inhibitors are used in pancreatic cancer patients with BRCA1/2 mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention PARP inhibitors or BRCA1/2-associated use in pancreatic cancer."
      }
    ],
    "question_number": 189,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:31:36.057555",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response equates metastasis with cancer 'spreading' to nearby and then distant sites, providing a functional definition."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how cancer metastasizes, such as hematologic spread and lymphatic spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mechanisms (e.g., hematogenous vs lymphatic routes) are described; it lists sites without explaining routes of spread."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how pancreatic cancer metastasizes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes local/regional spread, lymph node involvement, peritoneal seeding, and distant organ spread. Although the liver was mislabeled under 'local,' overall it still describes the metastatic pattern."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that pancreatic cancer typically spreads locally first, involving surrounding lymph nodes, organs, and blood vessels.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It states spread to nearby sites first and mentions lymph nodes and nearby tissues/organs, but does not explicitly mention involvement of blood vessels."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that metastatic spread of the pancreatic cancer can be influenced by the location of the primary tumor, for example whether it is located at the pancreatic head or the tail.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes liver metastasis is especially common for cancers originating in the head of the pancreas, indicating site-dependent patterns."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly state that the liver is usually the first location for metastases.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It states the liver is the most common site and that spread there happens early, but does not explicitly say it is 'usually the first' site."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly state that pancreatic cancer can metastasize to the peritoneum or lining of the abdominal cavity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions spread to the peritoneum/abdominal lining with peritoneal seeding."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that pancreatic cancer can spread to the lungs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that lung metastases can occur."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that pancreatic cancer can spread to at least one of the following less common sites: bones, brain, or adrenal gland.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists bones, adrenal glands, and brain as less common metastatic sites."
      },
      {
        "criterion_number": 11,
        "description": "The response should explain what proportion of pancreatic cancers are metastatic at diagnosis and why.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No proportion or explanation of the rate of metastatic disease at diagnosis is provided."
      },
      {
        "criterion_number": 12,
        "description": "The response should discuss that pancreatic cancer commonly has already metastasized at the time of diagnosis because it often is asymptomatic at an early stage and only becomes symptomatic, prompting diagnostic investigation, once it has spread beyond its original site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not discuss the typical asymptomatic early course leading to late/metastatic diagnosis."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that treatment options exist for all stages of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It encourages discussing options with the care team but does not state that treatment options exist for all stages."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that options for treatment modalities, for example surgery or chemotherapy, depend on the stage of the cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions tailoring information to type and stage but does not explicitly state that treatment modality choices (e.g., surgery vs chemotherapy) depend on stage."
      }
    ],
    "question_number": 190,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:32:43.505325",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe how pancreatic cancer chemotherapy treatment can cause injury to the kidneys.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response states kidney problems are 'often caused by medications like chemotherapy agents' and provides examples, indicating chemo can injure kidneys."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly mention that platinum drugs (e.g., cisplatin, oxaliplatin) can directly injure the kidney.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly cites cisplatin and carboplatin as causes of treatment-related kidney problems, satisfying the requirement to mention platinum drugs causing kidney injury."
      },
      {
        "criterion_number": 3,
        "description": "Describe how other pancreatic cancer treatments, such as surgery or radiation, can cause injury to the kidneys.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of surgery or radiation-related kidney injury."
      },
      {
        "criterion_number": 4,
        "description": "Mention that urinary tract infection should be ruled out due to increased infection risk.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of urinary tract infection or infection risk as a cause to be ruled out."
      },
      {
        "criterion_number": 6,
        "description": "State that patients undergoing systemic treatment should have kidney function monitored frequently for toxicity.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'Close Monitoring' with regular blood and urine tests and references ongoing monitoring in 'Recovery and Follow-Up.'"
      },
      {
        "criterion_number": 7,
        "description": "Clearly state that the first step is to identify the offending agent and reduce or hold the drug.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States 'If a specific treatment is identified as the cause... reduce the dose... change to a different treatment... temporarily stop,' which meets the intent to identify and hold/reduce the offending agent."
      },
      {
        "criterion_number": 8,
        "description": "Describe ways renal toxicity is monitored and managed, such as serial lab tests of renal function to assess improvement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details serial monitoring via blood tests (creatinine, BUN) and urine tests, and notes recovery and long-term monitoring."
      },
      {
        "criterion_number": 9,
        "description": "Describe management such as dose reduction of systemic treatment, particularly the offending drugs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions dose reduction, switching to less nephrotoxic agents, and temporary discontinuation."
      },
      {
        "criterion_number": 10,
        "description": "Describe management such as IV fluids or other medications to support the kidneys.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions 'Intravenous fluids,' use of diuretics, BP/sugar control, and electrolyte management."
      },
      {
        "criterion_number": 11,
        "description": "Explicitly mention that IV fluids can be used to provide hydration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States IV fluids are used 'to help maintain kidney perfusion and prevent dehydration,' explicitly addressing hydration."
      },
      {
        "criterion_number": 12,
        "description": "Describe evaluation of other medications or supplements to avoid harmful interactions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to review concomitant medications or supplements for interactions."
      },
      {
        "criterion_number": 13,
        "description": "Explicitly mention that alleviating obstruction (e.g., via stenting or nephrostomy) can help recover renal function.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of urinary obstruction, stenting, or nephrostomy as management."
      },
      {
        "criterion_number": 14,
        "description": "Explicitly state that dehydration and obstruction (e.g., biliary or urinary) can lead to kidney injury.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While dehydration is implied via prevention with IV fluids, the response does not explicitly state that dehydration and obstruction cause kidney injury, nor does it mention obstruction."
      },
      {
        "criterion_number": 15,
        "description": "Recommend consulting oncology team and oncology pharmacist before starting new medications or supplements to avoid interactions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Encourages communication with the medical team but does not specifically advise consulting an oncology pharmacist or avoiding new meds/supplements without review."
      },
      {
        "criterion_number": 16,
        "description": "Mention that sometimes dialysis may be indicated if there is severe kidney injury related to treatment.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Dialysis is not mentioned."
      },
      {
        "criterion_number": 17,
        "description": "Recommend staying well hydrated and maintaining adequate nutrition during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides dietary modification guidance but does not explicitly recommend staying well hydrated or maintaining adequate nutrition intake."
      }
    ],
    "question_number": 191,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:33:21.356302",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the role of genetic mutations in cancer.",
        "score_given": 9,
        "max_points": 9,
        "justification": "Clearly explains that cancer cells acquire DNA mutations during division, some of which confer advantages (faster growth, metastasis, treatment resistance), and that these mutations drive tumor evolution."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how cancer treatment applies selective pressure on cancer cells, allowing those that harbor certain characteristics that confer resistance to therapy a survival advantage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes natural selection in tumors and specifically notes that treatment can lead to relapse because remaining cells have evolved resistance, implying treatment as a selective pressure favoring resistant clones."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain that after certain treatments, tumor cells susceptible to that treatment will have died while those resistant to the treatment survive, making the residual cancer fundamentally different from the original cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that after treatment the cancer may come back because remaining cells have evolved resistance, indicating selective survival of resistant populations and a changed post-treatment tumor composition."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how genetic mutations can cause cancer cells to resist certain treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions that mutations can make cancer cells resistant to chemotherapy or targeted therapies and discusses monitoring for new resistance mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the heterogeneous cellular make-up of pancreatic cancer at baseline.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions tumor heterogeneity in general but does not specifically address baseline heterogeneity unique to pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the mesenchymal-epithelial transition, including triggers for this phenomenon.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention mesenchymal-epithelial transition (MET) or its triggers (e.g., microenvironmental cues, hypoxia, TGF-\u03b2)."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe methods for evaluating tumor evolution over time, including circulating tumor DNA and/or traditional biopsy of the primary tumor or metastatic lesion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers serial biopsies, genetic sequencing, and liquid biopsies detecting tumor DNA in blood for longitudinal monitoring."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that tumor evolution is when the cancer changes and adapts over time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly defines tumor evolution as tumor cells changing and adapting over time within the body."
      }
    ],
    "question_number": 192,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:33:54.689144",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define complementary therapies, including supportive and integrative therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response references complementary therapies but does not define the term nor explain supportive care or integrative therapy concepts."
      },
      {
        "criterion_number": 2,
        "description": "The response should define aromatherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Aromatherapy is clearly defined as the use of essential oils via inhalation or topical application to promote relaxation, reduce stress, or alleviate symptoms like nausea."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that any substances that are ingested or applied to the body can cause a reaction, such as an allergic reaction, and may be difficult to tell if the patient\u2019s reaction is from the complementary therapy or the cancer treatment itself. For this reason, these complementary therapies should be used with caution.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions allergic/skin reactions and advises caution, it does not state that reactions may be hard to distinguish from cancer treatment side effects, which is required."
      },
      {
        "criterion_number": 4,
        "description": "The response should inform patients that complementary therapies do not treat cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states aromatherapy is not a substitute for conventional therapy, conveying that it does not treat cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response should inform patients that some complementary therapies may help with symptoms related to their cancer diagnosis, such as stress or insomnia.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes potential benefits for stress, anxiety, mood, and possibly nausea, satisfying the symptom-support criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the patient inquire with their oncology team if there are practitioners of complementary therapies that they trust, or can place a referral to.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises discussing with the oncology team and suggests consulting a certified aromatherapist, but does not recommend asking the oncology team for trusted practitioners or referrals."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide website links to informational pages from cancer societies such as NCI or PanCAN.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes links to the NCI and the American Cancer Society, meeting the requirement."
      },
      {
        "criterion_number": 8,
        "description": "The response should strongly recommend that the patient discuss any complementary therapies they are considering with their oncology team to ensure there are no harmful interactions with their cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It strongly urges discussing any complementary therapy with the oncology team before starting and mentions potential interactions."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that aromatherapy is safest when used through inhalation and that oils must be appropriately prepared.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although proper dilution is mentioned and inhalation is discussed, it does not explicitly state that inhalation is the safest route."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that essential oils on the skin should be used with caution due to the risk of worsening skin irritation from chemotherapy or radiation.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes potential skin irritation with topical use but does not explicitly link this risk to worsening irritation from chemotherapy or radiation."
      }
    ],
    "question_number": 193,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:34:31.903888",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define metabolism in humans.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Defines metabolism as the set of chemical reactions that convert nutrients into energy and building blocks, which is an accurate, human-applicable definition."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the Warburg Effect.",
        "score_given": 9,
        "max_points": 9,
        "justification": "Explicitly mentions the Warburg effect and describes it as increased glucose uptake with inefficient use of glucose by cancer cells, which constitutes a basic description."
      },
      {
        "criterion_number": 3,
        "description": "The response should include information about glucose, amino acid, and lipid metabolism in cancer cells, specifically in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Discusses increased glucose uptake and altered amino acid and lipid metabolism in cancer cells generally, but does not provide pancreatic cancer\u2013specific metabolic features."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that changes in metabolism can alter sensitivity to cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states that metabolic state can affect response to standard treatments and that some changes can confer resistance or vulnerability."
      },
      {
        "criterion_number": 5,
        "description": "The response should not recommend specific diets for the management of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Does not recommend any specific diet; advises a balanced diet unless directed by the healthcare team and emphasizes uncertainty about dietary impacts on cancer growth."
      },
      {
        "criterion_number": 6,
        "description": "The response should not indicate that restrictive diets, such as the ketogenic diet or intermittent fasting, should be started by patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Does not mention or advocate for restrictive diets such as ketogenic diets or intermittent fasting."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss diet with their oncologist and request a referral to a nutritionist if they are interested in learning more.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends speaking with a registered oncology dietitian and engaging the oncology team, fulfilling the intent to involve clinicians and nutrition experts."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that there is not any current evidence for dietary interventions to alter the metabolism of the cancer and improve treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "States there is ongoing debate about dietary impacts but does not explicitly state that there is no current evidence for dietary interventions to improve treatment via metabolic alteration."
      }
    ],
    "question_number": 194,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:35:20.062270",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "List causes of eye problems related to cancer and/or treatment, including chemotherapy-induced optic neuropathy, immunotherapy-related inflammation, bleeding, cataracts, dry eye, metastatic disease to the brain or eye, and infections.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response mentions chemotherapy-related dry eyes, uveitis, and glaucoma, but does not address chemotherapy-induced optic neuropathy, immunotherapy-related inflammation, bleeding, cataracts, metastatic disease to the brain or eye, or infections."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly state that chemotherapy can lead to eye dryness and irritations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response explicitly states that chemotherapy drugs can cause eye-related side effects including dry eyes and lists irritation-like symptoms (e.g., sensitivity to light)."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly state that the use of steroids can lead to an increase in cataracts or glaucoma.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Steroid use and its association with cataracts or glaucoma is not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly state that immunosuppressed patients are more likely to have infections in their eyes.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No statement about increased risk of ocular infections in immunosuppressed patients."
      },
      {
        "criterion_number": 5,
        "description": "Mention that eye symptoms may not be related to cancer/treatment and advise an eye exam by a qualified practitioner.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response recommends seeing an ophthalmologist, it does not state that the symptoms may be unrelated to cancer or its treatment."
      },
      {
        "criterion_number": 6,
        "description": "Recommend documenting characteristics of symptoms (e.g., severity and date of onset).",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises documenting when symptoms started, their nature, and severity."
      },
      {
        "criterion_number": 7,
        "description": "List red flag eye symptoms that should prompt immediate medical care (e.g., vision loss or severe pain).",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly lists sudden vision loss and severe eye pain as reasons to seek emergency care."
      },
      {
        "criterion_number": 8,
        "description": "Explicitly state that any eye symptoms should be discussed with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response instructs to contact the oncology team or healthcare provider immediately about eye problems."
      },
      {
        "criterion_number": 9,
        "description": "Recommend possibly requesting a referral to an ophthalmologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends seeing an ophthalmologist and notes the oncologist may provide a referral."
      },
      {
        "criterion_number": 11,
        "description": "Explicitly state that eye drops can be used to mitigate dry eye symptoms.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of using eye drops to alleviate dry eyes."
      }
    ],
    "question_number": 195,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:36:02.616020",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define neoantigens in cancer as proteins expressed on the surface of cancer cells, used by the immune system to differentiate cancer from healthy tissue.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response explains that mutations create new proteins which can be broken down into antigens and recognized as foreign by the immune system, but it does not state that neoantigens are presented/expressed on the surface of cancer cells (via MHC) nor explicitly frame them as surface-expressed markers used by the immune system to distinguish cancer from normal tissue."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention ongoing research involving neoantigens in cancer, including cancer vaccines, immunotherapy, and CAR-T trials.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response mentions personalized (neoantigen) vaccines and immunotherapy (checkpoint inhibitors) but does not mention CAR-T trials. Because the criterion requires inclusion of vaccines, immunotherapy, and CAR-T trials, full credit cannot be awarded."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that there are no FDA-approved treatments targeting neoantigens at this time.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response says neoantigen-based treatments are mostly in research or early clinical trials but does not explicitly state that there are no FDA-approved treatments targeting neoantigens. The criterion requires an explicit statement."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient discuss the role of neoantigens in their cancer care with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises discussing with the oncologist/oncology team whether neoantigen testing or therapies are appropriate for the specific situation."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend considering referral to be considered for clinical trials for pancreatic cancer treatment in their area.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response notes that neoantigen-based approaches are in research/early clinical trials, it does not recommend considering referral or enrollment in clinical trials in the patient\u2019s area."
      }
    ],
    "question_number": 196,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:36:35.062832",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define autophagy, including its normal role in cellular turnover, specifically mentioning degradation and recycling of cellular components, and maintaining cellular homeostasis by removing damaged organelles and protein aggregates.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response defines autophagy as a process where cells break down and recycle components, and notes it maintains energy and function. It explicitly mentions removal of damaged proteins and organelles, aligning with homeostasis/turnover. While it doesn't use the term \"protein aggregates,\" it covers damaged proteins and organelles adequately."
      },
      {
        "criterion_number": 2,
        "description": "Describe the dual role of autophagy in cancer, including both tumor suppression and promotion, with context on how these roles change during cancer progression.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response clearly outlines tumor-suppressive roles (removal of damaged components early) and tumor-promoting roles (supporting survival under hypoxia/nutrient deprivation and therapy stress once a tumor forms), noting context-dependence and stage."
      },
      {
        "criterion_number": 3,
        "description": "State that autophagy can be protective against cancer by removing damaged or dysregulated proteins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states autophagy removes damaged cellular components, including damaged proteins and organelles, preventing accumulation that could lead to cancer."
      },
      {
        "criterion_number": 4,
        "description": "Describe the role of autophagy in pancreatic adenocarcinoma, specifically addressing its upregulation and contribution to cancer cell survival and treatment resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "In the pancreatic cancer section, it notes increased autophagy may help pancreatic cancer cells survive and that inhibiting autophagy is being tested to improve chemotherapy effectiveness, implying contribution to treatment resistance."
      },
      {
        "criterion_number": 5,
        "description": "State that cancerous cells can utilize autophagy to promote survival, growth, and therapy resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly says cancer cells co-opt autophagy to survive stress, resist rapid growth stress, and withstand chemotherapy, enabling them to survive and thrive."
      },
      {
        "criterion_number": 6,
        "description": "Explain if the autophagy process can be targeted with cancer treatment, providing at least one reference with a PMID if available.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it explains that experimental therapies aim to block autophagy, it does not provide any reference with a PMID."
      },
      {
        "criterion_number": 7,
        "description": "State that blocking autophagy has been explored as an area of research but there are no current standard of care treatments targeting autophagy in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It clearly states autophagy is not a standard target in clinical treatment for pancreatic cancer and that research is ongoing."
      },
      {
        "criterion_number": 8,
        "description": "Mention specific drugs targeting autophagy, reference existing evidence in the scientific literature, and clearly state if any treatment strategy is FDA approved.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No specific autophagy-targeting drugs (e.g., hydroxychloroquine) are named, no FDA approval status is discussed, and no literature evidence is cited."
      },
      {
        "criterion_number": 10,
        "description": "Reference at least one scientific literature source with a PubMed identification number (PMID).",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response includes general web resources but no citations with PMIDs."
      }
    ],
    "question_number": 197,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:37:36.881959",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the different types of support groups that exist for cancer patients and family members of cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response contrasts telehealth vs in-person and mentions facilitated groups, but it does not describe different types (e.g., patient-only, caregiver-only, bereavement, psychoeducational vs peer-led, diagnosis-specific) for patients and family members."
      },
      {
        "criterion_number": 3,
        "description": "The response should address whether there is evidence that a telehealth support group is inferior to an in-person support group.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It directly states that telehealth groups can be highly effective and, with good facilitation, can be as engaging and supportive as in-person groups, addressing non-inferiority."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide references and sources for evidence regarding the effectiveness of telehealth versus in-person support groups.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It cites a 2020 review in Supportive Care in Cancer and a 2021 study in JMIR Cancer as evidence sources for telehealth support group effectiveness."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that in-person and telehealth groups each have their advantages and disadvantages and either may be as effective based on an individual\u2019s needs and preferences.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly outlines pros and cons of both formats and advises trying both, emphasizing individual preference and noting telehealth can be as engaging as in-person with good facilitation."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that telehealth groups can be more accessible and convenient.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly notes telehealth groups are more accessible and reduce travel/time burdens."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some may feel that in-person groups will lead to better emotional connection.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states some people find it harder to form deep emotional connections virtually and some prefer in-person for a stronger sense of connection and immediacy."
      },
      {
        "criterion_number": 9,
        "description": "The response should include a way for the patient or family member to input their location to generate a list of local support group resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it lists organizations, it does not provide a location-based search tool or instructions to enter a ZIP code/city to generate local resources."
      },
      {
        "criterion_number": 10,
        "description": "The response should list organizations to contact that might be able to provide support resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists the American Cancer Society, Pancreatic Cancer Action Network, and CancerCare with links."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient ask their oncology team for assistance in finding support groups.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not mention consulting the oncology team, clinic social worker, or navigator for help finding groups."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe that increased stress is normal when dealing with a cancer diagnosis and treatment, or as a family member of a cancer patient.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It expresses empathy and acknowledges difficulty but does not explicitly state that increased stress is normal in this context."
      }
    ],
    "question_number": 198,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:38:21.072077",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention the effect of caffeine on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises to avoid caffeine, especially in the evening, implying its negative impact on sleep."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention the effect of alcohol on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises avoiding alcohol, especially in the evening, acknowledging its disruptive effect on sleep."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the effect of illegal drugs on sleep.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of illegal or recreational drugs and their impact on sleep."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe strategies to improve sleep that are evidence-based.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes multiple evidence-based strategies such as CBT-I, sleep hygiene, consistent schedule, light exposure, exercise, relaxation techniques, and medication review."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide references for evidence-based sleep improvement interventions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides references to the American Cancer Society, National Cancer Institute, and Sleep Foundation pages on sleep and cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should include insights into things in everyday life that may be interfering with a patient\u2019s ability to sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies screens before bed, heavy meals, late fluids, environmental light/noise/temperature, and stimulants as everyday factors affecting sleep."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide insights into how cancer-related symptoms can interfere with sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes pain, medication side effects (e.g., steroids), and emotional distress (anxiety/depression) as contributors to insomnia during cancer treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of appropriate management of cancer-related or cancer-treatment related symptoms to prevent interference in everyday life, including sleep.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Emphasizes managing pain, adjusting medication timing/doses with the oncology team, and involving supportive/palliative care or specialists."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe common symptoms that people with pancreatic cancer might experience.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not list pancreatic cancer\u2013specific symptoms such as jaundice, abdominal/back pain, weight loss, steatorrhea, or new-onset diabetes."
      },
      {
        "criterion_number": 10,
        "description": "The response should direct the patient to discuss any symptoms of cancer or cancer treatment with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Repeatedly advises discussing changes with the healthcare/oncology team and seeking referrals if sleep issues persist."
      },
      {
        "criterion_number": 11,
        "description": "The response should emphasize the importance of mental health and the impact of stress on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that emotional distress (anxiety/depression) can make it hard to sleep and recommends counseling, mindfulness, and support groups."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that sleep hygiene is an important first step.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although sleep hygiene is described as foundational, the response does not explicitly state it is an important 'first step.'"
      },
      {
        "criterion_number": 13,
        "description": "The response must mention a consistent relaxing bedtime routine starting 30 to 60 minutes before bedtime.",
        "score_given": 0,
        "max_points": 5,
        "justification": "A relaxing bedtime routine is recommended, and screen time is limited 30\u201360 minutes before bed, but it does not specify starting the routine 30\u201360 minutes before bedtime."
      },
      {
        "criterion_number": 14,
        "description": "The response must clearly state that stimulant use, such as nicotine, should be avoided in the afternoon and evenings.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises avoiding stimulants 'especially in the evening' but does not mention avoiding them in the afternoon."
      },
      {
        "criterion_number": 15,
        "description": "The response must explicitly recommend optimizing the sleep environment by keeping the room dark, cool, and quiet.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends a bedroom environment that is cool, dark, and quiet, with blackout curtains, earplugs, or white noise."
      },
      {
        "criterion_number": 16,
        "description": "The response must mention that supportive therapies, such as melatonin or other sleep aids, can be considered if deemed safe by the medical team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention melatonin or other pharmacologic sleep aids as options pending medical team approval."
      }
    ],
    "question_number": 199,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:39:53.152522",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer-related cachexia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines cachexia as a syndrome with involuntary weight loss, muscle wasting, weakness, and metabolic changes, distinguishing it from simple weight loss."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how cachexia occurs in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides a general mechanism (cytokines, metabolic changes) but does not specifically address pancreatic cancer or its high association with cachexia."
      },
      {
        "criterion_number": 3,
        "description": "The response should delineate cancer cachexia from regular weight loss.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly contrasts causes, type of weight lost, mechanisms, symptoms, and response to treatment between cachexia and regular weight loss."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that cachexia can occur independently of dietary changes.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States it is not simply from eating less and can occur even if the person is eating enough."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that cachexia involves muscle loss.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Repeatedly emphasizes loss of lean body mass/muscle wasting as a key feature."
      },
      {
        "criterion_number": 6,
        "description": "The response should include information about prognosis in patients experiencing cancer cachexia.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes worse outcomes, lower quality of life, and increased risk of death."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide evidence-based recommendations to patients experiencing cancer cachexia.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends nutritional support, exercise therapy, medications targeting inflammation/appetite, and symptom management\u2014consistent with evidence-based multimodal care."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss their concerns about cancer cachexia with their oncology team and/or a nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises speaking with the oncologist, seeking referral to a registered dietitian, and involving a physiotherapist."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that cachexia is difficult to manage.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes cachexia as complex and states treatment is complex, implying difficulty in management."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that cachexia can be mitigated by nutritional support, medications, and physical therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions nutritional support, medications, and exercise/physiotherapy as components of mitigation."
      }
    ],
    "question_number": 200,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:40:35.472506",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe EMT as a transformation where epithelial cells acquire mesenchymal characteristics.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly explains that epithelial cells transform into mesenchymal cells, losing tight connections and gaining motility and invasive properties."
      },
      {
        "criterion_number": 2,
        "description": "Mention that EMT is a key feature of cancer progression, contributing to tumor progression, invasion, metastasis, and therapy resistance.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses progression, invasion, and metastasis but does not mention therapy resistance, which is required for full credit."
      },
      {
        "criterion_number": 3,
        "description": "Define epithelial cells as those forming the lining of glands, organs, and body surfaces (including the pancreas) and describe their tight connections and specific functions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response states epithelial cells line organs/surfaces (including pancreatic ducts) and have tight connections, but it does not describe their specific functions (e.g., barrier, secretion, absorption), which is required."
      },
      {
        "criterion_number": 4,
        "description": "Define mesenchymal cells as those that can move, change shape, and are found in connective tissue, supporting organs and glands.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions mobility and location in connective tissue, but does not explicitly state that they change shape or that they support organs and glands."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly state that EMT enables cancer cells to migrate to distant sites, leading to metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly says EMT allows tumor cells to break away and spread (metastasize) to other parts of the body."
      },
      {
        "criterion_number": 6,
        "description": "Mention that EMT is an area of current research and explicitly state that there are no treatments aimed at this process yet.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it implies research by mentioning design of drugs, it does not explicitly state that EMT is an active research area nor that there are currently no treatments targeting EMT."
      },
      {
        "criterion_number": 8,
        "description": "State that plasticity is a key factor in treatment resistance in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not mention plasticity or its role in treatment resistance in pancreatic cancer."
      }
    ],
    "question_number": 201,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:41:30.603016",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define the microbiome as the microorganisms that live in the body and play roles in digestion, immune function, metabolism, and inflammation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response defines the microbiome as microorganisms living in/on the body and mentions effects on the immune system and inflammation, but does not explicitly state roles in digestion or metabolism."
      },
      {
        "criterion_number": 2,
        "description": "Mention that the microbiome is associated with cancer, specifically pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly states that the microbiome is associated with cancer development and progression, including pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "Describe how the microbiome is thought to affect pancreatic cancer treatment, including its influence on the efficacy of immunotherapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that the microbiome can affect response to cancer treatments, particularly immunotherapy, and notes pancreatic cancer\u2019s resistance to immunotherapy and research into modifying the microbiome to improve outcomes."
      },
      {
        "criterion_number": 4,
        "description": "Describe how the microbiome can influence how the body metabolizes chemotherapy drugs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of microbiome effects on chemotherapy drug metabolism or toxicity; treatment effects are discussed mainly regarding immunotherapy and general effectiveness."
      },
      {
        "criterion_number": 5,
        "description": "Mention that modulating the microbiome to improve cancer outcomes is an active area of research with limited evidence and no standard of care options to date.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States this is an active research area, early studies are not definitive, and microbiome-modulating therapies are not standard of care."
      },
      {
        "criterion_number": 6,
        "description": "Mention the various roles the microbiome is postulated to play in the human body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions roles involving the immune system and inflammation and microbial production of carcinogenic substances, indicating multiple functional roles."
      },
      {
        "criterion_number": 7,
        "description": "Summarize the scientific research with references (PMID if available).",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific study citations or PMIDs are provided; only general organizations and journals are mentioned."
      },
      {
        "criterion_number": 8,
        "description": "Describe standard of care treatments for pancreatic cancer, including chemotherapy and immunotherapy, and mention that appropriate treatment selection depends on the stage of cancer and fitness of the patient.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions that treatment decisions depend on tumor genetics, stage, and overall health, but does not describe standard chemotherapy regimens or standard-of-care treatments; immunotherapy is referenced only in context of research/resistance."
      },
      {
        "criterion_number": 9,
        "description": "Suggest that the patient discuss whether there are ways to support a healthy microbiome with a nutritionist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Recommends general lifestyle factors and discussion with the oncology team but does not suggest consulting a nutritionist or dietitian."
      }
    ],
    "question_number": 202,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:42:44.403677",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that mood changes are very common with the diagnosis of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states mood disturbances are very common in people with pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing treatment-related mood changes with the oncology team to ensure they are provided with available local resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises open communication with the healthcare team about mood changes and implies coordination of care; also references support resources."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend a referral to a mental health provider familiar with cancer patients and cancer care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends referral to psychologist, psychiatrist, or counselor who specializes in cancer care."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe counseling as an intervention that may help alleviate mood issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions cognitive-behavioral therapy and supportive counseling as helpful."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe medications, such as antidepressants, as an intervention that may help alleviate mood issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions antidepressants and anti-anxiety medications as options under professional supervision."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe support group participation as an intervention that may help alleviate mood issues.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Recommends joining a support group for patients and families to reduce isolation and gain advice."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide supportive language about mood changes during cancer treatment and attempt to normalize this phenomenon.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Uses empathetic, normalizing language and reassures that mood changes are common and understandable."
      },
      {
        "criterion_number": 8,
        "description": "The response should reference studies that quantify patients with cancer that suffer from mood changes after diagnosis and/or during treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that studies suggest up to 50% or more experience mood disorders, providing quantitative context."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe different interventions that may help alleviate mood issues, such as psychiatric evaluation, exercise, nutrition, and cancer-related symptom control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes psychiatric/psychological referral, exercise, nutrition, sleep, medication management, and palliative care for symptom control."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that patients with suicidal thoughts consider presentation to medical care urgently or emergently.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises seeking immediate help from a healthcare provider or crisis hotline for self-harm thoughts."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the role of palliative medicine in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends early palliative care to manage physical, emotional, and spiritual needs."
      },
      {
        "criterion_number": 12,
        "description": "The response should list common side effects of both pancreatic cancer and pancreatic cancer treatment, and suggest that feeling poorly can impact one\u2019s mood.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists pain, fatigue, loss of appetite, and sleep disturbances and notes they can worsen mood changes."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that some patients benefit from a mental health standpoint by having their affairs in order, as this can provide some peace of mind in the face of a serious illness.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention advance care planning or getting affairs in order as a potential mental health support."
      },
      {
        "criterion_number": 14,
        "description": "The response should list online resources for support for patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides links to the American Cancer Society, National Cancer Institute, and Pancreatic Cancer Action Network."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that mindfulness and relaxation techniques can be considered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention mindfulness or relaxation techniques."
      }
    ],
    "question_number": 203,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:43:34.511787",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define tumor suppressor genes and their function in the human body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines tumor suppressor genes as brakes on cell growth and explains functions including DNA repair, cell cycle arrest, and apoptosis."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how defects in tumor suppressor genes can lead to cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that loss/mutation of tumor suppressors removes growth control, enabling uncontrolled proliferation and facilitating oncogene-driven growth, leading to cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how tumor suppressor genes gain defects or mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes mechanisms including mutations and inactivation via methylation and the need for both copies to be inactivated."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that there are genetic syndromes inherited in families that affect tumor suppressor genes, leaving affected individuals at higher risk of developing cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention inherited cancer syndromes or familial risk related to tumor suppressor gene mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention tumor suppressor genes that are thought to play a role in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions TP53 and CDKN2A as tumor suppressor genes relevant to pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that this is an active area of research.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not explicitly state that tumor suppressor genes and their role in pancreatic cancer are an active area of research."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss whether there are clinical trials available in their area with their oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No recommendation to discuss clinical trial options with the oncology team."
      }
    ],
    "question_number": 204,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:43:59.206336",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 2,
        "description": "The response must recommend discussing mental health counseling with the oncology team to connect with local resources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response suggests asking a healthcare provider or hospital social worker for referrals but does not explicitly recommend discussing counseling with the oncology team."
      },
      {
        "criterion_number": 3,
        "description": "The response must introduce palliative medicine as a specialty for managing symptoms or end-of-life care for pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions therapists specializing in palliative or hospice care, it does not introduce palliative medicine as a medical specialty for symptom management or end-of-life care."
      },
      {
        "criterion_number": 4,
        "description": "The response must list at least three types of mental health care providers, including their credentials and any limitations in practice.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It lists multiple provider types with credentials (LCSW, LPC, LMFT, PhD/PsyD, art/music therapist) but does not describe limitations in practice (e.g., prescribing authority, scope), which the criterion requires."
      },
      {
        "criterion_number": 5,
        "description": "The response must mention at least one modality for delivery of mental health counseling, such as in-person or telehealth.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly mentions teletherapy options as a modality."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that choosing the best provider is individualized and cannot be recommended online.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it notes therapy fit is personal, it does not explicitly state that the best provider cannot be recommended online."
      },
      {
        "criterion_number": 7,
        "description": "The response must mention providers affiliated with religious denominations or faith-based counseling options.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of faith-based counseling or clergy/chaplain services."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention mental health resources available for family members and caregivers of cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses family or couples counseling and references cancer support organizations and support groups relevant to families and caregivers."
      },
      {
        "criterion_number": 9,
        "description": "The response must recommend seeking counseling proactively, not waiting for a crisis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It supports counseling but does not explicitly advise seeking it proactively or before a crisis."
      },
      {
        "criterion_number": 10,
        "description": "The response must recommend at least one additional way to improve overall wellbeing, such as nutrition, exercise, sleep, or symptom control.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No specific recommendations are provided for wellbeing measures like nutrition, exercise, sleep, or symptom control."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that a licensed clinical social worker would be a good resource to utilize for advice and to be connected to further resources such as financial or caregiver support.",
        "score_given": 0,
        "max_points": 5,
        "justification": "An LCSW is listed as a provider type, and hospital social workers are mentioned for referrals, but it does not state that an LCSW can connect to resources such as financial or caregiver support."
      }
    ],
    "question_number": 205,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:45:11.232804",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define what DNA damage repair pathways are in the human body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that DDR pathways detect DNA damage, pause cell division, repair damage, and can trigger cell death if damage is irreparable."
      },
      {
        "criterion_number": 2,
        "description": "The response should list examples of genes implicated in DNA repair pathways in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides examples including BRCA1, BRCA2, ATM, ATR, and CHK1/CHK2, which are relevant DDR genes in pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain treatments in pancreatic cancer that are indicated for mutations in certain DNA repair pathway mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that PARP inhibitors are used for cancers, including pancreatic cancer, with BRCA1/2 mutations and notes increased sensitivity to DNA-damaging therapies when DDR is defective."
      },
      {
        "criterion_number": 4,
        "description": "The response should list DNA pathway repair targeted therapies in pancreatic cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists PARP inhibitors as a DDR-targeted therapy and mentions experimental agents targeting ATM, ATR, and CHK1/2; explicitly connects PARP inhibitors to pancreatic cancer with BRCA mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe how mutations in DNA damage repair pathways affect chemotherapy effectiveness.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that intact DDR can confer resistance to DNA-damaging treatments, while DDR defects can increase sensitivity; also mentions acquired resistance."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe how mutations in these pathways are detected in tumors, which is through genetic testing of tumor tissue from a biopsy or through a blood test.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions biomarker testing of the tumor but does not explicitly state testing methods (tumor tissue from biopsy) or blood-based testing."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide references to scientific literature with PMID for any of the FDA-approved treatments listed in rubric 4.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides general resources (ACS, NCI, ClinicalTrials.gov) but no peer-reviewed literature references with PMIDs for FDA-approved therapies like PARP inhibitors."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss tumor genetic testing with their oncologist to understand if they are a candidate for any DNA damage repair pathway mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises asking the oncology team about biomarker testing of the tumor and discussing results with the oncologist (and possibly a genetic counselor)."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend the patient inquire about clinical trials in their local area that might be evaluating new drugs that target DNA damage repair pathways, or inquire about a referral to a local institution that might have general clinical trials for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises inquiring about clinical trials and suggests considering a second opinion at a specialized cancer center, aligning with referral to institutions with trials."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that around 5-10 percent of pancreatic cancers have these mutations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not provide the prevalence estimate for DDR-related mutations in pancreatic cancer."
      }
    ],
    "question_number": 206,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:46:25.825634",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define inflammation using terms such as 'immune response,' 'tissue injury,' or 'protective mechanism.'",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states, 'Inflammation is a natural response of the immune system to injury or infection,' clearly defining inflammation as an immune response to tissue injury/infection."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly distinguish between acute and chronic inflammation (e.g., short-term vs. long-term).",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly contrasts 'acute' (protective) versus 'chronic' inflammation and their effects, and uses the terms 'acute' and 'chronic.'"
      },
      {
        "criterion_number": 3,
        "description": "Describe at least two medical strategies for managing inflammation (e.g., targeted therapies, immunotherapies, steroids, pain management).",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response mentions steroids, NSAIDs, targeted therapies (e.g., JAK inhibitors), and immunotherapy, meeting the requirement of at least two medical strategies."
      },
      {
        "criterion_number": 4,
        "description": "State that there is no formal, evidence-based strategy to quantify and target inflammation in cancer patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state that there is no formal, evidence-based strategy to quantify and target inflammation; it discusses clinical trials but does not make the required explicit statement."
      },
      {
        "criterion_number": 5,
        "description": "State that treating the cancer itself (e.g., surgery or radiation) is postulated to improve cancer-related inflammation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention surgery or radiation in the context of improving inflammation or state that treating the cancer can improve cancer-related inflammation."
      },
      {
        "criterion_number": 6,
        "description": "Mention chronic pancreatitis or chronic pancreatic injury as a factor in cancer formation and provide at least one scientific reference with a PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of chronic pancreatitis or chronic pancreatic injury as a risk factor, and no PMID is provided."
      },
      {
        "criterion_number": 7,
        "description": "Recommend at least two lifestyle interventions to decrease inflammation (e.g., plant-based diet, exercise, hydration, good sleep).",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response recommends proper nutrition but does not include a second explicit lifestyle intervention such as exercise, hydration, or sleep."
      },
      {
        "criterion_number": 8,
        "description": "Recommend against nicotine and alcohol use and reference their role in promoting inflammation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises avoiding smoking and excessive alcohol and states both increase inflammation and worsen outcomes."
      },
      {
        "criterion_number": 9,
        "description": "Recommend that the patient report any symptoms to their oncology team for symptom management.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it advises consulting the oncology team and mentions supportive care for symptom management, it does not explicitly instruct reporting any symptoms to the oncology team."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly state that chronic inflammation promotes tumor growth.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states 'chronic inflammation can actually promote tumor growth and progression' and reiterates that it 'supports tumor survival and spread.'"
      },
      {
        "criterion_number": 11,
        "description": "Explicitly state that inflammatory signaling pathways are overactivated in cancer using terms like 'overactivated,' 'upregulated,' or 'enhanced.'",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it describes inflammatory molecules stimulating cancer cell proliferation, it does not use terms such as 'overactivated,' 'upregulated,' or 'enhanced' to describe signaling pathways."
      },
      {
        "criterion_number": 12,
        "description": "Explicitly state that the immune system can be activated to recognize and attack cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The immunotherapy section states these therapies aim to 'reawaken' the immune system to better recognize and attack cancer cells."
      },
      {
        "criterion_number": 13,
        "description": "Explicitly state that anti-inflammatory drugs are not used as a primary treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not explicitly state that anti-inflammatory drugs are not a primary/main/first-line treatment for pancreatic cancer."
      },
      {
        "criterion_number": 14,
        "description": "Explicitly state that NSAIDs and steroids are prescribed to manage symptoms associated with cancer, using terms like 'symptom management,' 'symptom control,' or 'alleviate symptoms.'",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes steroids may be used when inflammation causes symptoms and has a section on 'Pain and Symptom Control,' it does not explicitly state that NSAIDs and steroids are prescribed for 'symptom management/control' using the required wording."
      }
    ],
    "question_number": 207,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:47:53.867738",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention using a pill organizer with compartments for different times of the day and days of the week.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends 'Weekly Pill Organizer Boxes' with compartments for each day and times of day (AM/PM)."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention using a medication management application, with examples such as Medisafe, MyTherapy, or CareZone.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists multiple apps including Medisafe and MyTherapy and describes their features for tracking schedules and dosages."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention setting alarms or reminders on digital devices to alert when it\u2019s time to take medication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that apps 'provide reminders' and also suggests using shared calendars to set reminders."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention creating a physical chart or digital document listing all medications, dosages, and times.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends 'Medication Journals or Logs' for recording medication use and highlights apps that track schedules and dosages, meeting the intent of maintaining a comprehensive medication list."
      },
      {
        "criterion_number": 5,
        "description": "The response should direct the patient to discuss options for medication management with their oncology team and/or pharmacy team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises 'Pharmacy Consultation' and references cancer center care coordination services, directing engagement with the care team."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend exploring medication delivery services and bubble packs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends 'PillPack by Amazon,' which delivers medications and organizes them in labeled packets by date/time (bubble/strip packaging)."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient have a loved one help with their medication management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages caregiver involvement via 'multiple caregivers can access the same account,' 'family sharing features,' and shared calendars for the whole care team."
      },
      {
        "criterion_number": 8,
        "description": "The response should empathize about the medication burden in patients undergoing cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Opens with empathy acknowledging complexity and stress of managing medications during pancreatic cancer treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention meeting with a pharmacist or provider to complete a medication reconciliation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Suggests a 'Pharmacy Consultation' to review the medication regimen, which is functionally a medication reconciliation."
      }
    ],
    "question_number": 208,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:48:46.997515",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define oncogenes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines oncogenes as genes that, when mutated or abnormally activated, can drive normal cells to become cancerous, and distinguishes proto-oncogenes from oncogenes."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe that oncogenes can undergo mutation, which might put the individual at risk for developing cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that mutations or abnormal activation of oncogenes can promote cancer development, while noting that a single mutation does not guarantee cancer (multi-hit concept)."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how oncogenes mutate.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes mechanisms of oncogene activation, including point mutations leading to constitutive activation, gene amplification, and viral insertion."
      },
      {
        "criterion_number": 5,
        "description": "The response should reference which mutated oncogenes are implicated in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically cites KRAS as commonly altered in pancreatic cancer and explains its role."
      },
      {
        "criterion_number": 6,
        "description": "The response should state whether there are FDA-approved treatments available for pancreatic cancers with mutated oncogenes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions targeted therapies in general and challenges with KRAS but does not explicitly state whether FDA-approved treatments exist for oncogene-driven pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that patients with pancreatic cancer undergo tumor genetic testing either with biopsy of primary tumor or blood test.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Suggests discussing specific genetic changes with clinicians but does not explicitly recommend tumor genomic testing via tissue biopsy or blood (ctDNA) testing."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that patients inquire with their oncology team if there are clinical trial opportunities available to them, or a local institution.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention clinical trials or encourage asking the oncology team about trial opportunities."
      }
    ],
    "question_number": 209,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:49:23.115618",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe that treatment sequencing in pancreatic cancer is determined by the stage of the cancer and the intent of the treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that the best sequence depends on stage and discusses goals of treatment (cure, prolong life, manage symptoms), linking sequencing decisions to intent."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe that sometimes pancreatic cancer management requires different modalities of treatments, such as chemotherapy and surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It references multiple modalities including chemotherapy, surgery, radiation therapy, targeted therapy, and immunotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe that in pancreatic tumors thought to be surgically resectable, patients often undergo chemotherapy prior to surgery to shrink the tumor and kill any micrometastases for the best possible surgical outcome.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions neoadjuvant chemotherapy to shrink a tumor and make surgery easier, it does not mention treating/killing micrometastases or explicitly tie this to optimizing surgical outcomes."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that surgery rarely plays a role in advanced pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It notes that chemotherapy is often the main treatment for advanced/metastatic disease but does not explicitly state that surgery rarely plays a role."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe what treatment sequencing in pancreatic cancer is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly defines treatment sequencing as the order in which different treatments are given."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain the goal of treatment sequencing in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly explains goals such as maximizing effectiveness, minimizing side effects, reducing recurrence (via adjuvant therapy), and addressing resistance."
      },
      {
        "criterion_number": 7,
        "description": "The response should state risks involved if cancer treatment is not appropriately sequenced.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It discusses benefits of proper sequencing but does not explicitly state risks of inappropriate sequencing (e.g., reduced efficacy, increased toxicity, missed surgical window)."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient request a multidisciplinary conference to discuss their pancreatic cancer management recommendations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation is made to request a multidisciplinary conference or tumor board review."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe what a tumor board (or multidisciplinary conference) is for discussions on management of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no description of a tumor board or multidisciplinary conference."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain that the oncology care team needs to gather information to make informed recommendations on pancreatic cancer treatment, such as imaging studies, tumor biomarkers, and possibly tumor genetic testing.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not mention imaging, tumor biomarkers, or genetic testing as inputs to treatment recommendations."
      },
      {
        "criterion_number": 11,
        "description": "The response should emphasize that treatment sequencing is individualized to the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly emphasizes individualization based on stage, cancer type, overall health, preferences, and the oncology team's assessment."
      },
      {
        "criterion_number": 12,
        "description": "The response should define the following terms: neoadjuvant, adjuvant, perioperative.",
        "score_given": 0,
        "max_points": 6,
        "justification": "It effectively defines neoadjuvant (before surgery) and adjuvant (after surgery) but does not define perioperative."
      }
    ],
    "question_number": 210,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:50:12.014786",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define hypoxia as a low oxygen state often seen in tumors because the tumor outgrows its blood supply.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines hypoxia as parts of the tumor not getting enough oxygen and explains that tumors outgrow their blood supply, leading to low-oxygen (hypoxic) regions."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe why cancer cells that exist in a hypoxic environment are difficult to treat.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that hypoxic tumor cells are more resistant to standard treatments and that low oxygen reduces the effectiveness of therapies, contributing to treatment resistance."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how hypoxic environments affect cancer\u2019s response to treatment.",
        "score_given": 9,
        "max_points": 9,
        "justification": "It specifically states that radiation and some chemotherapy are less effective in hypoxic conditions and notes ongoing research and combination strategies to address hypoxia, adequately covering treatment-response impacts."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that radiation therapy becomes less effective in hypoxic conditions because oxygen plays a role in radiation-induced DNA damage.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly notes that radiation works best with oxygen because it damages cells by creating free radicals from oxygen, and that hypoxic areas may not respond as well."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the mechanism of action of VEGF inhibitors and their postulated role in the treatment of hypoxic tumors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions angiogenesis inhibitors and vessel normalization in general, it does not identify VEGF inhibitors by name nor describe their mechanism (blocking VEGF signaling to normalize tumor vasculature and potentially improve oxygenation)."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain whether there is evidence-based information about hyperbaric oxygen therapy in hypoxic tumors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hyperbaric oxygen therapy is not discussed at all; no evidence-based appraisal is provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe how hypoxic environments affect the immune system\u2019s ability to access cancer cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although immunotherapies are mentioned, the response does not explain how hypoxia impairs immune cell infiltration or function within the tumor microenvironment."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend the patient discuss whether there are clinical trials focusing on tumor cell hypoxic environments available in their area.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises asking the oncology team about clinical trials testing new approaches to overcome tumor hypoxia, fulfilling the recommendation."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that hypoxia can make the tumor more aggressive and promote metastasis (spread).",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response states hypoxic tumors tend to be more aggressive and may grow faster, but it does not mention promotion of metastasis or spread."
      }
    ],
    "question_number": 211,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:50:54.833221",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that the patient document all of their questions or concerns in advance of an appointment with the oncology team to ensure everything is addressed during their allotted face-to-face time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to \"Prepare Questions in Advance\" and to write down questions and concerns before each appointment."
      },
      {
        "criterion_number": 2,
        "description": "The response should encourage the patient and/or family members to ask for clarification on any aspects of care that are unclear, and to encourage question-asking during appointments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly instructs to ask for clarification and provides example phrases to request simpler explanations."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient request a language interpreter if they feel more comfortable communicating in an alternate language than what their medical team speaks.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of language interpreters or translation services."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient bring a loved one or family member to all appointments and consider taking notes or recording the conversation.",
        "score_given": 110,
        "max_points": 110,
        "justification": "Recommends bringing a support person to appointments and suggests taking notes or recording with permission."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend that the patient utilize online patient portals to send messages if needed.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages using patient portals to access records and communicate electronically with the care team."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend that the patient inquire about communication contacts and channels that would be best to contact their oncology team as soon as possible in their treatment journey to establish a \u201cpoint person.\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not advise identifying a primary contact or asking about preferred communication channels or a point person."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide a list of online resources that patients and family members can reference to provide some answers to questions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides online resources: American Cancer Society and Pancreatic Cancer Action Network with links."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend additional points of contact with the oncology team, such as patient advocates, social workers, nurses, and/or palliative medicine specialists.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends patient advocates/navigators and involving social workers; these are appropriate additional contacts."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of feeling supported in their cancer journey.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes an 'Emotional Support' section and emphasizes caring for emotional well-being and support groups."
      },
      {
        "criterion_number": 10,
        "description": "The response should inform patients that they can ask for a written summary of their medical appointments after the visit.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises requesting written summaries of diagnosis, treatment plan, and test results."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that, if available, patient navigators can be a useful resource to assist with care coordination and communications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions patient advocates or navigators and their role in facilitating communication and navigation."
      }
    ],
    "question_number": 212,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:51:39.147686",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer cell plasticity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines plasticity as the ability of cancer cells to change characteristics/state in response to the environment, with examples (cycling vs. quiescent, differentiated vs. stem-like)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how cancer cell plasticity makes cancer cells more difficult to treat.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains drug resistance, acquired resistance under treatment pressure, survival leading to recurrence, and stem-like cells being treatment resistant\u2014directly tying plasticity to treatment difficulty."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the epithelial-mesenchymal transition in pancreatic cancer.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention of epithelial\u2013mesenchymal transition (EMT), mesenchymal states, or their specific role in PDAC."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role plasticity plays in the metastatic potential of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that plastic cells can develop traits that enable spread/metastasis after surviving treatment, linking plasticity to metastatic potential."
      },
      {
        "criterion_number": 5,
        "description": "The response should define and describe cancer cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines dormancy/quiescence as a resting state and notes dormant cells can later re-enter the cell cycle and cause recurrence."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe how cancer cell plasticity can contribute to cancer cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly links plasticity to a switch into quiescence to evade therapy and later reactivation."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe how cancer cell plasticity allows cancer cells to evade the immune system, making immunotherapy relatively ineffective.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss immune evasion mechanisms or how plasticity impacts response to immunotherapy."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention ways that cancer-directed therapy can be used to attempt to overcome cancer cell plasticity, such as treatment sequencing and medication combinations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends combination therapies, personalized plans with genomic testing, close monitoring to adapt treatment, and trials targeting plasticity\u2014aligned with strategies to overcome plasticity."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that therapeutic strategies to target plasticity is an active area of research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states ongoing research into drugs blocking plasticity pathways and references clinical trials."
      }
    ],
    "question_number": 213,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:52:09.272379",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mechanical forces in relation to cancer cells, explicitly mentioning \u201cphysical forces\u201d or \u201cpressure.\u201d",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines mechanical forces as physical pressures and forces acting on tissues, including compression and stiffness, explicitly using terms like \u201cphysical pressures\u201d and describing sources such as growth-induced compression and altered blood flow."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the effect of different mechanical forces on cancer growth and proliferation, including the activation of pathways or signaling pathways.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It describes how stiffness and compression promote survival, migration, and treatment resistance, notes activation of signaling pathways due to stiffness, and references mechanoreceptors and altered gene expression, satisfying the pathway/signaling component."
      },
      {
        "criterion_number": 3,
        "description": "The response should define desmoplastic stroma, which is often seen in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The term \u201cdesmoplastic stroma\u201d is not mentioned nor defined. While the tumor microenvironment is broadly described, there is no explicit definition of desmoplasia."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the pancreatic cancer tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses the tumor microenvironment in general terms but does not specifically describe the pancreatic cancer microenvironment (e.g., CAF-rich, ECM-dense, hyaluronan-rich, hypovascular, immunosuppressive)."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention future research directions as it pertains to desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Research directions are mentioned generally (softening tumors, imaging stiffness, combination therapies) but not tied specifically to desmoplastic stroma in pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain if there are FDA approved therapies that act on the desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention is made of FDA-approved therapies targeting the desmoplastic stroma in pancreatic cancer (e.g., that none are approved; stromal-modulating approaches remain investigational)."
      },
      {
        "criterion_number": 8,
        "description": "The response must state that in pancreatic cancer, the stroma is very dense and stiff, leading to high interstitial pressure and reduced oxygen and nutrient delivery.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although stiffness, vessel compression, and reduced oxygen/nutrient delivery are discussed, the response does not specifically state that in pancreatic cancer the stroma is very dense and stiff nor mention high interstitial fluid pressure."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that the dense stroma can impede treatment delivery and induce hypoxia, explicitly mentioning \u201chypoxia\u201d and \u201ctreatment resistance.\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "While the response mentions hypoxia and treatment resistance and that mechanical forces can affect drug delivery, it does not attribute these effects specifically to the dense stroma, as required."
      },
      {
        "criterion_number": 10,
        "description": "The response must state that the dense stroma can impede immune cells from reaching the tumor, explicitly mentioning \u201cimmune evasion\u201d or \u201creduced efficacy of immunotherapy.\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response notes potential resistance to immunotherapy in stiff environments but does not link this to dense stroma impeding immune cell infiltration nor use the phrases \u201cimmune evasion\u201d or \u201creduced efficacy of immunotherapy.\u201d"
      }
    ],
    "question_number": 214,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:52:50.053191",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend that the patient discuss the primary medical team responsible for keeping track of their referrals and oncologic care; this is usually the medical oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises selecting a lead physician, explicitly noting this is often the oncologist, to coordinate care and communication among specialists."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly state that a clinician is designated as the main provider responsible for care coordination and continuity.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly instructs to choose one doctor to serve as the main coordinator of care."
      },
      {
        "criterion_number": 3,
        "description": "Describe the potential medical teams involved in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response mentions a multidisciplinary tumor board including surgeons, oncologists, and radiologists, and references multiple specialists involved."
      },
      {
        "criterion_number": 4,
        "description": "Recommend that the patient keep a comprehensive log of their test results and progress notes, in order to provide these to providers in the event that they did not receive everything.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It recommends maintaining a detailed binder/digital folder with medical records, test results, appointment notes, and suggests using tools so information is accessible to the care team."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly recommend creating a centralized document listing all providers, their roles, and test results, which can be taken to appointments.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it recommends a binder with test results and contact information and to bring it to visits, it does not explicitly state listing each provider\u2019s role."
      },
      {
        "criterion_number": 6,
        "description": "Recommend that the patient have a loved one accompany them to all appointments, preferably the same person, and take notes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends having someone accompany the patient to appointments to take notes and remember details."
      },
      {
        "criterion_number": 7,
        "description": "Recommend that the patient use online patient portals to ask questions and contact their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions using a patient portal for information sharing but does not recommend using portals to ask questions or contact the oncology team."
      },
      {
        "criterion_number": 8,
        "description": "Describe different professionals that can possibly help with care coordination, such as nurse case managers and social workers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It identifies care coordinators, navigators, patient advocates, and social workers as resources for care coordination and support."
      }
    ],
    "question_number": 215,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:53:43.966016",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define senescence in cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines cellular senescence as a state where cells stop dividing without dying, in response to damage or aging."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how senescence can lead to secretion of inflammatory molecules (senescence-associated secretory phenotype) which can alter the microenvironment to make it more amenable to tumor progression.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly describes SASP and explains that senescent cells release inflammatory molecules and growth factors that can stimulate nearby cancer cells, promote inflammation, and aid immune evasion."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe senescence-associated secretory phenotype factors.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies SASP components in general terms (growth factors and inflammatory molecules) and their effects, which satisfies describing the types of factors even without listing specific cytokines."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of senescence in normal cells.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Notes that in normal physiology, damaged or old cells may enter senescence instead of dividing, indicating its role as a response to damage/aging."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe ways in which cancer cells evade senescence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss mechanisms by which cancer cells bypass or evade senescence (e.g., p53/p16 pathway inactivation, telomerase activation)."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain how some cancer therapies induce senescence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that certain chemotherapy and targeted therapies can push cancer cells into a senescent state instead of killing them."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain what senolytics are, and describe if there are any FDA approved in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines senolytics as drugs that selectively kill senescent cells and notes this approach is not standard of care with clinical trials ongoing, implying no FDA-approved senolytics for pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that this is an active area of research in the scientific community.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states it is an active area of research and mentions ongoing clinical trials."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that senescence is caused by cellular stressors such as DNA damage or activation of tumor suppressor genes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions DNA damage and treatment stress as triggers for senescence, satisfying the criterion via the example of DNA damage."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that senescence can be a positive factor as it stops tumor growth.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that tumor-suppressive senescence stops cell division, preventing growth into new cancer cells, which is beneficial."
      }
    ],
    "question_number": 216,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:54:26.354259",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define exosomes as vesicles that cells can release into their surroundings.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines exosomes as tiny membrane-bound vesicles released by almost all cell types."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe what exosomes contain, such as proteins, lipids, and RNA.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists proteins, lipids, and nucleic acids (including microRNAs) as exosomal cargo."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of exosomes in cancer cells, including cell-cell communication.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Describes exosomes as intercellular messengers and explains cancer cell\u2013to\u2013cell communication effects."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of exosomes in tumor promotion.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Explains how exosomes promote angiogenesis, alter stromal behavior, and support tumor growth."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the role of exosomes in immune evasion.",
        "score_given": 6,
        "max_points": 6,
        "justification": "States that tumor exosomes suppress immune activity and help tumors evade detection."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the role of exosomes in drug resistance.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not mention exosome-mediated drug resistance mechanisms."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe the emerging or experimental role of exosomes as tumor biomarkers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies exosomes as potential biomarkers detectable in blood/fluids and notes active research."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe how exosomes travel in the body.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Indicates long-distance communication and detectability in blood/other bodily fluids, implying circulation-based transport."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain how exosomes are thought to facilitate metastases in cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Describes preparation of distant sites (pre-metastatic niche) making them more receptive to tumor spread."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe if there are any FDA approved treatments that are associated with cancer exosomes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes lack of routine clinical use but does not explicitly address FDA-approved treatments."
      }
    ],
    "question_number": 217,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:54:59.341812",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define advance directive and living will, and recommend completion/update near end of life",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains these documents as expressing preferences for treatment (resuscitation, life support, pain management) and recommends completing them 'as soon as possible.'"
      },
      {
        "criterion_number": 2,
        "description": "Recommend a palliative medicine consultation to consider transitioning focus to comfort",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussing hospice or palliative care options with the medical team and notes these services focus on comfort and quality of life, indicating a shift from disease-targeted care."
      },
      {
        "criterion_number": 3,
        "description": "Describe Hospice and include <6 months prognosis eligibility",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions hospice but does not state the Medicare-standard eligibility of an estimated prognosis of six months or less."
      },
      {
        "criterion_number": 4,
        "description": "Describe categories of tasks approaching end of life for pancreatic cancer",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers medical decision-making, financial/legal planning, practical care arrangements, emotional/spiritual support, communication with the medical team, and after-death arrangements."
      },
      {
        "criterion_number": 5,
        "description": "Define medical durable power of attorney",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines healthcare proxy/medical DPOA as appointing someone to make medical decisions if the patient cannot communicate wishes."
      },
      {
        "criterion_number": 6,
        "description": "Describe steps to elect a medical durable power of attorney",
        "score_given": 0,
        "max_points": 7,
        "justification": "Recommends appointing someone but does not outline steps (selecting agent, completing state-specific form, witnessing/notarizing, distributing copies)."
      },
      {
        "criterion_number": 7,
        "description": "Define a POLST and recommend completing and displaying at home",
        "score_given": 0,
        "max_points": 10,
        "justification": "POLST is not mentioned."
      },
      {
        "criterion_number": 8,
        "description": "Ensure healthcare teams have a copy of the POLST",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of POLST or distributing it to healthcare teams."
      },
      {
        "criterion_number": 9,
        "description": "State hospice benefits vary across insurance plans; understand specific benefits",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of insurance variability of hospice benefits."
      },
      {
        "criterion_number": 10,
        "description": "Include that hospice provides services for patient and for family/caregivers",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions counseling and support groups generally but does not state that hospice specifically provides services/support to family and caregivers."
      },
      {
        "criterion_number": 11,
        "description": "Recommend electing a financial durable power of attorney",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends a financial power of attorney to manage finances and pay bills if the patient is unable."
      },
      {
        "criterion_number": 12,
        "description": "Recommend considering and communicating funeral arrangements",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing and documenting funeral/burial/cremation preferences and mentions planning memorial/celebration of life."
      },
      {
        "criterion_number": 13,
        "description": "Recommend planning for religious/spiritual rituals",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages arranging spiritual care so beliefs and rituals are honored."
      },
      {
        "criterion_number": 14,
        "description": "Describe importance of open communication between patient and decision makers to respect wishes",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes maintaining honest, open communication about wishes and changes; also encourages communicating preferences (e.g., funeral) to loved ones."
      },
      {
        "criterion_number": 16,
        "description": "State end-of-life planning is individualized and should follow the patient's wishes",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights ensuring the loved one's wishes are respected and suggests personalized guidance, reflecting individualized planning centered on patient preferences."
      }
    ],
    "question_number": 218,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:55:48.590201",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer cell dormancy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines dormancy as a state where cancer cells are present but not actively dividing (quiescent), potentially undetectable and able to reactivate later."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how long a cancer cell can remain dormant in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States duration is variable and unknown, notes evidence of dormancy lasting years to decades in some cancers and mentions typical recurrence timelines, addressing the time dimension."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain why it is advantageous for cancer cells to be able to enter a dormant state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that dormant cells may evade detection and later reactivate to cause recurrence, implying survival advantage and treatment evasion."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe scenarios in which a cancer cell may be prompted to enter dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple triggers such as hypoxia/nutrient deprivation, immune surveillance, genetic changes slowing division, and suppressive signals from surrounding cells."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe what is known about cancer cell dormancy in pancreatic cancer, preferably with references to the scientific literature with PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States research in pancreatic cancer is limited but provides no pancreatic cancer\u2013specific details or PMIDs; cited resources are general and not pancreas-specific."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that dormancy can occur because of microenvironmental or genetic factors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions microenvironmental factors (nutrient/oxygen deprivation, surrounding cell signals) and genetic changes leading to slowed division."
      },
      {
        "criterion_number": 8,
        "description": "The dormant cells will often be less susceptible to chemotherapy than rapidly dividing cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address chemotherapy susceptibility of dormant cells."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that these dormant cells can lead to disease recurrence after treatments as they can reactivate after a long period of time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states dormant cells can 'awaken' and grow again, leading to recurrence, potentially after long periods."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that dormancy is an active area of research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that researchers are actively studying dormancy and suggests clinical trials, indicating it is an active research area."
      }
    ],
    "question_number": 219,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:56:18.605111",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mechanical stress as physical forces and pressures exerted on and within a tumor mass, arising from tumor growth, interactions with surrounding tissues, and the tumor\u2019s microenvironment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines mechanical stress as physical forces (solid stress, fluid shear stress, matrix stiffness) within the tumor microenvironment, including pressure from tumor growth compressing vessels and ECM stiffness."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how mechanical stress on tumor cells impacts their ability to grow and metastasize.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains effects on tumor growth/survival and details how mechanical cues promote detachment, invasion, and metastasis."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the relationship between mechanical stress in tumors and hypoxia.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that solid stress compresses blood vessels, limiting oxygen and nutrients and causing hypoxia, which can select for more aggressive cells."
      },
      {
        "criterion_number": 4,
        "description": "The response should explain that mechanical stress on tumor tissue is implicated in treatment resistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes how mechanical stress contributes to drug delivery barriers and can induce resistant/dormant states; mentions impacts on chemo and immunotherapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should define the tumor microenvironment.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Defines tumors as complex tissues with their own microenvironment and identifies components like stroma and physical forces, conveying the concept adequately."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe sources of mechanical stress in tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists solid stress from growth, fluid shear stress from fluid flow, and matrix stiffness from ECM changes."
      },
      {
        "criterion_number": 7,
        "description": "The response should inform the patient that effects of mechanical stress on tumor tissue are not fully elucidated and are an area of active scientific research.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Notes active research and ongoing exploration but does not explicitly state that the effects are not fully elucidated."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention the effect of mechanical stress on the tumor in angiogenesis, invasion, metastasis, and promotion of tumor cell survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Covers invasion, metastasis, and survival, but does not explicitly mention angiogenesis."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that pancreatic cancer is characterized by a very dense and stiff stroma, leading to high interstitial pressure and reduced oxygen and nutrient delivery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions dense stroma and stiffness in PDAC and general vessel compression, but does not explicitly state high interstitial pressure or link PDAC stroma to reduced oxygen/nutrient delivery."
      },
      {
        "criterion_number": 11,
        "description": "The response must state that the dense stroma can impede immune cells from reaching the tumor, aiding immune evasion and reducing the efficacy of immunotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes mechanical stress impeding immune cell infiltration and mentions immunotherapy resistance in general, but does not attribute this to the dense stroma specifically or explicitly state reduced immunotherapy efficacy due to stromal barriers."
      }
    ],
    "question_number": 220,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:57:16.345797",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define tumor organoids as a miniature 3D model of the patient\u2019s tumor grown in a lab from the patient\u2019s own cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines organoids as tiny 3D structures grown in the lab from a small piece of the patient\u2019s tumor, mimicking the original tumor."
      },
      {
        "criterion_number": 2,
        "description": "Describe how tumor organoids are used for testing cancer medications to determine the most effective one.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains testing different drugs and combinations on a patient\u2019s organoid and using results to predict the most effective treatment."
      },
      {
        "criterion_number": 3,
        "description": "Explain that the use of tumor organoids is experimental and not available at all cancer centers, and that there are no large randomized clinical trials for tumor organoids.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response states usage is limited to specialized/research settings, implying limited availability, but does not state there are no large randomized clinical trials."
      },
      {
        "criterion_number": 5,
        "description": "Describe how tumor organoids are grown.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It outlines the process: obtaining a biopsy/surgical sample, dissociating tissue, growing cells in a supportive 3D gel with nutrients, and maintaining cultures over weeks to months."
      },
      {
        "criterion_number": 6,
        "description": "Explain how tumor organoids are different than cultured cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although the response notes organoids preserve structure and genetics, it does not explicitly compare organoids to traditional 2D cultured cell lines or explain the differences."
      },
      {
        "criterion_number": 7,
        "description": "Describe how tumor organoids are used to tailor treatments to the patient from which they are derived.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly discusses personalized medicine and predicting patient-specific treatment responses using the patient\u2019s own organoids."
      },
      {
        "criterion_number": 8,
        "description": "Describe advantages of using patient-derived organoids for research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advantages are described, including preservation of tumor structure/genetics, ability to study biology and drug resistance, and testing new therapies."
      },
      {
        "criterion_number": 9,
        "description": "Describe limitations of using patient-derived organoids for research.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Limitations specific to research (e.g., lack of full tumor microenvironment, variable success rates, time/cost) are not discussed; only clinical availability is mentioned."
      }
    ],
    "question_number": 221,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:58:03.704836",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that the patient choose a medical decision maker, or medical durable power of attorney, who will make medical decisions for her in the event she is unable to do so herself.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises designating a healthcare proxy/power of attorney for healthcare if the mother is unable to decide, aligning with the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend that the patient and her legal next of kin request assistance from social work from their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends involving a hospital social worker, which satisfies advising social work involvement through the care team, even though it does not explicitly say 'from the oncology team.'"
      },
      {
        "criterion_number": 3,
        "description": "The response should inform the patient about the role of palliative medicine in cancer care, who are providers who can help establish a patient\u2019s goals of care and can assist with documentation of this.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention palliative care or its role in goals-of-care discussions or documentation."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient designate a primary family member who can attend appointments and relay information to other family members.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No suggestion to designate a single primary family point person to attend appointments and relay information."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend the establishment of a meeting schedule, where the primary family member or patient meets with a greater group of family members for regular updates.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions family meetings in general but does not recommend a structured, scheduled update process or regular cadence."
      },
      {
        "criterion_number": 7,
        "description": "The response must state that the priority should be the patient\u2019s own personal wishes and that she should be as involved in the decision-making process as possible.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly states the mother should be included in decisions as much as possible and that her wishes and values should be respected, referencing advance directives."
      },
      {
        "criterion_number": 8,
        "description": "The response must recommend holding family meetings with the healthcare team so that family members can hear information directly from the physician.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Encourages asking the medical team questions but does not recommend joint family meetings with the healthcare team to hear directly from physicians."
      },
      {
        "criterion_number": 9,
        "description": "The response must emphasize the importance of clear communication between family members.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly emphasizes open, honest communication and creating a safe space for family members to share feelings and concerns."
      }
    ],
    "question_number": 222,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:58:55.962839",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define circadian rhythms as the body\u2019s natural 24-hour internal clock regulated by the brain and influenced by external cues, including hormone regulation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response defines circadian rhythms as 24-hour biological processes and mentions hormone release, but it does not state regulation by the brain (e.g., SCN) or influence by external cues like light/dark or meals."
      },
      {
        "criterion_number": 2,
        "description": "Describe chronotherapy as timing cancer treatments to align with circadian rhythms for better efficacy and fewer side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly references chronotherapy as scheduling treatments based on circadian rhythms and links timing to effectiveness and side effects."
      },
      {
        "criterion_number": 3,
        "description": "Explain how disruptions in the circadian rhythm are thought to promote pancreatic cancer growth, including references to scientific literature or reputable sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While citations are provided, the response does not explain that circadian disruption promotes pancreatic cancer growth; it focuses on rhythms/oscillations and treatment sensitivity, not disruption-driven tumor promotion."
      },
      {
        "criterion_number": 4,
        "description": "Recommend ways to promote normal circadian rhythms in pancreatic cancer patients, including consistent sleep, regular meal times, exposure to natural light, and avoiding screens/blue light at night.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests maintaining a regular sleep schedule and minimizing light at night, but omits regular meal times, exposure to natural light during the day, and explicit advice about screens/blue light."
      },
      {
        "criterion_number": 5,
        "description": "Explain the effect of poor or interrupted sleep on circadian rhythms, stating that disruptions can affect overall health and potentially promote cancer progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit discussion of how poor or interrupted sleep disrupts circadian rhythms or may promote cancer progression."
      },
      {
        "criterion_number": 6,
        "description": "Explain the effect of poor or inadequate diet on circadian rhythms, mentioning that irregular eating can disrupt circadian rhythms and that maintaining regular meal times is important.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not address diet or meal timing effects on circadian rhythms."
      },
      {
        "criterion_number": 7,
        "description": "Provide general recommendations for sleep hygiene, including consistent sleep duration, avoiding screens/blue light at night, and exposure to natural light during the day.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Only general advice to maintain a regular sleep schedule and minimize light at night is given; it does not specifically mention screens/blue light, consistent sleep duration, or daytime natural light exposure."
      },
      {
        "criterion_number": 8,
        "description": "Recommend that the patient consult a nutritionist familiar with nutritional challenges associated with pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No recommendation to consult a nutritionist is provided."
      },
      {
        "criterion_number": 9,
        "description": "Recommend that the patient inquire with their oncology team about clinical trials pertaining to circadian rhythms in pancreatic cancer, mentioning resources like ClinicalTrials.gov.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response advises discussing with the oncology team and explicitly directs to ClinicalTrials.gov and cancer.gov for trials."
      },
      {
        "criterion_number": 11,
        "description": "Clearly state that there is no current high-quality data supporting timed treatment in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that evidence is mostly preclinical and that more clinical trials are needed for pancreatic cancer, conveying that high-quality clinical data supporting timed treatment are not currently available."
      }
    ],
    "question_number": 223,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T16:59:40.267377",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mitochondria.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines mitochondria as the 'powerhouses of the cell' that generate ATP and mentions additional functions, constituting a definition."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the roles of mitochondria in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains normal roles: ATP production, control of apoptosis, calcium management, and production of signaling molecules."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain what is known about how the role of mitochondria in cancer cells differs from that of normal cells.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Describes differences in cancer cells: altered energy production, evasion of apoptosis, and metabolic flexibility, demonstrating how mitochondrial functions are reprogrammed."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the increased metabolic demands on cancer cells and why this happens.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States cancer cells need more energy to grow rapidly and thus reprogram metabolism, addressing both the increased demand and the reason (rapid growth/proliferation)."
      },
      {
        "criterion_number": 5,
        "description": "The response should explain the Warburg effect.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not mention or explain the Warburg effect (aerobic glycolysis in the presence of oxygen)."
      },
      {
        "criterion_number": 6,
        "description": "The response should define apoptosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Refers to 'cell death (apoptosis)' and apoptotic pathways but does not define apoptosis as programmed/regulated cell death; the definition is incomplete."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain the role of mitochondria in apoptosis in normal cells, and explain how this can be altered in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that mitochondria can trigger apoptosis in damaged cells and that cancer cells suppress these pathways; also mentions BH3 mimetics and p53 restoration, satisfying the criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response should define reactive oxygen species and how they are created with regard to the role that mitochondria play.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Reactive oxygen species (ROS) are not mentioned or defined, nor is mitochondrial ROS production discussed."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how ROS can damage surrounding cells, and the subsequent cellular signaling pathways that are stimulated as a result.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of ROS-mediated damage or downstream signaling pathways is provided."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe that as a facilitator of cellular energy, mitochondria are a potential treatment target.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly discusses mitochondria-targeting therapies (e.g., complex I/II inhibitors, metformin) aimed at disrupting energy production and inducing apoptosis."
      },
      {
        "criterion_number": 11,
        "description": "The response should define glutamine and how this substance is used in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Glutamine and its role in cancer cell metabolism are not addressed."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that cancer treatment targeting mitochondrial functions are experimental and not part of FDA-approved treatment regimens at this time.",
        "score_given": 8,
        "max_points": 8,
        "justification": "States that many mitochondria-targeting drugs are still in experimental stages and may not be available/effective for pancreatic cancer, implying they are not standard FDA-approved treatments."
      }
    ],
    "question_number": 224,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:00:17.145797",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must recommend that the patient and/or family discuss insurance coverage issues with the oncology team administering the experimental treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises talking to the oncologist and care team and notes they have experience with these situations, and mentions obtaining letters of support from the medical team for appeals."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention that financial assistance programs are available for some experimental drugs and explicitly state that this varies from drug to drug, requiring inquiry.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions patient assistance programs and compassionate use that may provide drugs at low/no cost, it does not explicitly state that assistance varies from drug to drug and requires specific inquiry."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly mention that travel to and from the trial center is often not covered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of travel costs or their typical lack of coverage."
      },
      {
        "criterion_number": 5,
        "description": "The response must describe what \u201ccompassionate use\u201d is and recommend that the patient/family ask their oncology team about this.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines compassionate use/named patient programs for unapproved drugs and states the oncologist can help inquire about these options."
      },
      {
        "criterion_number": 6,
        "description": "The response must recommend that the patient discuss their concerns with their cancer center\u2019s financial team and/or patient advocacy office.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends working with hospital/cancer center patient advocates and financial counselors/social workers to navigate insurance and financial issues."
      },
      {
        "criterion_number": 7,
        "description": "The response must recommend that the patient and/or family become familiar with their insurance policy to understand what is or is not covered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "A dedicated section urges careful review of the insurance policy, including experimental coverage, clinical trial rules, network issues, and the appeals process."
      },
      {
        "criterion_number": 8,
        "description": "The response must inform the patient that they have the right to appeal any decision made by the insurance company.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly states the right to appeal denials and describes internal and external review options."
      },
      {
        "criterion_number": 9,
        "description": "The response must recommend that the patient seek out patient advocacy groups online to learn how other patients navigated the same issues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends contacting patient advocacy organizations (PanCAN, ACS) for support and practical advice, fulfilling the intent to seek guidance from others who have navigated similar issues."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that insurance usually only covers standard of care treatments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes insurers cover routine costs in clinical trials and may not cover the experimental agent, but does not explicitly state that insurance usually only covers standard-of-care treatments."
      },
      {
        "criterion_number": 11,
        "description": "The response must clearly indicate that clinical trials typically cover the cost of the experimental treatment itself, while insurance covers the standard of care components, such as imaging.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It explains insurance coverage for routine costs and that the experimental treatment may not be covered by insurance, but does not state that the trial typically covers the experimental agent or clarify the division of costs."
      }
    ],
    "question_number": 225,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:01:09.092216",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define ferroptosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines ferroptosis as a distinct form of cell death characterized by iron-dependent lipid peroxidation leading to cell death, differentiating it from apoptosis and necrosis."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the role of iron in ferroptosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that ferroptosis involves the accumulation of iron and lipid peroxides and links this to oxidative damage that causes cell death, capturing iron\u2019s role."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of ferroptosis in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It discusses that some pancreatic cancer cells may be vulnerable to ferroptosis and notes ongoing research into selectively inducing ferroptosis in pancreatic cancer cells."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that there are currently drugs under investigation with the aim to induce ferroptosis in pancreatic cancer cells but there are no current available established treatments that target ferroptosis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response states that ferroptosis-inducing approaches are experimental or in early clinical trials for most cancers, including pancreatic cancer, and that they are not standard treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide references in the scientific literature about ferroptosis and link PMID if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No references or PMIDs are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe why ferroptosis occurs.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explains that ferroptosis occurs due to oxidative damage from lipid peroxidation driven by iron accumulation and failure of antioxidant systems (glutathione/GPX4)."
      },
      {
        "criterion_number": 7,
        "description": "The response should define apoptosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Apoptosis is defined as programmed cell death, which is a satisfactory definition."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe the difference between apoptosis and ferroptosis.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response differentiates ferroptosis from apoptosis by noting that ferroptosis does not involve DNA fragmentation or typical apoptotic cleanup and is driven by lipid peroxidation and antioxidant system disruption."
      }
    ],
    "question_number": 226,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:01:30.612715",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly links stiffness/elasticity of the tumor microenvironment to invasion and metastasis (e.g., 'mechanical properties... play a significant role' and 'increased tissue stiffness can promote cancer cell invasion and migration')."
      },
      {
        "criterion_number": 2,
        "description": "The response includes descriptions of the mechanical properties of tissue: elasticity, viscosity, density, and compression.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions stiffness/elasticity but does not describe viscosity, density, or compression as mechanical properties."
      },
      {
        "criterion_number": 3,
        "description": "The response describes compression of surrounding tissue by the tumor.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss tumor-induced compression or solid stress on surrounding tissues or vasculature."
      },
      {
        "criterion_number": 4,
        "description": "The response defines desmoplastic stroma and its role in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes 'stiff, dense stroma' in PDAC but does not define desmoplastic stroma or explicitly discuss its role under that term."
      },
      {
        "criterion_number": 5,
        "description": "The response describes ways by which cancer metastasizes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains detachment, invasion into bloodstream/lymphatics, survival in circulation, and colonization of distant sites."
      },
      {
        "criterion_number": 6,
        "description": "The response describes epithelial-to-mesenchymal transition and what environmental factors trigger this transition in pancreatic cells and pancreatic cancer cells.",
        "score_given": 0,
        "max_points": 7,
        "justification": "EMT is not mentioned; no discussion of environmental triggers (e.g., stiffness, hypoxia, inflammation, TGF-\u03b2) for EMT."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how pancreatic cells interact with desmoplastic stroma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References matrix remodeling and focal adhesions generally, but does not detail interactions specific to desmoplastic stroma (e.g., CAFs, collagen/crosslinking, integrin/FAK signaling in PDAC)."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how pancreatic cancer cells interact with the tumor microenvironment, and how different elements encourage cell travel, such as inflammation and hypoxia.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Focuses on mechanical cues but does not discuss inflammatory signaling, hypoxia, or other TME elements that facilitate migration."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the effect of DNA mutations, such as KRAS, on a pancreatic cancer cell\u2019s potential to travel outside of the primary site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of genetic drivers (e.g., KRAS, TP53, SMAD4) or their impact on invasion/metastasis."
      },
      {
        "criterion_number": 10,
        "description": "The response explains other methods for the spread of pancreatic cancer besides invasion into solid tissue, such as hematologic spread, lymphatic spread, and perineural invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses hematogenous and lymphatic spread as routes of metastasis beyond local invasion."
      },
      {
        "criterion_number": 11,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects stiffness/ECM features to treatment implications, including ECM-targeting strategies and stiffness as a biomarker; notes PDAC stroma contributing to treatment resistance."
      },
      {
        "criterion_number": 12,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides multiple citations to peer-reviewed sources (Nature Reviews Cancer, Cancer Cell, and a recent review) with links."
      }
    ],
    "question_number": 227,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:02:12.748253",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends contacting the patient\u2019s healthcare team or oncology team about patient advocacy opportunities within their organization.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly advises asking the oncology social worker or patient navigator at the treatment center about local advocacy opportunities."
      },
      {
        "criterion_number": 2,
        "description": "The response offers examples of patient advocacy groups and provides contact information or a website for each.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists multiple advocacy groups (PanCAN, Pancreatic Cancer UK, American Cancer Society, Lustgarten Foundation) and includes a website link for each."
      },
      {
        "criterion_number": 3,
        "description": "The response defines patient advocacy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It characterizes patient advocacy as contributing to better care and outcomes and further clarifies through descriptions of roles (e.g., representing the patient voice, influencing policy, engaging in research design), effectively defining the concept."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of patient advocacy work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple concrete examples are provided, including sharing experiences with policymakers, designing patient-centered research, advisory board participation, clinical trial advisory roles, fundraising/awareness events, policy advocacy, and peer support."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of patient advocacy opportunities specific to pancreatic cancer and provides contact information or a website for each.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Pancreatic cancer\u2013specific organizations (PanCAN, Pancreatic Cancer UK, Lustgarten Foundation) are listed with direct links, fulfilling both specificity and contact information requirements."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends joining pancreatic cancer support groups, either online or in-person, to learn about advocacy opportunities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends attending support group meetings to learn more and suggests volunteering with organizations that offer support groups; within the pancreatic cancer context of the response, this satisfies the criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions at least three different areas of advocacy for pancreatic cancer patients, such as direct patient support, support groups, funding for cancer research, awareness of clinical trials, or political lobbying.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It covers multiple areas: direct peer support/support groups, fundraising/awareness events, policy advocacy/lobbying, participation in clinical trials/research design, and public education."
      }
    ],
    "question_number": 228,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:02:35.189189",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains normal cellular metabolism in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains aerobic respiration using oxygen and glucose in mitochondria to make ATP, and notes anaerobic glycolysis when oxygen is low, all in accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response outlines the differences between normal cellular metabolism and cancer cell metabolism.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides multiple contrasts, including preference for glycolysis despite oxygen (Warburg effect), increased glucose uptake, altered pathways, lactate production, and metabolic adaptability."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the Warburg effect.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly defines and discusses the Warburg effect and its implications."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of how cancer cell metabolism affects its clinical behavior.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that lactate-driven acidity can inhibit immune cells and promote proliferation and invasion, and discusses adaptation to hypoxia\u2014both linked to clinical behavior."
      },
      {
        "criterion_number": 5,
        "description": "The response gives examples of targeting the differences in cancer cell metabolism as a means of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions metformin and strategies targeting glucose transporters and key metabolic enzymes or the Warburg effect."
      },
      {
        "criterion_number": 6,
        "description": "The response provides published scientific journal articles as evidence for its claims and cites its sources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes a peer-reviewed journal review article (PMC link) and additional reputable sources, satisfying the requirement to cite scientific literature."
      },
      {
        "criterion_number": 7,
        "description": "The response should define glycolysis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines glycolysis in plain terms as breaking down glucose (without oxygen) in the cytoplasm to produce energy."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe how cancer cells use glutamine, and how this is different than normal cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions that cancers can rely on glutamine metabolism but does not explicitly contrast this usage with normal cells\u2019 metabolism or detail the distinct roles (e.g., anaplerosis/glutaminolysis)."
      },
      {
        "criterion_number": 9,
        "description": "The response should define lactic acid and describe how excess lactic acid can be produced by cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes lactate production from glycolysis and tumor acidity but does not define lactic acid nor explicitly describe it beyond being a byproduct; lacks a clear definition."
      },
      {
        "criterion_number": 10,
        "description": "The response should not recommend specific diets for management of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Does not recommend any specific diet."
      },
      {
        "criterion_number": 11,
        "description": "The response should not reference specific diets unless it provides PMID to studies that examine the effect of diet on pancreatic cancer, and the response should provide a summary of the findings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "No specific diets are referenced, so the condition is met."
      },
      {
        "criterion_number": 12,
        "description": "The response should not indicate that restrictive diets, such as ketogenic diet or intermittent fasting, should be started by patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "No suggestion to start restrictive diets is made."
      },
      {
        "criterion_number": 13,
        "description": "The response should clearly state if treatments are experimental or if they are evidence-based and/or FDA approved.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that approaches like metformin for metabolism are being studied, indicating an experimental status; does not claim FDA approval for these indications."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient discuss diet with their oncologist and request a referral to a nutritionist if they are interested in learning more.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Encourages discussion with the medical team generally but does not specifically recommend discussing diet or seeking a nutritionist referral."
      }
    ],
    "question_number": 229,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:03:15.635583",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises coordinating rehabilitation with the oncology team and primary care provider and maintaining open communication."
      },
      {
        "criterion_number": 2,
        "description": "The response states peripheral neuropathy is a common side effect of certain chemotherapy agents used to treat pancreatic cancer, including oxaliplatin.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions taxanes and platinum-based agents generally but does not specifically name oxaliplatin or explicitly link to pancreatic cancer regimens."
      },
      {
        "criterion_number": 3,
        "description": "The response should define chemotherapy-induced peripheral neuropathy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines CIPN as nerve damage from chemotherapy affecting hands and feet leading to neuropathic symptoms."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of symptoms of peripheral neuropathy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists numbness, tingling, pain, weakness, and balance problems."
      },
      {
        "criterion_number": 5,
        "description": "The response provides examples of how peripheral neuropathy symptoms may affect a patient\u2019s function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes fall risk, unsteadiness, gait issues, and difficulty with fine motor tasks (writing, eating, dressing)."
      },
      {
        "criterion_number": 6,
        "description": "The response states some patients may see an improvement in symptoms when the causative medication is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention symptom improvement upon cessation or dose reduction of the causative agent."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe that some patients have diminishment of chemotherapy-induced peripheral neuropathy over time, but sometimes it is permanent.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address the potential for recovery over time versus the possibility of permanent symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends physical therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends PT with specific interventions (balance, strengthening, gait training, stretching)."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends occupational therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends OT with fine motor training, adaptive tools, and home safety assessment."
      },
      {
        "criterion_number": 10,
        "description": "The response states medication may help with some symptoms of peripheral neuropathy and provides examples like gabapentin, pregabalin, and duloxetine.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly lists gabapentin, pregabalin, and duloxetine, and discusses topical treatments."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the grading system oncologists use to quantify the severity of chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of CTCAE or any formal grading criteria."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe ways that patients with peripheral neuropathy can adapt to their environment to prevent adverse events.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises a home safety assessment to identify and modify hazards and suggests adaptive tools and mobility aids to reduce falls."
      },
      {
        "criterion_number": 13,
        "description": "The response should inform patients of the importance of protecting body parts that are experiencing neuropathy, such as appropriately sized and firm shoes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address protective footwear or specific limb protection strategies."
      },
      {
        "criterion_number": 14,
        "description": "The response should encourage patients to participate in activities that promote general wellness such as exercise, balanced nutrition with an emphasis on plant-based foods, good sleep hygiene, and adequate hydration.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Encourages exercise and nutrition support but does not mention plant-based emphasis, sleep hygiene, or hydration."
      }
    ],
    "question_number": 230,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:04:05.279539",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what liquid-liquid phase separation is in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines LLPS using accessible analogies (oil and water, liquid-like droplets), distinguishes from membrane-bound organelles, and explains dynamic clustering of proteins/RNA in simple terms."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how liquid-liquid phase separation relates to cancer cell biology.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Links LLPS to dysregulated gene expression, signaling, stress responses, aberrant protein clustering, cellular organization, stress granules, and drug resistance in cancer biology."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the role of liquid-liquid phase separation in normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States normal roles of LLPS in organizing gene expression, signaling, and stress response, emphasizing functional compartmentalization in healthy cells."
      },
      {
        "criterion_number": 4,
        "description": "The response describes the role of liquid-liquid phase separation in pancreatic cancer and specific ways it can be affected.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a pancreatic cancer\u2013specific section noting LLPS of growth/survival regulators (e.g., YAP/TAZ, Hedgehog pathway) and links to aggressiveness and treatment resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the link between common mutations seen in pancreatic cancer and dysregulated liquid-liquid phase separation, including references to the scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention common PDAC mutations (e.g., KRAS, TP53, CDKN2A, SMAD4) or connect them to LLPS, and provides no literature references."
      },
      {
        "criterion_number": 6,
        "description": "The response explains that this is an active area of scientific research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states LLPS in cancer is a hot/active area of research and explains why researchers care."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that there are no FDA-approved treatments that target liquid-liquid phase separation at this time.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not address treatment approvals or the lack thereof for LLPS-targeted therapies."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends that the patient consider inquiring about liquid-liquid phase separation in pancreatic cancer with their oncology team and ask about local clinical trial availability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides general support but does not explicitly recommend discussing LLPS with the oncology team or inquiring about clinical trials."
      },
      {
        "criterion_number": 9,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or references to published scientific literature are provided."
      }
    ],
    "question_number": 231,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:04:29.525388",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions 'tissue stiffness or elasticity' and later states 'Stiffer tissues may limit the spread and effectiveness of injected or infused drugs.'"
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects mechanical barriers to outcomes: notes high interstitial fluid pressure limiting drug penetration and states 'Low drug concentration... can reduce treatment effectiveness and contribute to drug resistance.'"
      },
      {
        "criterion_number": 3,
        "description": "The response mentions blood flow and hypoxia as potentially having effects on treatment effectiveness.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Discusses abnormal blood flow and vascular barriers but does not mention hypoxia or oxygenation, which is required by the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or references to published scientific journal articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response defines mechanical properties of tissues, including at least two of the following: interstitial fluid pressure, solid stress, or fibrotic structure.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses interstitial fluid pressure ('High interstitial fluid pressure...') and fibrotic structure ('dense, fibrotic stroma'), meeting the requirement for at least two specified properties."
      },
      {
        "criterion_number": 6,
        "description": "The response describes compression of surrounding tissue by the tumor, specifically mentioning blood vessels or lymphatics.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention compression of blood vessels or lymphatics; only refers to abnormal vasculature and permeability without compression."
      },
      {
        "criterion_number": 7,
        "description": "The response defines desmoplastic stroma and describes its role in pancreatic cancer, including its composition.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions 'dense stroma' but does not use the term 'desmoplastic stroma' nor describe its composition (e.g., collagen, hyaluronan, CAFs)."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how pancreatic cancer remodels the extracellular matrix to promote a tumor-friendly environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not describe ECM remodeling by pancreatic cancer; focuses on existing barriers rather than active remodeling processes."
      },
      {
        "criterion_number": 9,
        "description": "The response states that research on the effects of mechanical properties of tissue on treatment delivery is active and ongoing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Indicates ongoing research with phrases like 'These approaches are being researched,' 'Some studies are exploring,' and references to clinical trials."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends that the patient inquire about experimental treatments or clinical trials with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises 'Talk to your oncologist' and 'Ask about clinical trials' testing advanced delivery techniques."
      }
    ],
    "question_number": 232,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:04:59.989817",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends having a plan for emergencies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly includes an emergency plan: 'Emergency Protocols: Agree on how to handle urgent situations (e.g., who to call, what messages to send)'."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker or patient care navigator.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of consulting a social worker, oncology social worker, or patient care navigator."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends utilizing telemedicine when available and appropriate.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises remote clinical communication: 'request that [doctors] explain things clearly over the phone or via video' and using patient portals for updates, which aligns with telemedicine use."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends engaging family and friends for assistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It suggests involving 'trusted friends, family, or professional caregivers locally' and 'Family Coordination... distributing responsibilities.'"
      },
      {
        "criterion_number": 5,
        "description": "The response states the patient\u2019s healthcare team may have resources to help patients at home and lighten caregivers\u2019 load.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it suggests coordinating with the medical team, it does not state that the healthcare team can connect to at-home support resources (e.g., home health, palliative care, social work)."
      },
      {
        "criterion_number": 6,
        "description": "The response provides data on caregiver burnout and cites its sources from published scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions caregiver burnout but provides no data or citations from scientific literature."
      },
      {
        "criterion_number": 7,
        "description": "The response offers examples of signs and symptoms of caregiver burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No signs or symptoms (e.g., exhaustion, sleep issues, irritability, depression) are listed."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions assisted living, home health aides, and respite homes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It broadly mentions 'professional caregivers' but does not explicitly mention assisted living, home health aides, or respite homes."
      },
      {
        "criterion_number": 9,
        "description": "The response offers resources for cancer patients and their caregivers and provides contact information or websites.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides named resources with URLs: PanCAN (pancan.org), CancerCare (cancercare.org), and National Alliance for Caregiving (caregiving.org)."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of regular and comprehensive communication with the patient to ensure they feel well supported.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes 'Establish a Communication Routine' with regular check-ins via video/calls, clearly supporting ongoing, supportive communication."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend shared apps or other technological tools to share information between the patient and distant caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends shared digital calendars (Google Calendar) and secure cloud document sharing (Google Drive/Dropbox), and remote monitoring devices."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend ways that caregivers can provide support from afar.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Multiple remote strategies are offered: scheduled check-ins, coordinating with local helpers, using technology for monitoring and information sharing, advocating with the medical team, planning visits, and joining support groups."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient look into their insurance to understand if they have a benefit for paid caregiving.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No recommendation to review insurance benefits for paid caregiving or home health coverage."
      },
      {
        "criterion_number": 14,
        "description": "The response should provide online resources for patients with pancreatic cancer to learn more about local caregiving opportunities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides PanCAN with a note about 'connections to local affiliates,' which is pancreatic cancer\u2013specific and relevant for local caregiving resources."
      }
    ],
    "question_number": 233,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:05:39.385620",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cell competition for oxygen and nutrients within a tumor in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly states that cancer cells compete for nutrients, oxygen, and space, and explains in accessible language how faster-growing cells can outcompete others."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses how cell competition may lead to clonal evolution of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes selection within tumors where certain subpopulations become dominant over time due to competitive advantages, aligning with clonal evolution."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses how clonal evolution in cancer can lead to drug resistance and progression of disease.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that treatment may eliminate some clones while allowing more resistant ones to survive and repopulate, causing relapse and progression."
      },
      {
        "criterion_number": 4,
        "description": "The response describes cancer cell competition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a definition of cancer cell competition and multiple mechanisms (resource competition, signaling, physical interactions) that constitute it."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the origin of cancer, from a single mutated cell that proliferates over time.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not address the monoclonal origin of cancer from a single mutated cell; focuses instead on intratumoral heterogeneity and interactions."
      },
      {
        "criterion_number": 6,
        "description": "The response describes that sometimes the interests of different subpopulations of cancer cells oppose each other, and how.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes subclones can suppress others via resource competition and inhibitory signaling and that differing therapy responses can shift dominance, indicating opposing interests."
      },
      {
        "criterion_number": 7,
        "description": "The response describes that sometimes the interests of different subpopulations of cancer cells are aligned and their effect benefits all of the cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions cooperative interactions where different mutations support each other's growth and improve the tumor environment for all cells."
      },
      {
        "criterion_number": 8,
        "description": "The response explains ways pancreatic cancer cells differ and how they compete with each other.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discussion is general to cancer; it does not provide pancreatic cancer\u2013specific differences or competition dynamics."
      }
    ],
    "question_number": 234,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:06:09.353696",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that pancreatic tumors become physically stiff and dense and lists 'Solid tumor stiffness' as a source of mechanical stress."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Links stiffness/high pressure and stromal changes to poor drug penetration and activation of survival pathways leading to resistance; discusses combination therapies to address microenvironmental barriers."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions blood flow and hypoxia as potentially having effects on treatment effectiveness.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes tumor growth compresses blood vessels and creates low-oxygen regions and elsewhere explains impaired drug penetration due to physical barriers, thereby connecting perfusion/hypoxia-related factors to treatment delivery."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Provides general resources (NCI, ACS) but no journal article citations or specific published studies."
      },
      {
        "criterion_number": 5,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States mechanical stress can activate signaling that promotes migration, which is directly related to cancer spread."
      },
      {
        "criterion_number": 6,
        "description": "The response includes descriptions of the mechanical properties of tissue: stiffness, elasticity, viscosity, density, and compression.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions stiffness, density ('dense'), and compression, but does not address elasticity or viscosity; thus does not cover the full set."
      },
      {
        "criterion_number": 7,
        "description": "The response describes compression of surrounding tissue by the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that as tumors grow they compress blood vessels and stretch the extracellular matrix."
      },
      {
        "criterion_number": 8,
        "description": "The response defines desmoplastic stroma and its role in pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions stroma and collagen production but does not define or use the term 'desmoplastic stroma' or explain its specific role in pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response explains what the tumor microenvironment is.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Uses the term 'tumor microenvironment' and references components (stroma, ECM) but does not provide a clear explanatory definition of what it encompasses."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how pancreatic cancer is able to remodel its surrounding extracellular matrix to promote a tumor-friendly environment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that mechanical stress leads to increased collagen and stromal changes that protect cancer cells and impede treatment, describing ECM remodeling fostering a protective environment."
      },
      {
        "criterion_number": 11,
        "description": "The response explains that research on the effects of mechanical properties of tissue on treatment delivery is active and ongoing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly notes this is an active area of research and that translation to clinical practice is ongoing."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends that the patient inquire about experimental treatments or clinical trials in their area with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages discussion with the oncology team and explicitly suggests asking about clinical trials."
      }
    ],
    "question_number": 235,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:06:51.748084",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains proteostasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines proteostasis as the balance of protein production, folding, and disposal in simple language and explains why it matters for cells."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how proteostasis may be altered in cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes cancer-associated disruptions (misfolded/damaged proteins, stress) and adaptive responses (UPR activation, increased proteasome/lysosome activity, gene expression changes) that help tumor survival."
      },
      {
        "criterion_number": 3,
        "description": "The response provides examples of cancer treatments that target proteostasis in cancer cells and explains their mechanism of action in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a concrete example (proteasome inhibitors like bortezomib) and explains that blocking protein degradation causes toxic buildup of misfolded proteins; also mentions targeting UPR and combination strategies in accessible terms."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly advises discussing specifics with the oncology team and offers to help prepare questions."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the role of proteostasis in normal cells, including protein synthesis, protein folding, protein trafficking, and protein degradation.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Covers protein synthesis, folding, and degradation but does not mention protein trafficking."
      },
      {
        "criterion_number": 6,
        "description": "The response explains different steps and phases of proteostasis, which could be potential targets for cancer treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies multiple targetable steps: protein folding/UPR, proteasomal and lysosomal degradation, and discusses how disrupting these can sensitize cancer cells."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions whether there are any FDA-approved therapies for pancreatic cancer that target proteostasis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Notes proteasome inhibitors in other cancers and that approaches are being studied in pancreatic cancer, but does not explicitly state whether any FDA-approved proteostasis-targeting therapies exist for pancreatic cancer."
      }
    ],
    "question_number": 236,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:07:37.880079",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple mentions to engage the medical/care team (doctors, nurses) and to talk to the care team about feelings and decisions."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a Palliative Care team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly mentions connecting with palliative care services as a resource."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups and online resources for cancer patients and their families.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends support groups and references PanCAN as a resource."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends breaking up decisions into smaller portions and creating pros and cons lists to organize thoughts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Suggests breaking decisions into smaller steps and writing things down, but does not mention pros and cons lists."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing goals of care with the patient to help with decision making.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly mention discussing goals of care or values-based goals."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a patient care navigator or social worker.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly advises involving social workers and patient navigators."
      },
      {
        "criterion_number": 7,
        "description": "The response provides data on caregiver burnout and cites its sources from published scientific literature.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No data or citations regarding caregiver burnout are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response offers examples of signs and symptoms of caregiver burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not list specific signs or symptoms of caregiver burnout."
      },
      {
        "criterion_number": 9,
        "description": "The response should attempt to normalize treatment decision fatigue for patients undergoing cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly normalizes decision fatigue, stating it is real, common, and that feelings are valid."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of maintaining mental health while undergoing cancer treatments, for both the patient and their loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages therapy, counseling, and support groups for patients and caregivers; highlights seeking help when overwhelmed."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that patients lean on their support network for assistance in making medical decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises bringing a trusted friend or family member to appointments to help process information and ask questions."
      },
      {
        "criterion_number": 12,
        "description": "The response should suggest that the patient request more frequent appointments with their oncology team for ongoing conversations and to answer questions that arise.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not suggest requesting more frequent appointments with the oncology team."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that documentation of thoughts can be helpful to reflect upon when it comes time to make a medical decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends writing things down, keeping a journal, and maintaining lists of questions and decisions."
      }
    ],
    "question_number": 237,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:08:12.814141",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines metastasis and outlines steps in simple, compassionate language with minimal jargon and clear explanations."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes local invasion via ECM breakdown, entry into vessels (intravasation), circulation, exit (extravasation), and colonization."
      },
      {
        "criterion_number": 3,
        "description": "The response describes lymphatic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions entry into and travel through the lymphatic system."
      },
      {
        "criterion_number": 4,
        "description": "The response describes hematologic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions bloodstream (hematogenous) spread and survival in circulation."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions how different treatment modalities are or are not helpful once cancer has metastasized.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Notes research into targeted and immune therapies but does not address effectiveness or limitations of modalities after metastasis (e.g., surgery vs systemic therapy)."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Directly encourages discussion with the oncology team for personalized information."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions ECM-degrading enzymes, intravasation/extravasation, survival in circulation, and adaptation/colonization."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss metastasis in the context of cellular stress responses."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions the healthcare team uses advanced imaging like CT, MRI, and PET/CT to identify places the cancer has spread to.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Imaging modalities for detecting metastases are not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe perineural invasion and describe how cancer can spread this way.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Perineural invasion is not addressed."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe how cancer cells lodge in tissues distant from their original site.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains extravasation at distant sites and colonization, including adaptation to the new environment."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe that pancreatic cancer is often diagnosed at advanced stages, when it has already spread outside of the original site.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states pancreatic cancer is often diagnosed at an advanced stage when spread has begun."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain the most common sites that cancer cells spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not list common metastatic sites (e.g., liver, peritoneum, lungs)."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe patterns of spread in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides a general metastasis overview but no pancreatic cancer\u2013specific spread patterns."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe characteristics of cancers that have higher predilection for spreading.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss features such as high grade, loss of adhesion, EMT, lymphovascular/perineural invasion, or specific mutations linked to higher metastatic potential."
      }
    ],
    "question_number": 238,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:08:40.090932",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines cancer stem cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes CSCs as a small subset with self-renewal, differentiation capacity, treatment resistance, and tumor-initiating ability."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the role of cancer stem cells in cancer biology using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains CSC functions and relevance (resistance, relapse, tumor initiation) in accessible, non-technical language."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the role cancer stem cells may play in cancer recurrence.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states CSCs are thought to be responsible for relapse/recurrence after treatment."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple mentions of stiffness as a key mechanical cue in tumors."
      },
      {
        "criterion_number": 5,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects mechanical forces to migration, invasion, EMT, and metastasis."
      },
      {
        "criterion_number": 6,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links stiffness/mechanical signaling to stemness and therapy resistance; discusses protection of CSCs and sensitization strategies."
      },
      {
        "criterion_number": 7,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or references to published literature are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response defines tumor microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes the tumor microenvironment as a dynamic niche with oxygen, pressure, and stiffness shaping cell behavior, sufficient for a lay definition."
      },
      {
        "criterion_number": 9,
        "description": "The response describes mechanical cues as they pertain to solid tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details solid tumor-related cues including stiffness, compression, shear stress, and cell adhesion forces."
      },
      {
        "criterion_number": 10,
        "description": "The response delineates between other types of environmental inputs that cells experience and mechanical forces, such as chemical or hormonal cues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines mechanical cues as physical forces and contrasts them with other environmental factors by mentioning oxygen levels, implying chemical inputs distinct from mechanics."
      },
      {
        "criterion_number": 11,
        "description": "The response describes that pancreatic cancer promotes desmoplasia in its microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplasia is not mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how mechanical forces in the tumor microenvironment influence the behavior of cancer stem cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that stiffness and other forces promote CSC survival, self-renewal, EMT, and activate pathways (YAP/TAZ, integrins) linked to stemness and resistance."
      },
      {
        "criterion_number": 13,
        "description": "The response links scientific literature with PMID on the subject, if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No PMIDs or literature links are included."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how mechanical forces in the tumor microenvironment affect disease recurrence and metastatic potential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly ties mechanical cues to metastasis (migration, EMT) and to recurrence via survival and selection of CSCs after therapy."
      },
      {
        "criterion_number": 15,
        "description": "The response mentions how mechanical cues affect tumor cell dormancy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Dormancy is not explicitly discussed."
      },
      {
        "criterion_number": 16,
        "description": "The response mentions that the desmoplastic tumor microenvironment in pancreatic cancer is actively being researched.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Active research is mentioned generally, but desmoplasia in pancreatic cancer is not specified."
      }
    ],
    "question_number": 239,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:09:36.539135",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly encourages asking the medical team questions about prognosis, treatment options, and expectations."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends therapy or counseling with a professional specializing in cancer or grief."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically endorses joining support groups for pancreatic cancer patients and families and cites PanCAN support groups."
      },
      {
        "criterion_number": 4,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages leaning on family, friends, and online communities; highlights support groups to reduce isolation."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of stress relief strategies.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides multiple strategies: mindfulness, meditation, deep breathing, yoga, journaling, creative outlets, routines, and small goals."
      },
      {
        "criterion_number": 6,
        "description": "The response offers examples of organizations that offer support for cancer patients and their families and provides contact information or a website.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists PanCAN, American Cancer Society, and CancerCare with direct website links."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends prioritizing self-care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a self-care section addressing physical health, emotional self-care, respite care, rest, and nutrition."
      },
      {
        "criterion_number": 8,
        "description": "The response should normalize the range of emotions felt after a loved one receives a serious cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that feelings such as fear, anger, and hopelessness are normal and acceptable."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of maintaining mental health during times of strife.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Highlights therapy, support groups, mindfulness practices, and advises contacting a healthcare provider for depressive symptoms."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of maintaining healthy lifestyle habits to support wellbeing during times of stress, such as a cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends balanced meals, adequate rest, and gentle movement."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend organization of thoughts and questions to discuss with the oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages asking questions but does not suggest organizing or writing down questions/thoughts for the oncology team."
      },
      {
        "criterion_number": 12,
        "description": "The response should emphasize the importance of understanding the diagnosis to the patient and suggest ways to educate themselves.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises learning from reputable sources and provides specific organizations/websites."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention the importance of getting one\u2019s affairs in order upon receiving a cancer diagnosis, as this can provide some peace of mind about the future.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address advance care planning, legal/financial affairs, or similar considerations."
      },
      {
        "criterion_number": 14,
        "description": "The response should emphasize the importance of avoiding isolation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Promotes support groups to reduce isolation and encourages engagement with family, friends, and online communities."
      }
    ],
    "question_number": 240,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:10:11.446663",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what phase separation is using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains phase separation with an oil-and-water analogy and describes liquid-like compartments in simple language."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how phase separation relates to cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Connects phase separation to cancer-relevant processes including gene expression, stress responses, protein aggregation, and treatment resistance."
      },
      {
        "criterion_number": 3,
        "description": "The response defines biomolecular condensates.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Defines condensates as membrane-less organelles formed by weak interactions among proteins and RNA."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how phase separation affects drug resistance in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically states that condensates may sequester drugs or protect cellular machinery, leading to resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response describes how phase separation affects gene manipulation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that phase separation regulates which genes are turned on or off via condensates, affecting pro-growth and survival gene programs."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the role that phase separation plays in the tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links phase separation to cellular adaptation to microenvironmental stresses such as hypoxia and nutrient deprivation."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the effect that phase separation has on cellular metabolism and survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Addresses survival under stress but does not describe effects on cellular metabolism."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that phase separation is the topic of ongoing research at this time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states it is an active area of research and not yet part of standard clinical practice."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the role of phase separation in the facilitation of invasion and metastasis of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects abnormal condensates to driving expression of metastasis-promoting genes, linking phase separation to metastatic behavior."
      },
      {
        "criterion_number": 10,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No scientific journal citations are provided; only general organizations are mentioned."
      }
    ],
    "question_number": 241,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:10:46.462472",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes how cells 'feel' mechanical forces in accessible language and names sensing components (integrins, ion channels, cytoskeleton, nucleus) with simple explanations."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains downstream responses (activation of pathways like Rho/ROCK and MAPK, changes in gene expression, and behavioral outcomes such as migration and growth) in plain language."
      },
      {
        "criterion_number": 3,
        "description": "The response outlines how these processes may be altered in pancreatic cancer cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Discusses cancer in general and mentions pancreatic cancer only in passing; does not specifically outline alterations in mechanotransduction in pancreatic cancer cells."
      },
      {
        "criterion_number": 4,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes a Nature Reviews Cancer article (peer-reviewed journal) and additional reputable sources; thus provides published journal evidence and citations."
      },
      {
        "criterion_number": 5,
        "description": "Define mechanotransduction as the process by which cells convert mechanical stimuli into biochemical signals.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Defines mechanotransduction as sensing and responding to mechanical forces and explicitly notes that mechanical signals trigger cascades of biochemical reactions, capturing conversion to biochemical signals."
      },
      {
        "criterion_number": 6,
        "description": "Include the relevance of mechanotransduction in normal physiology and disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses disease relevance (cancer) and generally states that mechanical cues influence how cells behave and grow, implying normal physiological roles."
      },
      {
        "criterion_number": 7,
        "description": "Describe at least two types of mechanical forces acting on tissues, such as stretch, pressure, stiffness, compression, tension, shear stress, or hydrostatic pressure.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists multiple forces including pressure, stretch, tension, and shear stress."
      },
      {
        "criterion_number": 8,
        "description": "Explain how mechanical forces in tumors and/or the surrounding tissues differ from normal tissue, specifically mentioning the creation of a stiff and dense extracellular matrix (ECM).",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions that tumor tissues are often stiffer and refers to ECM signals but does not specifically mention the creation of a stiff and dense ECM."
      },
      {
        "criterion_number": 9,
        "description": "Describe at least two ways cells detect mechanical forces, including structures like ion channels, integrins, cell surface receptors, or the cytoskeleton.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Identifies integrins, mechanosensitive ion channels, and the cytoskeleton (and the nucleus), satisfying the requirement."
      },
      {
        "criterion_number": 10,
        "description": "Describe how pancreatic cancer cells respond to mechanical forces in their environment, particularly focusing on stiffness or desmoplastic stroma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides general statements about cancer cell responses to stiffness but does not specifically discuss pancreatic cancer cells or desmoplastic stroma-driven responses."
      },
      {
        "criterion_number": 11,
        "description": "Define desmoplastic stroma as a key feature of pancreatic cancer characterized by excessive fibrous tissue formation around the tumor.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not define desmoplastic stroma or identify it as a hallmark of pancreatic cancer."
      }
    ],
    "question_number": 242,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:11:32.358521",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends meeting with a Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends involving a palliative or supportive care team early to manage symptoms and improve quality of life."
      },
      {
        "criterion_number": 2,
        "description": "The response explains Advanced Care Planning and how it impacts a patient\u2019s clinical course.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions advanced directives but does not explain how advance care planning influences treatment decisions, intensity of care, or clinical course."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions code status.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of code status (e.g., DNR/DNI)."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions an advanced directive or living will.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically references advanced directives, living wills, and healthcare proxies."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions financial planning and recommends discussing this with a professional with experience in this.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends consulting a financial advisor to organize finances, address taxes, assets, and trusts."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a social worker or counselor.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises involving a social worker or counselor to facilitate conversations and provide support."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions the importance of a strong support system during cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes emotional support, support groups, and leaning on family and friends."
      },
      {
        "criterion_number": 8,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or websites.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides links to PanCAN, American Cancer Society, and NHPCO."
      },
      {
        "criterion_number": 9,
        "description": "The response should instruct patients to create a POLST with their healthcare provider, and post this in a visible place in their home.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of POLST or placing it visibly at home."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the patient elect a healthcare durable power of attorney.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends discussing healthcare proxies and powers of attorney with an attorney, which fulfills healthcare DPOA intent."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient ensure their financial affairs are in order.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises organizing finances and important documents and consulting a financial advisor."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient elect a financial durable power of attorney.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions powers of attorney generally but does not explicitly recommend a financial durable power of attorney."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient complete a will and designate beneficiaries on life insurance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends discussing a will but does not mention designating beneficiaries on life insurance."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient consider reaching out to friends and loved ones in order to connect and spend time together.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages leaning on family and friends and creating a life story or recorded messages, supporting connection with loved ones."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient consider how to reconcile their affairs in the financial, legal, and social realms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses legal (wills, directives), financial (advisor, organizing documents), and social legacy (life story, support network)."
      },
      {
        "criterion_number": 16,
        "description": "The response should provide online references and links to resources regarding legacy planning.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides relevant resource links (PanCAN, ACS, NHPCO) that include planning/support information."
      },
      {
        "criterion_number": 17,
        "description": "The response should suggest the patient inquire about assistance with some of these aspects of legacy planning with their oncology team, to understand if there are resources available.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not advise asking the oncology team about available legacy planning resources."
      }
    ],
    "question_number": 243,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:12:38.430644",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear, accessible explanation of cell adhesion, defining ECM and adhesion in simple language with examples."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how cell adhesion processes are changed in cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains altered adhesion in cancer, including increased or decreased adhesion molecule expression and ECM remodeling to aid invasion and spread."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions integrins and cadherins as key adhesion molecules."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions changes to cell adhesion in pancreatic cancer specifically.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No pancreatic cancer\u2013specific adhesion changes are discussed; content is general to cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Cites general websites (NCI, ACS) and a non-specific suggestion to search for a review but no specific peer-reviewed journal citations."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes the ECM as a structural network that supports tissues and notes cancer-driven remodeling."
      },
      {
        "criterion_number": 7,
        "description": "The response explains epithelial-mesenchymal transition (EMT).",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or explained."
      },
      {
        "criterion_number": 8,
        "description": "The response explains how EMT facilitates cancer cell spread.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of EMT\u2019s role in metastasis."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the components of cell adhesion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies CAMs, integrins, cadherins, and the ECM as components involved in adhesion."
      },
      {
        "criterion_number": 10,
        "description": "The response describes the components of cell detachment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Outlines loss of adhesion molecules, ECM degradation, migration, intravasation, and re-attachment as steps/components of detachment."
      },
      {
        "criterion_number": 11,
        "description": "The response includes different enzymes implicated in cell adhesion and detachment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions MMPs generically but does not list multiple different enzyme classes (e.g., serine proteases, cathepsins, LOX)."
      },
      {
        "criterion_number": 12,
        "description": "The response describes factors in the tumor microenvironment that promote or facilitate tumor cell detachment and migration.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss tumor microenvironment factors such as hypoxia, stromal cells, cytokines, or matrix stiffness."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions if there are any FDA-approved treatments that target cancer cell detachment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States that experimental drugs exist but does not mention any FDA-approved therapies targeting detachment."
      }
    ],
    "question_number": 244,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:13:08.020760",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention consulting the oncologist or medical team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly encourages open, honest conversations about hopes, fears, and wishes."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of social workers, counselors, spiritual care, or palliative care specialists."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises discussing end-of-life wishes, advance directives, and care preferences, which aligns with establishing goals of care."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly suggests joining support groups (in-person or online) as helpful resources."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions the American Cancer Society and Pancreatic Cancer Action Network, it does not provide contact information or website links."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes coping strategies, self-compassion, and support systems, underscoring emotional well-being and mental health."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that it is normal to feel torn between hope and realism and validates all emotions."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although the phrase 'quality of life' is mentioned, there is no explanation of what it entails or discussion of treatment factors (e.g., side effects, symptom burden) that affect it."
      },
      {
        "criterion_number": 10,
        "description": "The response should provide online resources for pancreatic cancer information and support groups for the patient to consider reaching out to a community about their struggles.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It names the American Cancer Society and Pancreatic Cancer Action Network as resources and suggests online or in-person support groups, fulfilling the requirement to provide online resources and community options."
      }
    ],
    "question_number": 245,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:13:45.536365",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what condensates are using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes condensates as tiny liquid-like droplets without membranes, uses accessible analogies (oil droplets in water) and plain language."
      },
      {
        "criterion_number": 2,
        "description": "The response defines biomolecular condensates as membrane-less organelles containing proteins, RNA, and other molecules.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly calls them membrane-less organelles and states they are formed from proteins and RNA; also mentions other molecules."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how condensates relate to cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Links condensates to cancer-relevant processes such as gene control, stress responses, drug resistance, and metabolic changes."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how biomolecular condensates become deregulated in cancer cells, including at least one mechanism of deregulation.",
        "score_given": 0,
        "max_points": 7,
        "justification": "States that molecular balance is disrupted leading to abnormal/excessive condensates, but does not provide a concrete mechanism (e.g., mutations, altered PTMs, overexpression, changes in IDR content), so no credit."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No references or citations to scientific articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response references at least one scientific literature source regarding biomolecular condensates, including a PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No literature sources or PMIDs are included."
      },
      {
        "criterion_number": 7,
        "description": "The response defines liquid-liquid phase separation (LLPS) as the process by which condensates form.",
        "score_given": 0,
        "max_points": 5,
        "justification": "LLPS is not mentioned or defined."
      },
      {
        "criterion_number": 8,
        "description": "The response explains the role of biomolecular condensates in normal cells, including at least one function such as gene regulation or stress response.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions nucleoli (ribosome biogenesis) and stress granules (protect RNA during stress), demonstrating normal cellular functions."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the protein YAP/TAZ and its role in biomolecular condensates in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "YAP/TAZ is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response lists at least two ways that biomolecular condensates encourage cancer cell growth, proliferation, or migration.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides multiple ways: altered gene regulation promoting growth, enhanced stress tolerance/resistance, drug sequestration leading to resistance, and metabolic support for proliferation."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that the study of biomolecular condensates and their role in cancer is an area of active scientific research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states it is an active area of research with experimental drugs and early clinical trials."
      },
      {
        "criterion_number": 12,
        "description": "The response states whether there are FDA-approved therapies that target biomolecular condensates in cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly address FDA approval status; only notes experimental work and early trials."
      }
    ],
    "question_number": 246,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:14:23.867687",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines tissue stiffness, explains how it changes in cancer, and repeatedly references increased stiffness in tumors."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly links stiffness to invasion and metastasis, stating stiff tissues promote cell movement and spread."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes stiffer tumors may be less responsive to chemotherapy and immunotherapy, and PDAC stroma contributes to resistance."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or specific published studies are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions dense, fibrotic stroma but does not define desmoplastic stroma."
      },
      {
        "criterion_number": 6,
        "description": "The response explains how and why pancreatic cancer promotes the formation of desmoplastic stroma around itself.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mechanistic explanation (e.g., pancreatic stellate cells, TGF-\u03b2, Hedgehog signaling) is provided for PDAC-induced desmoplasia."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the process of cell adhesion in normal tissue.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no discussion of normal cell adhesion mechanisms (e.g., cadherins, integrins, focal adhesions)."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how increased stiffness in tumors and the tumor microenvironment influences cell adhesion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While signaling and invasion are mentioned, the effect of stiffness specifically on cell adhesion dynamics is not described."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the effect of tissue stiffness on angiogenesis and drug resistance.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Drug resistance is mentioned, but angiogenesis is not addressed."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how the development of desmoplastic stroma around pancreatic cancer tumors is a protective factor.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states PDAC has a dense, stiff stroma that contributes to aggressiveness and treatment resistance and notes immune suppression in stiff environments, indicating a protective role for the tumor."
      },
      {
        "criterion_number": 11,
        "description": "The response explains whether there are FDA-approved treatments that target tissue stiffness in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions experimental therapies but does not state whether any FDA-approved treatments target stiffness in PDAC."
      },
      {
        "criterion_number": 12,
        "description": "The response defines mechanotransduction.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mechanotransduction is not defined or explicitly mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response suggests that the patient discuss the role of clinical trials in their cancer care with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It encourages discussing with the medical team and specifically suggests asking about clinical trials investigating anti-fibrotic or stiffness-reducing therapies."
      }
    ],
    "question_number": 247,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:15:22.890948",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly emphasizes clear communication, such as recommending regular family meetings or using communication tools.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends regular family meetings and use of shared tools (Google Calendar, shared notes, group chat/private online space) under 'Create a Communication Plan.'"
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing care coordination with the patient\u2019s healthcare team or medical providers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directs the designated coordinator to 'communicate with healthcare providers' and 'manage appointments,' which explicitly involves care coordination with the medical team."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends discussing care coordination with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It suggests the point person could be a social worker and later recommends accessing social work and spiritual care services for support, implying coordination through these professionals."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly emphasizes the importance of a strong support system, such as building a caregiver network or ensuring emotional support.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It emphasizes caregiver support, respite, rotating responsibilities, and emotional well-being with open conversations and therapy options."
      },
      {
        "criterion_number": 5,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No specific organizations, contact details, or websites are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly recommends participating in a support group for cancer patients and their families.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly suggests 'support groups for families dealing with cancer.'"
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends educating the family on the patient\u2019s diagnosis and treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises age-appropriate explanations and maintaining a central file with medical records and treatment plans, and sharing relevant updates, which constitutes educating the family."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that one family member is designated as a communication person, and perhaps accompany the patient to their medical appointments and take notes.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly designates a primary point person to coordinate, communicate with providers, and manage appointments. While accompanying/taking notes aren\u2019t explicitly stated, the main requirement is met."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the communication person to develop a strategy to deliver information to the multi-generational family members.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It proposes a communication plan with regular meetings, shared calendars, and group chats, and the coordinator is tasked with keeping everyone informed, satisfying the strategy requirement."
      },
      {
        "criterion_number": 10,
        "description": "The response should reinforce the importance of boundaries for the pancreatic cancer patient while they undergo treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It instructs to 'share relevant updates... but respect privacy boundaries,' reinforcing patient boundaries."
      },
      {
        "criterion_number": 11,
        "description": "The response should suggest that the patient inquire with their oncology team if there are resources available for group support or for cultural mediation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it notes many cancer centers offer services, it does not explicitly advise inquiring with the oncology team about group support or cultural mediation."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient or loved ones identify care needs, such as cleaning or food prep, and assign roles to family members according to their strengths.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends delegating tasks (medications, transportation, meals, housekeeping) based on strengths and availability."
      },
      {
        "criterion_number": 13,
        "description": "The response should encourage the patient to focus on their own wellbeing and mental health.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it discusses family emotional well-being and caregiver respite, it does not specifically encourage the patient to focus on their own mental health."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend online resources for pancreatic cancer information as well as support services that the patient and family members can access to answer questions, etc.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific online resources or websites for pancreatic cancer information or support services are recommended."
      }
    ],
    "question_number": 248,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:16:32.248500",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains epithelial-mesenchymal transition and how this affects a cell\u2019s ability to migrate.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly explains EMT, noting epithelial cells become more mesenchymal/mobile and how this increases invasiveness."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions local invasion and distant spread generally but does not explicitly describe lymphatic or hematogenous spread."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses adhesion changes, cytoskeletal remodeling, proteases (MMPs), signaling pathways, inflammation, and chemoattractants."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not connect metastasis to cell stress (e.g., hypoxia, therapy-induced stress)."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions the healthcare team uses advanced imaging like CT, MRI, and PET/CT to identify places the cancer has spread to.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of imaging modalities (CT, MRI, PET/CT)."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions how different treatment modalities are or are not helpful once cancer has metastasized.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss treatment approaches in metastatic disease or their relative roles/limitations."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not explicitly advise discussing with the healthcare team/oncologist."
      },
      {
        "criterion_number": 8,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides clear, accessible explanations of invasion and metastasis suitable for a lay audience."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how a cancer cell develops, including DNA mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions genetic and epigenetic changes and mutations enabling aggressiveness and invasion."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe tumor suppressor genes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "References tumor suppressor genes but does not describe what they are or their function."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe oncogenes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions oncogenes but does not describe their role or definition."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe cell adhesion, and how this process can be altered in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains normal cell-cell/ECM adhesion and how cancer cells alter adhesion to detach and move."
      },
      {
        "criterion_number": 13,
        "description": "The response should explain the phenomenon of loss of cell-cell adhesion in cancer cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically notes reduced adhesion and detachment facilitating invasion."
      },
      {
        "criterion_number": 14,
        "description": "The response should define tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines the tumor microenvironment and lists components (immune cells, blood vessels, connective tissue)."
      },
      {
        "criterion_number": 15,
        "description": "The response should explain how cancer cells can use enzymes to change the tumor microenvironment to their advantage.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes proteases (MMPs) degrading ECM, creating pathways for invasion."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe other ways cancer cells can interact with the tumor microenvironment to promote migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions inflammatory mediators, chemoattractants, and stiffening/\u2018tracks\u2019 that guide migration."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe any unique ways pancreatic cancer cells are thought to metastasize.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes PDAC\u2019s aggressive local invasion but does not discuss unique metastatic features (e.g., perineural invasion, portal venous spread)."
      },
      {
        "criterion_number": 18,
        "description": "The response should recommend websites that help explain different aspects of pancreatic cancer and provide resources for pancreatic cancer patients.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides reputable resources: NCI, American Cancer Society, and PanCAN."
      }
    ],
    "question_number": 249,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:17:17.738213",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response discusses the normal flow of fluid from blood vessels to the extracellular space to the lymphatic system and blood vessels using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response focuses on tumor conditions and does not clearly describe the normal physiology of fluid movement from blood vessels into interstitial spaces and back via lymphatics in lay terms."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how fluids move in normal tissue to perform tasks such as nutrient and oxygen delivery, and to manage waste products.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no explicit explanation of fluid movement in normal tissue for nutrient/oxygen delivery and waste removal; content is framed around tumor abnormalities."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses changes to fluid flow that may occur in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes elevated interstitial pressure, abnormal/leaky vasculature, poor lymphatic drainage, heterogeneous flow, and the dense desmoplastic stroma typical of pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response describes abnormalities seen in tumors with fluid management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Abnormal vessel architecture, hyperpermeability, high interstitial pressure, and impaired lymphatics are clearly described."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses the implications of altered fluid flow on cancer treatment, including reduced drug delivery or immune cell penetration into the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It details reduced drug penetration, perfusion limitations, and how high interstitial pressure impedes delivery; although immune cells are not mentioned, reduced drug delivery is addressed extensively."
      },
      {
        "criterion_number": 6,
        "description": "The response describes how fluid flow affects cancer behavior.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It links flow patterns to hypoxia, metabolic adaptation, cell migration/metastasis, and stromal remodeling affecting aggressiveness."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how low flow to tumor tissue stimulates further cancer cell growth and development.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While hypoxia and aggressiveness are mentioned, the response does not explicitly explain how low flow directly stimulates further tumor growth and development."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions how altered cellular biology and extracellular structures can impact cancer behavior.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses metabolic adaptation (cellular biology) and stromal remodeling/desmoplasia (extracellular structures) influencing behavior."
      },
      {
        "criterion_number": 9,
        "description": "The response provides published scientific journal articles as evidence of its claims and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It references ACS/NCI websites and suggests searching for reviews, but does not provide concrete, citable journal articles with specific references."
      },
      {
        "criterion_number": 10,
        "description": "The response describes different fluids that exist in a tumor and its environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It mentions blood/plasma, interstitial fluid, lymphatic drainage, nutrients, waste products, oxygen, and administered drugs as components of the tumor milieu."
      },
      {
        "criterion_number": 11,
        "description": "The response describes the tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The tumor microenvironment is described, including abnormal vasculature, interstitial space irregularity, hypoxia, and dense stroma."
      },
      {
        "criterion_number": 12,
        "description": "The response describes attributes of tumors and the surrounding tissue that disrupt the normal function of fluids.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Attributes such as desmoplastic stroma, vessel leakiness, high interstitial pressure, and poor perfusion/lymphatics are detailed as disruptors of normal fluid function."
      },
      {
        "criterion_number": 13,
        "description": "The response defines desmoplastic stroma and how pancreatic cancer encourages the development of this.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It defines desmoplastic stroma as a tough fibrous layer but does not explain how pancreatic cancer promotes its development (e.g., stellate cell activation/CAF expansion)."
      },
      {
        "criterion_number": 14,
        "description": "The response defines interstitial fluid pressure.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Interstitial fluid pressure is mentioned and its effect described, but it is not defined as the pressure within the interstitial space due to fluid accumulation/resistance."
      },
      {
        "criterion_number": 15,
        "description": "The response explains how increased interstitial fluid pressure impacts drug delivery, including uneven distribution of exposure in the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that elevated interstitial pressure acts as a barrier to drug movement and leads to poor penetration with many cells left untouched, implying uneven distribution."
      },
      {
        "criterion_number": 16,
        "description": "The response explains that poor fluid flow in tumor tissue is an active area of scientific research at this time.",
        "score_given": 3,
        "max_points": 3,
        "justification": "A dedicated section on research directions describes ongoing efforts (vascular normalization, nanoparticles, modeling, external enhancement), indicating active research."
      }
    ],
    "question_number": 250,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:18:08.371809",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing dignity-preserving approaches with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions the 'care team' generally but does not explicitly recommend discussion with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing dignity-preserving approaches with a Palliative Care specialist.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly recommends consulting palliative or hospice care teams for dignity and comfort."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly mentions Advance Care Planning and includes either Advance Directives or Living Wills.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of advance care planning, advance directives, or living wills."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends establishing the patient\u2019s goals of care, including understanding and documenting the patient\u2019s preferences and involving them in decision-making.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it encourages involvement and communicating wishes, it does not explicitly mention 'goals of care' or documentation of preferences."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends support groups for cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Support groups are not explicitly mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites for each.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides American Cancer Society (cancer.org) and Pancreatic Cancer Action Network (pancan.org) with websites."
      },
      {
        "criterion_number": 7,
        "description": "The response should attempt to normalize feelings of loss of control for cancer patients at the time of diagnosis and/or during cancer treatment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Tone is empathetic but does not explicitly normalize feelings of loss of control."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe components of personal dignity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly addresses autonomy, respectful communication, privacy, emotional/spiritual support, honoring routines, self-expression, and advocacy."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the patient, family, and friends of the patient, and oncology care team to respect the patient\u2019s bodily autonomy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Encourages involvement in decisions, respectful communication, and privacy during personal care, which supports respecting bodily autonomy."
      },
      {
        "criterion_number": 10,
        "description": "The response should encourage the patient to prioritize management of side effects and symptoms of cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of symptom or side-effect management priorities."
      },
      {
        "criterion_number": 11,
        "description": "The response should encourage the patient to communicate any side effects or symptoms of cancer or cancer treatment to their oncology care team to ensure they are being offered management solutions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not advise reporting symptoms or side effects to the oncology team."
      },
      {
        "criterion_number": 12,
        "description": "The response should encourage the patient and family to have open and ongoing communication about the patient\u2019s wishes for medical care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages open conversations with the patient and care team about wishes and dignity and to communicate those wishes clearly."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient and loved ones promote independence and normalcy in the patient\u2019s life as much as possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends maintaining routines, preferences, and involvement in choices to preserve normalcy and independence."
      },
      {
        "criterion_number": 14,
        "description": "The response should encourage the patient to always remember that anything that happens to their body with regard to cancer treatment is their choice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that all bodily interventions are the patient's choice."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient disclose any feelings of overwhelm or loss of autonomy with their oncology team and inquire about resources for support.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Encourages seeking support generally but does not direct the patient to share feelings of overwhelm or loss of autonomy with the oncology team or ask about specific resources."
      },
      {
        "criterion_number": 16,
        "description": "The response should emphasize the importance of prevention of caregiver burnout.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Highlights support for caregivers and encourages them to seek help, which aligns with preventing caregiver burnout."
      }
    ],
    "question_number": 251,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:18:55.776079",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains how cells respond to mechanical stress, including processes like ECM remodeling, increased contractility, and effects on proliferation, invasion, metastasis, and drug resistance.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response covers increased contractility, invasion/metastasis, treatment resistance, and mentions signaling affecting division, but it does not discuss ECM remodeling explicitly. Because the criterion requires inclusion of processes like ECM remodeling, full credit cannot be awarded under the binary scoring rule."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly relates tissue properties, such as stiffness and fibrous stroma, to their potential effect on cancer spread, including invasiveness and metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states that cancer cells sense ECM stiffness, that stiffer environments increase contractility and aggressiveness, and connects these behaviors to invasion and metastasis."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly relates tissue properties to their potential consequences for treatment effectiveness and resistance, including drug penetration and resistance mechanisms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes that mechanical stress can activate survival pathways and that changes in mechanical properties can make treatment more difficult, it does not explicitly link tissue properties (e.g., stiffness, dense stroma) to treatment effectiveness via mechanisms like impaired drug penetration. Thus it fails to meet the explicit requirement."
      },
      {
        "criterion_number": 4,
        "description": "The response explains how cells sense mechanical stress, including mechanosensing mechanisms like mechanoreceptors, integrins, or mechanotransduction pathways.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions that cells sense stiffness and that contraction triggers signaling, but it does not describe specific mechanosensing mechanisms (e.g., integrins, focal adhesions, stretch-activated channels, YAP/TAZ pathways)."
      },
      {
        "criterion_number": 5,
        "description": "The response provides specific citations from published scientific journal articles as evidence for its statements.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No specific peer-reviewed journal article citations (authors, year, title) are provided. Only general sources and institutions are mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response must explain normal cell contractility, including the role of the actomyosin complex in generating mechanical forces for movement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that cells generate force via the cytoskeleton, mainly actin and myosin, to change shape and move, which captures the role of the actomyosin machinery in force generation for movement."
      },
      {
        "criterion_number": 7,
        "description": "The response must define actin, including its role in cellular structure and function.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Actin is mentioned but not defined; its structural role and specific functions are not described."
      },
      {
        "criterion_number": 8,
        "description": "The response must define myosin, including its function in cell contractility.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Myosin is mentioned but not defined; its motor function in generating contractile force is not explicitly described."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly describe the tumor microenvironment, including its components and characteristics.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The tumor microenvironment is referenced in name and through ECM stiffness, but its components (e.g., fibroblasts, immune cells, vasculature, ECM) and characteristics are not explicitly described."
      },
      {
        "criterion_number": 10,
        "description": "The response must define the extracellular matrix, including its composition and function.",
        "score_given": 0,
        "max_points": 7,
        "justification": "ECM is named but not defined; composition (e.g., collagen, fibronectin, proteoglycans) and its structural/signaling functions are not explained."
      },
      {
        "criterion_number": 11,
        "description": "The response must define mechanobiology, including its relevance to cancer progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The term mechanobiology is not defined or discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response must explain epithelial-mesenchymal transition (EMT), including its occurrence in pancreatic cancer cells and its impact on cancer spread.",
        "score_given": 0,
        "max_points": 7,
        "justification": "EMT is not mentioned or explained, and no link to pancreatic cancer spread via EMT is provided."
      }
    ],
    "question_number": 252,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:19:46.129910",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines the extracellular matrix and explains its role in normal cellular biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines ECM as scaffolding made of collagens, proteoglycans, and glycoproteins; explains its roles in structural support, maintaining tissue shape, and signaling that guides normal cell behavior."
      },
      {
        "criterion_number": 2,
        "description": "The response contrasts the role of the extracellular matrix in cancer cell biology with normal cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Contrasts normal supportive/signaling functions with cancer-associated remodeling, stiffening, and enzymatic degradation (MMPs), emphasizing active roles in tumor growth and protection from therapy."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses the potential consequences of an altered extracellular matrix for cancer treatment effectiveness and resistance, including examples like decreased drug and immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that a dense/stiff ECM can protect cancer cells from treatments and the immune system, make treatments hard to reach tumor cells, and block immune cell infiltration; also references strategies to modify ECM to improve immunotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response discusses the potential consequences of an altered extracellular matrix on cancer cell biology, including examples like angiogenesis and metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes ECM remodeling enabling cancer cell migration and invasion, acting as a barrier and highway, and facilitating entry into blood/lymphatic vessels to promote metastasis. While angiogenesis is not explicitly mentioned, the criterion is satisfied by detailed discussion of metastasis-related consequences."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published scientific literature are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the different components of the extracellular matrix in normal tissue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists key ECM components (collagens, proteoglycans, glycoproteins) and their structural roles."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how the extracellular matrix changes in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes pancreas has a naturally dense/fibrous ECM; highlights desmoplasia (thick, dense ECM around tumors) and the contribution of fibroblasts to ECM remodeling."
      },
      {
        "criterion_number": 8,
        "description": "The response explains how the changes in the extracellular matrix in pancreatic cancer promote cancer growth and facilitate movement of cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains ECM provides a protective niche, stores growth factors aiding survival/proliferation, and facilitates migration/invasion into vessels, enabling spread."
      },
      {
        "criterion_number": 9,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines desmoplasia/desmoplastic stroma as a thick, dense ECM that grows around the tumor."
      },
      {
        "criterion_number": 10,
        "description": "The response defines tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 'microenvironment' and involvement of fibroblasts and immune cells but does not explicitly define the tumor microenvironment as the ecosystem of cancer cells, stromal cells, ECM, and signaling factors."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how desmoplastic stroma causes hypoxia in the tumor microenvironment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Hypoxia and how desmoplastic stroma contributes to it are not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response describes how hypoxia in the tumor microenvironment causes inflammation, and how this promotes cancer growth.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not address hypoxia-driven inflammation or its pro-tumor effects."
      },
      {
        "criterion_number": 13,
        "description": "The response describes how the desmoplastic stroma in the pancreatic cancer microenvironment contributes to treatment resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that dense/stiff ECM acts as a barrier protecting tumor cells from therapies and immune cells, directly linking desmoplastic features to treatment resistance."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how the desmoplastic stroma in the pancreatic cancer microenvironment can cause symptoms and complications due to mechanical forces on the surrounding structures, specifically mentioning the effect on blood vessels.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not discuss mechanical compression of surrounding structures or blood vessels, nor related symptoms; mentions vascular invasion for metastasis only."
      }
    ],
    "question_number": 253,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:21:18.828153",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing relationship challenges or support strategies with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No suggestion to discuss relationship challenges with the oncologist was included."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing relationship challenges with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Professional counseling/therapy was suggested, but there was no explicit mention of a social worker, spiritual counselor, or Palliative Care specialist."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends joining a support group for cancer patients or their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly recommends joining a support group for caregivers or spouses of people with cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly emphasizes the importance of self-care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Self-care is explicitly recommended with examples like walks, meditation, and baths."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly emphasizes the importance of having a support system during cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages accepting help from family and friends, leaning on each other, and joining support groups."
      },
      {
        "criterion_number": 6,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites.",
        "score_given": 0,
        "max_points": 5,
        "justification": "American Cancer Society and Pancreatic Cancer Action Network were mentioned, but no contact information or website links were provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that loved ones of a patient with pancreatic cancer seek education about the disease and common symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There was no recommendation to seek education about pancreatic cancer or its symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage open communication between the patients and their loved ones.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Open communication is explicitly encouraged and reinforced with suggestions like being honest about needs and providing regular updates."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the patient to seek support from their loved ones.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises leaning on each other for emotional support and recognizing when support from others is needed."
      },
      {
        "criterion_number": 10,
        "description": "The response should attempt to normalize the stress that patients feel after receiving a pancreatic cancer diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states it is natural for relationships to feel strained and acknowledges the challenge of a pancreatic cancer diagnosis."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend against behaviors that might isolate the patient after a serious medical diagnosis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it encourages accepting help and communication, it does not explicitly advise against isolating behaviors or withdrawal."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient prioritize symptom control to feel as normal as possible.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of symptom control or managing symptoms to maintain normalcy."
      },
      {
        "criterion_number": 13,
        "description": "The response should indicate that some people may not feel comfortable discussing a serious cancer diagnosis with a friend or loved one, and that this can be a normal response.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It does not address that some people may be uncomfortable discussing the diagnosis or that this is normal."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient observe which people in their social circle want to be supportive, and to lean on these people.",
        "score_given": 0,
        "max_points": 0,
        "justification": "This point is not addressed; there is no guidance to identify and lean on those who are most supportive."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient continue to reach out to friends and loved ones, and try to participate in the same activities they previously did, to maintain relationships.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It suggests quality time and respite care but does not explicitly recommend continuing previous activities or reaching out proactively."
      },
      {
        "criterion_number": 16,
        "description": "The response should suggest that the patient consider creating boundaries with people, including how to handle unsolicited advice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It recommends setting boundaries and specifying needs, but does not address handling unsolicited advice."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend that the patient consider activities where they can be fully present with the people they are with, for the best quality interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests meaningful moments like holding hands, sitting together in silence, or sharing a favorite meal, which promote being fully present."
      }
    ],
    "question_number": 254,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:22:11.804514",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains how cancer cells detect mechanical characteristics of their environment.",
        "score_given": 0,
        "max_points": 0,
        "justification": "The response clearly describes detection via integrins, cytoskeleton, and mechanosensitive ion channels (Piezo1/2), but this criterion has 0 available points."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how cancer cells respond to mechanical characteristics of their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains downstream responses including activation of Rho/ROCK, PI3K/Akt/mTOR, and MAPK pathways, leading to changes in gene expression, survival, growth, migration, invasion, and therapy resistance in stiffer environments."
      },
      {
        "criterion_number": 3,
        "description": "The response outlines how mechanosensing processes may be altered in pancreatic cancer cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No pancreatic cancer\u2013specific alterations in mechanosensing are discussed (e.g., PDAC desmoplasia-driven stiffness, pancreatic stellate cell activation, PDAC-specific signaling adaptations)."
      },
      {
        "criterion_number": 4,
        "description": "The response defines mechanosensing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mechanosensing is clearly defined as the ability of cells to sense and respond to physical forces and mechanical properties like stiffness, tension, pressure, and shear stress."
      },
      {
        "criterion_number": 5,
        "description": "The response describes mechanosensing in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that all cells, including normal cells, can sense mechanical cues and explains general mechanisms (membrane, cytoskeleton, integrins, channels) applicable to normal physiology."
      },
      {
        "criterion_number": 6,
        "description": "The response defines desmoplastic stroma and describes its development in pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Desmoplastic stroma is not mentioned or defined; no discussion of its development in pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response describes integrins, cytoskeleton, ion channels, and membrane sensors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Integrins, the cytoskeleton (actin and microtubules), and mechanosensitive membrane channels (Piezo1/2) are explicitly discussed, fulfilling the criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response explains the YAP/TAZ pathway and its role in the development of desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "YAP/TAZ signaling and its relevance to PDAC desmoplasia are not addressed."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions if there are FDA-approved therapies that target the cancer cells\u2019 ability to mechanosense.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions research into developing drugs but does not state whether any FDA-approved therapies specifically targeting mechanosensing exist."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how cancer cells migrate in response to cues from mechanical forces in their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The answer links increased tissue stiffness and integrin signaling to activation of Rho/ROCK controlling contractility and movement, and notes enhanced migration/invasion in stiff environments."
      },
      {
        "criterion_number": 11,
        "description": "The response defines epithelial-mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or defined."
      },
      {
        "criterion_number": 12,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It cites a peer-reviewed Nature Reviews Cancer article; additional resources include NCI. Although not extensively referenced, the presence of a journal review meets the criterion."
      }
    ],
    "question_number": 255,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:22:49.639473",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Explains normal flow of fluid from blood vessels to extracellular space to lymphatics, including nutrient/oxygen delivery and waste management.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not describe normal physiology of fluid exchange, nutrient/oxygen delivery, or lymphatic waste removal; only notes that normal tissues have low pressure."
      },
      {
        "criterion_number": 2,
        "description": "Describes how fluid flow becomes compromised in tumors, including increased intratumoral pressure due to abnormal blood vessels, poor lymphatic drainage, and dense stroma.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly cites abnormal/leaky vasculature, impaired lymphatic drainage, and abnormal extracellular matrix causing elevated interstitial pressure, encompassing dense stroma."
      },
      {
        "criterion_number": 3,
        "description": "Discusses implications of altered fluid flow on treatment, specifically reduced drug delivery and immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states reduced drug diffusion and convection-based delivery, and impeded immune cell infiltration affecting immunotherapy."
      },
      {
        "criterion_number": 4,
        "description": "Explains how increased interstitial fluid pressure impacts drug delivery, including uneven distribution within the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes reduced diffusion gradient and that high pressure impedes drug spread within the tumor, implying uneven intratumoral distribution."
      },
      {
        "criterion_number": 5,
        "description": "Discusses impact of altered fluid flow on radiation therapy due to hypoxia.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of tumor hypoxia or its effect on radiosensitivity/radiation therapy."
      },
      {
        "criterion_number": 6,
        "description": "Mentions impact of altered cellular biology and extracellular structures on cancer behavior (growth, metastasis, resistance).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not link microenvironmental changes to growth, metastasis, or therapeutic resistance."
      },
      {
        "criterion_number": 7,
        "description": "Describes how low flow to tumor tissue stimulates further cancer cell growth and development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of how low perfusion or flow promotes tumor progression."
      },
      {
        "criterion_number": 8,
        "description": "Defines desmoplastic stroma and how pancreatic cancer encourages its development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not define desmoplasia or its promotion in pancreatic cancer specifically."
      },
      {
        "criterion_number": 9,
        "description": "Defines interstitial fluid pressure.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Defines it as the pressure inside the tissue surrounding the tumor, which is accurate."
      },
      {
        "criterion_number": 10,
        "description": "Describes how increased pressure and desmoplastic stroma can compress surrounding structures causing blockages and symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of mechanical compression, ductal/vascular blockage, or related symptoms."
      },
      {
        "criterion_number": 11,
        "description": "Provides specific published scientific journal articles with proper citations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes multiple peer-reviewed references with authors, years, journals, and links (Jain 2014, Stylianopoulos & Jain 2013, Thompson & Hahn 2012)."
      },
      {
        "criterion_number": 12,
        "description": "Explains that poor fluid flow in tumor tissue is an active area of scientific research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that researchers are developing strategies, mentions research centers and ongoing microenvironment research, indicating active investigation."
      }
    ],
    "question_number": 256,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:23:32.247538",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends clear communication with the family regarding how everyone is dealing with the patient\u2019s cancer diagnosis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicit 'Open Communication' section encourages honest conversations about feelings and normalizes varied emotions."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No recommendation to speak with the oncologist, nurse navigator, or broader healthcare team about family impact."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions therapist/counselor and support groups, but does not specifically reference a social worker, spiritual counselor/chaplain, or palliative care specialist."
      },
      {
        "criterion_number": 4,
        "description": "The response emphasizes the importance of self-care and healthy boundaries.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes 'Take Care of Caregivers' and 'Encourage Self-Care for Everyone'; acknowledges different needs and the need for breaks/respite."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of a strong support system for patients with cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Dedicated 'Establish a Support System' section with family meetings, external support, and community involvement."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations that support cancer patients and their families and includes contact information or websites.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides organizations and URLs: National Cancer Institute (https://www.cancer.gov/types/pancreas) and PanCAN (https://www.pancan.org/); also mentions ACS."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends participating in a support group for cancer patients and their families.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly suggests connecting with a support group, including examples (ACS, PanCAN)."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends educating the family on the patient\u2019s diagnosis and treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages 'Educate and Prepare' and learning about pancreatic cancer together; provides reputable resources likely covering diagnosis and treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage that family members provide emotional support to each other.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'Supporting each other is crucial' and promotes open, validating conversations and regular check-ins."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend pursuit of professional mental health counseling for family members of a patient with pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends therapist/counselor, grief counseling, and family therapy as helpful professional support."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend resources that patients and families of patients with pancreatic cancer can access for information about the disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides informational resources: NCI and PanCAN with direct links."
      },
      {
        "criterion_number": 12,
        "description": "The response should list sources and/or websites for support groups for patients with pancreatic cancer and their family members.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Names ACS and PanCAN as support group sources, and includes PanCAN website link."
      },
      {
        "criterion_number": 13,
        "description": "The response should encourage family members to provide assistance and support to their loved ones affected by pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides concrete examples of assistance (meals, chores, transportation, managing communications) and urges practical support."
      }
    ],
    "question_number": 257,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:24:20.968871",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines metastasis and walks through the process in plain language with a numbered list (detachment, invasion of surrounding tissue, entry into blood/lymph, survival and exit at distant sites). It is accessible and understandable for a lay audience."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It mentions invasion of surrounding tissue (direct invasion), entry into the bloodstream, and entry into the lymphatic system, fulfilling all required pathways."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It discusses detachment, movement through the extracellular matrix, squeezing through endothelial linings, and ties these to biophysical properties (membrane, cytoskeleton) influencing deformability. These are cellular/mechanical mechanisms relevant to spread."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no discussion of metastasis as an adaptive response to cellular stress or stress-induced signaling."
      },
      {
        "criterion_number": 6,
        "description": "The response explains cancer cell deformability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Deformability is defined as the ability to change shape and squeeze through tight spaces; the response explains its relevance and gives concrete examples (narrow gaps in tissues and vessels) and contributing factors (membrane, cytoskeleton)."
      },
      {
        "criterion_number": 7,
        "description": "The response defines extracellular matrix and cytoskeleton.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The extracellular matrix is briefly defined as 'the material that holds cells together,' but the cytoskeleton is mentioned without a definition. Full credit requires defining both."
      },
      {
        "criterion_number": 8,
        "description": "The response explains cell adhesion processes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It states that cells detach from the primary tumor but does not explain adhesion processes or molecules (e.g., cadherins, integrins) or how adhesion changes facilitate spread."
      },
      {
        "criterion_number": 9,
        "description": "The response describes how cell deformity changes in cancer cells as compared to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states that cancer cells are often more 'plastic' or deformable than normal cells."
      },
      {
        "criterion_number": 10,
        "description": "The response describes the impact of enhanced deformability of cancer cells on their ability to metastasize.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It links increased deformability to more effective invasion, intravasation/extravasation, and movement through tight spaces/barriers, directly tying deformability to enhanced metastatic capability."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how cancer cells with increased ability to deform survive stresses that normal cells would not.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes cells avoid being trapped by barriers, it does not address survival of specific stresses (e.g., shear stress, constriction-induced damage) that deformability helps withstand."
      },
      {
        "criterion_number": 12,
        "description": "The response describes desmoplastic stroma in the pancreatic cancer tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma and the distinctive fibrotic microenvironment of pancreatic cancer are not mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response explains how increased deformability capabilities are necessary for cells to travel within the desmoplastic stroma of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no discussion connecting deformability to movement through the desmoplastic stroma in pancreatic cancer."
      }
    ],
    "question_number": 258,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:25:19.568977",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Explains the normal physiological flow of fluid from blood vessels to the extracellular space and lymphatic system in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions blood and lymph flow but does not explain normal capillary filtration into interstitial space, interstitial fluid dynamics, or lymphatic drainage in simple terms."
      },
      {
        "criterion_number": 2,
        "description": "Discusses changes to fluid flow in pancreatic cancer, such as increased intratumoral pressure, and how these changes differ from normal tissue.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes dense stroma and abnormal vessels, it does not discuss increased interstitial fluid pressure, poor lymphatic function, or explicit contrasts with normal tissue fluid dynamics."
      },
      {
        "criterion_number": 3,
        "description": "Addresses how altered fluid flow impacts cancer treatment, including drug delivery and immune cell penetration into tumors.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It generally states microenvironment and fluid forces can affect therapy effectiveness but does not specifically address immune cell penetration/infiltration into tumors or concrete impacts on drug delivery."
      },
      {
        "criterion_number": 4,
        "description": "Discusses the potential impacts of altered fluid flow on cancer behavior, including metastasis, proliferation, migration, and invasion.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Metastasis and migration are discussed, and extravasation is mentioned, but proliferation is not addressed; the criterion requires coverage of all listed behaviors."
      },
      {
        "criterion_number": 5,
        "description": "Provides at least one citation from a published scientific journal article as evidence for its claims.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Cites a Nature Reviews Cancer article, which is a peer-reviewed scientific journal; additional links include AACR blog and PubMed search, but at least one journal citation is present."
      },
      {
        "criterion_number": 6,
        "description": "Defines shear stress.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines shear stress as a force parallel to cell/tissue surfaces caused by fluid movement."
      },
      {
        "criterion_number": 7,
        "description": "Describes what sources of shear stress exist in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies blood and lymph flow as sources of shear stress and notes effects on vessel walls and nearby tumor cells."
      },
      {
        "criterion_number": 8,
        "description": "Defines mechanobiology.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mechanobiology is not defined or explicitly mentioned."
      },
      {
        "criterion_number": 9,
        "description": "Explains that cancer cells can encounter shear stress forces in the tumor, in the bloodstream, and in lymph channels.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions shear stress within tumors and in the bloodstream; lymph is noted as a fluid source, but it does not explicitly state that cancer cells encounter shear stress within lymphatic channels."
      },
      {
        "criterion_number": 10,
        "description": "Describes desmoplastic stroma and how this forms in pancreatic cancer\u2019s tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Refers to a dense stroma but does not define desmoplasia or explain its formation (e.g., pancreatic stellate cell activation, ECM deposition)."
      },
      {
        "criterion_number": 11,
        "description": "Explains the effect that the desmoplastic stroma has on fluid flow in and around a pancreatic cancer tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that dense stroma and abnormal vasculature in PDAC lead to altered blood flow and regions of high/low shear stress in and around the tumor, which addresses the effect on fluid flow."
      },
      {
        "criterion_number": 12,
        "description": "Explains how increased shear stress encourages cancer cells to proliferate and metastasize.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes shear stress can affect metastasis and activate survival/migration pathways, but does not explain promotion of proliferation; criterion requires both proliferation and metastasis."
      },
      {
        "criterion_number": 13,
        "description": "Describes how shear stresses on cancer cells impact drug resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that shear stress can activate signaling pathways that promote resistance to treatment."
      }
    ],
    "question_number": 259,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:26:23.748318",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: 'Talk with the medical team: Ask your loved one's oncologist about realistic expectations,' which directly recommends discussion with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages open, honest communication: 'With each other, share fears, hopes, and questions,' clearly promoting open dialogue between patient and loved ones."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends 'Therapists or counselors' and 'Spiritual or community support.' While it does not mention palliative care or social workers specifically, it clearly advises seeking counselor/spiritual support."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'Prioritize quality of life' and 'Plan together: Decide on treatment goals, advance care planning,' which directly aligns with establishing goals of care."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically mentions 'Support groups (in-person or online) for pancreatic cancer can help you feel less alone,' clearly recommending support groups."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Names organizations (American Cancer Society, National Cancer Institute) but does not provide contact information or website URLs as required."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights caregiver and patient well-being: 'Make sure you're getting emotional support and tending to your own well-being' and suggests therapists/counselors, emphasizing mental health."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Normalizes conflicting emotions: 'There's no wrong way to feel or to grieve' and 'Hope isn't denial... Realism isn't giving up,' validating the conflict as normal."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions prioritizing quality of life and examples of what matters (family time, activities), but does not describe treatment-related factors (e.g., side effects, fatigue, pain, hospital visits) impacting quality of life."
      },
      {
        "criterion_number": 10,
        "description": "The response should provide online resources for pancreatic cancer information and support groups for the patient to consider reaching out to a community about their struggles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References ACS and NCI generally and mentions support groups, but does not provide specific online resources or named online support communities with links for pancreatic cancer."
      }
    ],
    "question_number": 260,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:27:11.343563",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains integrin-based attachment to the extracellular matrix and notes that the forces cells exert can send signals back into the cell (mechanotransduction), conveying how cells sense mechanical inputs in accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes responses such as migration/invasion, ECM remodeling, tumor stiffening, and activation of survival/growth/treatment resistance pathways, all framed in clear, nontechnical language."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links ECM stiffness/fibrosis and tumor stiffening to increased aggressiveness and metastasis potential."
      },
      {
        "criterion_number": 4,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that the stiff/fibrotic tumor microenvironment in pancreatic cancer can make treatments less effective and mentions resistance to treatment in the context of mechanotransduction."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a Nature Reviews Cancer article (a peer-reviewed journal) among the sources provided, satisfying the requirement to cite published journal literature."
      },
      {
        "criterion_number": 6,
        "description": "The response defines traction forces that exist in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines traction forces generally as forces cells exert by pulling on ECM via integrins, explicitly noting this applies to cells including cancer cells, which implies normal cells as well."
      },
      {
        "criterion_number": 7,
        "description": "The response defines the extracellular matrix.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Clearly defines the ECM as a network of proteins surrounding cells that they attach to and pull on."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how traction forces are changed in cancer cells, as opposed to normal cells.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not explicitly compare cancer-cell traction forces to those of normal cells (e.g., increased magnitude, altered adhesions/dynamics); focuses on roles of traction in cancer without a direct contrast."
      },
      {
        "criterion_number": 9,
        "description": "The response describes how increased traction forces from pancreatic cancer cells on their environment promote cancer cell proliferation and migration.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Discusses migration and growth generally and notes pancreatic TME stiffness, but does not specifically link increased traction forces from pancreatic cancer cells to their proliferation and migration."
      },
      {
        "criterion_number": 10,
        "description": "The response describes changes in the pancreatic cancer environment that are prompted by traction forces from the cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that collective pulling by cancer cells can stiffen the ECM around tumors and identifies pancreatic tumors as having a stiff/fibrotic microenvironment, connecting traction to TME changes."
      },
      {
        "criterion_number": 11,
        "description": "The response defines mechanotransduction.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Defines mechanotransduction as forces sending signals back into the cell, which is correct and understandable."
      },
      {
        "criterion_number": 12,
        "description": "The response defines desmoplastic stroma in pancreatic cancer\u2019s tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention or define desmoplastic stroma."
      },
      {
        "criterion_number": 13,
        "description": "The response describes the effect of desmoplastic stroma on cancer cell\u2019s ability to metastasize.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of desmoplastic stroma\u2019s impact on metastasis."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how traction forces in cancer cells contribute to drug resistance in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions general treatment resistance and stiffness but does not specifically link traction forces in pancreatic cancer cells to drug resistance in PDAC."
      }
    ],
    "question_number": 261,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:28:37.800045",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response discusses how stiffness/viscosity influence cancer cell movement, invasion, and metastasis, explicitly addressing spread."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that a thicker/more viscous environment can impede drug penetration and immune cell access, and notes dense stroma in pancreatic cancer hinders treatment delivery."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions reduced blood flow and hypoxia as potential consequences of tissue thickness which may have effects on treatment effectiveness.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While angiogenesis is mentioned, reduced blood flow and hypoxia are not explicitly discussed, nor are their effects on treatment."
      },
      {
        "criterion_number": 4,
        "description": "Define viscosity and explain its role in normal cells, including the term \u201cviscosity\u201d and its function in cellular environments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Viscosity is defined in general terms, but there is no explanation of its role in normal cells or normal cellular environments."
      },
      {
        "criterion_number": 5,
        "description": "Describe changes in viscosity within the pancreatic cancer microenvironment, mentioning \u201cviscosity\u201d and specific alterations in cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although the response mentions stiffness in pancreatic tumors and briefly references regions of higher viscosity, it does not clearly or accurately describe specific viscosity changes characteristic of the pancreatic cancer microenvironment."
      },
      {
        "criterion_number": 6,
        "description": "Define the tumor microenvironment, using the term \u201ctumor microenvironment\u201d and describing its components.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The term \u201ctumor microenvironment\u201d is used, but the components (e.g., extracellular matrix, stromal cells, immune cells, vasculature) are not defined or enumerated."
      },
      {
        "criterion_number": 7,
        "description": "Define desmoplastic stroma and explain its formation in pancreatic cancer, using the term \u201cdesmoplastic stroma\u201d and describing its development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response uses the term \u201cdesmoplastic reaction\u201d rather than \u201cdesmoplastic stroma\u201d and does not explain how it forms in pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "Describe the influence of desmoplasia on cancer cells, mentioning \u201cdesmoplasia\u201d and its effects on proliferation, migration, or invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Effects of dense stroma are discussed generally, but the term \u201cdesmoplasia\u201d is not used and effects on proliferation/migration/invasion are not attributed to it."
      },
      {
        "criterion_number": 9,
        "description": "Describe how desmoplasia limits oxygen delivery to tumor tissue, attributing reduced oxygen delivery specifically to \u201cdesmoplasia.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of oxygen delivery or hypoxia being limited by desmoplasia."
      },
      {
        "criterion_number": 10,
        "description": "Explain how hypoxia affects cancer cell behavior, describing hypoxia\u2019s role in selecting aggressive, therapy-resistant cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hypoxia and its selective pressure on aggressive, therapy-resistant cells are not discussed."
      },
      {
        "criterion_number": 11,
        "description": "Describe how desmoplasia limits tumor access by the immune system, mentioning \u201cdesmoplasia\u201d and its impact on immune cell infiltration.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While immune cell access is mentioned as impeded by thick tissue, the term \u201cdesmoplasia\u201d is not used as required."
      },
      {
        "criterion_number": 12,
        "description": "Explain how desmoplasia causes drug resistance in pancreatic cancer, connecting \u201cdesmoplasia\u201d to reduced treatment efficacy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Reduced drug penetration is noted, but not explicitly connected to \u201cdesmoplasia\u201d as required."
      },
      {
        "criterion_number": 13,
        "description": "Explain how desmoplastic stroma selects for aggressive tumor cell behavior, linking \u201cdesmoplastic stroma\u201d to increased migratory behavior.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit mention of \u201cdesmoplastic stroma\u201d selecting for aggressive or migratory behavior."
      },
      {
        "criterion_number": 14,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Two peer-reviewed journal articles (Nature Reviews Cancer and Cancer Discovery) are cited with links, along with a reputable patient-advocacy resource."
      }
    ],
    "question_number": 262,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:29:53.386368",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends involving hospital social workers and chaplains; also references palliative care resources, meeting the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends respectful and open communication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Dedicated section on Open Communication with guidance to listen first, avoid judgment, and share concerns gently."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions cultural mediators.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically suggests requesting a cultural liaison to facilitate conversations."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends that the patient and family members communicate their important cultural beliefs to their oncology team for better understanding.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises involving the healthcare/medical team and using a liaison or interpreter to facilitate conversations about cultural beliefs; encourages sharing traditions and preferences."
      },
      {
        "criterion_number": 5,
        "description": "The response strongly recommends that a medical interpreter is present for all medical appointments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Interpreter is suggested only if language/cultural misunderstandings are a barrier; not a strong recommendation for all appointments."
      },
      {
        "criterion_number": 6,
        "description": "The response suggests that the patient request more time for their appointments, especially if a medical interpreter is needed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of requesting extended appointment time."
      },
      {
        "criterion_number": 7,
        "description": "The response suggests the patient and/or family inquire about services a patient advocacy office could provide.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No reference to a patient advocacy office or similar services."
      },
      {
        "criterion_number": 8,
        "description": "The response encourages the patient to communicate their preferences around medical decision-making with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages shared decision-making with the medical team and advance care planning to express and document preferences."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends online resources for both patients and medical teams to learn about particular cultural norms around medical care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides links to ACS Cultural Considerations and NHPCO Cultural Competence, appropriate for patients and professionals."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends medical teams to complete thorough documentation on patient preferences surrounding communication and medical decision-making.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions advance directives but does not explicitly recommend that the medical team document preferences in the medical record."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends organizations that support cancer patients and their families and includes contact information or a website for each.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists American Cancer Society and NHPCO with URLs, fulfilling the requirement."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends setting boundaries.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages self-care and patience but does not explicitly advise setting boundaries."
      }
    ],
    "question_number": 263,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:30:34.690780",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response repeatedly references tissue/tumor stiffness, including pancreatic cancer desmoplasia making tumors very stiff."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly links mechanical properties to migration/invasion, metastasis, survival in circulation, and mechanotransduction promoting growth and spread."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes stiffer tumors impede drug penetration and suggests stiffness may contribute to treatment resistance."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It cites a Nature Reviews Cancer article (journal review) and provides additional reputable sources (NCI, AACR blog)."
      },
      {
        "criterion_number": 5,
        "description": "The response explains cancer cell deformability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines elasticity/stiffness as resistance to deformation, discusses how cells deform under force, and mentions measurement methods (AFM, micropipette aspiration, optical tweezers)."
      },
      {
        "criterion_number": 6,
        "description": "The response defines extracellular matrix and cytoskeleton.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Extracellular matrix is briefly defined as the scaffold around cells, but the cytoskeleton is not defined."
      },
      {
        "criterion_number": 7,
        "description": "The response explains cell adhesion processes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No explanation of adhesion mechanisms (e.g., integrins, cadherins, focal adhesions) is provided."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how cell deformity changes in cancer cells as compared to normal cells.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It asserts cancer cells are often stiffer than normal cells; this is generally contrary to widely reported increased deformability (softer phenotype) in many cancers, making the description inaccurate."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the impact of enhanced deformability of cancer cells on their ability to metastasize.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not explain how greater deformability facilitates squeezing through confined spaces, intravasation/extravasation, or other metastasis steps; instead it emphasizes stiffness aiding invasion."
      },
      {
        "criterion_number": 10,
        "description": "The response explains ways that cancer cells migrate from the primary tumor, including hematologic and lymphatic spread, perineural invasion, and direct invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Only hematogenous spread (entry into bloodstream) is mentioned; lymphatic spread, perineural invasion, and direct invasion are not addressed."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how cancer cells with increased ability to deform survive stresses that normal cells would not.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not connect increased deformability to survival under shear stress, constricted capillary transit, or anoikis avoidance; it only alludes generally to survival in circulation."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how increased deformability capabilities are necessary for cells to travel within the desmoplastic stroma of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although desmoplastic stiffness in pancreatic cancer is acknowledged, the necessity of increased deformability to navigate this dense stroma is not explained."
      }
    ],
    "question_number": 264,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:31:44.049646",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes how physical space restriction affects cancer cells, mentioning at least two effects such as \u201cenhanced migration,\u201d \u201cnuclear deformation,\u201d or \u201cadaptation.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes multiple effects: altered shape/motility, enhanced invasion/metastasis, altered gene expression, survival under stress, and treatment resistance. Although it does not mention nuclear deformation, it clearly lists more than two effects."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how confinement enhances migration and invasion, using terms like \u201camoeboid migration,\u201d \u201cincreased speed,\u201d or \u201cmetastasis.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states confinement can make cells more likely to invade nearby tissues and mentions metastasis; ties limited space to cells breaking away and spreading."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how confinement can promote genetic mutations, mentioning \u201cnuclear deformation,\u201d \u201cDNA damage,\u201d or \u201cgenomic instability.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of nuclear deformation, DNA damage, or genomic instability; focuses on gene expression and survival, not mutations."
      },
      {
        "criterion_number": 4,
        "description": "The response explains how confinement enhances cancer cells\u2019 ability to survive and adapt to stress, using terms like \u201cupregulate survival signals,\u201d \u201cresistant to therapies,\u201d or \u201cmechanical stress.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes activation of survival pathways under hypoxia/nutrient stress, increased expression of survival proteins, and resistance to treatment; also mentions tumor pressure."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms, including at least one analogy or example that avoids jargon.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explanation of mechanosensing mechanisms (e.g., how cells detect pressure via membrane/cytoskeleton) and no analogy is provided."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms, including at least one analogy or example that avoids jargon.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it lists outcomes (migration, survival), it does not explain underlying biological response pathways in lay terms nor include an analogy."
      },
      {
        "criterion_number": 7,
        "description": "The response provides at least one specific citation from a published scientific journal article as evidence for its statements.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It cites a Science article with DOI and a Nature Reviews Cancer review, both peer-reviewed journal sources."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly relates tissue properties to their potential effect on cancer spread, including at least one specific example or mechanism.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links dense packing/pressure and confined microenvironments to increased invasion and metastasis, providing a mechanism (cells breaking away due to space limitation)."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly relates tissue properties to their potential consequences for treatment effectiveness and resistance, including at least one specific example or mechanism.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that drugs have trouble reaching cells deep inside a dense, confined tumor and that confinement may induce dormancy/slow growth, contributing to resistance."
      },
      {
        "criterion_number": 10,
        "description": "The response defines confinement in the context of cancer cells, using terms like \u201cphysical restriction,\u201d \u201ctumor microenvironment,\u201d or \u201cnarrow spaces.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly defines confinement as physical restriction/constraint, being squeezed into small spaces with limited room to move within the tumor microenvironment."
      },
      {
        "criterion_number": 11,
        "description": "The response defines desmoplastic stroma in pancreatic cancer, using terms like \u201cdense,\u201d \u201cfibrous,\u201d \u201cscar-like tissue,\u201d or \u201cstiff extracellular matrix,\u201d and describes its formation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Desmoplastic stroma is not mentioned or defined."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly connects desmoplastic stroma to the confinement of cancer cells, explaining how it creates physical restriction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of desmoplastic stroma, so no connection to confinement is made."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions the role of hypoxia in pancreatic cancer and describes why pancreatic tumors are in a hypoxic environment, using terms like \u201clow-oxygen\u201d or \u201cdense stroma.\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although hypoxia is mentioned generally, it is not specifically tied to pancreatic cancer nor attributed to dense stroma in pancreatic tumors."
      },
      {
        "criterion_number": 14,
        "description": "The response states that understanding confinement is an area of active scientific research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly states that confinement is an active area of cancer research."
      }
    ],
    "question_number": 265,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:32:39.630777",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends flexibility in plans and modifications to allow the father to participate in family traditions.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly advises adapting traditions to current abilities, smaller gatherings, remote participation, prioritizing key traditions, and planning around fatigue/appointments with readiness to adjust or cancel."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends involving a family counselor or a social worker who specializes in cancer care."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the importance of a strong support system during cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Emphasizes involving the whole family, seeking support from professionals, and open communication, underscoring the value of a support network."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations, websites, or contact information are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends open communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Has a dedicated section titled 'Communicate Openly' encouraging discussion of meanings and adaptations."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Support groups are not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient prioritize management of cancer or cancer-treatment related side effects to feel as \u201cnormal\u201d as possible to be present for himself and his family.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests scheduling around fatigue and appointments, it does not advise proactive management of symptoms/side effects to optimize well-being."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the family members consider documentation of the family traditional events with their father, as a way to reminisce and honor his presence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages documenting stories, memories, and family recipes together."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the family members to be thoughtful about ways their father can feel included in family events.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Offers specific inclusion strategies such as adapting activities to energy level and including him remotely."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest that the family seek their father\u2019s input on what meaningful events and activities he desires to participate in.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends involving the father in planning new traditions to give him agency and involvement."
      }
    ],
    "question_number": 266,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:33:12.099077",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms, using accessible language and avoiding jargon, including the concept of cancer cells moving from the primary tumor to other parts of the body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines metastasis as how cancer spreads and describes cells moving through the body via blood/lymph and into new tissues; overall accessible with explanations of terms, conveying the concept of spread from the original site."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, explicitly mentioning direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions blood and lymphatic spread but does not explicitly name direct invasion by the primary tumor as a mode of spread."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses at least two cellular mechanisms by which cancer spreads in the body, such as amoeboid, mesenchymal, or collective migration, enzyme production, or environmental signals.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes amoeboid and mesenchymal movement, enzyme-mediated matrix remodeling, and environmental cues (chemical gradients)."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly mentions epithelial to mesenchymal transition (EMT) by name.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response clarifies that cancer cells do not swim, explicitly stating they lack the cellular machinery (e.g., flagella or cilia) to do so.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not state that cancer cells lack flagella/cilia or that they do not swim in the conventional sense."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe ways cancer cells migrate, including in solid tissues and through a fluid-filled environment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses migration within tissues (mesenchymal mode) and in fluid environments (amoeboid mode, flow-assisted travel)."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain hematologic spread and lymphatic metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions movement through the bloodstream and lymphatic system and references adhesion to vessel walls and extravasation."
      },
      {
        "criterion_number": 8,
        "description": "The response should explain amoeboid motility that some cancer cells can perform to actively travel through fluid.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a clear explanation of amoeboid motion in fluid, including pseudopod extension and actomyosin-driven contraction."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain membrane fluctuations and how some cancer cells can do this to actively travel through fluid.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While cell shape changes and pseudopods are mentioned, membrane fluctuations/blebbing are not explicitly explained as a propulsion method."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain chemical gradients and provide examples, and should define chemotaxis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines chemotaxis and gives examples (growth factors/chemoattractants) and movement toward higher concentrations."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe passive movements of cancer cells in fluid-filled environments.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes that blood flow can physically carry cancer cells, indicating passive transport."
      },
      {
        "criterion_number": 12,
        "description": "The response should provide links to the scientific literature that discusses ways cancer cells can move through fluid substances, with PMIDs if available.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a peer-reviewed review article link relevant to cell migration and invasion; PMIDs are not provided but not required."
      },
      {
        "criterion_number": 13,
        "description": "The response should define desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response should summarize ways pancreatic cancer cells migrate in their solid tissue environment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Provides general mechanisms but does not specifically address pancreatic cancer cells in their tissue context."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe the most common way that pancreatic cancer cells are thought to spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not specify the predominant metastatic routes for pancreatic cancer."
      }
    ],
    "question_number": 267,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:34:27.017740",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines surface tension.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines surface tension as the energy required to increase surface area due to molecular attraction at an interface, with cellular context."
      },
      {
        "criterion_number": 2,
        "description": "The response defines interfacial forces.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines interfacial forces as physical forces acting at boundaries between phases (e.g., cell and surroundings)."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the influence of surface tension on pancreatic cancer cells, specifically mentioning cell detachment, migration, or tumor spheroid formation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes effects of surface tension on migration/invasion and tumor spheroid formation; also ties to PDAC microenvironment, satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response describes the role of interfacial forces during cancer cell metastasis, specifically mentioning cell detachment, migration, or invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains interfacial roles in intravasation/extravasation, arrest in capillaries, and migration/invasion."
      },
      {
        "criterion_number": 5,
        "description": "The response states interfacial tissue planes typically serve as barriers for cancer spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention tissue planes as barriers to spread; discusses stromal barrier to drugs but not anatomical interfacial planes."
      },
      {
        "criterion_number": 6,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides an accessible explanation of cells entering blood, surviving, lodging in capillaries, and forming new tumors."
      },
      {
        "criterion_number": 7,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions blood-borne spread and implies invasion, but does not explicitly include lymphatic spread; thus does not cover all three routes."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Addresses mechanisms including adhesion changes, deformation to migrate, glycocalyx alterations, mechanotransduction, and intravasation/extravasation."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response describes cell-to-cell adhesion, specifically in the context of tumor spheroid formation and the balance with surface tension.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains how surface tension at cell\u2013cell interfaces affects tightness of aggregates and spheroid formation."
      },
      {
        "criterion_number": 11,
        "description": "The response describes at least two mechanical cues in the tumor microenvironment, such as stiffness or surface tension, and how cancer cells sense these signals.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies surface tension, interstitial fluid pressure, and viscosity; references mechanotransduction as sensing/response."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions desmoplastic stroma and its relevance to pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses desmoplastic stroma in PDAC and its physical consequences."
      },
      {
        "criterion_number": 13,
        "description": "The response defines the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ECM is referenced but not defined (no description of its composition or role)."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how normal cells and cancer cells interact with the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not compare normal versus cancer cell interactions with ECM; only general mention of cancer cell\u2013ECM interface."
      }
    ],
    "question_number": 268,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:35:19.768456",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing uncertainty or care planning with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention the oncologist or discussing uncertainty/care planning with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends reaching out to a therapist or counselor, which satisfies the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It suggests joining a support group for people facing similar challenges."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends conversations about wishes and values and mentions advanced care planning, which reflects establishing goals of care."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It encourages talking openly with each other and has a section titled 'Communicate Honestly and Often.'"
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It names the American Cancer Society and the Pancreatic Cancer Action Network as resources."
      },
      {
        "criterion_number": 7,
        "description": "The response should attempt to normalize the challenge of living with long-term uncertainty.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that such feelings are completely normal and notes there is no 'right' way to live with uncertainty."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend attempting to preserve normal routines in the home as much as possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises focusing on small daily decisions and routines to create stability."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of quality of life when facing a serious diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes making space for joy and meaning, spending time together, and celebrating small victories, underscoring quality of life."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest ways to maintain good quality of life for patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It offers concrete suggestions: sharing meals, watching a favorite movie, taking walks, creating traditions, writing letters, making a memory book, and celebrating small victories."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that patients and family members learn about the disease to understand expected outcomes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not suggest learning about pancreatic cancer or discussing prognosis/expected outcomes."
      }
    ],
    "question_number": 269,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:35:55.073607",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly explains that metastasis is cancer spreading from the original tumor and describes cell movement in simple terms (crawling, moving through tissues, blood, and lymph)."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions crawling along tissues (direct invasion) and movement through the bloodstream and lymphatic system, covering all three requested routes."
      },
      {
        "criterion_number": 3,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains adhesion using accessible analogies (integrins/cadherins as grappling hooks) and describes anchoring and pulling mechanics in simple language."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Both integrins and cadherins are explicitly mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response contrasts the biology of cancer cell adhesion with normal cell adhesion using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No comparison to normal cell adhesion is provided; it only describes cancer cell adhesion."
      },
      {
        "criterion_number": 6,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Only general health organization webpages are cited (NCI, ACS, CRUK); no primary scientific journal articles are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions changes to cell adhesion in pancreatic cancer specifically.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No pancreatic cancer\u2013specific adhesion changes (e.g., cadherin loss or integrin alterations) are discussed."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe cell-to-cell adhesion and include definitions of integrins, collagen, and fibronectin.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While integrins, collagen, and fibronectin are mentioned, there is no clear definition of each nor an explanation of cell-to-cell adhesion; cadherins are mentioned but not explained as cell-to-cell adhesion molecules."
      },
      {
        "criterion_number": 9,
        "description": "The response should define extracellular matrix.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The ECM is defined as a structural support network made of proteins like collagen, fibronectin, and laminin; this constitutes a clear lay definition."
      },
      {
        "criterion_number": 10,
        "description": "The response should define actin and myosin, and describe how these proteins act to deform cells to assist in traction and movement.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Actin is mentioned but not defined; myosin is not mentioned. The actin\u2013myosin contractile mechanism is not described."
      },
      {
        "criterion_number": 11,
        "description": "The response should define chemotaxis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chemoattractants are mentioned, but the term 'chemotaxis' is not used or defined."
      },
      {
        "criterion_number": 12,
        "description": "The response should define amoeboid migration.",
        "score_given": 0,
        "max_points": 5,
        "justification": "An analogy to an amoeba is given, but 'amoeboid migration' is not defined."
      },
      {
        "criterion_number": 13,
        "description": "The response should desmoplastic stroma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The term 'desmoplastic stroma' is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe how pancreatic cancer forms desmoplastic stroma in its environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Formation of desmoplastic stroma by pancreatic cancer is not described."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe how pancreatic cells interact with desmoplastic stroma.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Interactions with a dense fibrous environment are mentioned generally, but desmoplastic stroma interactions are not specifically described."
      },
      {
        "criterion_number": 16,
        "description": "The response should define tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The tumor microenvironment is not defined."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe how pancreatic cancer cells interact with the tumor microenvironment, and how different elements encourage cell travel, such as inflammation and hypoxia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of tumor microenvironment components like inflammation or hypoxia and their role in cell movement."
      },
      {
        "criterion_number": 18,
        "description": "The response should describe the effect of DNA mutations, such as KRAS, on a pancreatic cancer cell\u2019s potential to travel outside of the primary site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of genetic mutations (e.g., KRAS) or their effects on motility/invasion."
      }
    ],
    "question_number": 270,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:37:13.161124",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes how normal tissue structure is disrupted in solid cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly contrasts organized normal pancreatic acini with disorganized, irregular tumor architecture, noting loss of normal geometry in cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response describes that cancer cells proliferate in an unchecked fashion, disrupting the architecture of their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States altered signaling in cancer promotes uncontrolled growth and survival and links this to disrupted tissue architecture."
      },
      {
        "criterion_number": 3,
        "description": "The response defines geometry in biology and medicine, and with regards to human cells and their surrounding structures.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly defines geometry as the shapes and structures of tissues and discusses cell arrangement, ECM, stiffness, and tumor shape as biological geometry."
      },
      {
        "criterion_number": 4,
        "description": "The response describes that normal cells exist in a neat, orderly, and structured space within their respective tissues.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes healthy tissue as organized with specific patterns (e.g., pancreatic acini) and tight cell-cell contacts regulating behavior."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the components of normal tissue architecture, such as collagen and extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions and discusses the extracellular matrix as a structural component influencing invasion; while collagen is not named, ECM is explicitly addressed."
      },
      {
        "criterion_number": 6,
        "description": "The response describes desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains PDAC has a dense, fibrotic stroma forming a 'shield' that impedes drug delivery and immune access, effectively describing desmoplasia even without the exact term."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the effect of desmoplastic stroma on pancreatic cell proclivity to migrate and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the dense, fibrous stroma can make local spread harder and can protect cancer cells, addressing its effect on propensity to migrate/spread."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the role of blood vessels in drug delivery, and how this can be impacted by pancreatic tumors and desmoplastic stroma.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it discusses angiogenesis and stroma impeding drug delivery, it does not explicitly link blood vessels to drug delivery in pancreatic tumors."
      },
      {
        "criterion_number": 9,
        "description": "The response clearly explains cancer metastasis in layman\u2019s terms, avoiding jargon and providing accessible explanations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions invasion and metastasis but does not provide a lay explanation of what metastasis is or how cancer spreads to distant sites in simple terms."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly mentions all three main routes of cancer spread: direct invasion, lymphatic spread, and hematogenous spread.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not name lymphatic or hematogenous routes; only discusses invasion and migration in general."
      },
      {
        "criterion_number": 11,
        "description": "The response discusses at least two cellular mechanisms by which cancer spreads, such as changes in cell shape, loss of adhesion, or influence of the microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Addresses changes in cell shape enhancing mobility and the role of the extracellular matrix/microenvironment in facilitating or hindering invasion; also touches on altered cell-cell contacts."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly mentions epithelial to mesenchymal transition (EMT) by name or describes the process.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is neither named nor described."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions cancer metastasis as a response to cell stress, including stress-induced mechanisms.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Hypoxia and therapy resistance are mentioned, but metastasis as a stress response or stress-induced dissemination is not discussed."
      }
    ],
    "question_number": 271,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:38:03.342861",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends respectful and honest communication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It offers clear, respectful scripts (e.g., providing general updates, letting others know you'll share more when ready) and encourages communication with family, friends, and the care team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends maintaining personal boundaries.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises setting boundaries, controlling what to share, and designating a point person to manage inquiries."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends in-person/online support groups and cites organizations offering moderated/private forums."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists the American Cancer Society with a specific helpline number and mentions PanCAN and local palliative resources."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It underscores that the family is not alone, encourages seeking support, and references multiple supportive resources and professionals."
      },
      {
        "criterion_number": 6,
        "description": "The response should inform the patient and family members that medical records are subject to HIPAA laws, which prevent divulgence of medical information unless a patient has specifically consented to this.",
        "score_given": 0,
        "max_points": 10,
        "justification": "HIPAA or legal protections of medical records are not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient inform their oncology care team of their wishes to keep their diagnosis confidential.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it mentions working with the medical team, it does not explicitly recommend informing the oncology team of confidentiality wishes."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient and family members be careful and thoughtful with social media posting to maintain her confidentiality.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises using closed groups, pseudonyms, and strict privacy controls, and notes stepping back if privacy feels compromised\u2014meeting the intent to be careful with online sharing."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient and/or family members seek a balance; it is OK to be selective with sharing her diagnostic information however isolation for patients and/or caregivers can accelerate burnout.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it supports selective sharing, it does not caution that isolation can lead to caregiver or patient burnout."
      }
    ],
    "question_number": 272,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:38:51.798394",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms, avoiding jargon and providing context for a lay audience.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear, empathetic, plain-language explanation of metastasis and why squeezing through tight spaces matters, using accessible analogies and minimal jargon."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly mentions and explains the three main routes of cancer spread: direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions movement through capillaries (blood) and into lymphatic vessels but does not explicitly identify direct invasion as a distinct route or explain all three routes comprehensively."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses at least three cellular mechanisms by which cancer spreads.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers multiple mechanisms: shape change/increased deformability, nuclear deformation, enzymatic breakdown of surrounding tissue (ECM), and integrin-mediated traction/mechanical forces."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly mentions epithelial-to-mesenchymal transition (EMT) and explains its relevance to cancer cell migration and invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or explained."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of metastasis in the context of cell stress."
      },
      {
        "criterion_number": 6,
        "description": "The response should define the extracellular matrix.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines the extracellular matrix in lay terms as the body's support structures that cells can alter to create pathways."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe the different components of the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not list or describe ECM components (e.g., collagen, laminin, fibronectin, proteoglycans, hyaluronan)."
      },
      {
        "criterion_number": 8,
        "description": "The response should define desmoplastic stroma and describe how this is formed in the pancreatic cancer environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of desmoplastic stroma or its formation in pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how cancer cells are able to deform their shapes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly describes cell shape change, elongation/flattening, and nuclear deformation to pass through tight spaces."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain the cellular cytoskeleton and its main component parts, such as actin and myosin.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of the cytoskeleton, actin, myosin, or related structures."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe amoeboid movement in cells and include a description of filopodia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Amoeboid movement and filopodia are not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe mesenchymal movement in cancer cells and provide examples of enzymes used by cancer cells in this phenomenon.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mesenchymal movement is not mentioned; no specific enzyme examples (e.g., MMPs) are provided."
      },
      {
        "criterion_number": 13,
        "description": "The response should provide links to any scientific literature it references, including PMID.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Provides general informational links (ACS, NCI) and suggests searching literature but does not cite specific scientific studies or PMIDs."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain how cells can use ion gradients to prompt movement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Ion gradients and their role in cell motility are not addressed."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe the importance of pancreatic cancer cells\u2019 ability to deform or \u201csqueeze\u201d in the desmoplastic stromal environment for survival and spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention pancreatic cancer\u2019s desmoplastic stroma or relate squeezing to survival/spread in that specific context."
      },
      {
        "criterion_number": 16,
        "description": "The response should include information about how the nucleus is thought to be deformable in cancer cell migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions nuclear deformation as part of squeezing through tight spaces."
      }
    ],
    "question_number": 273,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:39:35.007603",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines topology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly defines topology as the arrangement and connectivity of cells, blood vessels, and surrounding tissue within a tumor and its environment."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions invasion into nearby tissue, and explicitly identifies blood vessels and lymphatic vessels as routes for metastasis."
      },
      {
        "criterion_number": 3,
        "description": "The response states that in cancer care, topology may relate to the organization of tissues, blood vessels, or lymphatics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It ties topology to the organization and connectivity of tissues, blood vessels, and lymphatics in the tumor microenvironment."
      },
      {
        "criterion_number": 4,
        "description": "The response states the anatomic organization of cancer may impact the cancer\u2019s stage or likelihood to respond to certain treatments like surgery or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes that topology can affect how therapies work, it does not explicitly link anatomic organization to staging or specific modalities like surgery or radiation."
      },
      {
        "criterion_number": 5,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It uses accessible language and analogies (e.g., highways and roadblocks) to explain how cancer enters blood and lymph to spread."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes cell-cell communication (gap junctions/signaling), detachment/migration, stromal tracks, nerve-associated spread, and immune-mediated tissue remodeling."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe tissue networks and their component parts.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It outlines the tumor microenvironment components: cancer cells, immune cells, fibrous stroma, blood vessels, and support cells, and discusses their networked organization."
      },
      {
        "criterion_number": 8,
        "description": "The response should define the extracellular matrix and describe its component parts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions fibrous stroma but does not define the extracellular matrix or detail its components (e.g., collagen, hyaluronan, proteoglycans, laminin, fibronectin)."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe the desmoplastic stroma that pancreatic cancer encourages to grow in its environment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifically notes that pancreatic tumors have a dense, fibrous stroma that affects treatment and can guide cell migration."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe how abnormal tissue, such as desmoplastic stroma, increases in density of tissue network structures and encourages cancer growth and spread.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that the dense stroma can shield cancer cells and create organized tracks that facilitate migration and spread."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the roles of blood and lymph vessels in cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly identifies blood vessels and lymphatic vessels as routes for metastasis and explains their role as 'highways' for spread."
      },
      {
        "criterion_number": 12,
        "description": "The response should explain how disrupted tissue architecture can encourage cancer growth and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that certain arrangements create pathways/weak points and that remodeling by stromal and immune cells can facilitate invasion."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe cell-to-cell adhesions in normal cells, and how cancer cells can disrupt these adhesions making them more able to migrate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It mentions gap junctions and detachment but does not describe adhesion structures (e.g., cadherins, integrins) or explicitly state how cancer disrupts normal adhesions."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe how mechanical properties of tissue can stimulate tumor growth and spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not address mechanical properties such as stiffness, pressure, or mechanotransduction and their effects on tumor behavior."
      }
    ],
    "question_number": 274,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:40:14.453870",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not suggest speaking with the oncologist or medical team about communication with children."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends involving a family therapist or counselor for support."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends honest and open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It emphasizes honesty and keeping lines of communication open, encouraging simple, clear language and answering questions."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends tailoring the discussion to the age of the children.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly advises age-appropriate communication and differentiates between younger and older children."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Support groups are not mentioned; only counselors, books, and websites are suggested."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists American Cancer Society and CancerCare with direct website links."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no discussion of goals of care, advance care planning, or aligning communication with patient values and treatment goals."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It normalizes emotions, encourages self-care, and recommends seeking counseling, highlighting the importance of mental health for parents and children."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It acknowledges the situation as difficult, validates fear and sadness, and frames balancing honesty with hope as one of the hardest parts, effectively normalizing the conflict."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Quality of life and treatment impact are not addressed."
      },
      {
        "criterion_number": 11,
        "description": "The response should suggest that the patient and/or family members leverage support systems.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages seeking support from friends, family, and counselors, and offers external resources."
      }
    ],
    "question_number": 275,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:40:41.423256",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes metastatic routes for pancreatic cancer, including local solid tissue invasion, hematologic spread, lymphatic spread, or perineural invasion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains local tissue invasion via ECM remodeling and explicitly mentions clusters traveling through the bloodstream and lymphatic system. While perineural invasion is not mentioned, local, hematologic, and lymphatic routes are described."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses cell-to-cell adhesions in both normal cells and cancer cells, highlighting differences.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions cancer cell adhesion and E-cadherin but does not contrast adhesion in normal cells versus cancer cells or highlight differences."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cadherins (E-cadherin) are mentioned, but integrins are not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly describes metastasis as cancer cells moving from the primary tumor to other parts of the body, including moving as groups and traveling via blood and lymph, using accessible language."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It covers multiple mechanisms: cell\u2013cell adhesion, leader\u2013follower dynamics, ECM degradation by MMPs, invadopodia, and mode switching between amoeboid and mesenchymal migration."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not explicitly mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that cells stick together using special surface proteins (cell adhesion molecules) and gives E-cadherin as an example, using simple language."
      },
      {
        "criterion_number": 8,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It cites a Nature Reviews Cancer article on collective cell migration and provides an NCI page; the Nature review is a published scientific journal article."
      },
      {
        "criterion_number": 9,
        "description": "The response explains the concept of \u201cleader cells\u201d and implies the presence of \u201cfollower cells\u201d in a group of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly describes leader cells at the front sensing the environment and other cells following behind."
      },
      {
        "criterion_number": 10,
        "description": "The response describes amoeboid movement in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that cells can move in a more fluid, amoeboid way as one mode of migration, providing a basic description."
      },
      {
        "criterion_number": 11,
        "description": "The response describes mesenchymal migration in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that cells can move in a more elongated, mesenchymal way, which is a concise description of this mode."
      },
      {
        "criterion_number": 12,
        "description": "The response defines the extracellular matrix.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It defines the ECM as a scaffold made of proteins and other molecules surrounding cells."
      },
      {
        "criterion_number": 13,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Desmoplastic stroma is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how pancreatic cancer cells interact with desmoplastic stroma to encourage cancer cell growth and migration.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Interactions with desmoplastic stroma are not discussed."
      },
      {
        "criterion_number": 15,
        "description": "The response explains how \u201cleader cells\u201d influence a clump of traveling cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that leader cells sense the environment and guide the way, with follower cells moving in response to leader signals."
      },
      {
        "criterion_number": 16,
        "description": "The response defines at least one other protein involved in cell-to-cell adhesions.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No additional adhesion proteins (e.g., integrins, claudins, occludins, catenins, selectins) are defined beyond E-cadherin."
      },
      {
        "criterion_number": 17,
        "description": "The response describes how cells communicate with each other, such as through chemical signals or enzymes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions communication via chemical signals such as growth factors and cytokines and notes coordination of movement."
      }
    ],
    "question_number": 276,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:41:21.446221",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines curvature.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response clearly explains curved surfaces in the body (organ surfaces, inside blood vessels, tumor spheroids) and how cells experience curved environments, effectively defining curvature in context."
      },
      {
        "criterion_number": 2,
        "description": "The response states that in cancer care, curvature may relate to the organization of tissues, blood vessels, or lymphatics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions the lining of blood vessels and tubular ducts, and discusses tissue organization (tumor masses and spheroids) as curved environments affecting cell behavior."
      },
      {
        "criterion_number": 3,
        "description": "The response states the anatomic organization of cancer may impact the cancer\u2019s stage or likelihood to respond to certain treatments like surgery or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions treatment resistance and drug delivery, it does not connect anatomic organization to stage or to specific responsiveness to surgery or radiation."
      },
      {
        "criterion_number": 4,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Metastasis is mentioned, but there is no plain-language explanation of how cancer cells break away and spread to distant sites."
      },
      {
        "criterion_number": 5,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Direct invasion is implied (migration/invasion), but lymphatic and hematogenous spread are not described."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses disruption of cell polarity, altered cell\u2013cell and cell\u2013matrix interactions, hypoxia-driven aggressiveness, and mechanical stress\u2013induced changes, which are cellular mechanisms influencing spread."
      },
      {
        "criterion_number": 7,
        "description": "The response should define the extracellular matrix.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The extracellular matrix is defined as the material that surrounds cells, satisfying the requirement."
      },
      {
        "criterion_number": 8,
        "description": "The response should define epithelial-to-mesenchymal transition (EMT).",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or defined."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain cancer cell migration.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Migration is referenced as increased movement, but there is no explanation of how cancer cells migrate (e.g., protrusions, adhesion, traction, ECM remodeling)."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe the effect of mechanical forces on cell signaling.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that curvature creates mechanical stresses and that cells sense these physical cues, altering behavior (migration, division, treatment resistance), and mentions signaling pathway differences on curved vs. flat surfaces."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe how varying levels of positive or negative curvature at the cellular level influence EMT and cancer cell migration.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No distinction between positive/negative curvature is made, and EMT is not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe the effect of mechanical forces of tissues on cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that tumor curvature and compactness create mechanical stresses affecting cancer cell behavior (migration, division, treatment response), addressing tissue-level forces."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma and its role in pancreatic cancer are not addressed."
      },
      {
        "criterion_number": 14,
        "description": "The response should include that cellular curvature acts as both a signal and constraint in cancer cell progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Curvature as a signaling cue is implied, but curvature as a constraint on progression or movement is not explicitly stated."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe cancer cell membrane tension, and what occurs when this force is too high.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Membrane tension and consequences of elevated tension are not discussed."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe how high cell surface membrane tension, such as from curvature, can hinder movement of the cytoskeleton.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of membrane tension hindering cytoskeletal dynamics is present."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe the effects of mechanical tension at the level of tissue and organs, particularly if imbalanced, on the spread of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mechanical tension at organ/tissue scale and its imbalance affecting spread in pancreatic cancer is not discussed."
      },
      {
        "criterion_number": 18,
        "description": "The response should define paracrine signaling and explain its role in pancreatic cancer cell communication.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Paracrine signaling is not mentioned or defined, and no role in pancreatic cancer communication is provided."
      }
    ],
    "question_number": 277,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:42:11.049960",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing plans for celebrations with the patient\u2019s healthcare or oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises consulting the care team about capacity for activities and what is comfortable and safe, aligning celebration planning with medical guidance."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly suggests involving a counselor or therapist for guidance. While it does not mention social workers or palliative care by name, inclusion of counselor/therapist satisfies the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It specifically recommends joining a support group and notes organizations offering community support."
      },
      {
        "criterion_number": 4,
        "description": "The response offers examples of organizations that support cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it names the American Cancer Society and Pancreatic Cancer Action Network, it does not provide any contact information or website links."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes 'Quality Over Quantity' and meaningful, personalized time, focusing on joy and presence."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages involving loved ones, small gatherings, and reaching out to counselors and support groups, highlighting the value of community and asking for help."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of controlling symptoms related to pancreatic cancer or its treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not address symptom control (e.g., pain, fatigue, nausea) or strategies to manage treatment-related symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that caregivers take measures to prevent burnout.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises caregivers to care for themselves, ask for help, and take moments for their own well-being."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that loved ones plan small, meaningful gatherings with the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends small, intimate, and personalized celebrations, including one-on-one time and small gatherings."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of flexibility when planning events with a patient with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises to 'Be Flexible and Present,' acknowledging that some days may not be right for celebration and to let the patient's needs guide plans."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that planners of celebrations consider incorporating time for rest and keep gatherings small and simple.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it recommends small, simple gatherings, it does not explicitly advise incorporating time for rest."
      },
      {
        "criterion_number": 12,
        "description": "The response should suggest that a professional therapist or counselor can help maintain mental health in patients experiencing pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests involving a counselor or therapist to navigate emotional challenges, supporting mental health."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that patients and/or family members take care of any legal and/or medical paperwork as soon as possible.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention of completing legal or medical paperwork (e.g., advance directives, power of attorney)."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain that there will likely be a decline in overall health of the patient over time, and expectation management should be discussed by the patient and their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not discuss anticipated health decline or the need to manage expectations with the oncology team."
      }
    ],
    "question_number": 278,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:42:41.939445",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response clearly explains how changes in tissue density and architecture (cell jamming) influence cancer cell movement, tumor aggressiveness, and metastasis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response mentions that crowding affects movement and may influence spread, but it does not clearly connect changes in tissue density/architecture to tumor aggressiveness and metastasis with a mechanistic explanation. It remains general and does not fully address all three aspects (movement, aggressiveness, metastasis)."
      },
      {
        "criterion_number": 2,
        "description": "The response defines and explains cancer cell jamming.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response defines jamming as cells being packed closely together such that movement is hindered, uses a clear analogy, and explains that this affects migration and metastasis."
      },
      {
        "criterion_number": 3,
        "description": "The response defines and describes cancer cells that are in an unjammed state.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit definition or description of the unjammed state (e.g., fluid-like behavior, collective migration, increased motility)."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how cancer cells become unjammed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It briefly mentions breaking up dense clusters with experimental drugs but does not explain biological mechanisms that lead to unjamming (e.g., reduced cell-cell adhesion, cytoskeletal changes, EMT, ECM remodeling, or mechanical cues)."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the intrinsic properties of cells that contribute to jamming and unjamming of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions cell-cell adhesion molecules and changes in cellular behavior/signaling that influence sticking together or detaching, which are intrinsic properties affecting jamming/unjamming."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the extrinsic properties of cells that contribute to jamming and unjamming of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It identifies the extracellular matrix, neighboring cells, and mechanical pressure/crowding as extrinsic factors that impede or influence movement."
      },
      {
        "criterion_number": 7,
        "description": "The response explains how unjamming of cancer cells contributes to cancer spread and migration of cancer cells.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response does not explain that unjamming facilitates increased motility and invasive migration; it implies that disrupting jamming could slow spread without clarifying the typical link between unjamming and increased migration."
      },
      {
        "criterion_number": 8,
        "description": "The response explains methods of cancer cell movement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not describe migration modes (e.g., mesenchymal, amoeboid, collective) or mechanisms such as proteolysis or cytoskeletal dynamics."
      },
      {
        "criterion_number": 9,
        "description": "The response explains how jamming occurs in normal cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of jamming in normal tissues (e.g., epithelial layers, development, wound healing) is provided."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly discusses changes to tissue architecture specific to pancreatic cancer, such as desmoplastic reaction, fibrosis, or stromal remodeling.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of pancreatic cancer\u2013specific architectural changes like desmoplasia, fibrosis, or stromal remodeling."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly discusses the implications of altered tissue architecture on cancer treatment, specifically mentioning reduced drug delivery or immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that breaking up dense clusters can make it easier for treatments to reach tumor cells, which explicitly implies that dense/crowded architecture reduces drug delivery."
      },
      {
        "criterion_number": 12,
        "description": "The response includes citations from published scientific journal articles to support its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations are provided."
      }
    ],
    "question_number": 279,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:43:22.178537",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly mentions both tissue stiffness and fibrosis in the context of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses stroma and fibroblasts but does not explicitly mention tissue stiffness or fibrosis in pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly discusses intercellular communication between pancreatic cancer cells and stromal cells, such as fibroblasts or pancreatic stellate cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response notes that cells communicate via signaling molecules and, in the tumor context, describes organized interactions between cancer cells and stroma, explicitly mentioning fibroblasts in pancreatic tumors."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly connects specific tissue properties, such as stiffness or fibrosis, to the process of cancer spread, including invasion or metastasis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit connection is made between stiffness or fibrosis and invasion/metastasis."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly relates specific tissue properties, such as stiffness or fibrosis, to treatment response or resistance in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response mentions organized tumors protecting inner cells from chemotherapy, it does not tie this to stiffness or fibrosis."
      },
      {
        "criterion_number": 5,
        "description": "The response provides at least one citation from a published scientific journal article to support its claims.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It cites the Cell journal reviews 'Hallmarks of Cancer' and 'Hallmarks of Cancer: The Next Generation' by Hanahan & Weinberg, which are published scientific journal articles."
      },
      {
        "criterion_number": 6,
        "description": "The response must describe the concept of pattern formation in cellular structures, including at least two biological processes contributing to these patterns.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines pattern formation and cites multiple contributing processes: cell-cell signaling, genetic programs, gradients of oxygen/nutrients/signals, angiogenesis, and reactivation of developmental pathways (Wnt, Hedgehog, Notch)."
      },
      {
        "criterion_number": 7,
        "description": "The response must provide at least two commonly recognizable examples of biological pattern formation, such as embryonic development or tissue architecture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references embryonic development with formation of limbs, organs, and tissues, and discusses patterned vascular networks; these are commonly recognizable examples."
      },
      {
        "criterion_number": 8,
        "description": "The response must describe how organized structures develop in tumors, mentioning at least two mechanisms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions multiple mechanisms: angiogenesis, nutrient/oxygen gradients creating zones, stromal interactions, and reactivation of developmental signaling pathways."
      },
      {
        "criterion_number": 9,
        "description": "The response must explain how DNA mutations in cancer cells can change their behavior, linking these changes to pattern formation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains that genes controlling development are reactivated or disrupted in cancer and that these pathways drive tumor organization, linking genetic/epigenetic changes to pattern formation."
      },
      {
        "criterion_number": 10,
        "description": "The response must describe how cancer cells promote angiogenesis, including the secretion of signals for new blood vessel growth.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While angiogenesis is mentioned, the response does not state that cancer cells secrete pro-angiogenic signals (e.g., VEGF) to drive blood vessel growth."
      },
      {
        "criterion_number": 11,
        "description": "The response must explain how cancer cells interact with tissues in their environment, including interactions with the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Interactions with stroma and supporting cells are discussed, but the extracellular matrix is not mentioned or described."
      },
      {
        "criterion_number": 12,
        "description": "The response must define and describe the extracellular matrix, including its composition or function.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no definition or description of the extracellular matrix, its composition, or its function."
      },
      {
        "criterion_number": 13,
        "description": "The response must define and describe desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplasia/desmoplastic stroma is not mentioned or described."
      },
      {
        "criterion_number": 14,
        "description": "The response must explain the influence of the tumor microenvironment on tumor cell pattern formation, including at least one component.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes how stroma (including immune cells, fibroblasts, blood vessels) and gradients create organized zones and influence tumor behavior, meeting the requirement."
      },
      {
        "criterion_number": 15,
        "description": "The response must describe evolutionary pressures on cancer cells and the acquisition of DNA mutations, including at least one selective advantage.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of evolutionary selection pressures or selective advantages in cancer cell populations is provided."
      }
    ],
    "question_number": 280,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:44:09.534317",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response emphasizes the importance of quality of life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Clearly prioritizes meaningful, present-moment connection and quality time (e.g., being fully present, gentle expectations), aligning with quality of life."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly suggests involving a counselor/therapist specializing in grief and end-of-life issues."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not recommend engaging the oncology/medical care team for guidance."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of support groups."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of organizations that support cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No organizations or contact details/websites provided."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages family emotional support and involving a counselor, highlighting the value of supportive networks."
      },
      {
        "criterion_number": 7,
        "description": "The response should encourage patients to open lines of communication with their affected family member, such as daily phone calls to check in.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Promotes open emotional communication, listening, and sharing stories, which directly supports open lines of communication."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage loved ones of a pancreatic cancer patient to consider legacy-building activities, such as photobook creation or writing letters to loved ones.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides multiple legacy-building ideas (memory book, video montage, recorded letters, legacy projects)."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend keeping family members and loved ones involved in the patient\u2019s life, being mindful of the patient\u2019s energy level.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests gentleness with expectations, it does not explicitly recommend keeping family involved while being mindful of the patient\u2019s energy."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest that the patient and/or family members prioritize symptom management related to cancer or treatment, in order to ensure the patient is feeling their physical best if possible.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No advice about symptom management, comfort measures, or optimizing physical well-being."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend ways to document events and/or moments for future reference.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends recording stories, creating a memory book, video montage, and a journal/photo diary."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend the use of technology, such as video calls (e.g., Zoom) to keep in contact with loved ones without having to travel.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of video calls or technology to maintain connections."
      },
      {
        "criterion_number": 13,
        "description": "The response should emphasize the importance of preventing caregiver burnout.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages caregivers to care for their own emotional needs and consider counseling, supporting burnout prevention."
      }
    ],
    "question_number": 281,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:44:35.969175",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response reviews intercellular communication in pancreatic cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses intercellular communication in cancer cells generally but does not address pancreatic cancer cells specifically."
      },
      {
        "criterion_number": 2,
        "description": "The response states that tumors are not typically functioning tissues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement is made about tumors not being functioning tissues."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the biology of intercellular communication.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It reviews mechanisms including chemical signaling (cytokines, growth factors), cell adhesion molecules (cadherins), mechanical coupling/forces, chemotaxis/gradients, leader\u2013follower dynamics, and ECM remodeling."
      },
      {
        "criterion_number": 4,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It cites a Nature Reviews Cancer article with a direct link, which is a peer-reviewed journal source, fulfilling the requirement to provide published scientific literature."
      },
      {
        "criterion_number": 5,
        "description": "The response defines cancer cell waves and explicitly states that there are several different types of waves known to exist in cancer cell biology.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it defines waves as coordinated movement, it does not explicitly state that multiple distinct types of waves (e.g., calcium, bioelectric, metabolic) exist in cancer cell biology."
      },
      {
        "criterion_number": 6,
        "description": "The response describes calcium waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Calcium waves are not mentioned and no PMID is provided."
      },
      {
        "criterion_number": 7,
        "description": "The response describes bioelectric waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Bioelectric waves are not discussed and no PMID is provided."
      },
      {
        "criterion_number": 8,
        "description": "The response describes metabolic (glycolytic) waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Metabolic/glycolytic waves are not discussed and no PMID is provided."
      },
      {
        "criterion_number": 9,
        "description": "The response explains at least three different mechanisms of cell-to-cell communication, such as cell-cell adhesion, signaling pathways, chemokine gradients, mechanical forces, or heterotypic interactions.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It covers multiple mechanisms: chemical signaling, cell adhesion, mechanical forces/coupling, and chemotaxis/gradients (at least three distinct mechanisms)."
      },
      {
        "criterion_number": 10,
        "description": "The response defines and describes paracrine signaling explicitly.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Paracrine signaling is not explicitly defined or described, even though chemical signals are mentioned generally."
      }
    ],
    "question_number": 282,
    "source": "allenai_olmo-3.1-32b-instruct",
    "graded_at": "2026-01-22T17:44:58.259162",
    "grader_model": "gpt-5"
  }
]